ID,Description,GeneRatio,BgRatio,pvalue,p.adjust,qvalue,geneID,Count
GO:0098657,import into cell,15/565,118/10364,0.0018311832745736265,0.010035962953285711,0.006608413113764614,FABP3/ATP1A2/RGS2/AGT/FOLR2/SLC2A3/THBS1/SLC7A5/P2RX1/ITGB3/SLC1A3/RAMP3/CD36/STEAP4/LCN2,15
GO:0008361,regulation of cell size,16/565,130/10364,0.0018421240891681855,0.010082427835634428,0.006639008995721536,CXCL12/KCNMA1/NTN1/SEMA6B/APOE/FN1/SEMA3G/SPP1/IL7R/MAP1B/EDN1/VEGFA/AQP1/SEMA3C/PLXNA4/KCNN4,16
GO:0010656,negative regulation of muscle cell apoptotic process,6/565,25/10364,0.0018583486624727482,0.01013205589041224,0.006671687742099027,MDK/IGF1/HSPB6/HMOX1/SFRP2/EDN1,6
GO:0048841,regulation of axon extension involved in axon guidance,6/565,25/10364,0.0018583486624727482,0.01013205589041224,0.006671687742099027,CXCL12/SEMA6B/SEMA3G/VEGFA/SEMA3C/PLXNA4,6
GO:0003158,endothelium development,13/565,95/10364,0.0018586160170248147,0.01013205589041224,0.006671687742099027,GSTM3/ITGAX/ICAM1/ATOH8/ID1/SOX18/CLDN5/SCUBE1/VEGFA/PTN/S1PR3/COL15A1/LCN2,13
GO:0006979,response to oxidative stress,32/565,342/10364,0.0019370877045038323,0.010545793965742938,0.006944123196016678,JUN/PTGS2/AKR1C3/ALOX5/H19/HBB/CRYAB/FOS/HBA2/HBA1/MMP2/NQO1/COL1A1/KLF2/APOE/CYP1B1/NR4A2/HMOX1/APOD/CD38/PDGFRB/GPX3/DUSP1/EDN1/HSPA1A/HSPA1B/AQP1/HSPB1/CD36/NR4A3/KLF4/LCN2,32
GO:0071695,anatomical structure maturation,15/565,119/10364,0.001993005425873067,0.010821297903868904,0.007125535168747144,C1QA/ZBTB16/CLEC7A/IGF1/MMP2/CX3CL1/C3/KLF2/NR4A2/SOX18/LTF/FGFR3/CDKN1A/VEGFA/CCL21,15
GO:0046942,carboxylic acid transport,16/565,131/10364,0.001995659828755705,0.010821297903868904,0.007125535168747144,PLA2G2A/ATP1A2/RGS2/AGT/FOLR2/CES1/SLC7A5/ABCC3/ACE/SLC16A3/SLC11A1/ABCG2/SLC1A3/EDN1/CD36/NTRK2,16
GO:0048144,fibroblast proliferation,10/565,63/10364,0.0020009092606811823,0.010821297903868904,0.007125535168747144,AGT/IGF1/NGFR/IFI30/FOSL2/FN1/PDGFRB/CDKN1A/AQP1/SFRP1,10
GO:0048145,regulation of fibroblast proliferation,10/565,63/10364,0.0020009092606811823,0.010821297903868904,0.007125535168747144,AGT/IGF1/NGFR/IFI30/FOSL2/FN1/PDGFRB/CDKN1A/AQP1/SFRP1,10
GO:0062014,negative regulation of small molecule metabolic process,10/565,63/10364,0.0020009092606811823,0.010821297903868904,0.007125535168747144,MFSD2A/AKR1C3/DDIT4/H19/DGAT2/SOX9/PLIN5/APOE/APOC1/SIK1,10
GO:0010720,positive regulation of cell development,21/565,194/10364,0.0020377632541356177,0.010998620834063465,0.007242297574380103,CXCL12/EGR2/MDK/CLEC7A/CX3CL1/NTN1/TYROBP/FN1/SERPINE2/TGM2/CLDN5/LIF/MME/SLIT2/MAP1B/VEGFA/GPER1/RELN/PLXNA4/PTN/NTRK2,21
GO:0031103,axon regeneration,7/565,34/10364,0.002044443198515461,0.010998620834063465,0.007242297574380103,CHL1/APOD/SPP1/MAP1B/PTN/KLF4/TNC,7
GO:0046460,neutral lipid biosynthetic process,7/565,34/10364,0.002044443198515461,0.010998620834063465,0.007242297574380103,MFSD2A/DGAT2/PLIN5/C3/LDLR/SIK1/LPL,7
GO:0046463,acylglycerol biosynthetic process,7/565,34/10364,0.002044443198515461,0.010998620834063465,0.007242297574380103,MFSD2A/DGAT2/PLIN5/C3/LDLR/SIK1/LPL,7
GO:0051153,regulation of striated muscle cell differentiation,9/565,53/10364,0.0020541930014400214,0.011036569747894288,0.00726728591889473,RGS2/IGF1/TMEM119/CYP26B1/SIK1/HOPX/EDN1/PI16/CCN3,9
GO:0071466,cellular response to xenobiotic stimulus,12/565,85/10364,0.0021004123580094032,0.01125925952694942,0.007413921180808234,GSTM1/GSTM3/FMO2/NQO1/CYP4F12/CYP1B1/CYP26B1/AOX1/UCHL1/EDN1/ABCA1/RORC,12
GO:0032990,cell part morphogenesis,37/565,415/10364,0.0021011417387858714,0.01125925952694942,0.007413921180808234,MFSD2A/NES/CXCL12/EGR2/MDK/THY1/DCLK1/POSTN/FLRT2/NTN1/NGFR/SEMA6B/NOTCH3/APOE/NR4A2/FN1/ID1/S100B/CHL1/SEMA3G/SLIT2/UCHL1/SPP1/MAP1B/SLIT3/TUBB2B/CPNE5/VEGFA/LAMA2/SGK1/ADCY1/SEMA3C/RELN/PLXNA4/PTN/ENPP2/NTRK2,37
GO:0010867,positive regulation of triglyceride biosynthetic process,4/565,11/10364,0.002120081880212118,0.011301582314568244,0.007441789604198511,MFSD2A/DGAT2/PLIN5/LDLR,4
GO:0045591,positive regulation of regulatory T cell differentiation,4/565,11/10364,0.002120081880212118,0.011301582314568244,0.007441789604198511,LILRB2/BCL6/HLA-G/HLA-DRB1,4
GO:0060192,negative regulation of lipase activity,4/565,11/10364,0.002120081880212118,0.011301582314568244,0.007441789604198511,RGS2/PLIN5/ANGPTL4/APOC1,4
GO:0071294,cellular response to zinc ion,4/565,11/10364,0.002120081880212118,0.011301582314568244,0.007441789604198511,MT2A/MT1E/MT1M/MT1X,4
GO:1902532,negative regulation of intracellular signal transduction,36/565,401/10364,0.0021357696757280083,0.011370404489506457,0.007487107165203517,GBP1/MUC1/PTGS2/RGS2/ATF3/AGT/CXCL12/DDIT4/DUSP5/CREB3L1/APLNR/LMO3/THBS1/APOE/EMILIN1/DUSP2/SERPINE2/ACKR3/LIF/TIMP3/FBLN1/BCL6/SLIT2/UCHL1/SFRP2/DUSP1/HLA-G/HSPA1A/GPER1/HSPB1/CLU/DUSP4/SFRP1/CCN3/KLF4/CD22,36
GO:1990138,neuron projection extension,15/565,120/10364,0.0021665581694319974,0.011519336552798179,0.007585174944518585,CXCL12/DCLK1/POSTN/NTN1/SEMA6B/APOE/FN1/SEMA3G/SLIT2/MAP1B/SLIT3/CPNE5/VEGFA/SEMA3C/PLXNA4,15
GO:0090092,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,18/565,157/10364,0.002211621591140328,0.011743681963850198,0.007732900395809107,CCN1/CDKN1C/THBS1/FBN1/LRG1/GDF15/EMILIN1/LTBP1/INHBB/HTRA3/SFRP2/HSPA1A/PEG10/SFRP1/SULF1/CCN3/CHRDL1/GPC3,18
GO:0014829,vascular associated smooth muscle contraction,5/565,18/10364,0.002238975375742285,0.01181232627356819,0.007778100837325004,AGT/ACTA2/P2RX1/CD38/EDN1,5
GO:0033688,regulation of osteoblast proliferation,5/565,18/10364,0.002238975375742285,0.01181232627356819,0.007778100837325004,CCN1/TMEM119/LTF/NPR3/SFRP1,5
GO:0055090,acylglycerol homeostasis,5/565,18/10364,0.002238975375742285,0.01181232627356819,0.007778100837325004,DGAT2/ANGPTL4/APOE/MLXIPL/LPL,5
GO:0070328,triglyceride homeostasis,5/565,18/10364,0.002238975375742285,0.01181232627356819,0.007778100837325004,DGAT2/ANGPTL4/APOE/MLXIPL/LPL,5
GO:0150077,regulation of neuroinflammatory response,5/565,18/10364,0.002238975375742285,0.01181232627356819,0.007778100837325004,PTGS2/IGF1/CX3CL1/LDLR/IL33,5
GO:0043534,blood vessel endothelial cell migration,13/565,97/10364,0.0022477728669137074,0.01184347762824288,0.007798613170989642,PTGS2/NR4A1/THBS1/APOE/ID1/SOX18/HMOX1/SLIT2/VEGFA/HSPB1/EGR3/ANGPT1/KLF4,13
GO:0045637,regulation of myeloid cell differentiation,17/565,145/10364,0.0022851233447340005,0.012024800736942157,0.007918009587151638,ISG15/C1QC/CSF3R/JUN/ZBTB16/FOS/FBN1/TYROBP/ZFP36/LIF/CCR1/LTF/HSPA1A/HSPA1B/HLA-DRB1/SFRP1/CA2,17
GO:0060135,maternal process involved in female pregnancy,8/565,44/10364,0.002304883009411257,0.012027791516229328,0.007919978935300262,PTGS2/RGS2/TPPP3/JUNB/LIF/SPP1/STC2/PTN,8
GO:0060337,type I interferon signaling pathway,8/565,44/10364,0.002304883009411257,0.012027791516229328,0.007919978935300262,ISG15/IFITM2/IFITM1/IFITM3/OAS1/OAS3/OAS2/IFI27,8
GO:0014002,astrocyte development,6/565,26/10364,0.002306257044513928,0.012027791516229328,0.007919978935300262,C1QA/S100A9/S100A8/LDLR/C5AR1/LAMC3,6
GO:0030501,positive regulation of bone mineralization,6/565,26/10364,0.002306257044513928,0.012027791516229328,0.007919978935300262,ISG15/CCN1/ALOX5/TMEM119/LTF/PTN,6
GO:0042554,superoxide anion generation,6/565,26/10364,0.002306257044513928,0.012027791516229328,0.007919978935300262,AGT/CLEC7A/ACP5/TYROBP/EDN1/CYBB,6
GO:0050795,regulation of behavior,6/565,26/10364,0.002306257044513928,0.012027791516229328,0.007919978935300262,MDK/APOE/ARRDC3/RELN/NR4A3/PTGDS,6
GO:0090322,regulation of superoxide metabolic process,6/565,26/10364,0.002306257044513928,0.012027791516229328,0.007919978935300262,AGT/H19/CLEC7A/ACP5/TYROBP/CD36,6
GO:0051592,response to calcium ion,12/565,86/10364,0.0023233918529117882,0.012086361176392453,0.007958545489610233,AKR1C3/KCNMA1/SYT7/FOS/THBS1/JUNB/FOSB/DUSP1/EDN1/CPNE5/ADCY1/AQP3,12
GO:0062013,positive regulation of small molecule metabolic process,12/565,86/10364,0.0023233918529117882,0.012086361176392453,0.007958545489610233,MTCO2P12/PTGS2/IGF2/ADM/DGAT2/NNMT/IGF1/CES1/PLIN5/GPER1/MLXIPL/NR4A3,12
GO:0060349,bone morphogenesis,9/565,54/10364,0.0023486623581862862,0.012202314333013524,0.008034897541163611,ALPL/TMEM119/COL1A1/SOX9/ACP5/CYP26B1/LTF/FGFR3/SFRP2,9
GO:0019915,lipid storage,10/565,65/10364,0.0025422148621892884,0.01315780991884064,0.008664065822166169,DGAT2/CES1/ITGB3/PLIN5/C3/APOE/CD36/MSR1/LPL/ABCA1,10
GO:0030301,cholesterol transport,10/565,65/10364,0.0025422148621892884,0.01315780991884064,0.008664065822166169,SYT7/CES1/ABCA8/LDLR/APOE/APOC1/CD36/MSR1/CLU/ABCA1,10
GO:0097306,cellular response to alcohol,10/565,65/10364,0.0025422148621892884,0.01315780991884064,0.008664065822166169,AKR1C2/AKR1C3/CES1/KLF2/ADCY1/SFRP1/ABCA1/KLF4/TNC/CYBB,10
GO:0098742,cell-cell adhesion via plasma-membrane adhesion molecules,15/565,122/10364,0.002551447533013591,0.013188921969896012,0.00868455227544897,VCAM1/SELP/SELL/HMCN1/PCDH9/CX3CL1/ICAM1/IL1RN/CLDN5/CLSTN2/SPARCL1/MDGA1/KLF4/TENM1/LRRC4,15
GO:0035051,cardiocyte differentiation,12/565,87/10364,0.0025653181687470532,0.013243899852270412,0.008720753740175486,VCAM1/RGS2/AGT/IGF1/SOX18/SIK1/PDGFRB/EDN1/PI16/VEGFA/GPER1/SEMA3C,12
GO:0021782,glial cell development,11/565,76/10364,0.002601257670264942,0.013412530103356012,0.008831792249169452,C1QA/PHGDH/S100A9/S100A8/MDK/ITGB4/LDLR/C5AR1/CLU/NTRK2/LAMC3,11
GO:0002042,cell migration involved in sprouting angiogenesis,8/565,45/10364,0.002672320532957451,0.013709875014947122,0.00902758591861764,PTGS2/NR4A1/THBS1/HMOX1/SLIT2/VEGFA/EGR3/KLF4,8
GO:0015718,monocarboxylic acid transport,8/565,45/10364,0.002672320532957451,0.013709875014947122,0.00902758591861764,PLA2G2A/CES1/ABCC3/ACE/SLC16A3/ABCG2/EDN1/CD36,8
GO:0032370,positive regulation of lipid transport,8/565,45/10364,0.002672320532957451,0.013709875014947122,0.00902758591861764,FABP3/CES1/ABCA8/C1QTNF1/APOE/SPP1/EDN1/ABCA1,8
GO:0045453,bone resorption,8/565,45/10364,0.002672320532957451,0.013709875014947122,0.00902758591861764,TMEM119/ITGB3/ACP5/CD38/SPP1/CSF1R/PDK4/CA2,8
GO:0051250,negative regulation of lymphocyte activation,13/565,99/10364,0.0027015173942344147,0.013842318162697988,0.009114796188175135,MNDA/FCGR2B/MDK/LRRC32/TYROBP/LILRB2/BCL6/HLA-G/HLA-DRB1/GPNMB/FGL2/SFRP1/VSIG4,13
GO:0060348,bone development,16/565,135/10364,0.0027209308585148025,0.013924363668449501,0.009168820958758435,ALPL/ZBTB16/IGF1/TMEM119/FBN1/COL1A1/SOX9/ACP5/TYROBP/CYP26B1/TGM2/LTF/FGFR3/SFRP2/SULF1/BGN,16
GO:0070665,positive regulation of leukocyte proliferation,12/565,88/10364,0.0028273580330337358,0.014414669905211223,0.00949167449855911,VCAM1/IGF2/IGF1/CCL5/LILRB2/IGFBP2/BCL6/CD38/CSF1R/CDKN1A/CD24/CD3E,12
GO:0002474,antigen processing and presentation of peptide antigen via MHC class I,6/565,27/10364,0.002830824280359019,0.014414669905211223,0.00949167449855911,FCER1G/ACE/IFI30/ERAP2/HLA-G/AZGP1,6
GO:0010524,positive regulation of calcium ion transport into cytosol,6/565,27/10364,0.002830824280359019,0.014414669905211223,0.00949167449855911,APLNR/THY1/CX3CL1/P2RX1/GPER1/RAMP3,6
GO:0061082,myeloid leukocyte cytokine production,6/565,27/10364,0.002830824280359019,0.014414669905211223,0.00949167449855911,HMOX1/BCL6/SPON2/HLA-G/CD36/NR4A3,6
GO:0048812,neuron projection morphogenesis,34/565,379/10364,0.002841260350813146,0.014449838355563998,0.009514831982258866,MFSD2A/CXCL12/EGR2/THY1/DCLK1/POSTN/FLRT2/NTN1/NGFR/SEMA6B/NOTCH3/APOE/NR4A2/FN1/ID1/S100B/CHL1/SEMA3G/SLIT2/UCHL1/SPP1/MAP1B/SLIT3/TUBB2B/CPNE5/VEGFA/LAMA2/SGK1/ADCY1/SEMA3C/RELN/PLXNA4/PTN/NTRK2,34
GO:0001516,prostaglandin biosynthetic process,5/565,19/10364,0.0029041188749286614,0.014678348980194987,0.009665300115259652,PTGS2/AKR1C3/PTGIS/EDN1/PTGDS,5
GO:0008207,C21-steroid hormone metabolic process,5/565,19/10364,0.0029041188749286614,0.014678348980194987,0.009665300115259652,AKR1C2/AKR1C3/ADM/CACNA1H/EGR1,5
GO:0010884,positive regulation of lipid storage,5/565,19/10364,0.0029041188749286614,0.014678348980194987,0.009665300115259652,PLIN5/C3/CD36/MSR1/LPL,5
GO:0040036,regulation of fibroblast growth factor receptor signaling pathway,5/565,19/10364,0.0029041188749286614,0.014678348980194987,0.009665300115259652,CREB3L1/THBS1/NGFR/SMOC2/SULF1,5
GO:0046457,prostanoid biosynthetic process,5/565,19/10364,0.0029041188749286614,0.014678348980194987,0.009665300115259652,PTGS2/AKR1C3/PTGIS/EDN1/PTGDS,5
GO:0120039,plasma membrane bounded cell projection morphogenesis,35/565,394/10364,0.0029138340824962556,0.014709293136547067,0.009685676014372006,MFSD2A/CXCL12/EGR2/THY1/DCLK1/POSTN/FLRT2/NTN1/NGFR/SEMA6B/NOTCH3/APOE/NR4A2/FN1/ID1/S100B/CHL1/SEMA3G/SLIT2/UCHL1/SPP1/MAP1B/SLIT3/TUBB2B/CPNE5/VEGFA/LAMA2/SGK1/ADCY1/SEMA3C/RELN/PLXNA4/PTN/ENPP2/NTRK2,35
GO:0001101,response to acid chemical,13/565,100/10364,0.002954998655250596,0.014880399132344329,0.009798344735025282,COL4A1/MMP2/NQO1/COL1A1/ICAM1/KLF2/EDN1/VEGFA/CCN2/COL1A2/PTN/NTRK2/CYBB,13
GO:0001952,regulation of cell-matrix adhesion,13/565,100/10364,0.002954998655250596,0.014880399132344329,0.009798344735025282,THY1/POSTN/THBS1/CX3CL1/FAM107A/BCL6/APOD/VEGFA/CD36/SERPINE1/SFRP1/CCL21/CD3E,13
GO:0090596,sensory organ morphogenesis,15/565,124/10364,0.002991246180655464,0.015044424893861756,0.009906351310821989,MFSD2A/PRRX1/THY1/FBN1/ALDH1A3/NTN1/SOX9/CYP26B1/FRZB/COL8A1/EDN1/VEGFA/PTN/NTRK2/COL5A1,15
GO:0001570,vasculogenesis,9/565,56/10364,0.003037766869442743,0.015088105137176571,0.009935113582472219,ADM/APLNR/JUNB/ACKR3/SOX18/PDGFRB/VEGFA/ITGB8/NTRK2,9
GO:0006883,cellular sodium ion homeostasis,4/565,12/10364,0.0030441560437977156,0.015088105137176571,0.009935113582472219,ATP1A2/AGT/SLC1A3/C7,4
GO:0019835,cytolysis,4/565,12/10364,0.0030441560437977156,0.015088105137176571,0.009935113582472219,PLA2G2A/PRF1/LYZ/C7,4
GO:0034104,negative regulation of tissue remodeling,4/565,12/10364,0.0030441560437977156,0.015088105137176571,0.009935113582472219,AGT/TMEM119/CD38/SFRP1,4
GO:0043031,negative regulation of macrophage activation,4/565,12/10364,0.0030441560437977156,0.015088105137176571,0.009935113582472219,FCGR2B/CX3CL1/LDLR/VSIG4,4
GO:0051770,positive regulation of nitric-oxide synthase biosynthetic process,4/565,12/10364,0.0030441560437977156,0.015088105137176571,0.009935113582472219,CCL2/AKAP12/NAMPT/IL33,4
GO:0060343,trabecula formation,4/565,12/10364,0.0030441560437977156,0.015088105137176571,0.009935113582472219,MMP2/COL1A1/ADAMTS1/SFRP1,4
GO:0070293,renal absorption,4/565,12/10364,0.0030441560437977156,0.015088105137176571,0.009935113582472219,AKR1C3/HBB/SGK1/AQP3,4
GO:0090183,regulation of kidney development,4/565,12/10364,0.0030441560437977156,0.015088105137176571,0.009935113582472219,AGT/SOX9/BASP1/VEGFA,4
GO:0098581,detection of external biotic stimulus,4/565,12/10364,0.0030441560437977156,0.015088105137176571,0.009935113582472219,CLEC7A/SSC5D/C4B/HLA-DRB1,4
GO:1901623,regulation of lymphocyte chemotaxis,4/565,12/10364,0.0030441560437977156,0.015088105137176571,0.009935113582472219,CCL2/CCL5/CCL21/PADI2,4
GO:1905906,regulation of amyloid fibril formation,4/565,12/10364,0.0030441560437977156,0.015088105137176571,0.009935113582472219,CRYAB/LDLR/APOE/CLU,4
GO:0045927,positive regulation of growth,18/565,162/10364,0.003121798243023179,0.015454222499319098,0.010176192070746977,MFSD2A/S100A9/S100A8/CXCL12/IGF2/IGF1/NTN1/FN1/CD38/HOPX/SFRP2/BASP1/MAP1B/HBEGF/EDN1/CPNE5/VEGFA/SFRP1,18
GO:0007420,brain development,40/565,469/10364,0.0031483021166547817,0.015566604910126422,0.010250192881709759,MFSD2A/PHGDH/NES/ATP1A2/FCGR2B/RGS2/PFKFB3/ITGA8/CXCL12/EGR2/DDIT4/MDK/CNTN1/DCLK1/PCDH9/COL4A1/CKB/ALDH1A3/SEMA6B/TYROBP/C5AR1/NR4A2/COL3A1/SERPINE2/ID1/APOD/SLIT2/ANXA3/SFRP2/BASP1/MDGA1/AQP1/ADCY1/RELN/PLXNA4/PTN/SFRP1/NTRK2/PADI2/CD3E,40
GO:0061387,regulation of extent of cell growth,11/565,78/10364,0.0032029832839447015,0.015798811523457357,0.010403094724391099,CXCL12/NTN1/SEMA6B/APOE/FN1/SEMA3G/SPP1/MAP1B/VEGFA/SEMA3C/PLXNA4,11
GO:1904064,positive regulation of cation transmembrane transport,11/565,78/10364,0.0032029832839447015,0.015798811523457357,0.010403094724391099,AGT/APLNR/THY1/CX3CL1/P2RX1/CCL2/GPER1/RAMP3/RELN/KCNN4/LCN2,11
GO:0009314,response to radiation,29/565,311/10364,0.003254785790363167,0.016035009657938394,0.010558624876965066,JUN/VCAM1/ATP1A2/PTGS2/CXCL12/ADIRF/CRYAB/FOS/CRIP1/MMP2/MFAP4/ICAM1/BCL3/COL3A1/THBD/SIK1/BHLHE40/MME/SFRP2/SLC1A3/EGR1/DUSP1/CDKN1A/AQP1/NAMPT/PTN/SFRP1/TIMP1/LCN2,29
GO:0044403,biological process involved in symbiotic interaction,21/565,202/10364,0.0033224310874640692,0.016348597202016705,0.010765113885368776,JUN/MRC1/IFIT1/IFITM2/IFITM1/IFITM3/IFI27/ANPEP/CCL5/ITGB3/ICAM1/LDLR/APOE/INHBB/FN1/SIGLEC1/LTF/CXCL8/HSPA1A/HSPA1B/HLA-DRB1,21
GO:0015909,long-chain fatty acid transport,7/565,37/10364,0.0033962599059781675,0.01665184198212529,0.010964792460397211,PLA2G2A/FABP3/MFSD2A/THBS1/ACE/APOE/CD36,7
GO:0021675,nerve development,7/565,37/10364,0.0033962599059781675,0.01665184198212529,0.010964792460397211,VCAM1/EGR2/NGFR/SERPINE2/SLC1A3/PLXNA4/SULF1,7
GO:0085029,extracellular matrix assembly,7/565,37/10364,0.0033962599059781675,0.01665184198212529,0.010964792460397211,LAMB3/AGT/MFAP4/SOX9/EMILIN1/TNXB/COL1A2,7
GO:0001953,negative regulation of cell-matrix adhesion,6/565,28/10364,0.0034397968927158636,0.01676491485568898,0.011039247922613193,POSTN/THBS1/FAM107A/BCL6/APOD/SERPINE1,6
GO:0035633,maintenance of blood-brain barrier,6/565,28/10364,0.0034397968927158636,0.01676491485568898,0.011039247922613193,MFSD2A/PTGS2/CLDN5/VEGFA/LAMA2/ANGPT1,6
GO:0046530,photoreceptor cell differentiation,6/565,28/10364,0.0034397968927158636,0.01676491485568898,0.011039247922613193,MFSD2A/THY1/SOX9/VEGFA/PTN/NTRK2,6
GO:0070169,positive regulation of biomineral tissue development,6/565,28/10364,0.0034397968927158636,0.01676491485568898,0.011039247922613193,ISG15/CCN1/ALOX5/TMEM119/LTF/PTN,6
GO:0110151,positive regulation of biomineralization,6/565,28/10364,0.0034397968927158636,0.01676491485568898,0.011039247922613193,ISG15/CCN1/ALOX5/TMEM119/LTF/PTN,6
GO:2001235,positive regulation of apoptotic signaling pathway,13/565,102/10364,0.0035202229763327607,0.01713649567789099,0.011283923953173793,S100A9/S100A8/G0S2/ATF3/AGT/THBS1/TNFRSF12A/NGFR/INHBB/TIMP3/TNFSF10/GPER1/SFRP1,13
GO:0048705,skeletal system morphogenesis,14/565,114/10364,0.0035381998981978877,0.017167021332256453,0.011304024279924094,ALPL/PRRX1/MGP/TMEM119/MMP2/COL1A1/SOX9/ACP5/CYP26B1/LTF/FGFR3/SFRP2/CCN2/SFRP1,14
GO:0015908,fatty acid transport,8/565,47/10364,0.003543266493834075,0.017167021332256453,0.011304024279924094,PLA2G2A/FABP3/MFSD2A/THBS1/ACE/APOE/EDN1/CD36,8
GO:0042632,cholesterol homeostasis,8/565,47/10364,0.003543266493834075,0.017167021332256453,0.011304024279924094,FABP3/DGAT2/CES1/LDLR/APOE/LPL/ABCA1/CD24,8
GO:0060993,kidney morphogenesis,8/565,47/10364,0.003543266493834075,0.017167021332256453,0.011304024279924094,AGT/SOX9/LIF/FRAS1/BASP1/PDGFRB/VEGFA/GPC3,8
GO:0009914,hormone transport,18/565,164/10364,0.0035641722351717896,0.017245618053149673,0.011355778117943157,AGT/ALOX5/ADRA2A/ADM/SYT7/SLC7A5/CCL5/C1QTNF1/IL1RN/INHBB/LIF/CD38/SPP1/EDN1/HLA-DRB1/GPER1/SFRP1/CCN3,18
GO:0098869,cellular oxidant detoxification,10/565,68/10364,0.003567913651933995,0.017245618053149673,0.011355778117943157,S100A9/PTGS2/H19/HBB/HBA2/HBA1/NQO1/APOE/GPX3/CD36,10
GO:0002701,negative regulation of production of molecular mediator of immune response,5/565,20/10364,0.0037010265833303767,0.01774239207512244,0.011682890521273383,FCGR2B/HMOX1/BCL6/ANGPT1/CD22,5
GO:0003298,physiological muscle hypertrophy,5/565,20/10364,0.0037010265833303767,0.01774239207512244,0.011682890521273383,RGS2/AGT/IGF1/EDN1/PI16,5
GO:0003301,physiological cardiac muscle hypertrophy,5/565,20/10364,0.0037010265833303767,0.01774239207512244,0.011682890521273383,RGS2/AGT/IGF1/EDN1/PI16,5
GO:0045933,positive regulation of muscle contraction,5/565,20/10364,0.0037010265833303767,0.01774239207512244,0.011682890521273383,PTGS2/RGS2/EDN1/CCN2/GPER1,5
GO:0051937,catecholamine transport,5/565,20/10364,0.0037010265833303767,0.01774239207512244,0.011682890521273383,AGT/CXCL12/SNCG/ADRA2A/SYT7,5
GO:0061049,cell growth involved in cardiac muscle cell development,5/565,20/10364,0.0037010265833303767,0.01774239207512244,0.011682890521273383,RGS2/AGT/IGF1/EDN1/PI16,5
GO:1901020,negative regulation of calcium ion transmembrane transporter activity,5/565,20/10364,0.0037010265833303767,0.01774239207512244,0.011682890521273383,ATP1A2/ADRA2A/RRAD/PLN/GEM,5
GO:0021700,developmental maturation,17/565,152/10364,0.003753537628975375,0.017973079594181506,0.011834792081016848,C1QA/ZBTB16/CLEC7A/IGF1/MMP2/CX3CL1/C3/KLF2/NR4A2/SOX18/LTF/FGFR3/MAP1B/CDKN1A/VEGFA/RELN/CCL21,17
GO:0042098,T cell proliferation,15/565,127/10364,0.003766519625446324,0.018014172133851928,0.01186185041904579,VCAM1/IGF2/LRRC32/IGF1/CCL5/TNFSF14/LILRB2/IGFBP2/SLC11A1/HLA-G/HLA-DRB1/GPNMB/VSIG4/CD24/CD3E,15
GO:0042129,regulation of T cell proliferation,13/565,103/10364,0.0038340722236597353,0.018294512451821628,0.012046447018516234,VCAM1/IGF2/LRRC32/IGF1/CCL5/LILRB2/IGFBP2/HLA-G/HLA-DRB1/GPNMB/VSIG4/CD24/CD3E,13
GO:0050770,regulation of axonogenesis,13/565,103/10364,0.0038340722236597353,0.018294512451821628,0.012046447018516234,CXCL12/THY1/NTN1/SEMA6B/FN1/SEMA3G/SLIT2/SPP1/MAP1B/VEGFA/SEMA3C/PLXNA4/NTRK2,13
GO:0007613,memory,9/565,58/10364,0.003877184979966064,0.018478690696136283,0.012167723465097839,PTGS2/MDK/LDLR/APOE/S100B/SGK1/ADCY1/RELN/PTN,9
GO:0050671,positive regulation of lymphocyte proliferation,11/565,80/10364,0.00391167720822091,0.01862140289587954,0.012261695630665547,VCAM1/IGF2/IGF1/CCL5/LILRB2/IGFBP2/BCL6/CD38/CDKN1A/CD24/CD3E,11
GO:0051090,regulation of DNA-binding transcription factor activity,28/565,301/10364,0.003930287435003437,0.018688265689784052,0.012305722991678954,ID3/S100A9/S100A8/AGT/CLEC7A/CMKLR1/CX3CL1/ICAM1/BCL3/CYP1B1/ID1/PTGIS/SIK1/HMOX1/BHLHE40/LTF/ANXA3/EDN1/HSPA1A/HSPA1B/VEGFA/SGK1/ADCY1/CD36/RELN/CLU/KLF4/NLRP2,28
GO:0002763,positive regulation of myeloid leukocyte differentiation,7/565,38/10364,0.003971666116118606,0.018833279666596873,0.01240121081586779,JUN/FOS/TYROBP/LIF/CCR1/HLA-DRB1/CA2,7
GO:0032757,positive regulation of interleukin-8 production,7/565,38/10364,0.003971666116118606,0.018833279666596873,0.01240121081586779,F3/CHI3L1/CLEC7A/CD14/HSPA1A/HSPA1B/SERPINE1,7
GO:0043500,muscle adaptation,10/565,69/10364,0.003974585645319907,0.018833279666596873,0.01240121081586779,RGS2/AGT/IGF1/IGFBP5/HMOX1/KLF15/EDN1/PI16/NR4A3/KLF4,10
GO:0046394,carboxylic acid biosynthetic process,20/565,192/10364,0.004018573145622211,0.019019697639511366,0.012523962063813182,GSTM1/PHGDH/PTGS2/AKR1C3/ALOX5/SCD/FADS2/BCAT1/ALDH1A3/CES1/APOC1/THNSL2/PTGIS/GGT5/SLC1A3/EDN1/MLXIPL/PDK4/LPL/PTGDS,20
GO:0043627,response to estrogen,8/565,48/10364,0.004053818375342499,0.019136625508258443,0.012600955937225175,GSTM3/KRT19/IGFBP2/HMOX1/PDGFRB/SFRP1/CA2/CD24,8
GO:0055092,sterol homeostasis,8/565,48/10364,0.004053818375342499,0.019136625508258443,0.012600955937225175,FABP3/DGAT2/CES1/LDLR/APOE/LPL/ABCA1/CD24,8
GO:2001234,negative regulation of apoptotic signaling pathway,18/565,166/10364,0.004057301158077267,0.019136625508258443,0.012600955937225175,IFI6/MUC1/PTGS2/CXCL12/CREB3L1/IGF1/THBS1/CX3CL1/ICAM1/NR4A2/ACKR3/HMOX1/SFRP2/HSPA1A/HSPA1B/HSPB1/SERPINE1/CLU,18
GO:0010543,regulation of platelet activation,6/565,29/10364,0.004141060128297536,0.01950920617405076,0.012846290338041293,FCER1G/SELP/C1QTNF1/APOE/SERPINE2/THBD,6
GO:0001562,response to protozoan,4/565,13/10364,0.004209484500220518,0.019628279662759453,0.012924697044796483,GBP4/CLEC7A/BCL3/SLC11A1,4
GO:0010224,response to UV-B,4/565,13/10364,0.004209484500220518,0.019628279662759453,0.012924697044796483,CRIP1/MFAP4/MME/CDKN1A,4
GO:0010738,regulation of protein kinase A signaling,4/565,13/10364,0.004209484500220518,0.019628279662759453,0.012924697044796483,SPATC1L/AKAP12/RAMP3/TCIM,4
GO:0040037,negative regulation of fibroblast growth factor receptor signaling pathway,4/565,13/10364,0.004209484500220518,0.019628279662759453,0.012924697044796483,CREB3L1/THBS1/NGFR/SULF1,4
GO:0042832,defense response to protozoan,4/565,13/10364,0.004209484500220518,0.019628279662759453,0.012924697044796483,GBP4/CLEC7A/BCL3/SLC11A1,4
GO:0045672,positive regulation of osteoclast differentiation,4/565,13/10364,0.004209484500220518,0.019628279662759453,0.012924697044796483,FOS/TYROBP/CCR1/CA2,4
GO:0050995,negative regulation of lipid catabolic process,4/565,13/10364,0.004209484500220518,0.019628279662759453,0.012924697044796483,MFSD2A/ADRA2A/PLIN5/APOC1,4
GO:0060263,regulation of respiratory burst,4/565,13/10364,0.004209484500220518,0.019628279662759453,0.012924697044796483,CLEC7A/IGHA2/IGHA1/JCHAIN,4
GO:0060740,prostate gland epithelium morphogenesis,4/565,13/10364,0.004209484500220518,0.019628279662759453,0.012924697044796483,SOX9/SFRP1/SULF1/TNC,4
GO:0016053,organic acid biosynthetic process,20/565,193/10364,0.004262127809086621,0.019851139078954066,0.013071444008228052,GSTM1/PHGDH/PTGS2/AKR1C3/ALOX5/SCD/FADS2/BCAT1/ALDH1A3/CES1/APOC1/THNSL2/PTGIS/GGT5/SLC1A3/EDN1/MLXIPL/PDK4/LPL/PTGDS,20
GO:0002761,regulation of myeloid leukocyte differentiation,11/565,81/10364,0.004310141975078303,0.020006486673436023,0.013173736243197913,C1QC/JUN/FOS/FBN1/TYROBP/LIF/CCR1/LTF/HLA-DRB1/SFRP1/CA2,11
GO:0009408,response to heat,11/565,81/10364,0.004310141975078303,0.020006486673436023,0.013173736243197913,HSPA6/PTGS2/CXCL12/IGF1/THBS1/HMOX1/CD14/HSPA1A/HSPA1B/CDKN1A/TCIM,11
GO:0032946,positive regulation of mononuclear cell proliferation,11/565,81/10364,0.004310141975078303,0.020006486673436023,0.013173736243197913,VCAM1/IGF2/IGF1/CCL5/LILRB2/IGFBP2/BCL6/CD38/CDKN1A/CD24/CD3E,11
GO:0031344,regulation of cell projection organization,38/565,448/10364,0.0043340806424200014,0.020094820102001684,0.013231901442734248,MFSD2A/NEGR1/S100A9/FCGR2B/PRRX1/RGS2/AGT/CXCL12/MDK/THY1/CNTN1/CX3CL1/NTN1/SEMA6B/ICAM1/APOE/FN1/ID1/SEMA3G/CD38/SLIT2/SPP1/SFRP2/MAP1B/SPOCK1/VEGFA/SEMA3C/RELN/PLXNA4/PTN/SFRP1/ENPP2/CCL21/NTRK2/KLF4/TENM1/RAP1GAP/LCN2,38
GO:0045582,positive regulation of T cell differentiation,9/565,59/10364,0.004359822224795789,0.02019130338044566,0.013295433100383443,MDK/ZBTB16/LILRB2/NFKBIZ/BCL6/IL7R/HLA-G/HLA-DRB1/EGR3,9
GO:2001237,negative regulation of extrinsic apoptotic signaling pathway,10/565,70/10364,0.004417046354199552,0.02043320652439883,0.013454719849069346,IFI6/IGF1/THBS1/CX3CL1/ICAM1/HMOX1/SFRP2/HSPA1A/HSPA1B/SERPINE1,10
GO:0098739,import across plasma membrane,12/565,93/10364,0.004482694188434213,0.02071348759305832,0.013639277434454105,ATP1A2/RGS2/AGT/FOLR2/SLC2A3/THBS1/SLC7A5/P2RX1/SLC1A3/RAMP3/CD36/LCN2,12
GO:0048511,rhythmic process,20/565,194/10364,0.004517801895862597,0.0208521769579047,0.013730600670864665,ID3/JUN/EGR2/MDK/NGFR/ID1/ADAMTS1/SIK1/BHLHE40/SLIT2/EGR1/SLIT3/ADCY1/NAMPT/PTN/EGR3/NTRK2/PTGDS/RORC/TOP2A,20
GO:0019233,sensory perception of pain,7/565,39/10364,0.004618036863215641,0.0211685914809561,0.013938951169292307,PTGS2/CXCL12/CCL2/MME/UCHL1/EDN1/CCN3,7
GO:0032615,interleukin-12 production,7/565,39/10364,0.004618036863215641,0.0211685914809561,0.013938951169292307,MDK/CLEC7A/CMKLR1/THBS1/ACP5/HLA-G/CD36,7
GO:0032655,regulation of interleukin-12 production,7/565,39/10364,0.004618036863215641,0.0211685914809561,0.013938951169292307,MDK/CLEC7A/CMKLR1/THBS1/ACP5/HLA-G/CD36,7
GO:0045670,regulation of osteoclast differentiation,7/565,39/10364,0.004618036863215641,0.0211685914809561,0.013938951169292307,FOS/FBN1/TYROBP/CCR1/LTF/SFRP1/CA2,7
GO:0003170,heart valve development,8/565,49/10364,0.004619264518579034,0.0211685914809561,0.013938951169292307,CCN1/APLNR/SOX9/EMILIN1/ADAMTS9/SLIT2/SLIT3/ELN,8
GO:0071277,cellular response to calcium ion,8/565,49/10364,0.004619264518579034,0.0211685914809561,0.013938951169292307,AKR1C3/SYT7/FOS/JUNB/FOSB/EDN1/CPNE5/ADCY1,8
GO:0001754,eye photoreceptor cell differentiation,5/565,21/10364,0.004643232816291787,0.0211685914809561,0.013938951169292307,THY1/SOX9/VEGFA/PTN/NTRK2,5
GO:0007616,long-term memory,5/565,21/10364,0.004643232816291787,0.0211685914809561,0.013938951169292307,LDLR/APOE/SGK1/ADCY1/RELN,5
GO:0042572,retinol metabolic process,5/565,21/10364,0.004643232816291787,0.0211685914809561,0.013938951169292307,AKR1C3/DGAT2/ALDH1A3/CYP1B1/ADH1B,5
GO:0045922,negative regulation of fatty acid metabolic process,5/565,21/10364,0.004643232816291787,0.0211685914809561,0.013938951169292307,MFSD2A/DGAT2/SOX9/PLIN5/APOC1,5
GO:0050901,leukocyte tethering or rolling,5/565,21/10364,0.004643232816291787,0.0211685914809561,0.013938951169292307,VCAM1/SELP/SELL/CXCL12/CCL21,5
GO:0045667,regulation of osteoblast differentiation,11/565,82/10364,0.004740237539694341,0.021586799207462325,0.014214329768932974,ID3/CCN1/IFITM1/IGF1/TMEM119/SMOC1/SOX9/IGFBP5/LTF/SFRP2/SFRP1,11
GO:0120035,regulation of plasma membrane bounded cell projection organization,37/565,436/10364,0.0048086259029683906,0.02187390494083621,0.014403381213452688,MFSD2A/NEGR1/S100A9/FCGR2B/PRRX1/RGS2/AGT/CXCL12/MDK/THY1/CNTN1/CX3CL1/NTN1/SEMA6B/ICAM1/APOE/FN1/ID1/SEMA3G/CD38/SLIT2/SPP1/SFRP2/MAP1B/SPOCK1/VEGFA/SEMA3C/RELN/PLXNA4/PTN/SFRP1/ENPP2/CCL21/NTRK2/KLF4/TENM1/RAP1GAP,37
GO:0035821,modulation of process of other organism,10/565,71/10364,0.004897413302102527,0.022228392526394396,0.014636801804976741,JUN/S100A9/PRF1/MPEG1/CLEC7A/IFI27/CCL5/APOE/SLPI/LTF,10
GO:0048640,negative regulation of developmental growth,10/565,71/10364,0.004897413302102527,0.022228392526394396,0.014636801804976741,RGS2/NTN1/SEMA6B/GDF15/SEMA3G/FGFR3/SPP1/CDKN1A/PI16/SEMA3C,10
GO:0055001,muscle cell development,13/565,106/10364,0.004913798372955972,0.02225716336270018,0.014655746630981195,RGS2/LMOD1/AGT/ADM/IGF1/KRT19/DYSF/UCHL1/PDGFRB/EDN1/PI16/VEGFA/FLNC,13
GO:0001974,blood vessel remodeling,6/565,30/10364,0.0049425878348785144,0.02225716336270018,0.014655746630981195,AGT/ACE/TGM2/LIF/SEMA3C/BGN,6
GO:0031343,positive regulation of cell killing,6/565,30/10364,0.0049425878348785144,0.02225716336270018,0.014655746630981195,PRF1/CLEC7A/TYROBP/HLA-G/HLA-DRB1/AZGP1,6
GO:0032964,collagen biosynthetic process,6/565,30/10364,0.0049425878348785144,0.02225716336270018,0.014655746630981195,CREB3L1/COL1A1/EMILIN1/PDGFRB/CCN2/COL5A1,6
GO:0034405,response to fluid shear stress,6/565,30/10364,0.0049425878348785144,0.02225716336270018,0.014655746630981195,PTGS2/KLF2/PDGFRB/CA2/ABCA1/KLF4,6
GO:0097028,dendritic cell differentiation,6/565,30/10364,0.0049425878348785144,0.02225716336270018,0.014655746630981195,FCGR2B/LILRB2/HLA-G/ITGB8/TMEM176B/TMEM176A,6
GO:0048880,sensory system development,21/565,209/10364,0.004947244421118017,0.02225716336270018,0.014655746630981195,C1QA/MFSD2A/NES/CRYAB/THY1/COL4A1/SMOC1/FBN1/ALDH1A3/SOX9/C3/CYP1B1/COL8A1/PDGFRB/VEGFA/PTN/NTRK2/KLF4/LAMC3/COL5A1/CHRDL1,21
GO:0150063,visual system development,21/565,209/10364,0.004947244421118017,0.02225716336270018,0.014655746630981195,C1QA/MFSD2A/NES/CRYAB/THY1/COL4A1/SMOC1/FBN1/ALDH1A3/SOX9/C3/CYP1B1/COL8A1/PDGFRB/VEGFA/PTN/NTRK2/KLF4/LAMC3/COL5A1/CHRDL1,21
GO:0043405,regulation of MAP kinase activity,15/565,131/10364,0.005048576025992143,0.022688112239749543,0.01493951493739197,RGS2/AGT/ADRA2A/THBS1/APOE/UCHL1/SFRP2/PDGFRB/DUSP1/EDN1/TNXB/VEGFA/SFRP1/TENM1/CD24,15
GO:0045446,endothelial cell differentiation,11/565,83/10364,0.005203676223683558,0.023359485153246144,0.015381596039766382,GSTM3/ICAM1/ATOH8/ID1/SOX18/CLDN5/SCUBE1/VEGFA/PTN/S1PR3/COL15A1,11
GO:0001823,mesonephros development,8/565,50/10364,0.005243329218206035,0.023511708454912936,0.015481831011501305,AGT/ZBTB16/SOX9/SLIT2/BASP1/VEGFA/SFRP1/GPC3,8
GO:0044409,entry into host,13/565,107/10364,0.0053235980486747905,0.023843625944867653,0.015700389798885675,MRC1/IFITM2/IFITM1/IFITM3/ANPEP/ITGB3/ICAM1/LDLR/SIGLEC1/CXCL8/HSPA1A/HSPA1B/HLA-DRB1,13
GO:0003179,heart valve morphogenesis,7/565,40/10364,0.005340646065325754,0.023843625944867653,0.015700389798885675,CCN1/SOX9/EMILIN1/ADAMTS9/SLIT2/SLIT3/ELN,7
GO:0032729,positive regulation of interferon-gamma production,7/565,40/10364,0.005340646065325754,0.023843625944867653,0.015700389798885675,ISG15/CLEC7A/SLC7A5/BCL3/SLC11A1/CD14/CD3E,7
GO:0060193,positive regulation of lipase activity,7/565,40/10364,0.005340646065325754,0.023843625944867653,0.015700389798885675,CCN1/AGT/CCL5/PLIN5/C5AR1/FGFR3/PDGFRB,7
GO:0051046,regulation of secretion,31/565,351/10364,0.005373294919792397,0.023963256428790925,0.01577916327208844,S100A8/FCGR2B/AGT/CXCL12/ALOX5/SNCG/ADRA2A/SYT7/IGF1/OAS2/CACNA1H/CES1/P2RX1/CCL5/C1QTNF1/APOE/INHBB/LIF/HMOX1/CD38/SPP1/EDN1/HLA-DRB1/SGK1/GPER1/AQP1/ADCY1/SFRP1/CCN3/KCNN4/RAB27B,31
GO:0032940,secretion by cell,40/565,484/10364,0.005409873635357038,0.023983929872706648,0.01579277618183265,FCGR2B/AGT/CXCL12/ALOX5/SNCG/ADRA2A/ADM/CREB3L1/SYT7/NR4A1/IGF1/TNFAIP2/FGF7/CACNA1H/P2RX1/CCL5/C1QTNF1/APOE/IL1RN/INHBB/SERPINE2/LIF/HMOX1/CCR1/CD38/ANXA3/SPP1/EDN1/HLA-DRB1/CCN2/GPER1/ADCY1/SFRP1/CCN3/NTRK2/NR4A3/ABCA1/PTGDS/KCNN4/RAB27B,40
GO:0030516,regulation of axon extension,10/565,72/10364,0.005417849594612966,0.023983929872706648,0.01579277618183265,CXCL12/NTN1/SEMA6B/APOE/FN1/SEMA3G/MAP1B/VEGFA/SEMA3C/PLXNA4,10
GO:0031623,receptor internalization,10/565,72/10364,0.005417849594612966,0.023983929872706648,0.01579277618183265,FCER1G/ADM/ITGB3/ACKR3/RAMP1/CXCL8/VEGFA/RAMP3/CD36/ANGPT1,10
GO:0045639,positive regulation of myeloid cell differentiation,10/565,72/10364,0.005417849594612966,0.023983929872706648,0.01579277618183265,ISG15/JUN/FOS/TYROBP/LIF/CCR1/HSPA1A/HSPA1B/HLA-DRB1/CA2,10
GO:1901216,positive regulation of neuron death,10/565,72/10364,0.005417849594612966,0.023983929872706648,0.01579277618183265,C1QA/JUN/FCGR2B/DDIT4/FOS/NQO1/TYROBP/EGR1/CLU/LCN2,10
GO:2000027,regulation of animal organ morphogenesis,10/565,72/10364,0.005417849594612966,0.023983929872706648,0.01579277618183265,AGT/FGF7/NGFR/SOX9/SFRP2/EDN1/VEGFA/SFRP1/SULF1/GPC3,10
GO:0046883,regulation of hormone secretion,15/565,132/10364,0.005418938723071238,0.023983929872706648,0.01579277618183265,AGT/ALOX5/ADRA2A/SYT7/CCL5/C1QTNF1/INHBB/LIF/CD38/SPP1/EDN1/HLA-DRB1/GPER1/SFRP1/CCN3,15
GO:0001676,long-chain fatty acid metabolic process,9/565,61/10364,0.005464639028301697,0.02410800881666719,0.015874478846960808,GSTM1/PTGS2/AKR1C3/ALOX5/FADS2/CYP4F12/CYP1B1/PTGIS/PTGDS,9
GO:0072676,lymphocyte migration,9/565,61/10364,0.005464639028301697,0.02410800881666719,0.015874478846960808,CXCL12/CX3CL1/CCL2/CCL5/CCL14/ICAM1/APOD/CCL21/PADI2,9
GO:0150104,transport across blood-brain barrier,9/565,61/10364,0.005464639028301697,0.02410800881666719,0.015874478846960808,MFSD2A/ATP1A2/SLC2A3/SLC7A5/ABCC3/APOE/ABCG2/SLC1A3/CD36,9
GO:0002573,myeloid leukocyte differentiation,16/565,145/10364,0.005528343638384994,0.02436279747637047,0.01604225036304342,C1QC/JUN/FOS/FBN1/JUNB/TYROBP/LIF/CCR1/LTF/CSF1R/HLA-DRB1/VEGFA/ITGB8/SFRP1/CA2/GPC3,16
GO:0002693,positive regulation of cellular extravasation,4/565,14/10364,0.005642305992336546,0.02460021377276445,0.016198582642647716,MDK/THY1/ICAM1/PLVAP,4
GO:0042104,positive regulation of activated T cell proliferation,4/565,14/10364,0.005642305992336546,0.02460021377276445,0.016198582642647716,IGF2/IGF1/IGFBP2/CD24,4
GO:0045907,positive regulation of vasoconstriction,4/565,14/10364,0.005642305992336546,0.02460021377276445,0.016198582642647716,PTGS2/ICAM1/CD38/HRH2,4
GO:0050927,positive regulation of positive chemotaxis,4/565,14/10364,0.005642305992336546,0.02460021377276445,0.016198582642647716,F3/CXCL12/CXCL8/VEGFA,4
GO:0071605,monocyte chemotactic protein-1 production,4/565,14/10364,0.005642305992336546,0.02460021377276445,0.016198582642647716,CLEC7A/OAS1/OAS3/APOD,4
GO:0071636,positive regulation of transforming growth factor beta production,4/565,14/10364,0.005642305992336546,0.02460021377276445,0.016198582642647716,PTGS2/LUM/THBS1/CX3CL1,4
GO:0071637,regulation of monocyte chemotactic protein-1 production,4/565,14/10364,0.005642305992336546,0.02460021377276445,0.016198582642647716,CLEC7A/OAS1/OAS3/APOD,4
GO:0090208,positive regulation of triglyceride metabolic process,4/565,14/10364,0.005642305992336546,0.02460021377276445,0.016198582642647716,MFSD2A/DGAT2/PLIN5/LDLR,4
GO:0120255,olefinic compound biosynthetic process,4/565,14/10364,0.005642305992336546,0.02460021377276445,0.016198582642647716,AKR1C3/ADM/CACNA1H/EGR1,4
GO:1904754,positive regulation of vascular associated smooth muscle cell migration,4/565,14/10364,0.005642305992336546,0.02460021377276445,0.016198582642647716,AGT/IGFBP5/ADAMTS1/NR4A3,4
GO:0003180,aortic valve morphogenesis,5/565,22/10364,0.005744117615435814,0.02493787647677012,0.016420924499783583,SOX9/EMILIN1/SLIT2/SLIT3/ELN,5
GO:0007157,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules,5/565,22/10364,0.005744117615435814,0.02493787647677012,0.016420924499783583,VCAM1/SELP/HMCN1/ICAM1/TENM1,5
GO:0030279,negative regulation of ossification,5/565,22/10364,0.005744117615435814,0.02493787647677012,0.016420924499783583,SRGN/MDK/SOX9/CCR1/SFRP1,5
GO:0036003,positive regulation of transcription from RNA polymerase II promoter in response to stress,5/565,22/10364,0.005744117615435814,0.02493787647677012,0.016420924499783583,MUC1/ATF3/CREB3L1/KLF2/VEGFA,5
GO:0002263,cell activation involved in immune response,19/565,185/10364,0.00579650006676038,0.02513863482342902,0.01655311850019328,FCER1G/FCGR2B/MDK/CLEC7A/ICAM1/TYROBP/BCL3/DYSF/SLC11A1/HMOX1/NFKBIZ/BCL6/ANXA3/HLA-DRB1/FGL2/TCIM/NR4A3/PTGDS/RORC,19
GO:0001913,T cell mediated cytotoxicity,6/565,31/10364,0.005852392363443932,0.025247306992560017,0.016624676216271877,FCGR2B/PRF1/IL7R/HLA-G/HLA-DRB1/AZGP1,6
GO:0033574,response to testosterone,6/565,31/10364,0.005852392363443932,0.025247306992560017,0.016624676216271877,THBS1/NQO1/SPP1/DUSP1/EDN1/PLN,6
GO:0045744,negative regulation of G protein-coupled receptor signaling pathway,6/565,31/10364,0.005852392363443932,0.025247306992560017,0.016624676216271877,RGS2/ADM/APLNR/CCL5/CXCL8/ARRDC3,6
GO:0046888,negative regulation of hormone secretion,6/565,31/10364,0.005852392363443932,0.025247306992560017,0.016624676216271877,ADRA2A/INHBB/LIF/EDN1/SFRP1/CCN3,6
GO:1904036,negative regulation of epithelial cell apoptotic process,6/565,31/10364,0.005852392363443932,0.025247306992560017,0.016624676216271877,MDK/ANGPTL4/ICAM1/HMOX1/SERPINE1/ANGPT1,6
GO:0042886,amide transport,18/565,172/10364,0.005885014238895027,0.025361313993722358,0.016699746776520957,S100A8/ALOX5/ADRA2A/SYT7/FOLR2/CCL5/IL1RN/INHBB/CD38/ABCG2/EDN1/HLA-DRB1/GPER1/SFRP1/CA2/CCN3/AQP3/ABCA1,18
GO:0002532,production of molecular mediator involved in inflammatory response,8/565,51/10364,0.005929797292111057,0.02552420028775283,0.016807003043461548,GBP5/ALOX5/H19/CLEC7A/P2RX1/APOD/CD36/SERPINE1,8
GO:0060627,regulation of vesicle-mediated transport,32/565,368/10364,0.005935280574973301,0.02552420028775283,0.016807003043461548,FCER1G/FCGR2B/ADRA2A/SYT7/CLEC7A/CACNA1H/P2RX1/CCL2/ITGB3/C3/APOE/APOC1/DYSF/SLC11A1/TGM2/HMOX1/CD14/C2/C4A/C4B/VEGFA/ADCY1/CD36/SERPINE1/CLU/ANGPT1/CCL21/GAS1/GPC3/CD22/IL2RB/RAB27B,32
GO:1903131,mononuclear cell differentiation,26/565,282/10364,0.006000193658047701,0.02577627789721646,0.016972989405489768,JUN/VCAM1/FCER1G/FCGR2B/MDK/ZBTB16/BCL3/LILRB2/CYP26B1/CD8A/NFKBIZ/BCL6/IL7R/EGR1/CSF1R/HLA-G/HLA-DRB1/VEGFA/ITGB8/FGL2/TMEM176B/TMEM176A/EGR3/SFRP1/RORC/CD3E,26
GO:0019722,calcium-mediated signaling,14/565,121/10364,0.006051179215447806,0.025968058394175386,0.017099271732055426,GBP1/VCAM1/ATP1A2/SELP/CLEC7A/IGF1/CMKLR1/ACKR3/CCR1/CXCL8/EDN1/PLN/CD22/CD3E,14
GO:0010232,vascular transport,9/565,62/10364,0.006092456722910913,0.026117819710573066,0.017197885552355855,MFSD2A/ATP1A2/SLC2A3/SLC7A5/ABCC3/APOE/ABCG2/SLC1A3/CD36,9
GO:0034765,regulation of ion transmembrane transport,22/565,227/10364,0.006238759410121809,0.026717030360919124,0.017592449734994443,ATP1A2/RGS2/AGT/KCNMA1/ADRA2A/APLNR/THY1/CACNA1H/CX3CL1/RRAD/P2RX1/CCL2/SCN7A/CLIC6/PLN/GPER1/RAMP3/RELN/GEM/CYBB/KCNN4/LCN2,22
GO:0046879,hormone secretion,17/565,160/10364,0.0063061431133523875,0.02697737712232463,0.01776388111235271,AGT/ALOX5/ADRA2A/ADM/SYT7/CCL5/C1QTNF1/IL1RN/INHBB/LIF/CD38/SPP1/EDN1/HLA-DRB1/GPER1/SFRP1/CCN3,17
GO:0002697,regulation of immune effector process,20/565,200/10364,0.0063322256469506445,0.027060680374338137,0.01781873407520119,FCGR2B/CLEC7A/SLC7A5/C3/ICAM1/TYROBP/HMOX1/NFKBIZ/BCL6/SPON2/IL7R/HLA-G/HLA-DRB1/FGL2/CD36/AZGP1/ANGPT1/NR4A3/VSIG4/CD22,20
GO:0050868,negative regulation of T cell activation,10/565,74/10364,0.0065877865570287695,0.02812346002552219,0.018518546043082902,FCGR2B/MDK/LRRC32/LILRB2/BCL6/HLA-G/HLA-DRB1/GPNMB/FGL2/VSIG4,10
GO:0007589,body fluid secretion,8/565,52/10364,0.006682501974153793,0.028438838962770923,0.0187262146359644,MTCO2P12/OAS2/HK2/NPR3/EDN1/VEGFA/AQP1/KCNN4,8
GO:0048678,response to axon injury,8/565,52/10364,0.006682501974153793,0.028438838962770923,0.0187262146359644,TYROBP/CHL1/APOD/SPP1/MAP1B/PTN/KLF4/TNC,8
GO:0051591,response to cAMP,8/565,52/10364,0.006682501974153793,0.028438838962770923,0.0187262146359644,JUN/FOS/COL1A1/FOSB/IGFBP5/THBD/DUSP1/AQP1,8
GO:0002367,cytokine production involved in immune response,9/565,63/10364,0.006774381299949209,0.028770038425302968,0.018944300621500244,CLEC7A/SLC7A5/HMOX1/BCL6/SPON2/HLA-G/CD36/ANGPT1/NR4A3,9
GO:0002718,regulation of cytokine production involved in immune response,9/565,63/10364,0.006774381299949209,0.028770038425302968,0.018944300621500244,CLEC7A/SLC7A5/HMOX1/BCL6/SPON2/HLA-G/CD36/ANGPT1/NR4A3,9
GO:0007519,skeletal muscle tissue development,11/565,86/10364,0.006811692708786888,0.02889851808266686,0.019028901038672726,ATF3/EGR2/IGF2/NR4A1/DCN/FOS/CYP26B1/S100B/MAFF/EGR1/ELN,11
GO:0008016,regulation of heart contraction,12/565,98/10364,0.006836405288672625,0.028973336699612554,0.019078167096317527,HSPB7/ATP1A2/RGS2/AGT/ADM/CACNA1H/DES/HOPX/HBEGF/EDN1/PLN/CCN2,12
GO:0051347,positive regulation of transferase activity,33/565,387/10364,0.007016105235526496,0.029554239637584176,0.01946067614014169,CCN1/CHI3L1/AGT/ADRA2A/IGF2/GPRC5A/IGF1/THBS1/CCL5/ITGB3/ACE/SLC11A1/SPATC1L/LTF/FGFR3/ARRDC3/EGR1/HBEGF/CSF1R/PDGFRB/EDN1/HLA-DRB1/CDKN1A/VEGFA/RELN/CLU/TCIM/ANGPT1/CCL21/NTRK2/KLF4/TENM1/CD24,33
GO:0001569,branching involved in blood vessel morphogenesis,5/565,23/10364,0.007016785766422036,0.029554239637584176,0.01946067614014169,MDK/COL4A1/SFRP2/EDN1/VEGFA,5
GO:0010463,mesenchymal cell proliferation,5/565,23/10364,0.007016785766422036,0.029554239637584176,0.01946067614014169,PRRX1/FGF7/SOX9/PTN/GPC3,5
GO:0031295,T cell costimulation,5/565,23/10364,0.007016785766422036,0.029554239637584176,0.01946067614014169,TNFSF14/LILRB2/CCL21/CD24/CD3E,5
GO:0046006,regulation of activated T cell proliferation,5/565,23/10364,0.007016785766422036,0.029554239637584176,0.01946067614014169,IGF2/LRRC32/IGF1/IGFBP2/CD24,5
GO:0070570,regulation of neuron projection regeneration,5/565,23/10364,0.007016785766422036,0.029554239637584176,0.01946067614014169,PRRX1/THY1/SPP1/PTN/KLF4,5
GO:0001910,regulation of leukocyte mediated cytotoxicity,7/565,42/10364,0.007035944514765755,0.029574083001489733,0.01947374246440625,FCGR2B/ICAM1/TYROBP/IL7R/HLA-G/HLA-DRB1/AZGP1,7
GO:0010517,regulation of phospholipase activity,7/565,42/10364,0.007035944514765755,0.029574083001489733,0.01947374246440625,CCN1/RGS2/AGT/CCL5/C5AR1/FGFR3/PDGFRB,7
GO:0071478,cellular response to radiation,15/565,136/10364,0.007126141225742876,0.029922484285324447,0.019703155389071532,PTGS2/ADIRF/CRYAB/CRIP1/MMP2/MFAP4/MME/SFRP2/EGR1/CDKN1A/AQP1/NAMPT/PTN/SFRP1/TIMP1,15
GO:0010544,negative regulation of platelet activation,4/565,15/10364,0.007367053064875259,0.030620015479796252,0.020162461019658604,C1QTNF1/APOE/SERPINE2/THBD,4
GO:0019934,cGMP-mediated signaling,4/565,15/10364,0.007367053064875259,0.030620015479796252,0.020162461019658604,THBS1/APOE/AQP1/CD36,4
GO:0042744,hydrogen peroxide catabolic process,4/565,15/10364,0.007367053064875259,0.030620015479796252,0.020162461019658604,HBB/HBA2/HBA1/GPX3,4
GO:0048730,epidermis morphogenesis,4/565,15/10364,0.007367053064875259,0.030620015479796252,0.020162461019658604,FGF7/NGFR/IGFBP5/KLF4,4
GO:0050926,regulation of positive chemotaxis,4/565,15/10364,0.007367053064875259,0.030620015479796252,0.020162461019658604,F3/CXCL12/CXCL8/VEGFA,4
GO:0061050,regulation of cell growth involved in cardiac muscle cell development,4/565,15/10364,0.007367053064875259,0.030620015479796252,0.020162461019658604,RGS2/IGF1/EDN1/PI16,4
GO:0071379,cellular response to prostaglandin stimulus,4/565,15/10364,0.007367053064875259,0.030620015479796252,0.020162461019658604,AKR1C2/AKR1C3/SFRP1/TNC,4
GO:0071542,dopaminergic neuron differentiation,4/565,15/10364,0.007367053064875259,0.030620015479796252,0.020162461019658604,NR4A2/SFRP2/VEGFA/SFRP1,4
GO:1903428,positive regulation of reactive oxygen species biosynthetic process,4/565,15/10364,0.007367053064875259,0.030620015479796252,0.020162461019658604,MTCO2P12/H19/CD36/LCN2,4
GO:2001026,regulation of endothelial cell chemotaxis,4/565,15/10364,0.007367053064875259,0.030620015479796252,0.020162461019658604,THBS1/VEGFA/SMOC2/HSPB1,4
GO:0043200,response to amino acid,11/565,87/10364,0.007426299550108449,0.030834959795277884,0.020303996101022462,COL4A1/MMP2/NQO1/COL1A1/ICAM1/EDN1/CCN2/COL1A2/PTN/NTRK2/CYBB,11
GO:0031100,animal organ regeneration,8/565,53/10364,0.0075053124581918,0.031099948586879787,0.02047848413107735,CXCL12/ADM/NNMT/C5AR1/HMOX1/ANXA3/CDKN1A/NR4A3,8
GO:0042100,B cell proliferation,8/565,53/10364,0.0075053124581918,0.031099948586879787,0.02047848413107735,MNDA/FCGR2B/TYROBP/BCL6/CD38/IL7R/CDKN1A/CD22,8
GO:0007292,female gamete generation,9/565,64/10364,0.007513334032171158,0.031101708319220146,0.020479642867745555,PTGS2/RGS2/MDK/IGF1/INHBB/ADAMTS1/HPGD/PTN/TOP2A,9
GO:0015711,organic anion transport,18/565,177/10364,0.007877697665829022,0.03257706489283234,0.021451125701422782,PLA2G2A/MFSD2A/ATP1A2/RGS2/AGT/FOLR2/SLC2A3/CES1/SLC7A5/ABCC3/ACE/SLC16A3/SLC11A1/ABCG2/SLC1A3/EDN1/CD36/NTRK2,18
GO:0015918,sterol transport,10/565,76/10364,0.007944917773612682,0.03272283034725384,0.021547108353512735,SYT7/CES1/ABCA8/LDLR/APOE/APOC1/CD36/MSR1/CLU/ABCA1,10
GO:0045471,response to ethanol,10/565,76/10364,0.007944917773612682,0.03272283034725384,0.021547108353512735,VCAM1/S100A8/RGS2/NQO1/ICAM1/CLDN5/HPGD/CD14/TNC/CYBB,10
GO:0046683,response to organophosphorus,10/565,76/10364,0.007944917773612682,0.03272283034725384,0.021547108353512735,JUN/PTGS2/FOS/P2RX1/COL1A1/FOSB/IGFBP5/THBD/DUSP1/AQP1,10
GO:0072073,kidney epithelium development,10/565,76/10364,0.007944917773612682,0.03272283034725384,0.021547108353512735,AGT/SOX9/LIF/KLF15/SLIT2/BASP1/VEGFA/SFRP1/GPC3/CD24,10
GO:0010660,regulation of muscle cell apoptotic process,7/565,43/10364,0.008019380565246972,0.03293568649336054,0.02168726843120776,AGT/MDK/IGF1/HSPB6/HMOX1/SFRP2/EDN1,7
GO:0001523,retinoid metabolic process,6/565,33/10364,0.008028777508640405,0.03293568649336054,0.02168726843120776,AKR1C3/DGAT2/ALDH1A3/CYP1B1/CYP26B1/ADH1B,6
GO:0032613,interleukin-10 production,6/565,33/10364,0.008028777508640405,0.03293568649336054,0.02168726843120776,ISG15/FCGR2B/CLEC7A/TYROBP/BCL3/HLA-DRB1,6
GO:0032653,regulation of interleukin-10 production,6/565,33/10364,0.008028777508640405,0.03293568649336054,0.02168726843120776,ISG15/FCGR2B/CLEC7A/TYROBP/BCL3/HLA-DRB1,6
GO:1903169,regulation of calcium ion transmembrane transport,11/565,88/10364,0.008083291195404858,0.03312612027426175,0.021812663981277958,ATP1A2/ADRA2A/APLNR/THY1/CX3CL1/RRAD/P2RX1/PLN/GPER1/RAMP3/GEM,11
GO:0043523,regulation of neuron apoptotic process,15/565,138/10364,0.008128116859487234,0.03327651042274074,0.021911691870680847,JUN/NES/MDK/CX3CL1/NQO1/CCL2/TYROBP/APOE/C5AR1/NR4A2/HMOX1/ANGPT1/CNTFR/NTRK2/LCN2,15
GO:0002698,negative regulation of immune effector process,9/565,65/10364,0.008312263898775374,0.033996411989596784,0.02238572779301092,FCGR2B/HMOX1/BCL6/IL7R/HLA-G/FGL2/ANGPT1/VSIG4/CD22,9
GO:0001659,temperature homeostasis,13/565,113/10364,0.00839133375467824,0.03428554929306659,0.022576116972088434,PTGS2/G0S2/SCD/CMKLR1/ID1/ADAMTS5/NPR3/ARRDC3/EGR1/VEGFA/CD36/GADD45G/LCN2,13
GO:0001914,regulation of T cell mediated cytotoxicity,5/565,24/10364,0.008473955465220954,0.03438292732865668,0.022640237803381008,FCGR2B/IL7R/HLA-G/HLA-DRB1/AZGP1,5
GO:0009620,response to fungus,5/565,24/10364,0.008473955465220954,0.03438292732865668,0.022640237803381008,S100A9/S100A8/CLEC7A/LTF/SPON2,5
GO:0031294,lymphocyte costimulation,5/565,24/10364,0.008473955465220954,0.03438292732865668,0.022640237803381008,TNFSF14/LILRB2/CCL21/CD24/CD3E,5
GO:0048009,insulin-like growth factor receptor signaling pathway,5/565,24/10364,0.008473955465220954,0.03438292732865668,0.022640237803381008,IGFBP6/IGF1/IGFBP2/IGFBP5/IGFBP3,5
GO:0050869,negative regulation of B cell activation,5/565,24/10364,0.008473955465220954,0.03438292732865668,0.022640237803381008,MNDA/FCGR2B/TYROBP/BCL6/SFRP1,5
GO:1903170,negative regulation of calcium ion transmembrane transport,5/565,24/10364,0.008473955465220954,0.03438292732865668,0.022640237803381008,ATP1A2/ADRA2A/RRAD/PLN/GEM,5
GO:2001222,regulation of neuron migration,5/565,24/10364,0.008473955465220954,0.03438292732865668,0.022640237803381008,MDK/FLRT2/CX3CL1/COL3A1/RELN,5
GO:0046718,viral entry into host cell,12/565,101/10364,0.008659124650733452,0.03509946170307204,0.023112056519570996,MRC1/IFITM2/IFITM1/IFITM3/ANPEP/ITGB3/ICAM1/LDLR/SIGLEC1/HSPA1A/HSPA1B/HLA-DRB1,12
GO:0006639,acylglycerol metabolic process,10/565,77/10364,0.008699453470699028,0.035193243586009705,0.02317380938054942,MFSD2A/DGAT2/PLIN5/C3/LDLR/APOE/APOC1/SIK1/TNXB/LPL,10
GO:0045807,positive regulation of endocytosis,10/565,77/10364,0.008699453470699028,0.035193243586009705,0.02317380938054942,C3/APOE/CD14/VEGFA/CD36/SERPINE1/CLU/ANGPT1/CCL21/GPC3,10
GO:0030888,regulation of B cell proliferation,7/565,44/10364,0.00910050172445912,0.03674305134115941,0.02419431632548511,MNDA/FCGR2B/TYROBP/BCL6/CD38/CDKN1A/CD22,7
GO:1902893,regulation of pri-miRNA transcription by RNA polymerase II,7/565,44/10364,0.00910050172445912,0.03674305134115941,0.02419431632548511,JUN/FOS/NGFR/SOX9/ATOH8/EGR1/KLF4,7
GO:0001909,leukocyte mediated cytotoxicity,9/565,66/10364,0.009174139928080092,0.03700387080350728,0.02436605896376781,FCGR2B/PRF1/ICAM1/TYROBP/IL7R/HLA-G/HLA-DRB1/AZGP1/SLAMF7,9
GO:0023061,signal release,23/565,249/10364,0.009221517244499867,0.03715835787301423,0.024467784566063158,AGT/CXCL12/ALOX5/SNCG/ADRA2A/ADM/SYT7/NR4A1/P2RX1/CCL5/C1QTNF1/IL1RN/INHBB/LIF/CD38/SPP1/EDN1/HLA-DRB1/GPER1/ADCY1/SFRP1/CCN3/ABCA1,23
GO:0010518,positive regulation of phospholipase activity,6/565,34/10364,0.009311134860810066,0.03724240432392161,0.024523126905500545,CCN1/AGT/CCL5/C5AR1/FGFR3/PDGFRB,6
GO:0071385,cellular response to glucocorticoid stimulus,6/565,34/10364,0.009311134860810066,0.03724240432392161,0.024523126905500545,DDIT4/ICAM1/ZFP36/FAM107A/EDN1/AQP1,6
GO:1902895,positive regulation of pri-miRNA transcription by RNA polymerase II,6/565,34/10364,0.009311134860810066,0.03724240432392161,0.024523126905500545,JUN/FOS/NGFR/ATOH8/EGR1/KLF4,6
GO:2000107,negative regulation of leukocyte apoptotic process,6/565,34/10364,0.009311134860810066,0.03724240432392161,0.024523126905500545,CXCL12/CCL5/BCL6/IL7R/CCL21/TSC22D3,6
GO:0032609,interferon-gamma production,8/565,55/10364,0.009376830852870293,0.03724240432392161,0.024523126905500545,ISG15/CLEC7A/SLC7A5/BCL3/SLC11A1/CD14/HLA-DRB1/CD3E,8
GO:0032649,regulation of interferon-gamma production,8/565,55/10364,0.009376830852870293,0.03724240432392161,0.024523126905500545,ISG15/CLEC7A/SLC7A5/BCL3/SLC11A1/CD14/HLA-DRB1/CD3E,8
GO:0034308,primary alcohol metabolic process,8/565,55/10364,0.009376830852870293,0.03724240432392161,0.024523126905500545,AKR1C2/AKR1C3/DGAT2/IGF1/ALDH1A3/CACNA1H/CYP1B1/ADH1B,8
GO:0034605,cellular response to heat,8/565,55/10364,0.009376830852870293,0.03724240432392161,0.024523126905500545,HSPA6/PTGS2/THBS1/HMOX1/HSPA1A/HSPA1B/CDKN1A/TCIM,8
GO:0001990,regulation of systemic arterial blood pressure by hormone,4/565,16/10364,0.00940611775059476,0.03724240432392161,0.024523126905500545,AGT/ACE/MME/EDN1,4
GO:0008045,motor neuron axon guidance,4/565,16/10364,0.00940611775059476,0.03724240432392161,0.024523126905500545,EGR2/NTN1/SLIT2/PLXNA4,4
GO:0009593,detection of chemical stimulus,4/565,16/10364,0.00940611775059476,0.03724240432392161,0.024523126905500545,CLEC7A/SSC5D/C4B/AZGP1,4
GO:0034377,plasma lipoprotein particle assembly,4/565,16/10364,0.00940611775059476,0.03724240432392161,0.024523126905500545,MFSD2A/APOE/APOC1/ABCA1,4
GO:0034383,low-density lipoprotein particle clearance,4/565,16/10364,0.00940611775059476,0.03724240432392161,0.024523126905500545,DGAT2/LDLR/HMOX1/CD36,4
GO:0045932,negative regulation of muscle contraction,4/565,16/10364,0.00940611775059476,0.03724240432392161,0.024523126905500545,ATP1A2/PTGS2/RGS2/KCNMA1,4
GO:0070977,bone maturation,4/565,16/10364,0.00940611775059476,0.03724240432392161,0.024523126905500545,ZBTB16/IGF1/LTF/FGFR3,4
GO:0071875,adrenergic receptor signaling pathway,4/565,16/10364,0.00940611775059476,0.03724240432392161,0.024523126905500545,RGS2/ADRA2A/ARRDC3/PLN,4
GO:1902430,negative regulation of amyloid-beta formation,4/565,16/10364,0.00940611775059476,0.03724240432392161,0.024523126905500545,IGF1/APOE/CLU/NTRK2,4
GO:1904996,positive regulation of leukocyte adhesion to vascular endothelial cell,4/565,16/10364,0.00940611775059476,0.03724240432392161,0.024523126905500545,SELP/ALOX5/MDK/ICAM1,4
GO:0006638,neutral lipid metabolic process,10/565,78/10364,0.009507757909927608,0.03755913386296993,0.02473168483353457,MFSD2A/DGAT2/PLIN5/C3/LDLR/APOE/APOC1/SIK1/TNXB/LPL,10
GO:0043271,negative regulation of ion transport,10/565,78/10364,0.009507757909927608,0.03755913386296993,0.02473168483353457,ATP1A2/PTGS2/RGS2/ADRA2A/RRAD/ICAM1/LILRB2/SERPINE2/PLN/GEM,10
GO:0034767,positive regulation of ion transmembrane transport,11/565,90/10364,0.009531983410753727,0.03755913386296993,0.02473168483353457,AGT/APLNR/THY1/CX3CL1/P2RX1/CCL2/GPER1/RAMP3/RELN/KCNN4/LCN2,11
GO:0051147,regulation of muscle cell differentiation,11/565,90/10364,0.009531983410753727,0.03755913386296993,0.02473168483353457,RGS2/IGF2/IGF1/TMEM119/CYP26B1/SIK1/HOPX/EDN1/PI16/GPER1/CCN3,11
GO:0055067,monovalent inorganic cation homeostasis,11/565,90/10364,0.009531983410753727,0.03755913386296993,0.02473168483353457,ATP1A2/AGT/KCNMA1/CYP4F12/SCN7A/SLC11A1/SLC1A3/C7/EDN1/PDK4/CA2,11
GO:0008406,gonad development,13/565,115/10364,0.00967654689881835,0.03809209904207916,0.025082628145621254,AKR1C3/SOX9/ICAM1/INHBB/ADAMTS1/TNFSF10/SLIT2/SFRP2/BASP1/PDGFRB/SLIT3/VEGFA/SFRP1,13
GO:0002366,leukocyte activation involved in immune response,18/565,181/10364,0.009836506221338782,0.03868458834789719,0.025472766502703494,FCER1G/FCGR2B/MDK/CLEC7A/ICAM1/TYROBP/BCL3/DYSF/SLC11A1/HMOX1/NFKBIZ/BCL6/ANXA3/HLA-DRB1/FGL2/NR4A3/PTGDS/RORC,18
GO:0002062,chondrocyte differentiation,9/565,67/10364,0.010101943375542448,0.03960214635838337,0.026076953905283678,MDK/ZBTB16/SOX9/FGFR3/SFRP2/TGFBI/CCN2/SULF1/CCN3,9
GO:0002444,myeloid leukocyte mediated immunity,9/565,67/10364,0.010101943375542448,0.03960214635838337,0.026076953905283678,FCGR2B/ACE/C3/TYROBP/HMOX1/SPON2/ANXA3/NR4A3/PTGDS,9
GO:0051965,positive regulation of synapse assembly,5/565,25/10364,0.010127857165908008,0.03960214635838337,0.026076953905283678,FLRT2/CLSTN2/THBS2/NTRK2/LRRN3,5
GO:0060042,retina morphogenesis in camera-type eye,5/565,25/10364,0.010127857165908008,0.03960214635838337,0.026076953905283678,MFSD2A/THY1/SOX9/PTN/NTRK2,5
GO:0089718,amino acid import across plasma membrane,5/565,25/10364,0.010127857165908008,0.03960214635838337,0.026076953905283678,ATP1A2/RGS2/AGT/SLC7A5/SLC1A3,5
GO:2000273,positive regulation of signaling receptor activity,5/565,25/10364,0.010127857165908008,0.03960214635838337,0.026076953905283678,ADRA2A/CCL2/HBEGF/EDN1/RELN,5
GO:0003073,regulation of systemic arterial blood pressure,7/565,45/10364,0.010284640364998912,0.03994811921660868,0.026304767776652565,AGT/ADM/POSTN/ACE/CYP4F12/MME/EDN1,7
GO:0007422,peripheral nervous system development,7/565,45/10364,0.010284640364998912,0.03994811921660868,0.026304767776652565,GSTM3/EGR2/ITGB4/LAMA2/PLXNA4/EGR3/NTRK2,7
GO:0014743,regulation of muscle hypertrophy,7/565,45/10364,0.010284640364998912,0.03994811921660868,0.026304767776652565,RGS2/AGT/IGF1/IGFBP5/EDN1/PI16/NR4A3,7
GO:0032387,negative regulation of intracellular transport,7/565,45/10364,0.010284640364998912,0.03994811921660868,0.026304767776652565,CRYAB/APOD/MAP1B/PLN/CD36/ANGPT1/DERL3,7
GO:0043407,negative regulation of MAP kinase activity,7/565,45/10364,0.010284640364998912,0.03994811921660868,0.026304767776652565,RGS2/AGT/APOE/UCHL1/SFRP2/DUSP1/SFRP1,7
GO:0061614,pri-miRNA transcription by RNA polymerase II,7/565,45/10364,0.010284640364998912,0.03994811921660868,0.026304767776652565,JUN/FOS/NGFR/SOX9/ATOH8/EGR1/KLF4,7
GO:0070509,calcium ion import,7/565,45/10364,0.010284640364998912,0.03994811921660868,0.026304767776652565,CXCL12/CACNA1H/P2RX1/CCL2/PDGFRB/PLN/RAMP3,7
GO:0014033,neural crest cell differentiation,8/565,56/10364,0.01043334151677488,0.040487298739029724,0.02665980306755846,SOX9/SEMA6B/FRZB/FN1/SEMA3G/EDN1/SEMA3C/SFRP1,8
GO:0032890,regulation of organic acid transport,6/565,35/10364,0.01073323008193929,0.041532933795330296,0.0273483257783768,FABP3/ATP1A2/RGS2/AGT/THBS1/EDN1,6
GO:0035249,"synaptic transmission, glutamatergic",6/565,35/10364,0.01073323008193929,0.041532933795330296,0.0273483257783768,ATP1A2/PTGS2/P2RX1/CCL2/SERPINE2/RELN,6
GO:0042698,ovulation cycle,6/565,35/10364,0.01073323008193929,0.041532933795330296,0.0273483257783768,MDK/ADAMTS1/SLIT2/EGR1/SLIT3/PTN,6
GO:0045137,development of primary sexual characteristics,13/565,117/10364,0.011110715180590555,0.04295303866792987,0.02828342684507968,AKR1C3/SOX9/ICAM1/INHBB/ADAMTS1/TNFSF10/SLIT2/SFRP2/BASP1/PDGFRB/SLIT3/VEGFA/SFRP1,13
GO:0010952,positive regulation of peptidase activity,15/565,143/10364,0.011127694002002423,0.04297809362660181,0.028299924865072698,CCN1/F3/S100A9/S100A8/CLEC7A/P2RX1/NGFR/FN1/FBLN1/PCOLCE2/TNFSF10/SFRP2/CCN2/GPER1/NLRP2,15
GO:0097696,receptor signaling pathway via STAT,11/565,92/10364,0.011173037208417598,0.043112548851330486,0.028388460033491214,AGT/IGF1/CCL2/CCL5/SOCS3/BCL3/CYP1B1/LIF/FGFR3/IL7R/CSF1R,11
GO:0003015,heart process,14/565,130/10364,0.011191755159941648,0.04314411075781648,0.028409242704540153,HSPB7/ATP1A2/RGS2/AGT/ADM/CACNA1H/ACE/DES/HOPX/HBEGF/EDN1/PLN/CCN2/RAMP3,14
GO:0046916,cellular transition metal ion homeostasis,10/565,80/10364,0.011295121644908455,0.04350162560136897,0.028644656664465563,S100A9/S100A8/MT2A/MT1E/MT1M/MT1X/SLC11A1/HMOX1/STEAP4/LCN2,10
GO:0016032,viral process,28/565,326/10364,0.011346703719797045,0.04365921525267773,0.028748425233874386,ISG15/JUN/MRC1/IFIT1/IFITM2/IFITM1/IFITM3/OAS1/OAS3/OAS2/IFI27/ANPEP/CCL2/CCL5/ITGB3/ICAM1/LDLR/ZFP36/APOE/SIGLEC1/SLPI/MX1/LTF/CXCL8/HSPA1A/HSPA1B/HLA-DRB1/TOP2A,28
GO:0042102,positive regulation of T cell proliferation,8/565,57/10364,0.011575537368400121,0.044420363314469816,0.029249620869657066,VCAM1/IGF2/IGF1/CCL5/LILRB2/IGFBP2/CD24/CD3E,8
GO:0072009,nephron epithelium development,8/565,57/10364,0.011575537368400121,0.044420363314469816,0.029249620869657066,AGT/SOX9/LIF/KLF15/BASP1/VEGFA/GPC3/CD24,8
GO:0055013,cardiac muscle cell development,7/565,46/10364,0.011577070751475158,0.044420363314469816,0.029249620869657066,RGS2/AGT/IGF1/PDGFRB/EDN1/PI16/VEGFA,7
GO:0032682,negative regulation of chemokine production,4/565,17/10364,0.011779680960625608,0.04498695322089667,0.029622705165123903,OAS1/OAS3/APOD/KLF4,4
GO:0070633,transepithelial transport,4/565,17/10364,0.011779680960625608,0.04498695322089667,0.029622705165123903,ABCG2/SLC1A3/EDN1/AQP1,4
GO:0071498,cellular response to fluid shear stress,4/565,17/10364,0.011779680960625608,0.04498695322089667,0.029622705165123903,PTGS2/KLF2/CA2/KLF4,4
GO:0072012,glomerulus vasculature development,4/565,17/10364,0.011779680960625608,0.04498695322089667,0.029622705165123903,ACTA2/EGR1/PDGFRB/ANGPT1,4
GO:0072210,metanephric nephron development,4/565,17/10364,0.011779680960625608,0.04498695322089667,0.029622705165123903,SOX9/LIF/EGR1/PDGFRB,4
GO:0030857,negative regulation of epithelial cell differentiation,5/565,26/10364,0.011990142909097074,0.045409477400410195,0.029900926033592293,SOX9/FRZB/ID1/VEGFA/S1PR3,5
GO:0032570,response to progesterone,5/565,26/10364,0.011990142909097074,0.045409477400410195,0.029900926033592293,FOS/THBS1/FOSB/CD38/PTN,5
GO:0035272,exocrine system development,5/565,26/10364,0.011990142909097074,0.045409477400410195,0.029900926033592293,IGF2/FGF7/SOX9/TGM2/SEMA3C,5
GO:0045687,positive regulation of glial cell differentiation,5/565,26/10364,0.011990142909097074,0.045409477400410195,0.029900926033592293,EGR2/MDK/SERPINE2/LIF/PTN,5
GO:0050798,activated T cell proliferation,5/565,26/10364,0.011990142909097074,0.045409477400410195,0.029900926033592293,IGF2/LRRC32/IGF1/IGFBP2/CD24,5
GO:0051966,"regulation of synaptic transmission, glutamatergic",5/565,26/10364,0.011990142909097074,0.045409477400410195,0.029900926033592293,ATP1A2/PTGS2/CCL2/SERPINE2/RELN,5
GO:0071548,response to dexamethasone,5/565,26/10364,0.011990142909097074,0.045409477400410195,0.029900926033592293,DDIT4/FIBIN/ICAM1/EDN1/AQP1,5
GO:1902230,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage,5/565,26/10364,0.011990142909097074,0.045409477400410195,0.029900926033592293,MUC1/CXCL12/ACKR3/SFRP2/CLU,5
GO:1990000,amyloid fibril formation,5/565,26/10364,0.011990142909097074,0.045409477400410195,0.029900926033592293,CRYAB/LDLR/APOE/CD36/CLU,5
GO:0043524,negative regulation of neuron apoptotic process,11/565,93/10364,0.012070522247683634,0.04567164332903586,0.03007355528389706,NES/MDK/CX3CL1/CCL2/APOE/C5AR1/NR4A2/HMOX1/ANGPT1/CNTFR/NTRK2,11
GO:0007423,sensory organ development,25/565,284/10364,0.012176384081042376,0.046029655057975516,0.030309296429556813,MFSD2A/NES/PRRX1/CRYAB/THY1/COL4A1/SMOC1/FBN1/ALDH1A3/NTN1/SOX9/CYP1B1/CYP26B1/MYO7B/FRZB/COL8A1/PDGFRB/EDN1/VEGFA/PTN/NTRK2/KLF4/LAMC3/COL5A1/CHRDL1,25
GO:0048260,positive regulation of receptor-mediated endocytosis,6/565,36/10364,0.01230255096122782,0.04642086970992322,0.03056690081174334,C3/VEGFA/SERPINE1/CLU/ANGPT1/CCL21,6
GO:0072028,nephron morphogenesis,6/565,36/10364,0.01230255096122782,0.04642086970992322,0.03056690081174334,AGT/SOX9/LIF/PDGFRB/VEGFA/GPC3,6
GO:0043502,regulation of muscle adaptation,8/565,58/10364,0.012807273750549518,0.04828082756422627,0.03179163329956123,RGS2/AGT/IGF1/IGFBP5/EDN1/PI16/NR4A3/KLF4,8
GO:0048732,gland development,24/565,271/10364,0.01294146585193779,0.04874182262910148,0.032095186216833084,MTCO2P12/IGF2/MDK/OAS2/CRIP1/FGF7/ALDH1A3/NTN1/SOX9/HK2/FRZB/IGFBP5/SERPINE2/TGM2/HMOX1/CSF1R/VEGFA/SEMA3C/PTN/SFRP1/SULF1/TNC/RAP1GAP/ELF3,24
GO:0010657,muscle cell apoptotic process,7/565,47/10364,0.012982986496562373,0.04880839918909674,0.03213902510047483,AGT/MDK/IGF1/HSPB6/HMOX1/SFRP2/EDN1,7
GO:0051963,regulation of synapse assembly,7/565,47/10364,0.012982986496562373,0.04880839918909674,0.03213902510047483,FLRT2/NTN1/CLSTN2/MDGA1/THBS2/NTRK2/LRRN3,7
GO:0045580,regulation of T cell differentiation,11/565,94/10364,0.013021896836998732,0.048909766651993404,0.03220577286292009,MDK/ZBTB16/LILRB2/CYP26B1/NFKBIZ/BCL6/IL7R/HLA-G/HLA-DRB1/FGL2/EGR3,11
GO:0051345,positive regulation of hydrolase activity,34/565,420/10364,0.013281644568550395,0.04983964515457866,0.032818072979938794,CCN1/F3/S100A9/S100A8/RGS16/RGS1/AGT/THY1/CLEC7A/CX3CL1/P2RX1/CCL2/CCL5/CCL14/NGFR/PLIN5/ICAM1/C5AR1/FN1/TGM2/FBLN1/PCOLCE2/TNFSF10/FGFR3/SFRP2/PDGFRB/HSPA1A/VEGFA/CCN2/GPER1/SFRP1/CCL21/RAP1GAP/NLRP2,34
GO:0060485,mesenchyme development,17/565,173/10364,0.013301833367696426,0.049869693962773964,0.03283785931624306,S100A4/ACTA2/MDK/APLNR/COL1A1/SOX9/SEMA6B/ACTG2/FRZB/FN1/SEMA3G/SFRP2/BASP1/PDGFRB/EDN1/SEMA3C/SFRP1,17
GO:0090101,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,10/565,82/10364,0.013325961051004438,0.049914441484732085,0.032867324362327116,FBN1/EMILIN1/LTBP1/HTRA3/SFRP2/HSPA1A/PEG10/SFRP1/CCN3/CHRDL1,10
GO:0034614,cellular response to reactive oxygen species,13/565,120/10364,0.013565080921107584,0.0507172979826616,0.03339598388748524,JUN/AKR1C3/H19/FOS/MMP2/NQO1/KLF2/CYP1B1/AQP1/CD36/NR4A3/KLF4/LCN2,13
GO:0050807,regulation of synapse organization,13/565,120/10364,0.013565080921107584,0.0507172979826616,0.03339598388748524,FCGR2B/SRGN/FLRT2/NTN1/APOE/LILRB2/CLSTN2/MDGA1/THBS2/RELN/PTN/NTRK2/LRRN3,13
GO:0030217,T cell differentiation,17/565,174/10364,0.014024704362525444,0.051872154977354305,0.034156426322732726,FCER1G/MDK/ZBTB16/BCL3/LILRB2/CYP26B1/CD8A/NFKBIZ/BCL6/IL7R/EGR1/HLA-G/HLA-DRB1/FGL2/EGR3/RORC/CD3E,17
GO:0016101,diterpenoid metabolic process,6/565,37/10364,0.0140263492299858,0.051872154977354305,0.034156426322732726,AKR1C3/DGAT2/ALDH1A3/CYP1B1/CYP26B1/ADH1B,6
GO:0043030,regulation of macrophage activation,6/565,37/10364,0.0140263492299858,0.051872154977354305,0.034156426322732726,FCGR2B/THBS1/CX3CL1/LDLR/IL33/VSIG4,6
GO:0050886,endocrine process,6/565,37/10364,0.0140263492299858,0.051872154977354305,0.034156426322732726,AGT/ACE/C1QTNF1/INHBB/MME/EDN1,6
GO:0051055,negative regulation of lipid biosynthetic process,6/565,37/10364,0.0140263492299858,0.051872154977354305,0.034156426322732726,AKR1C3/CCDC3/APOE/APOC1/SIK1/GPER1,6
GO:1903556,negative regulation of tumor necrosis factor superfamily cytokine production,6/565,37/10364,0.0140263492299858,0.051872154977354305,0.034156426322732726,IGF1/CX3CL1/ACP5/BCL3/LTF/GPNMB,6
GO:0003176,aortic valve development,5/565,27/10364,0.01407180623381028,0.051872154977354305,0.034156426322732726,SOX9/EMILIN1/SLIT2/SLIT3/ELN,5
GO:0010712,regulation of collagen metabolic process,5/565,27/10364,0.01407180623381028,0.051872154977354305,0.034156426322732726,CREB3L1/MFAP4/EMILIN1/PDGFRB/CCN2,5
GO:0030858,positive regulation of epithelial cell differentiation,5/565,27/10364,0.01407180623381028,0.051872154977354305,0.034156426322732726,SOX9/ATOH8/LIF/SERPINE1/CD24,5
GO:0035850,epithelial cell differentiation involved in kidney development,5/565,27/10364,0.01407180623381028,0.051872154977354305,0.034156426322732726,ACTA2/LIF/KLF15/BASP1/CD24,5
GO:0042531,positive regulation of tyrosine phosphorylation of STAT protein,5/565,27/10364,0.01407180623381028,0.051872154977354305,0.034156426322732726,IGF1/CCL5/LIF/FGFR3/CSF1R,5
GO:0010522,regulation of calcium ion transport into cytosol,8/565,59/10364,0.01413236418596189,0.051872154977354305,0.034156426322732726,ATP1A2/APLNR/THY1/CX3CL1/P2RX1/PLN/GPER1/RAMP3,8
GO:0014897,striated muscle hypertrophy,8/565,59/10364,0.01413236418596189,0.051872154977354305,0.034156426322732726,RGS2/AGT/IGF1/IGFBP5/KLF15/EDN1/PI16/NR4A3,8
GO:0050772,positive regulation of axonogenesis,8/565,59/10364,0.01413236418596189,0.051872154977354305,0.034156426322732726,CXCL12/NTN1/FN1/SLIT2/MAP1B/VEGFA/PLXNA4/NTRK2,8
GO:0060047,heart contraction,13/565,121/10364,0.014469532052344412,0.051872154977354305,0.034156426322732726,HSPB7/ATP1A2/RGS2/AGT/ADM/CACNA1H/ACE/DES/HOPX/HBEGF/EDN1/PLN/CCN2,13
GO:0010958,regulation of amino acid import across plasma membrane,3/565,10/10364,0.01450046339506392,0.051872154977354305,0.034156426322732726,ATP1A2/RGS2/AGT,3
GO:0032695,negative regulation of interleukin-12 production,3/565,10/10364,0.01450046339506392,0.051872154977354305,0.034156426322732726,CMKLR1/THBS1/ACP5,3
GO:0034638,phosphatidylcholine catabolic process,3/565,10/10364,0.01450046339506392,0.051872154977354305,0.034156426322732726,LDLR/APOC1/ENPP2,3
GO:0046851,negative regulation of bone remodeling,3/565,10/10364,0.01450046339506392,0.051872154977354305,0.034156426322732726,TMEM119/CD38/SFRP1,3
GO:0048251,elastic fiber assembly,3/565,10/10364,0.01450046339506392,0.051872154977354305,0.034156426322732726,MFAP4/EMILIN1/TNXB,3
GO:0051412,response to corticosterone,3/565,10/10364,0.01450046339506392,0.051872154977354305,0.034156426322732726,FOS/FOSB/CDKN1A,3
GO:0060841,venous blood vessel development,3/565,10/10364,0.01450046339506392,0.051872154977354305,0.034156426322732726,APLNR/VEGFA/SEMA3C,3
GO:0070486,leukocyte aggregation,3/565,10/10364,0.01450046339506392,0.051872154977354305,0.034156426322732726,S100A9/S100A8/NR4A3,3
GO:0072109,glomerular mesangium development,3/565,10/10364,0.01450046339506392,0.051872154977354305,0.034156426322732726,ACTA2/EGR1/PDGFRB,3
GO:0086103,G protein-coupled receptor signaling pathway involved in heart process,3/565,10/10364,0.01450046339506392,0.051872154977354305,0.034156426322732726,RGS2/PLN/RAMP3,3
GO:0098543,detection of other organism,3/565,10/10364,0.01450046339506392,0.051872154977354305,0.034156426322732726,CLEC7A/SSC5D/HLA-DRB1,3
GO:1903789,regulation of amino acid transmembrane transport,3/565,10/10364,0.01450046339506392,0.051872154977354305,0.034156426322732726,ATP1A2/RGS2/AGT,3
GO:1904948,midbrain dopaminergic neuron differentiation,3/565,10/10364,0.01450046339506392,0.051872154977354305,0.034156426322732726,NR4A2/SFRP2/SFRP1,3
GO:2000402,negative regulation of lymphocyte migration,3/565,10/10364,0.01450046339506392,0.051872154977354305,0.034156426322732726,CCL2/APOD/PADI2,3
GO:0001958,endochondral ossification,4/565,18/10364,0.014505596842020855,0.051872154977354305,0.034156426322732726,ALPL/TMEM119/COL1A1/FGFR3,4
GO:0002483,antigen processing and presentation of endogenous peptide antigen,4/565,18/10364,0.014505596842020855,0.051872154977354305,0.034156426322732726,ERAP2/HLA-G/HLA-DRB1/AZGP1,4
GO:0003401,axis elongation,4/565,18/10364,0.014505596842020855,0.051872154977354305,0.034156426322732726,SOX9/SFRP2/SFRP1/TNC,4
GO:0009595,detection of biotic stimulus,4/565,18/10364,0.014505596842020855,0.051872154977354305,0.034156426322732726,CLEC7A/SSC5D/C4B/HLA-DRB1,4
GO:0010955,negative regulation of protein processing,4/565,18/10364,0.014505596842020855,0.051872154977354305,0.034156426322732726,THBS1/SERPINE2/SERPINE1/GAS1,4
GO:0021952,central nervous system projection neuron axonogenesis,4/565,18/10364,0.014505596842020855,0.051872154977354305,0.034156426322732726,DCLK1/NR4A2/SLIT2/PLXNA4,4
GO:0031640,killing of cells of other organism,4/565,18/10364,0.014505596842020855,0.051872154977354305,0.034156426322732726,PRF1/CLEC7A/LYZ/LTF,4
GO:0033622,integrin activation,4/565,18/10364,0.014505596842020855,0.051872154977354305,0.034156426322732726,SELP/CXCL12/CX3CL1/FN1,4
GO:0035455,response to interferon-alpha,4/565,18/10364,0.014505596842020855,0.051872154977354305,0.034156426322732726,IFIT3/IFITM2/IFITM1/IFITM3,4
GO:0036075,replacement ossification,4/565,18/10364,0.014505596842020855,0.051872154977354305,0.034156426322732726,ALPL/TMEM119/COL1A1/FGFR3,4
GO:0042596,fear response,4/565,18/10364,0.014505596842020855,0.051872154977354305,0.034156426322732726,ATP1A2/ADRA2A/MDK/APOE,4
GO:0043171,peptide catabolic process,4/565,18/10364,0.014505596842020855,0.051872154977354305,0.034156426322732726,ANPEP/ACE/GGT5/ERAP2,4
GO:0048799,animal organ maturation,4/565,18/10364,0.014505596842020855,0.051872154977354305,0.034156426322732726,ZBTB16/IGF1/LTF/FGFR3,4
GO:0051043,regulation of membrane protein ectodomain proteolysis,4/565,18/10364,0.014505596842020855,0.051872154977354305,0.034156426322732726,ADRA2A/APOE/TIMP3/TIMP1,4
GO:0060669,embryonic placenta morphogenesis,4/565,18/10364,0.014505596842020855,0.051872154977354305,0.034156426322732726,CCN1/IGF2/ADM/SOCS3,4
GO:1901099,negative regulation of signal transduction in absence of ligand,4/565,18/10364,0.014505596842020855,0.051872154977354305,0.034156426322732726,IFI6/CX3CL1/HSPA1A/HSPA1B,4
GO:1903318,negative regulation of protein maturation,4/565,18/10364,0.014505596842020855,0.051872154977354305,0.034156426322732726,THBS1/SERPINE2/SERPINE1/GAS1,4
GO:2001240,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand,4/565,18/10364,0.014505596842020855,0.051872154977354305,0.034156426322732726,IFI6/CX3CL1/HSPA1A/HSPA1B,4
GO:0001657,ureteric bud development,7/565,48/10364,0.014507478614819415,0.051872154977354305,0.034156426322732726,AGT/SOX9/SLIT2/BASP1/VEGFA/SFRP1/GPC3,7
GO:0061326,renal tubule development,7/565,48/10364,0.014507478614819415,0.051872154977354305,0.034156426322732726,AGT/COL4A1/SOX9/LIF/VEGFA/GPC3/CD24,7
GO:0070527,platelet aggregation,7/565,48/10364,0.014507478614819415,0.051872154977354305,0.034156426322732726,HBB/ITGB3/C1QTNF1/FN1/SERPINE2/MYL9/HSPB1,7
GO:0045621,positive regulation of lymphocyte differentiation,9/565,71/10364,0.01453203696902706,0.051914624215703996,0.0341843911800113,MDK/ZBTB16/LILRB2/NFKBIZ/BCL6/IL7R/HLA-G/HLA-DRB1/EGR3,9
GO:0002790,peptide secretion,14/565,135/10364,0.015249460598819693,0.05443007122194231,0.035840745738151915,S100A8/ALOX5/ADRA2A/SYT7/CCL5/IL1RN/INHBB/CD38/EDN1/HLA-DRB1/GPER1/SFRP1/CCN3/ABCA1,14
GO:0048568,embryonic organ development,21/565,232/10364,0.015429921665290865,0.05502621890043624,0.03623329303576922,ID3/CCN1/NES/PRRX1/IGF2/ADM/APLNR/FBN1/ALDH1A3/NTN1/KRT19/SOX9/SOCS3/JUNB/FRZB/SOX18/LIF/CXCL8/TUBB2B/EDN1/VEGFA,21
GO:0014896,muscle hypertrophy,8/565,60/10364,0.015554567582930452,0.05542245403352243,0.03649420327047308,RGS2/AGT/IGF1/IGFBP5/KLF15/EDN1/PI16/NR4A3,8
GO:0048592,eye morphogenesis,10/565,84/10364,0.01561919697637931,0.05560434123591035,0.03661397112723791,MFSD2A/THY1/FBN1/ALDH1A3/SOX9/COL8A1/VEGFA/PTN/NTRK2/COL5A1,10
GO:0002437,inflammatory response to antigenic stimulus,6/565,38/10364,0.01591160231383592,0.056546961695177304,0.0372346614818474,FCGR2B/CD68/C3/ICAM1/IL1RN/HLA-DRB1,6
GO:0042509,regulation of tyrosine phosphorylation of STAT protein,6/565,38/10364,0.01591160231383592,0.056546961695177304,0.0372346614818474,IGF1/CCL5/SOCS3/LIF/FGFR3/CSF1R,6
GO:0001954,positive regulation of cell-matrix adhesion,7/565,49/10364,0.01615551429752614,0.057165665975861715,0.03764206169855293,THY1/CX3CL1/VEGFA/CD36/SFRP1/CCL21/CD3E,7
GO:0002292,T cell differentiation involved in immune response,7/565,49/10364,0.01615551429752614,0.057165665975861715,0.03764206169855293,FCER1G/BCL3/NFKBIZ/BCL6/HLA-DRB1/FGL2/RORC,7
GO:0048008,platelet-derived growth factor receptor signaling pathway,7/565,49/10364,0.01615551429752614,0.057165665975861715,0.03764206169855293,F3/CSPG4/APOD/PDGFRB/VEGFA/PLAT/NR4A3,7
GO:0072163,mesonephric epithelium development,7/565,49/10364,0.01615551429752614,0.057165665975861715,0.03764206169855293,AGT/SOX9/SLIT2/BASP1/VEGFA/SFRP1/GPC3,7
GO:0072164,mesonephric tubule development,7/565,49/10364,0.01615551429752614,0.057165665975861715,0.03764206169855293,AGT/SOX9/SLIT2/BASP1/VEGFA/SFRP1/GPC3,7
GO:0043280,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process,11/565,97/10364,0.016218728826056326,0.0573397891311525,0.037756717138014956,CCN1/F3/S100A9/S100A8/CLEC7A/P2RX1/NGFR/TNFSF10/CCN2/GPER1/NLRP2,11
GO:0014075,response to amine,5/565,28/10364,0.01638311261230907,0.0577712859903474,0.038040846276008455,RGS2/NR4A1/NQO1/ICAM1/NR4A2,5
GO:0030850,prostate gland development,5/565,28/10364,0.01638311261230907,0.0577712859903474,0.038040846276008455,CRIP1/SOX9/SFRP1/SULF1/TNC,5
GO:1905314,semi-lunar valve development,5/565,28/10364,0.01638311261230907,0.0577712859903474,0.038040846276008455,SOX9/EMILIN1/SLIT2/SLIT3/ELN,5
GO:0050803,regulation of synapse structure or activity,13/565,123/10364,0.01641621066105095,0.05783818110700739,0.03808489492069163,FCGR2B/SRGN/FLRT2/NTN1/APOE/LILRB2/CLSTN2/MDGA1/THBS2/RELN/PTN/NTRK2/LRRN3,13
GO:0015833,peptide transport,15/565,150/10364,0.0167122890504773,0.0588307062533569,0.038738446176650565,S100A8/ALOX5/ADRA2A/SYT7/CCL5/IL1RN/INHBB/CD38/EDN1/HLA-DRB1/GPER1/SFRP1/CA2/CCN3/ABCA1,15
GO:0048469,cell maturation,10/565,85/10364,0.016870075544484026,0.059335128246664606,0.03907059456449954,C1QA/CLEC7A/CX3CL1/C3/KLF2/NR4A2/SOX18/CDKN1A/VEGFA/CCL21,10
GO:0071900,regulation of protein serine/threonine kinase activity,23/565,263/10364,0.01692647147857894,0.059482381316139206,0.03916755677130397,RGS2/AGT/ADRA2A/IGF2/CDKN1C/THY1/THBS1/APOE/SPATC1L/LTF/UCHL1/SFRP2/CSF1R/PDGFRB/DUSP1/EDN1/TNXB/CDKN1A/VEGFA/TCIM/SFRP1/TENM1/CD24,23
GO:0014902,myotube differentiation,8/565,61/10364,0.017077575666648026,0.059910535372113986,0.03944948476280666,IGF1/TMEM119/CACNA1H/GDF15/CYP26B1/ADAMTS5/SIK1/CCN3,8
GO:0030510,regulation of BMP signaling pathway,8/565,61/10364,0.017077575666648026,0.059910535372113986,0.03944948476280666,CCN1/FBN1/HTRA3/SFRP2/SFRP1/SULF1/CHRDL1/GPC3,8
GO:0007548,sex differentiation,14/565,137/10364,0.01715682650918133,0.060137027164887294,0.039598623549038744,AKR1C3/SOX9/ICAM1/INHBB/ADAMTS1/TNFSF10/SLIT2/SFRP2/BASP1/PDGFRB/SLIT3/VEGFA/SFRP1/CNTFR,14
GO:0030099,myeloid cell differentiation,24/565,278/10364,0.01720655881514568,0.060202821363740854,0.0396419472687991,ISG15/C1QC/CSF3R/JUN/ZBTB16/FOS/FBN1/JUNB/KLF2/TYROBP/ZFP36/LIF/CCR1/LTF/BCL6/CSF1R/HSPA1A/HSPA1B/HLA-DRB1/VEGFA/ITGB8/SFRP1/CA2/GPC3,24
GO:0001654,eye development,19/565,206/10364,0.01721430847156245,0.060202821363740854,0.0396419472687991,MFSD2A/NES/CRYAB/THY1/COL4A1/SMOC1/FBN1/ALDH1A3/SOX9/CYP1B1/COL8A1/PDGFRB/VEGFA/PTN/NTRK2/KLF4/LAMC3/COL5A1/CHRDL1,19
GO:0035637,multicellular organismal signaling,9/565,73/10364,0.017219712705652306,0.060202821363740854,0.0396419472687991,ATP1A2/AGT/CACNA1H/P2RX1/SCN7A/TYMP/PLN/GPER1/NTRK2,9
GO:0048639,positive regulation of developmental growth,11/565,98/10364,0.01740499961813928,0.06069511791879235,0.03996611137994683,CXCL12/IGF2/IGF1/NTN1/FN1/HOPX/BASP1/MAP1B/EDN1/CPNE5/VEGFA,11
GO:0071772,response to BMP,11/565,98/10364,0.01740499961813928,0.06069511791879235,0.03996611137994683,CCN1/FBN1/SOX9/GDF15/HTRA3/SFRP2/EGR1/SFRP1/SULF1/CHRDL1/GPC3,11
GO:0071773,cellular response to BMP stimulus,11/565,98/10364,0.01740499961813928,0.06069511791879235,0.03996611137994683,CCN1/FBN1/SOX9/GDF15/HTRA3/SFRP2/EGR1/SFRP1/SULF1/CHRDL1/GPC3,11
GO:0001975,response to amphetamine,4/565,19/10364,0.017599324299912095,0.060803066399865074,0.040037192566799794,RGS2/NR4A1/ICAM1/NR4A2,4
GO:0032928,regulation of superoxide anion generation,4/565,19/10364,0.017599324299912095,0.060803066399865074,0.040037192566799794,AGT/CLEC7A/ACP5/TYROBP,4
GO:0035094,response to nicotine,4/565,19/10364,0.017599324299912095,0.060803066399865074,0.040037192566799794,VCAM1/ATP1A2/HMOX1/EDN1,4
GO:0061437,renal system vasculature development,4/565,19/10364,0.017599324299912095,0.060803066399865074,0.040037192566799794,ACTA2/EGR1/PDGFRB/ANGPT1,4
GO:0061440,kidney vasculature development,4/565,19/10364,0.017599324299912095,0.060803066399865074,0.040037192566799794,ACTA2/EGR1/PDGFRB/ANGPT1,4
GO:0065005,protein-lipid complex assembly,4/565,19/10364,0.017599324299912095,0.060803066399865074,0.040037192566799794,MFSD2A/APOE/APOC1/ABCA1,4
GO:0071715,icosanoid transport,4/565,19/10364,0.017599324299912095,0.060803066399865074,0.040037192566799794,PLA2G2A/ABCC3/ACE/EDN1,4
GO:0140353,lipid export from cell,4/565,19/10364,0.017599324299912095,0.060803066399865074,0.040037192566799794,AGT/C1QTNF1/SPP1/EDN1,4
GO:1902992,negative regulation of amyloid precursor protein catabolic process,4/565,19/10364,0.017599324299912095,0.060803066399865074,0.040037192566799794,IGF1/APOE/CLU/NTRK2,4
GO:1904706,negative regulation of vascular associated smooth muscle cell proliferation,4/565,19/10364,0.017599324299912095,0.060803066399865074,0.040037192566799794,CNN1/HMOX1/CDKN1A/GPER1,4
GO:1990776,response to angiotensin,4/565,19/10364,0.017599324299912095,0.060803066399865074,0.040037192566799794,PTGS2/AGT/CA2/CYBB,4
GO:0008585,female gonad development,7/565,50/10364,0.017931916519741055,0.06184773903270419,0.040725081547516376,ICAM1/INHBB/ADAMTS1/SLIT2/SLIT3/VEGFA/SFRP1,7
GO:0051899,membrane depolarization,7/565,50/10364,0.017931916519741055,0.06184773903270419,0.040725081547516376,IFI6/JUN/ATP1A2/DCN/CACNA1H/SCN7A/EDN1,7
GO:0042130,negative regulation of T cell proliferation,6/565,39/10364,0.01796497785031233,0.06185754358215196,0.04073153758102774,LRRC32/LILRB2/HLA-G/HLA-DRB1/GPNMB/VSIG4,6
GO:2000401,regulation of lymphocyte migration,6/565,39/10364,0.01796497785031233,0.06185754358215196,0.04073153758102774,CXCL12/CCL2/CCL5/APOD/CCL21/PADI2,6
GO:0007626,locomotory behavior,11/565,99/10364,0.018654782738728875,0.06412483671902268,0.042224489455022,NEGR1/ATP1A2/CXCL12/SNCG/ALDH1A3/APOE/NR4A2/UCHL1/ARRDC3/EGR1/RELN,11
GO:0055076,transition metal ion homeostasis,11/565,99/10364,0.018654782738728875,0.06412483671902268,0.042224489455022,S100A9/S100A8/MT2A/MT1E/MT1M/MT1X/SLC11A1/HMOX1/LTF/STEAP4/LCN2,11
GO:0007612,learning,9/565,74/10364,0.01869182555700016,0.06419826663620692,0.042272841091025616,JUN/ATP1A2/PTGS2/AGT/FOS/CLDN5/RELN/PTN/NTRK2,9
GO:0051402,neuron apoptotic process,16/565,166/10364,0.018920289462019995,0.0644515840976562,0.04243964386241676,JUN/NES/MDK/CX3CL1/NQO1/CCL2/NGFR/TYROBP/APOE/C5AR1/NR4A2/HMOX1/ANGPT1/CNTFR/NTRK2/LCN2,16
GO:0045601,regulation of endothelial cell differentiation,5/565,29/10364,0.018933540213144782,0.0644515840976562,0.04243964386241676,ATOH8/ID1/CLDN5/VEGFA/S1PR3,5
GO:0050873,brown fat cell differentiation,5/565,29/10364,0.018933540213144782,0.0644515840976562,0.04243964386241676,FABP3/PTGS2/RGS2/LAMB3/LRG1,5
GO:0017014,protein nitrosylation,3/565,11/10364,0.019143106463133375,0.0644515840976562,0.04243964386241676,S100A9/S100A8/ACE,3
GO:0018119,peptidyl-cysteine S-nitrosylation,3/565,11/10364,0.019143106463133375,0.0644515840976562,0.04243964386241676,S100A9/S100A8/ACE,3
GO:0030502,negative regulation of bone mineralization,3/565,11/10364,0.019143106463133375,0.0644515840976562,0.04243964386241676,SRGN/SOX9/CCR1,3
GO:0032488,Cdc42 protein signal transduction,3/565,11/10364,0.019143106463133375,0.0644515840976562,0.04243964386241676,NTN1/APOE/ABCA1,3
GO:0032717,negative regulation of interleukin-8 production,3/565,11/10364,0.019143106463133375,0.0644515840976562,0.04243964386241676,BCL3/SSC5D/KLF4,3
GO:0034433,steroid esterification,3/565,11/10364,0.019143106463133375,0.0644515840976562,0.04243964386241676,AGT/APOE/APOC1,3
GO:0034434,sterol esterification,3/565,11/10364,0.019143106463133375,0.0644515840976562,0.04243964386241676,AGT/APOE/APOC1,3
GO:0034435,cholesterol esterification,3/565,11/10364,0.019143106463133375,0.0644515840976562,0.04243964386241676,AGT/APOE/APOC1,3
GO:0038065,collagen-activated signaling pathway,3/565,11/10364,0.019143106463133375,0.0644515840976562,0.04243964386241676,COL4A1/COL4A2/COL1A1,3
GO:0042044,fluid transport,3/565,11/10364,0.019143106463133375,0.0644515840976562,0.04243964386241676,EDN1/AQP1/AQP3,3
GO:0042308,negative regulation of protein import into nucleus,3/565,11/10364,0.019143106463133375,0.0644515840976562,0.04243964386241676,APOD/CD36/ANGPT1,3
GO:0045986,negative regulation of smooth muscle contraction,3/565,11/10364,0.019143106463133375,0.0644515840976562,0.04243964386241676,PTGS2/RGS2/KCNMA1,3
GO:0050746,regulation of lipoprotein metabolic process,3/565,11/10364,0.019143106463133375,0.0644515840976562,0.04243964386241676,DGAT2/ITGB3/APOD,3
GO:0051547,regulation of keratinocyte migration,3/565,11/10364,0.019143106463133375,0.0644515840976562,0.04243964386241676,FGF7/HBEGF/EPPK1,3
GO:0060026,convergent extension,3/565,11/10364,0.019143106463133375,0.0644515840976562,0.04243964386241676,FRZB/SFRP2/SFRP1,3
GO:0060384,innervation,3/565,11/10364,0.019143106463133375,0.0644515840976562,0.04243964386241676,VCAM1/SERPINE2/SULF1,3
GO:0070424,regulation of nucleotide-binding oligomerization domain containing signaling pathway,3/565,11/10364,0.019143106463133375,0.0644515840976562,0.04243964386241676,BIRC3/HSPA1A/HSPA1B,3
GO:0071880,adenylate cyclase-activating adrenergic receptor signaling pathway,3/565,11/10364,0.019143106463133375,0.0644515840976562,0.04243964386241676,ADRA2A/ARRDC3/PLN,3
GO:0090649,response to oxygen-glucose deprivation,3/565,11/10364,0.019143106463133375,0.0644515840976562,0.04243964386241676,"NAMPT/AQP3/LCN2",3
GO:1904590,negative regulation of protein import,3/565,11/10364,0.019143106463133375,0.0644515840976562,0.04243964386241676,APOD/CD36/ANGPT1,3
GO:0071214,cellular response to abiotic stimulus,21/565,237/10364,0.019159154334843085,0.0644515840976562,0.04243964386241676,ATP1A2/PTGS2/AGT/ADIRF/CRYAB/CRIP1/MMP2/MFAP4/COL1A1/SOX9/TNFSF14/MYLK/MME/SFRP2/EGR1/CDKN1A/AQP1/NAMPT/PTN/SFRP1/TIMP1,21
GO:0104004,cellular response to environmental stimulus,21/565,237/10364,0.019159154334843085,0.0644515840976562,0.04243964386241676,ATP1A2/PTGS2/AGT/ADIRF/CRYAB/CRIP1/MMP2/MFAP4/COL1A1/SOX9/TNFSF14/MYLK/MME/SFRP2/EGR1/CDKN1A/AQP1/NAMPT/PTN/SFRP1/TIMP1,21
GO:0008630,intrinsic apoptotic signaling pathway in response to DNA damage,10/565,87/10364,0.019591890791029173,0.06574524663809297,0.04329148603608777,MUC1/CXCL12/DDIT4/CRIP1/BCL3/ACKR3/HMOX1/SFRP2/CDKN1A/CLU,10
GO:0014074,response to purine-containing compound,10/565,87/10364,0.019591890791029173,0.06574524663809297,0.04329148603608777,JUN/PTGS2/FOS/P2RX1/COL1A1/FOSB/IGFBP5/THBD/DUSP1/AQP1,10
GO:0048754,branching morphogenesis of an epithelial tube,10/565,87/10364,0.019591890791029173,0.06574524663809297,0.04329148603608777,AGT/MDK/COL4A1/SOX9/SLIT2/SFRP2/EDN1/VEGFA/TNC/GPC3,10
GO:0010633,negative regulation of epithelial cell migration,7/565,51/10364,0.019841344578682203,0.06647337537244268,0.04377093932811192,DCN/THBS1/APOE/ADAMTS9/SLIT2/KLF4/EPPK1,7
GO:0055006,cardiac cell development,7/565,51/10364,0.019841344578682203,0.06647337537244268,0.04377093932811192,RGS2/AGT/IGF1/PDGFRB/EDN1/PI16/VEGFA,7
GO:0008643,carbohydrate transport,11/565,100/10364,0.01996996167065145,0.0667404270037935,0.043946785682954556,MFSD2A/SLC2A3/IGF1/C3/HK2/KLF15/EDN1/AQP1/AQP3/NR4A3/GPC3,11
GO:0106106,cold-induced thermogenesis,11/565,100/10364,0.01996996167065145,0.0667404270037935,0.043946785682954556,G0S2/SCD/CMKLR1/ID1/ADAMTS5/NPR3/ARRDC3/VEGFA/CD36/GADD45G/LCN2,11
GO:0120161,regulation of cold-induced thermogenesis,11/565,100/10364,0.01996996167065145,0.0667404270037935,0.043946785682954556,G0S2/SCD/CMKLR1/ID1/ADAMTS5/NPR3/ARRDC3/VEGFA/CD36/GADD45G/LCN2,11
GO:0007260,tyrosine phosphorylation of STAT protein,6/565,40/10364,0.020192801106486403,0.06737516522408747,0.04436474381993881,IGF1/CCL5/SOCS3/LIF/FGFR3/CSF1R,6
GO:0045685,regulation of glial cell differentiation,6/565,40/10364,0.020192801106486403,0.06737516522408747,0.04436474381993881,EGR2/MDK/LDLR/SERPINE2/LIF/PTN,6
GO:0031644,regulation of nervous system process,8/565,63/10364,0.02044036351649902,0.06809019384584783,0.04483557103828872,AGT/EGR2/ITGAX/S100B/TYMP/EDN1/RELN/CCN3,8
GO:0071229,cellular response to acid chemical,8/565,63/10364,0.02044036351649902,0.06809019384584783,0.04483557103828872,COL4A1/MMP2/COL1A1/KLF2/VEGFA/COL1A2/NTRK2/CYBB,8
GO:0044089,positive regulation of cellular component biogenesis,31/565,388/10364,0.020715618750781744,0.06895101070382151,0.045402395909929005,ISG15/GBP5/LMOD1/AGT/THY1/CLEC7A/FLRT2/CX3CL1/TPPP3/SOX9/ICAM1/EMILIN1/ID1/CLDN5/CLSTN2/SYNPO2/MAP1B/HSPA1A/HSPA1B/VEGFA/CCN2/THBS2/CD36/CLU/SFRP1/CCL21/NTRK2/ABCA1/TENM1/LRRN3/ELAPOR1,31
GO:0044283,small molecule biosynthetic process,30/565,373/10364,0.020870535626234473,0.06929842682470799,0.04563116013114884,GSTM1/PHGDH/PTGS2/ATF3/AKR1C3/ALOX5/SCD/ADM/FADS2/DGAT2/NNMT/BCAT1/ALDH1A3/CACNA1H/CES1/APOE/APOC1/THNSL2/PTGIS/SIK1/GGT5/SLC1A3/EGR1/EDN1/GPER1/MLXIPL/PDK4/LPL/PTGDS/MOXD1,30
GO:0032504,multicellular organism reproduction,33/565,419/10364,0.020957666858115172,0.06929842682470799,0.04563116013114884,PTGS2/RGS2/MDK/FOLR2/BIRC3/ZBTB16/IGF1/TMEM119/TPPP3/P2RX1/ACE/SOX9/JUNB/CYP26B1/INHBB/SERPINE2/ADAMTS1/SPATC1L/GGT5/LIF/BCL6/SLIT2/SPP1/HPGD/EGR1/SLIT3/STC2/ADAMTS2/EDN1/PTN/ADAM28/SFRP1/TOP2A,33
GO:0007259,receptor signaling pathway via JAK-STAT,10/565,88/10364,0.02106735227764763,0.06929842682470799,0.04563116013114884,AGT/IGF1/CCL2/CCL5/SOCS3/BCL3/CYP1B1/LIF/FGFR3/CSF1R,10
GO:0090090,negative regulation of canonical Wnt signaling pathway,10/565,88/10364,0.02106735227764763,0.06929842682470799,0.04563116013114884,MDK/IGFBP6/SOX9/APOE/FRZB/IGFBP2/SFRP2/EGR1/SFRP1/GPC3,10
GO:0003044,regulation of systemic arterial blood pressure mediated by a chemical signal,4/565,20/10364,0.021073898729057513,0.06929842682470799,0.04563116013114884,AGT/ACE/MME/EDN1,4
GO:0006929,substrate-dependent cell migration,4/565,20/10364,0.021073898729057513,0.06929842682470799,0.04563116013114884,CSPG4/NTN1/FN1/SLIT2,4
GO:0010837,regulation of keratinocyte proliferation,4/565,20/10364,0.021073898729057513,0.06929842682470799,0.04563116013114884,MDK/FGF7/ZFP36/EPPK1,4
GO:0010875,positive regulation of cholesterol efflux,4/565,20/10364,0.021073898729057513,0.06929842682470799,0.04563116013114884,CES1/ABCA8/APOE/ABCA1,4
GO:0019883,antigen processing and presentation of endogenous antigen,4/565,20/10364,0.021073898729057513,0.06929842682470799,0.04563116013114884,ERAP2/HLA-G/HLA-DRB1/AZGP1,4
GO:0032069,regulation of nuclease activity,4/565,20/10364,0.021073898729057513,0.06929842682470799,0.04563116013114884,OAS1/OAS3/OAS2/HSPA1A,4
GO:0035886,vascular associated smooth muscle cell differentiation,4/565,20/10364,0.021073898729057513,0.06929842682470799,0.04563116013114884,ADM/APLNR/VEGFA/GPER1,4
GO:0036336,dendritic cell migration,4/565,20/10364,0.021073898729057513,0.06929842682470799,0.04563116013114884,ALOX5/CCL5/CCR1/CCL21,4
GO:0045742,positive regulation of epidermal growth factor receptor signaling pathway,4/565,20/10364,0.021073898729057513,0.06929842682470799,0.04563116013114884,AGT/ADRA2A/HBEGF/GPER1,4
GO:0060325,face morphogenesis,4/565,20/10364,0.021073898729057513,0.06929842682470799,0.04563116013114884,MMP2/CRISPLD2/COL1A1/CLDN5,4
GO:2000352,negative regulation of endothelial cell apoptotic process,4/565,20/10364,0.021073898729057513,0.06929842682470799,0.04563116013114884,ANGPTL4/ICAM1/SERPINE1/ANGPT1,4
GO:0045619,regulation of lymphocyte differentiation,12/565,114/10364,0.021259505569787653,0.06979664458918255,0.04595922320029222,MDK/ZBTB16/LILRB2/CYP26B1/NFKBIZ/BCL6/IL7R/HLA-G/HLA-DRB1/FGL2/EGR3/SFRP1,12
GO:0090087,regulation of peptide transport,12/565,114/10364,0.021259505569787653,0.06979664458918255,0.04595922320029222,S100A8/ALOX5/ADRA2A/SYT7/CCL5/INHBB/CD38/HLA-DRB1/GPER1/SFRP1/CA2/CCN3,12
GO:0002700,regulation of production of molecular mediator of immune response,11/565,101/10364,0.02135239730641921,0.07004544436897456,0.04612305119917308,FCGR2B/CLEC7A/SLC7A5/HMOX1/BCL6/SPON2/HLA-G/CD36/ANGPT1/NR4A3/CD22,11
GO:0019933,cAMP-mediated signaling,5/565,30/10364,0.021731730688798037,0.07117576435195133,0.04686733666864149,RGS2/ADM/APLNR/SOX9/ADCY1,5
GO:0043090,amino acid import,5/565,30/10364,0.021731730688798037,0.07117576435195133,0.04686733666864149,ATP1A2/RGS2/AGT/SLC7A5/SLC1A3,5
GO:0001885,endothelial cell development,7/565,52/10364,0.021888275650497713,0.0715739620711962,0.047129539213826,GSTM3/ICAM1/SOX18/CLDN5/VEGFA/S1PR3/COL15A1,7
GO:0046545,development of primary female sexual characteristics,7/565,52/10364,0.021888275650497713,0.0715739620711962,0.047129539213826,ICAM1/INHBB/ADAMTS1/SLIT2/SLIT3/VEGFA/SFRP1,7
GO:0097553,calcium ion transmembrane import into cytosol,9/565,76/10364,0.02190654232689405,0.07157652377199063,0.04713122602526623,ATP1A2/APLNR/THY1/CX3CL1/P2RX1/PLN/GPER1/RAMP3/CCL21,9
GO:0052126,movement in host environment,13/565,128/10364,0.02215070617367401,0.07231657980464226,0.04761853312413257,MRC1/IFITM2/IFITM1/IFITM3/ANPEP/ITGB3/ICAM1/LDLR/SIGLEC1/CXCL8/HSPA1A/HSPA1B/HLA-DRB1,13
GO:0003151,outflow tract morphogenesis,6/565,41/10364,0.02260102539347817,0.07361065868011107,0.04847064944328401,SOX18/CLDN5/SFRP2/VEGFA/ELN/SEMA3C,6
GO:0010596,negative regulation of endothelial cell migration,6/565,41/10364,0.02260102539347817,0.07361065868011107,0.04847064944328401,DCN/THBS1/APOE/ADAMTS9/SLIT2/KLF4,6
GO:1904427,positive regulation of calcium ion transmembrane transport,6/565,41/10364,0.02260102539347817,0.07361065868011107,0.04847064944328401,APLNR/THY1/CX3CL1/P2RX1/GPER1/RAMP3,6
GO:0007623,circadian rhythm,14/565,142/10364,0.022719226704570335,0.07393681568244113,0.0486854151036772,ID3/JUN/NGFR/ID1/SIK1/BHLHE40/EGR1/ADCY1/NAMPT/EGR3/NTRK2/PTGDS/RORC/TOP2A,14
GO:0001933,negative regulation of protein phosphorylation,22/565,256/10364,0.022962181178870673,0.07466812529491385,0.04916696291884771,NIBAN1/RGS2/AGT/DDIT4/CDKN1C/THY1/GPRC5A/SOCS3/GADD45B/APOE/EMILIN1/FBLN1/SLIT2/UCHL1/SFRP2/DUSP1/CDKN1A/IGFBP3/MLXIPL/HSPB1/SFRP1/ANGPT1,22
GO:0031345,negative regulation of cell projection organization,13/565,129/10364,0.023457225249068514,0.07621736521403691,0.05018709595895111,THY1/NTN1/SEMA6B/APOE/ID1/SEMA3G/CD38/SLIT2/SPP1/SPOCK1/SEMA3C/CCL21/RAP1GAP,13
GO:0010469,regulation of signaling receptor activity,9/565,77/10364,0.023654539381390373,0.0767366752990588,0.050529047756894443,FCGR2B/ADRA2A/GPRC5A/CCL2/HBEGF/EDN1/RAMP3/SERPINE1/RELN,9
GO:0034644,cellular response to UV,9/565,77/10364,0.023654539381390373,0.0767366752990588,0.050529047756894443,PTGS2/CRIP1/MMP2/MFAP4/MME/CDKN1A/AQP1/PTN/TIMP1,9
GO:1904892,regulation of receptor signaling pathway via STAT,7/565,53/10364,0.0240769874406312,0.07804527837050208,0.0513907278705309,AGT/CCL5/SOCS3/BCL3/CYP1B1/LIF/IL7R,7
GO:0034109,homotypic cell-cell adhesion,8/565,65/10364,0.02424845999538074,0.07839185848879258,0.05161894160640676,HBB/CCL5/ITGB3/C1QTNF1/FN1/SERPINE2/MYL9/HSPB1,8
GO:0002643,regulation of tolerance induction,3/565,12/10364,0.024509423269578532,0.07839185848879258,0.05161894160640676,LILRB2/HLA-G/CD3E,3
GO:0003091,renal water homeostasis,3/565,12/10364,0.024509423269578532,0.07839185848879258,0.05161894160640676,CYP4F12/AQP1/AQP3,3
GO:0015872,dopamine transport,3/565,12/10364,0.024509423269578532,0.07839185848879258,0.05161894160640676,CXCL12/SNCG/SYT7,3
GO:0034114,regulation of heterotypic cell-cell adhesion,3/565,12/10364,0.024509423269578532,0.07839185848879258,0.05161894160640676,THY1/IL1RN/KLF4,3
GO:0035809,regulation of urine volume,3/565,12/10364,0.024509423269578532,0.07839185848879258,0.05161894160640676,ADM/NPR3/EDN1,3
GO:0043117,positive regulation of vascular permeability,3/565,12/10364,0.024509423269578532,0.07839185848879258,0.05161894160640676,APOE/VEGFA/ANGPT1,3
GO:0048265,response to pain,3/565,12/10364,0.024509423269578532,0.07839185848879258,0.05161894160640676,THBS1/THBS4/RELN,3
GO:0048385,regulation of retinoic acid receptor signaling pathway,3/565,12/10364,0.024509423269578532,0.07839185848879258,0.05161894160640676,AKR1C3/KLF2/CYP26B1,3
GO:0055089,fatty acid homeostasis,3/565,12/10364,0.024509423269578532,0.07839185848879258,0.05161894160640676,DGAT2/APOE/MLXIPL,3
GO:0060907,positive regulation of macrophage cytokine production,3/565,12/10364,0.024509423269578532,0.07839185848879258,0.05161894160640676,SPON2/HLA-G/CD36,3
GO:0061450,trophoblast cell migration,3/565,12/10364,0.024509423269578532,0.07839185848879258,0.05161894160640676,ITGB4/VEGFA/TIMP1,3
GO:0070206,protein trimerization,3/565,12/10364,0.024509423269578532,0.07839185848879258,0.05161894160640676,HLA-G/STEAP4/COL1A2,3
GO:0070278,extracellular matrix constituent secretion,3/565,12/10364,0.024509423269578532,0.07839185848879258,0.05161894160640676,AGT/CREB3L1/CCN2,3
GO:0072273,metanephric nephron morphogenesis,3/565,12/10364,0.024509423269578532,0.07839185848879258,0.05161894160640676,SOX9/LIF/PDGFRB,3
GO:0090399,replicative senescence,3/565,12/10364,0.024509423269578532,0.07839185848879258,0.05161894160640676,MME/CDKN1A/SERPINE1,3
GO:0099560,synaptic membrane adhesion,3/565,12/10364,0.024509423269578532,0.07839185848879258,0.05161894160640676,SPARCL1/MDGA1/LRRC4,3
GO:0010171,body morphogenesis,5/565,31/10364,0.024785449597519996,0.07884486889540768,0.05191723683982698,MMP2/CRISPLD2/COL1A1/CLDN5/GPC3,5
GO:0038084,vascular endothelial growth factor signaling pathway,5/565,31/10364,0.024785449597519996,0.07884486889540768,0.05191723683982698,DCN/PDGFRB/VEGFA/SMOC2/HSPB1,5
GO:1905953,negative regulation of lipid localization,5/565,31/10364,0.024785449597519996,0.07884486889540768,0.05191723683982698,THBS1/CES1/ITGB3/APOC1/ABCA1,5
GO:0031346,positive regulation of cell projection organization,22/565,258/10364,0.02482458683496218,0.07884486889540768,0.05191723683982698,NEGR1/S100A9/RGS2/AGT/CXCL12/MDK/CNTN1/CX3CL1/NTN1/APOE/FN1/SLIT2/MAP1B/VEGFA/RELN/PLXNA4/PTN/ENPP2/CCL21/NTRK2/TENM1/LCN2,22
GO:0001941,postsynaptic membrane organization,4/565,21/10364,0.024939937767355386,0.07884486889540768,0.05191723683982698,APOE/RELN/PTN/LRRC4,4
GO:0010560,positive regulation of glycoprotein biosynthetic process,4/565,21/10364,0.024939937767355386,0.07884486889540768,0.05191723683982698,IGF1/RAMP1/IL33/CCL21,4
GO:0010737,protein kinase A signaling,4/565,21/10364,0.024939937767355386,0.07884486889540768,0.05191723683982698,SPATC1L/AKAP12/RAMP3/TCIM,4
GO:0032633,interleukin-4 production,4/565,21/10364,0.024939937767355386,0.07884486889540768,0.05191723683982698,FCER1G/SLC7A5/HLA-DRB1/CD3E,4
GO:0032673,regulation of interleukin-4 production,4/565,21/10364,0.024939937767355386,0.07884486889540768,0.05191723683982698,FCER1G/SLC7A5/HLA-DRB1/CD3E,4
GO:0042461,photoreceptor cell development,4/565,21/10364,0.024939937767355386,0.07884486889540768,0.05191723683982698,MFSD2A/THY1/VEGFA/NTRK2,4
GO:0042908,xenobiotic transport,4/565,21/10364,0.024939937767355386,0.07884486889540768,0.05191723683982698,SLC7A5/ABCC3/ABCA8/ABCG2,4
GO:0051281,positive regulation of release of sequestered calcium ion into cytosol,4/565,21/10364,0.024939937767355386,0.07884486889540768,0.05191723683982698,APLNR/THY1/CX3CL1/GPER1,4
GO:0061081,positive regulation of myeloid leukocyte cytokine production involved in immune response,4/565,21/10364,0.024939937767355386,0.07884486889540768,0.05191723683982698,SPON2/HLA-G/CD36/NR4A3,4
GO:1902742,apoptotic process involved in development,4/565,21/10364,0.024939937767355386,0.07884486889540768,0.05191723683982698,CCN1/CRYAB/SLIT2/SLIT3,4
GO:1904752,regulation of vascular associated smooth muscle cell migration,4/565,21/10364,0.024939937767355386,0.07884486889540768,0.05191723683982698,AGT/IGFBP5/ADAMTS1/NR4A3,4
GO:0002931,response to ischemia,6/565,42/10364,0.025195205539930283,0.07952904508903207,0.05236774855964083,CX3CL1/NQO1/HK2/UCHL1/EGR1/CSF1R,6
GO:0050771,negative regulation of axonogenesis,6/565,42/10364,0.025195205539930283,0.07952904508903207,0.05236774855964083,THY1/NTN1/SEMA6B/SEMA3G/SPP1/SEMA3C,6
GO:1904062,regulation of cation transmembrane transport,17/565,186/10364,0.02530463103031058,0.0798129117396699,0.05255466715483367,ATP1A2/RGS2/AGT/ADRA2A/APLNR/THY1/CX3CL1/RRAD/P2RX1/CCL2/PLN/GPER1/RAMP3/RELN/GEM/KCNN4/LCN2,17
GO:0007416,synapse assembly,9/565,78/10364,0.025499771747233307,0.08036648616872452,0.05291918110665248,FLRT2/NTN1/CLSTN2/MAP1B/MDGA1/THBS2/NTRK2/LRRN3/LRRC4,9
GO:0032147,activation of protein kinase activity,10/565,91/10364,0.025978271021852007,0.08181157043343239,0.05387073043478785,CHI3L1/AGT/ADRA2A/GPRC5A/IGF1/CCL5/ITGB3/SLC11A1/VEGFA/ANGPT1,10
GO:0001892,embryonic placenta development,7/565,54/10364,0.026411541991392114,0.08298453792230186,0.05464309814594273,CCN1/IGF2/ADM/KRT19/SOCS3/JUNB/LIF,7
GO:0010827,regulation of glucose transmembrane transport,7/565,54/10364,0.026411541991392114,0.08298453792230186,0.05464309814594273,IGF1/C3/HK2/KLF15/EDN1/NR4A3/GPC3,7
GO:0032755,positive regulation of interleukin-6 production,7/565,54/10364,0.026411541991392114,0.08298453792230186,0.05464309814594273,CLEC7A/TYROBP/LILRB2/SPON2/CD36/LPL/IL33,7
GO:0034329,cell junction assembly,21/565,245/10364,0.026543246062521574,0.08333439369629089,0.054873468813462827,AGT/APLNR/THY1/FLRT2/THBS1/NTN1/ACE/ITGB4/FN1/CLDN5/FAM107A/CLSTN2/APOD/MAP1B/MDGA1/VEGFA/THBS2/SFRP1/NTRK2/LRRN3/LRRC4,21
GO:0060041,retina development in camera-type eye,9/565,79/10364,0.02744474640312187,0.08609869101485129,0.05669368464480349,MFSD2A/THY1/COL4A1/SOX9/CYP1B1/PDGFRB/PTN/NTRK2/LAMC3,9
GO:0006721,terpenoid metabolic process,6/565,43/10364,0.027980474454743786,0.08757802937134637,0.0576677893759849,AKR1C3/DGAT2/ALDH1A3/CYP1B1/CYP26B1/ADH1B,6
GO:0044070,regulation of anion transport,6/565,43/10364,0.027980474454743786,0.08757802937134637,0.0576677893759849,ATP1A2/RGS2/AGT/CES1/EDN1/CA2,6
GO:0061035,regulation of cartilage development,6/565,43/10364,0.027980474454743786,0.08757802937134637,0.0576677893759849,CCN1/MDK/ZBTB16/SOX9/FRZB/CCN2,6
GO:0060976,coronary vasculature development,5/565,32/10364,0.02810155600146538,0.08788981686019808,0.05787309309617855,APLNR/PDGFRB/VEGFA/GPER1/GPC3,5
GO:0008625,extrinsic apoptotic signaling pathway via death domain receptors,8/565,67/10364,0.028527775970739647,0.08908673899634487,0.058661234301709615,ATF3/THBS1/ICAM1/TIMP3/HMOX1/SFRP2/SERPINE1/SFRP1,8
GO:0048593,camera-type eye morphogenesis,8/565,67/10364,0.028527775970739647,0.08908673899634487,0.058661234301709615,MFSD2A/THY1/ALDH1A3/SOX9/COL8A1/VEGFA/PTN/NTRK2,8
GO:0002831,regulation of response to biotic stimulus,19/565,218/10364,0.02908056504917751,0.09058184531817279,0.05964572181622412,ISG15/GBP5/MNDA/FCGR2B/IFIT1/BIRC3/CLEC7A/OAS1/OAS3/CX3CL1/CCL5/TYROBP/APOE/LTF/HLA-G/HLA-DRB1/FGL2/CD36/VSIG4,19
GO:0010830,regulation of myotube differentiation,4/565,22/10364,0.02920567557889303,0.09058184531817279,0.05964572181622412,TMEM119/CYP26B1/SIK1/CCN3,4
GO:0048483,autonomic nervous system development,4/565,22/10364,0.02920567557889303,0.09058184531817279,0.05964572181622412,VCAM1/EGR2/FN1/PLXNA4,4
GO:0050858,negative regulation of antigen receptor-mediated signaling pathway,4/565,22/10364,0.02920567557889303,0.09058184531817279,0.05964572181622412,GBP1/FCGR2B/THY1/CD22,4
GO:0060323,head morphogenesis,4/565,22/10364,0.02920567557889303,0.09058184531817279,0.05964572181622412,MMP2/CRISPLD2/COL1A1/CLDN5,4
GO:0060674,placenta blood vessel development,4/565,22/10364,0.02920567557889303,0.09058184531817279,0.05964572181622412,CCN1/SOCS3/JUNB/ITGB8,4
GO:0090075,relaxation of muscle,4/565,22/10364,0.02920567557889303,0.09058184531817279,0.05964572181622412,ATP1A2/RGS2/KCNMA1/PLN,4
GO:1901186,positive regulation of ERBB signaling pathway,4/565,22/10364,0.02920567557889303,0.09058184531817279,0.05964572181622412,AGT/ADRA2A/HBEGF/GPER1,4
GO:1904738,vascular associated smooth muscle cell migration,4/565,22/10364,0.02920567557889303,0.09058184531817279,0.05964572181622412,AGT/IGFBP5/ADAMTS1/NR4A3,4
GO:0035265,organ growth,11/565,106/10364,0.029336501363195586,0.09084995202792945,0.05982226291197062,RGS2/AGT/IGF2/IGF1/FGF7/SOX9/FGFR3/BASP1/PDGFRB/EDN1/PI16,11
GO:1990845,adaptive thermogenesis,11/565,106/10364,0.029336501363195586,0.09084995202792945,0.05982226291197062,G0S2/SCD/CMKLR1/ID1/ADAMTS5/NPR3/ARRDC3/VEGFA/CD36/GADD45G/LCN2,11
GO:0050768,negative regulation of neurogenesis,9/565,80/10364,0.029491881935853163,0.09112435067576065,0.06000294708061168,THY1/NTN1/SEMA6B/LDLR/ID1/SEMA3G/SPP1/SEMA3C/PTN,9
GO:1903531,negative regulation of secretion by cell,9/565,80/10364,0.029491881935853163,0.09112435067576065,0.06000294708061168,FCGR2B/ADRA2A/APOE/INHBB/LIF/HMOX1/EDN1/SFRP1/CCN3,9
GO:2001243,negative regulation of intrinsic apoptotic signaling pathway,9/565,80/10364,0.029491881935853163,0.09112435067576065,0.06000294708061168,MUC1/PTGS2/CXCL12/CREB3L1/ACKR3/SFRP2/HSPA1A/HSPB1/CLU,9
GO:0003007,heart morphogenesis,14/565,147/10364,0.029532446615378113,0.09118087212922926,0.06004016494560876,CCN1/APLNR/FLRT2/SOX9/SOX18/ADAMTS1/CLDN5/SLIT2/SFRP2/SLIT3/VEGFA/ELN/SEMA3C/COL5A1,14
GO:0030509,BMP signaling pathway,10/565,93/10364,0.029676951809585107,0.09155798094079988,0.06028848100927891,CCN1/FBN1/GDF15/HTRA3/SFRP2/EGR1/SFRP1/SULF1/CHRDL1/GPC3,10
GO:0030900,forebrain development,19/565,219/10364,0.03029345445386704,0.09231684868252041,0.06078817511529961,MFSD2A/ATP1A2/CXCL12/MDK/DCLK1/PCDH9/ALDH1A3/SEMA6B/TYROBP/NR4A2/COL3A1/SLIT2/ANXA3/MDGA1/AQP1/RELN/PLXNA4/PTN/NTRK2,19
GO:0043112,receptor metabolic process,12/565,120/10364,0.030319506578232375,0.09231684868252041,0.06078817511529961,FCER1G/ADM/ITGB3/APOE/ACKR3/RAMP1/CXCL8/VEGFA/RAMP3/CD36/ANGPT1/NSG1,12
GO:0002026,regulation of the force of heart contraction,3/565,13/10364,0.030599404900385978,0.09231684868252041,0.06078817511529961,ATP1A2/ADM/PLN,3
GO:0002283,neutrophil activation involved in immune response,3/565,13/10364,0.030599404900385978,0.09231684868252041,0.06078817511529961,FCER1G/TYROBP/ANXA3,3
GO:0002710,negative regulation of T cell mediated immunity,3/565,13/10364,0.030599404900385978,0.09231684868252041,0.06078817511529961,FCGR2B/IL7R/HLA-G,3
GO:0002719,negative regulation of cytokine production involved in immune response,3/565,13/10364,0.030599404900385978,0.09231684868252041,0.06078817511529961,HMOX1/BCL6/ANGPT1,3
GO:0003081,regulation of systemic arterial blood pressure by renin-angiotensin,3/565,13/10364,0.030599404900385978,0.09231684868252041,0.06078817511529961,AGT/ACE/MME,3
GO:0006700,C21-steroid hormone biosynthetic process,3/565,13/10364,0.030599404900385978,0.09231684868252041,0.06078817511529961,ADM/CACNA1H/EGR1,3
GO:0010771,negative regulation of cell morphogenesis involved in differentiation,3/565,13/10364,0.030599404900385978,0.09231684868252041,0.06078817511529961,GBP1/POSTN/FBLN1,3
GO:0030889,negative regulation of B cell proliferation,3/565,13/10364,0.030599404900385978,0.09231684868252041,0.06078817511529961,MNDA/FCGR2B/TYROBP,3
GO:0031069,hair follicle morphogenesis,3/565,13/10364,0.030599404900385978,0.09231684868252041,0.06078817511529961,FGF7/NGFR/IGFBP5,3
GO:0031643,positive regulation of myelination,3/565,13/10364,0.030599404900385978,0.09231684868252041,0.06078817511529961,EGR2/ITGAX/S100B,3
GO:0032793,positive regulation of CREB transcription factor activity,3/565,13/10364,0.030599404900385978,0.09231684868252041,0.06078817511529961,VEGFA/ADCY1/RELN,3
GO:0034616,response to laminar fluid shear stress,3/565,13/10364,0.030599404900385978,0.09231684868252041,0.06078817511529961,KLF2/ABCA1/KLF4,3
GO:0036035,osteoclast development,3/565,13/10364,0.030599404900385978,0.09231684868252041,0.06078817511529961,FBN1/TYROBP/LTF,3
GO:0044058,regulation of digestive system process,3/565,13/10364,0.030599404900385978,0.09231684868252041,0.06078817511529961,TYMP/SGK1/AQP1,3
GO:0044060,regulation of endocrine process,3/565,13/10364,0.030599404900385978,0.09231684868252041,0.06078817511529961,AGT/C1QTNF1/INHBB,3
GO:0046717,acid secretion,3/565,13/10364,0.030599404900385978,0.09231684868252041,0.06078817511529961,CES1/HRH2/SGK1,3
GO:0051482,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway,3/565,13/10364,0.030599404900385978,0.09231684868252041,0.06078817511529961,C3AR1/TGM2/EDN1,3
GO:0051546,keratinocyte migration,3/565,13/10364,0.030599404900385978,0.09231684868252041,0.06078817511529961,FGF7/HBEGF/EPPK1,3
GO:0051968,"positive regulation of synaptic transmission, glutamatergic",3/565,13/10364,0.030599404900385978,0.09231684868252041,0.06078817511529961,PTGS2/CCL2/RELN,3
GO:0061318,renal filtration cell differentiation,3/565,13/10364,0.030599404900385978,0.09231684868252041,0.06078817511529961,KLF15/BASP1/CD24,3
GO:0072112,glomerular visceral epithelial cell differentiation,3/565,13/10364,0.030599404900385978,0.09231684868252041,0.06078817511529961,KLF15/BASP1/CD24,3
GO:0072311,glomerular epithelial cell differentiation,3/565,13/10364,0.030599404900385978,0.09231684868252041,0.06078817511529961,KLF15/BASP1/CD24,3
GO:0140374,antiviral innate immune response,3/565,13/10364,0.030599404900385978,0.09231684868252041,0.06078817511529961,IFIT1/OAS1/MX1,3
GO:1900017,positive regulation of cytokine production involved in inflammatory response,3/565,13/10364,0.030599404900385978,0.09231684868252041,0.06078817511529961,GBP5/H19/CLEC7A,3
GO:1900025,negative regulation of substrate adhesion-dependent cell spreading,3/565,13/10364,0.030599404900385978,0.09231684868252041,0.06078817511529961,GBP1/POSTN/FBLN1,3
GO:1902644,tertiary alcohol metabolic process,3/565,13/10364,0.030599404900385978,0.09231684868252041,0.06078817511529961,AKR1C2/AKR1C3/CACNA1H,3
GO:2000095,"regulation of Wnt signaling pathway, planar cell polarity pathway",3/565,13/10364,0.030599404900385978,0.09231684868252041,0.06078817511529961,SFRP2/SFRP1/GPC3,3
GO:2001028,positive regulation of endothelial cell chemotaxis,3/565,13/10364,0.030599404900385978,0.09231684868252041,0.06078817511529961,VEGFA/SMOC2/HSPB1,3
GO:0002456,T cell mediated immunity,8/565,68/10364,0.030851658130297083,0.0929409038892099,0.06119909877362677,FCGR2B/PRF1/ICAM1/CD8A/IL7R/HLA-G/HLA-DRB1/AZGP1,8
GO:0033138,positive regulation of peptidyl-serine phosphorylation,8/565,68/10364,0.030851658130297083,0.0929409038892099,0.06119909877362677,PTGS2/LIF/SFRP2/VEGFA/RAMP3/ANGPT1/NTRK2/TENM1,8
GO:0010611,regulation of cardiac muscle hypertrophy,6/565,44/10364,0.03096152278057818,0.09299814692860386,0.06123679178365117,RGS2/AGT/IGF1/EDN1/PI16/NR4A3,6
GO:0042471,ear morphogenesis,6/565,44/10364,0.03096152278057818,0.09299814692860386,0.06123679178365117,PRRX1/ALDH1A3/NTN1/SOX9/FRZB/EDN1,6
GO:0045669,positive regulation of osteoblast differentiation,6/565,44/10364,0.03096152278057818,0.09299814692860386,0.06123679178365117,CCN1/IFITM1/IGF1/TMEM119/LTF/SFRP2,6
GO:0072678,T cell migration,6/565,44/10364,0.03096152278057818,0.09299814692860386,0.06123679178365117,CXCL12/CCL2/CCL5/ICAM1/APOD/CCL21,6
GO:2001056,positive regulation of cysteine-type endopeptidase activity,11/565,107/10364,0.031159818168481457,0.09352514338838935,0.061583804853743644,CCN1/F3/S100A9/S100A8/CLEC7A/P2RX1/NGFR/TNFSF10/CCN2/GPER1/NLRP2,11
GO:0051588,regulation of neurotransmitter transport,7/565,56/10364,0.03153326058228162,0.09448099425939295,0.06221320708053,ATP1A2/SNCG/ADRA2A/P2RX1/ITGB3/GPER1/ADCY1,7
GO:0002534,cytokine production involved in inflammatory response,5/565,33/10364,0.031685980732326945,0.09448099425939295,0.06221320708053,GBP5/ALOX5/H19/CLEC7A/APOD,5
GO:0010828,positive regulation of glucose transmembrane transport,5/565,33/10364,0.031685980732326945,0.09448099425939295,0.06221320708053,IGF1/C3/KLF15/NR4A3/GPC3,5
GO:0030514,negative regulation of BMP signaling pathway,5/565,33/10364,0.031685980732326945,0.09448099425939295,0.06221320708053,FBN1/HTRA3/SFRP2/SFRP1/CHRDL1,5
GO:0042743,hydrogen peroxide metabolic process,5/565,33/10364,0.031685980732326945,0.09448099425939295,0.06221320708053,MTCO2P12/HBB/HBA2/HBA1/GPX3,5
GO:0061005,cell differentiation involved in kidney development,5/565,33/10364,0.031685980732326945,0.09448099425939295,0.06221320708053,ACTA2/LIF/KLF15/BASP1/CD24,5
GO:0090049,regulation of cell migration involved in sprouting angiogenesis,5/565,33/10364,0.031685980732326945,0.09448099425939295,0.06221320708053,PTGS2/THBS1/HMOX1/VEGFA/KLF4,5
GO:1900015,regulation of cytokine production involved in inflammatory response,5/565,33/10364,0.031685980732326945,0.09448099425939295,0.06221320708053,GBP5/ALOX5/H19/CLEC7A/APOD,5
GO:1902229,regulation of intrinsic apoptotic signaling pathway in response to DNA damage,5/565,33/10364,0.031685980732326945,0.09448099425939295,0.06221320708053,MUC1/CXCL12/ACKR3/SFRP2/CLU,5
GO:1903530,regulation of secretion by cell,26/565,325/10364,0.03181978786248017,0.09481092540683685,0.062430457914511406,FCGR2B/AGT/CXCL12/ALOX5/SNCG/ADRA2A/SYT7/IGF1/CACNA1H/P2RX1/CCL5/C1QTNF1/APOE/INHBB/LIF/HMOX1/CD38/SPP1/EDN1/HLA-DRB1/GPER1/ADCY1/SFRP1/CCN3/KCNN4/RAB27B,26
GO:0043010,camera-type eye development,16/565,177/10364,0.03213926614593415,0.09569320407378504,0.06301141481319607,MFSD2A/NES/CRYAB/THY1/COL4A1/FBN1/ALDH1A3/SOX9/CYP1B1/COL8A1/PDGFRB/VEGFA/PTN/NTRK2/KLF4/LAMC3,16
GO:0060562,epithelial tube morphogenesis,18/565,206/10364,0.03232762748230385,0.09618408932598252,0.06333464961917086,AGT/ADM/MDK/APLNR/COL4A1/ITGAX/NTN1/SOX9/SOX18/SLIT2/SFRP2/CSF1R/EDN1/VEGFA/SFRP1/TNC/GPC3/LCN2,18
GO:0055007,cardiac muscle cell differentiation,8/565,69/10364,0.033302069571205475,0.09901138186239304,0.06519634611616193,RGS2/AGT/IGF1/SIK1/PDGFRB/EDN1/PI16/VEGFA,8
GO:0055088,lipid homeostasis,10/565,95/10364,0.03373388424037333,0.09927882832192284,0.06537245245479761,FABP3/DGAT2/CES1/ANGPTL4/LDLR/APOE/MLXIPL/LPL/ABCA1/CD24,10
GO:0010613,positive regulation of cardiac muscle hypertrophy,4/565,23/10364,0.03387702080257113,0.09927882832192284,0.06537245245479761,AGT/IGF1/EDN1/NR4A3,4
GO:0010665,regulation of cardiac muscle cell apoptotic process,4/565,23/10364,0.03387702080257113,0.09927882832192284,0.06537245245479761,AGT/MDK/HSPB6/SFRP2,4
GO:0014742,positive regulation of muscle hypertrophy,4/565,23/10364,0.03387702080257113,0.09927882832192284,0.06537245245479761,AGT/IGF1/EDN1/NR4A3,4
GO:0032350,regulation of hormone metabolic process,4/565,23/10364,0.03387702080257113,0.09927882832192284,0.06537245245479761,AKR1C3/ADM/EGR1/STC2,4
GO:0032366,intracellular sterol transport,4/565,23/10364,0.03387702080257113,0.09927882832192284,0.06537245245479761,SYT7/CES1/LDLR/ABCA1,4
GO:0032367,intracellular cholesterol transport,4/565,23/10364,0.03387702080257113,0.09927882832192284,0.06537245245479761,SYT7/CES1/LDLR/ABCA1,4
GO:0032965,regulation of collagen biosynthetic process,4/565,23/10364,0.03387702080257113,0.09927882832192284,0.06537245245479761,CREB3L1/EMILIN1/PDGFRB/CCN2,4
GO:0036296,response to increased oxygen levels,4/565,23/10364,0.03387702080257113,0.09927882832192284,0.06537245245479761,COL1A1/PDGFRB/CDKN1A/LCN2,4
GO:0045923,positive regulation of fatty acid metabolic process,4/565,23/10364,0.03387702080257113,0.09927882832192284,0.06537245245479761,PTGS2/PLIN5/MLXIPL/NR4A3,4
GO:0046676,negative regulation of insulin secretion,4/565,23/10364,0.03387702080257113,0.09927882832192284,0.06537245245479761,ADRA2A/INHBB/SFRP1/CCN3,4
GO:0051154,negative regulation of striated muscle cell differentiation,4/565,23/10364,0.03387702080257113,0.09927882832192284,0.06537245245479761,RGS2/TMEM119/PI16/CCN3,4
GO:0051602,response to electrical stimulus,4/565,23/10364,0.03387702080257113,0.09927882832192284,0.06537245245479761,NR4A1/NQO1/CD14/AKAP12,4
GO:0061036,positive regulation of cartilage development,4/565,23/10364,0.03387702080257113,0.09927882832192284,0.06537245245479761,CCN1/MDK/ZBTB16/SOX9,4
GO:0070229,negative regulation of lymphocyte apoptotic process,4/565,23/10364,0.03387702080257113,0.09927882832192284,0.06537245245479761,CCL5/BCL6/IL7R/TSC22D3,4
GO:0071711,basement membrane organization,4/565,23/10364,0.03387702080257113,0.09927882832192284,0.06537245245479761,LAMB3/NID1/COL4A1/FLRT2,4
GO:0090278,negative regulation of peptide hormone secretion,4/565,23/10364,0.03387702080257113,0.09927882832192284,0.06537245245479761,ADRA2A/INHBB/SFRP1/CCN3,4
GO:0090312,positive regulation of protein deacetylation,4/565,23/10364,0.03387702080257113,0.09927882832192284,0.06537245245479761,APLNR/NNMT/BCL6/VEGFA,4
GO:1902042,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors,4/565,23/10364,0.03387702080257113,0.09927882832192284,0.06537245245479761,ICAM1/HMOX1/SFRP2/SERPINE1,4
GO:1903020,positive regulation of glycoprotein metabolic process,4/565,23/10364,0.03387702080257113,0.09927882832192284,0.06537245245479761,IGF1/RAMP1/IL33/CCL21,4
GO:0051961,negative regulation of nervous system development,9/565,82/10364,0.03390182894164049,0.09928046329547652,0.06537352904114246,THY1/NTN1/SEMA6B/LDLR/ID1/SEMA3G/SPP1/SEMA3C/PTN,9
GO:1902905,positive regulation of supramolecular fiber organization,15/565,164/10364,0.03404537715683227,0.09962957403864997,0.06560340912580223,LMOD1/CX3CL1/ICAM1/APOE/ID1/SYNPO2/MAP1B/EDN1/HSPA1A/HSPA1B/CCN2/CLU/SFRP1/CCL21/TENM1,15
GO:0031663,lipopolysaccharide-mediated signaling pathway,6/565,45/10364,0.0341425816137442,0.09984266366190625,0.06574372294195406,CX3CL1/CCL2/CCL5/LTF/CD14/CD36,6
GO:0061077,chaperone-mediated protein folding,7/565,57/10364,0.03432734183222503,0.10031130439766543,0.06605231032895924,HSPA6/HSPB6/HSPA1A/HSPA1B/FKBP5/HSPB1/CLU,7
GO:0032365,intracellular lipid transport,5/565,34/10364,0.035543712779140264,0.10349641544651511,0.06814962074371357,FABP3/SYT7/CES1/LDLR/ABCA1,5
GO:0033344,cholesterol efflux,5/565,34/10364,0.035543712779140264,0.10349641544651511,0.06814962074371357,CES1/ABCA8/APOE/APOC1/ABCA1,5
GO:0060324,face development,5/565,34/10364,0.035543712779140264,0.10349641544651511,0.06814962074371357,ALDH1A3/MMP2/CRISPLD2/COL1A1/CLDN5,5
GO:0060350,endochondral bone morphogenesis,5/565,34/10364,0.035543712779140264,0.10349641544651511,0.06814962074371357,ALPL/TMEM119/COL1A1/SOX9/FGFR3,5
GO:1903426,regulation of reactive oxygen species biosynthetic process,5/565,34/10364,0.035543712779140264,0.10349641544651511,0.06814962074371357,MTCO2P12/ALOX5/H19/CD36/LCN2,5
GO:0009743,response to carbohydrate,15/565,165/10364,0.03565326510137448,0.10374162567521474,0.06831108511923095,PTGS2/ADRA2A/CLEC7A/THBS1/NQO1/ICAM1/COL6A2/MAP1B/EGR1/HLA-DRB1/CCN2/GPER1/MLXIPL/NAMPT/LPL,15
GO:0033135,regulation of peptidyl-serine phosphorylation,10/565,96/10364,0.035901304721691125,0.1043891630188945,0.06873747113655126,PTGS2/DDIT4/LIF/SFRP2/VEGFA/RAMP3/MLXIPL/ANGPT1/NTRK2/TENM1,10
GO:0051701,biological process involved in interaction with host,14/565,151/10364,0.03597728546040693,0.10453584575933711,0.06883405779694607,MRC1/IFIT1/IFITM2/IFITM1/IFITM3/ANPEP/ITGB3/ICAM1/LDLR/SIGLEC1/CXCL8/HSPA1A/HSPA1B/HLA-DRB1,14
GO:0001505,regulation of neurotransmitter levels,11/565,110/10364,0.03711192885764169,0.10709069860601685,0.07051636004679741,ATP1A2/SNCG/ADRA2A/SYT7/NR4A1/P2RX1/ITGB3/SLC1A3/GPER1/ADCY1/MOXD1,11
GO:0003300,cardiac muscle hypertrophy,7/565,58/10364,0.03728107666696482,0.10709069860601685,0.07051636004679741,RGS2/AGT/IGF1/KLF15/EDN1/PI16/NR4A3,7
GO:0032922,circadian regulation of gene expression,7/565,58/10364,0.03728107666696482,0.10709069860601685,0.07051636004679741,ID3/NGFR/ID1/BHLHE40/EGR1/NAMPT/RORC,7
GO:0010566,regulation of ketone biosynthetic process,3/565,14/10364,0.03740588642076309,0.10709069860601685,0.07051636004679741,AKR1C3/ADM/EGR1,3
GO:0010667,negative regulation of cardiac muscle cell apoptotic process,3/565,14/10364,0.03740588642076309,0.10709069860601685,0.07051636004679741,MDK/HSPB6/SFRP2,3
GO:0032309,icosanoid secretion,3/565,14/10364,0.03740588642076309,0.10709069860601685,0.07051636004679741,PLA2G2A/ACE/EDN1,3
GO:0032691,negative regulation of interleukin-1 beta production,3/565,14/10364,0.03740588642076309,0.10709069860601685,0.07051636004679741,IGF1/CX3CL1/ACP5,3
GO:0043931,ossification involved in bone maturation,3/565,14/10364,0.03740588642076309,0.10709069860601685,0.07051636004679741,ZBTB16/IGF1/LTF,3
GO:0045987,positive regulation of smooth muscle contraction,3/565,14/10364,0.03740588642076309,0.10709069860601685,0.07051636004679741,PTGS2/EDN1/GPER1,3
GO:0046597,negative regulation of viral entry into host cell,3/565,14/10364,0.03740588642076309,0.10709069860601685,0.07051636004679741,IFITM2/IFITM1/IFITM3,3
GO:0048143,astrocyte activation,3/565,14/10364,0.03740588642076309,0.10709069860601685,0.07051636004679741,C1QA/LDLR/C5AR1,3
GO:0048569,post-embryonic animal organ development,3/565,14/10364,0.03740588642076309,0.10709069860601685,0.07051636004679741,FBN1/VEGFA/KLF4,3
GO:0060445,branching involved in salivary gland morphogenesis,3/565,14/10364,0.03740588642076309,0.10709069860601685,0.07051636004679741,FGF7/TGM2/SEMA3C,3
GO:0060706,cell differentiation involved in embryonic placenta development,3/565,14/10364,0.03740588642076309,0.10709069860601685,0.07051636004679741,KRT19/SOCS3/LIF,3
GO:0060713,labyrinthine layer morphogenesis,3/565,14/10364,0.03740588642076309,0.10709069860601685,0.07051636004679741,CCN1/ADM/SOCS3,3
GO:0061298,retina vasculature development in camera-type eye,3/565,14/10364,0.03740588642076309,0.10709069860601685,0.07051636004679741,COL4A1/CYP1B1/PDGFRB,3
GO:0072111,cell proliferation involved in kidney development,3/565,14/10364,0.03740588642076309,0.10709069860601685,0.07051636004679741,EGR1/PDGFRB/GPC3,3
GO:0090136,epithelial cell-cell adhesion,3/565,14/10364,0.03740588642076309,0.10709069860601685,0.07051636004679741,CYP1B1/THBS4/CCN3,3
GO:1901201,regulation of extracellular matrix assembly,3/565,14/10364,0.03740588642076309,0.10709069860601685,0.07051636004679741,AGT/SOX9/EMILIN1,3
GO:1901550,regulation of endothelial cell development,3/565,14/10364,0.03740588642076309,0.10709069860601685,0.07051636004679741,CLDN5/VEGFA/S1PR3,3
GO:1903140,regulation of establishment of endothelial barrier,3/565,14/10364,0.03740588642076309,0.10709069860601685,0.07051636004679741,CLDN5/VEGFA/S1PR3,3
GO:0042475,odontogenesis of dentin-containing tooth,6/565,46/10364,0.03752740824308463,0.10713891865215375,0.07054811165715315,CSF3R/ADM/NGFR/SERPINE1/CA2/TNC,6
GO:0046470,phosphatidylcholine metabolic process,6/565,46/10364,0.03752740824308463,0.10713891865215375,0.07054811165715315,PLA2G2A/FABP3/MFSD2A/LDLR/APOC1/ENPP2,6
GO:0050435,amyloid-beta metabolic process,6/565,46/10364,0.03752740824308463,0.10713891865215375,0.07054811165715315,IGF1/ACE/APOE/MME/CLU/NTRK2,6
GO:0072080,nephron tubule development,6/565,46/10364,0.03752740824308463,0.10713891865215375,0.07054811165715315,AGT/SOX9/LIF/VEGFA/GPC3/CD24,6
GO:0030258,lipid modification,14/565,152/10364,0.03773531155028047,0.10765739755181063,0.07088951614177023,FABP3/MFSD2A/AGT/ALOX5/DGAT2/SOX9/PLIN5/APOE/APOC1/APOD/PDK4/NR4A3/ABO/PLPP2,14
GO:0048259,regulation of receptor-mediated endocytosis,8/565,71/10364,0.03859265011210079,0.1099501110361452,0.07239920663450179,ITGB3/C3/APOC1/VEGFA/SERPINE1/CLU/ANGPT1/CCL21,8
GO:1904659,glucose transmembrane transport,8/565,71/10364,0.03859265011210079,0.1099501110361452,0.07239920663450179,SLC2A3/IGF1/C3/HK2/KLF15/EDN1/NR4A3/GPC3,8
GO:0060402,calcium ion transport into cytosol,9/565,84/10364,0.03874695179673354,0.11007077506138623,0.0724786606670121,ATP1A2/APLNR/THY1/CX3CL1/P2RX1/PLN/GPER1/RAMP3/CCL21,9
GO:0071482,cellular response to light stimulus,9/565,84/10364,0.03874695179673354,0.11007077506138623,0.0724786606670121,PTGS2/CRIP1/MMP2/MFAP4/MME/CDKN1A/AQP1/PTN/TIMP1,9
GO:0002792,negative regulation of peptide secretion,4/565,24/10364,0.03895763387004119,0.11007077506138623,0.0724786606670121,ADRA2A/INHBB/SFRP1/CCN3,4
GO:0010662,regulation of striated muscle cell apoptotic process,4/565,24/10364,0.03895763387004119,0.11007077506138623,0.0724786606670121,AGT/MDK/HSPB6/SFRP2,4
GO:0014912,negative regulation of smooth muscle cell migration,4/565,24/10364,0.03895763387004119,0.11007077506138623,0.0724786606670121,IGFBP5/SLIT2/IGFBP3/SERPINE1,4
GO:0019674,"NAD metabolic process",4/565,24/10364,0.03895763387004119,0.11007077506138623,0.0724786606670121,NQO1/HK2/CD38/HK3,4
GO:0043616,keratinocyte proliferation,4/565,24/10364,0.03895763387004119,0.11007077506138623,0.0724786606670121,MDK/FGF7/ZFP36/EPPK1,4
GO:0051155,positive regulation of striated muscle cell differentiation,4/565,24/10364,0.03895763387004119,0.11007077506138623,0.0724786606670121,IGF1/CYP26B1/HOPX/EDN1,4
GO:0090181,regulation of cholesterol metabolic process,4/565,24/10364,0.03895763387004119,0.11007077506138623,0.0724786606670121,DGAT2/CES1/LDLR/APOE,4
GO:1901889,negative regulation of cell junction assembly,4/565,24/10364,0.03895763387004119,0.11007077506138623,0.0724786606670121,THBS1/ACE/FAM107A/APOD,4
GO:1904894,positive regulation of receptor signaling pathway via STAT,4/565,24/10364,0.03895763387004119,0.11007077506138623,0.0724786606670121,AGT/CCL5/CYP1B1/IL7R,4
GO:2000179,positive regulation of neural precursor cell proliferation,4/565,24/10364,0.03895763387004119,0.11007077506138623,0.0724786606670121,NES/MDK/CX3CL1/VEGFA,4
GO:0021537,telencephalon development,14/565,153/10364,0.039554029611024936,0.11118752873250534,0.07321401308306023,MFSD2A/ATP1A2/CXCL12/MDK/ALDH1A3/SEMA6B/COL3A1/SLIT2/ANXA3/MDGA1/AQP1/RELN/PLXNA4/NTRK2,14
GO:0001707,mesoderm formation,5/565,35/10364,0.039678793228673744,0.11118752873250534,0.07321401308306023,ITGA8/ITGB3/ITGB4/SFRP2/KLF4,5
GO:0002704,negative regulation of leukocyte mediated immunity,5/565,35/10364,0.039678793228673744,0.11118752873250534,0.07321401308306023,FCGR2B/HMOX1/BCL6/IL7R/HLA-G,5
GO:0010676,positive regulation of cellular carbohydrate metabolic process,5/565,35/10364,0.039678793228673744,0.11118752873250534,0.07321401308306023,IGF2/DGAT2/NNMT/IGF1/GPER1,5
GO:0030225,macrophage differentiation,5/565,35/10364,0.039678793228673744,0.11118752873250534,0.07321401308306023,C1QC/LIF/CSF1R/HLA-DRB1/VEGFA,5
GO:0031638,zymogen activation,5/565,35/10364,0.039678793228673744,0.11118752873250534,0.07321401308306023,THBS1/SERPINE2/CLEC3B/SERPINE1/PLAT,5
GO:0031641,regulation of myelination,5/565,35/10364,0.039678793228673744,0.11118752873250534,0.07321401308306023,EGR2/ITGAX/S100B/TYMP/PTN,5
GO:0042472,inner ear morphogenesis,5/565,35/10364,0.039678793228673744,0.11118752873250534,0.07321401308306023,PRRX1/ALDH1A3/NTN1/SOX9/FRZB,5
GO:0046503,glycerolipid catabolic process,5/565,35/10364,0.039678793228673744,0.11118752873250534,0.07321401308306023,PLIN5/LDLR/APOC1/LPL/ENPP2,5
GO:0050994,regulation of lipid catabolic process,5/565,35/10364,0.039678793228673744,0.11118752873250534,0.07321401308306023,MFSD2A/ADRA2A/PLIN5/LDLR/APOC1,5
GO:0052372,modulation by symbiont of entry into host,5/565,35/10364,0.039678793228673744,0.11118752873250534,0.07321401308306023,IFITM2/IFITM1/IFITM3/CXCL8/HLA-DRB1,5
GO:0072088,nephron epithelium morphogenesis,5/565,35/10364,0.039678793228673744,0.11118752873250534,0.07321401308306023,AGT/SOX9/LIF/VEGFA/GPC3,5
GO:0034599,cellular response to oxidative stress,19/565,226/10364,0.039868068510075454,0.1116414996444931,0.07351294078357207,JUN/AKR1C3/ALOX5/H19/FOS/MMP2/NQO1/KLF2/CYP1B1/NR4A2/HMOX1/HSPA1A/HSPA1B/AQP1/HSPB1/CD36/NR4A3/KLF4/LCN2,19
GO:0008202,steroid metabolic process,16/565,182/10364,0.03999910590107776,0.1118554231960467,0.07365380371919769,AGT/AKR1C2/AKR1C3/ADM/DGAT2/CACNA1H/CES1/LDLR/APOE/APOC1/CYP1B1/CYP26B1/SPP1/EGR1/ABCA1/RORC,16
GO:0051047,positive regulation of secretion,16/565,182/10364,0.03999910590107776,0.1118554231960467,0.07365380371919769,S100A8/AGT/CXCL12/SYT7/IGF1/CACNA1H/C1QTNF1/INHBB/CD38/SPP1/EDN1/HLA-DRB1/GPER1/AQP1/KCNN4/RAB27B,16
GO:0002720,positive regulation of cytokine production involved in immune response,6/565,47/10364,0.04111927484013659,0.11467459890702943,0.07551015550379306,CLEC7A/SLC7A5/SPON2/HLA-G/CD36/NR4A3,6
GO:0043536,positive regulation of blood vessel endothelial cell migration,6/565,47/10364,0.04111927484013659,0.11467459890702943,0.07551015550379306,PTGS2/THBS1/HMOX1/VEGFA/HSPB1/ANGPT1,6
GO:0051781,positive regulation of cell division,6/565,47/10364,0.04111927484013659,0.11467459890702943,0.07551015550379306,IGF2/MDK/FGF7/THBS4/VEGFA/PTN,6
GO:0060395,SMAD protein signal transduction,6/565,47/10364,0.04111927484013659,0.11467459890702943,0.07551015550379306,JUN/FOS/GDF15/ATOH8/INHBB/CCN3,6
GO:0034440,lipid oxidation,9/565,85/10364,0.041337634510815624,0.11520508896343033,0.07585946901379301,FABP3/MFSD2A/ALOX5/DGAT2/SOX9/PLIN5/APOD/PDK4/NR4A3,9
GO:0090100,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,8/565,72/10364,0.04143747340901325,0.11540477288197296,0.07599095553203217,CCN1/CDKN1C/THBS1/LRG1/GDF15/INHBB/SULF1/GPC3,8
GO:0002791,regulation of peptide secretion,11/565,112/10364,0.041496577757378965,0.11549081532203229,0.07604761217692764,S100A8/ALOX5/ADRA2A/SYT7/CCL5/INHBB/CD38/HLA-DRB1/GPER1/SFRP1/CCN3,11
GO:0021549,cerebellum development,7/565,60/10364,0.04367835843351404,0.12131560341031647,0.07988307930317036,FCGR2B/MDK/CNTN1/CKB/SERPINE2/PTN/CD3E,7
GO:0021761,limbic system development,7/565,60/10364,0.04367835843351404,0.12131560341031647,0.07988307930317036,MFSD2A/ATP1A2/MDK/ALDH1A3/SEMA6B/ANXA3/RELN,7
GO:0046660,female sex differentiation,7/565,60/10364,0.04367835843351404,0.12131560341031647,0.07988307930317036,ICAM1/INHBB/ADAMTS1/SLIT2/SLIT3/VEGFA/SFRP1,7
GO:0034446,substrate adhesion-dependent cell spreading,9/565,86/10364,0.04404278759997465,0.12172766717504865,0.08015441226835154,GBP1/LAMB3/ITGA8/MDK/POSTN/ITGB3/FN1/FBLN1/LAMC3,9
GO:0051224,negative regulation of protein transport,9/565,86/10364,0.04404278759997465,0.12172766717504865,0.08015441226835154,ADRA2A/APOE/INHBB/APOD/CD36/SFRP1/ANGPT1/CCN3/DERL3,9
GO:0048863,stem cell differentiation,12/565,127/10364,0.044067091142955324,0.12172766717504865,0.08015441226835154,ACE/SOX9/SEMA6B/FRZB/FN1/SOX18/LIF/SEMA3G/EDN1/SEMA3C/PTN/SFRP1,12
GO:0010559,regulation of glycoprotein biosynthetic process,5/565,36/10364,0.044094316175035946,0.12172766717504865,0.08015441226835154,IGF1/RAMP1/HBEGF/IL33/CCL21,5
GO:0014015,positive regulation of gliogenesis,5/565,36/10364,0.044094316175035946,0.12172766717504865,0.08015441226835154,EGR2/MDK/SERPINE2/LIF/PTN,5
GO:0032720,negative regulation of tumor necrosis factor production,5/565,36/10364,0.044094316175035946,0.12172766717504865,0.08015441226835154,IGF1/CX3CL1/ACP5/BCL3/GPNMB,5
GO:0045773,positive regulation of axon extension,5/565,36/10364,0.044094316175035946,0.12172766717504865,0.08015441226835154,CXCL12/NTN1/FN1/MAP1B/VEGFA,5
GO:0061333,renal tubule morphogenesis,5/565,36/10364,0.044094316175035946,0.12172766717504865,0.08015441226835154,AGT/COL4A1/SOX9/VEGFA/GPC3,5
GO:2000378,negative regulation of reactive oxygen species metabolic process,5/565,36/10364,0.044094316175035946,0.12172766717504865,0.08015441226835154,H19/CRYAB/PLIN5/ACP5/HK2,5
GO:0008645,hexose transmembrane transport,8/565,73/10364,0.04441812088019617,0.12179232470341361,0.08019698752100438,SLC2A3/IGF1/C3/HK2/KLF15/EDN1/NR4A3/GPC3,8
GO:0010165,response to X-ray,4/565,25/10364,0.04444901990892372,0.12179232470341361,0.08019698752100438,THBD/SFRP2/CDKN1A/SFRP1,4
GO:0021955,central nervous system neuron axonogenesis,4/565,25/10364,0.04444901990892372,0.12179232470341361,0.08019698752100438,DCLK1/NR4A2/SLIT2/PLXNA4,4
GO:0032373,positive regulation of sterol transport,4/565,25/10364,0.04444901990892372,0.12179232470341361,0.08019698752100438,CES1/ABCA8/APOE/ABCA1,4
GO:0032376,positive regulation of cholesterol transport,4/565,25/10364,0.04444901990892372,0.12179232470341361,0.08019698752100438,CES1/ABCA8/APOE/ABCA1,4
GO:0032735,positive regulation of interleukin-12 production,4/565,25/10364,0.04444901990892372,0.12179232470341361,0.08019698752100438,MDK/CLEC7A/HLA-G/CD36,4
GO:0045840,positive regulation of mitotic nuclear division,4/565,25/10364,0.04444901990892372,0.12179232470341361,0.08019698752100438,IGF2/IGF1/PDGFRB/EDN1,4
GO:0050891,multicellular organismal water homeostasis,4/565,25/10364,0.04444901990892372,0.12179232470341361,0.08019698752100438,CYP4F12/CYP26B1/AQP1/AQP3,4
GO:2001239,regulation of extrinsic apoptotic signaling pathway in absence of ligand,4/565,25/10364,0.04444901990892372,0.12179232470341361,0.08019698752100438,IFI6/CX3CL1/HSPA1A/HSPA1B,4
GO:0002407,dendritic cell chemotaxis,3/565,15/10364,0.04491559475973495,0.12179232470341361,0.08019698752100438,CCL5/CCR1/CCL21,3
GO:0002920,regulation of humoral immune response,3/565,15/10364,0.04491559475973495,0.12179232470341361,0.08019698752100438,FCGR2B/C3/VSIG4,3
GO:0010226,response to lithium ion,3/565,15/10364,0.04491559475973495,0.12179232470341361,0.08019698752100438,PTGS2/IGFBP2/ADCY1,3
GO:0032753,positive regulation of interleukin-4 production,3/565,15/10364,0.04491559475973495,0.12179232470341361,0.08019698752100438,FCER1G/SLC7A5/CD3E,3
GO:0035357,peroxisome proliferator activated receptor signaling pathway,3/565,15/10364,0.04491559475973495,0.12179232470341361,0.08019698752100438,LMO3/PLIN5/PTGIS,3
GO:0035458,cellular response to interferon-beta,3/565,15/10364,0.04491559475973495,0.12179232470341361,0.08019698752100438,MNDA/IFITM2/OAS1,3
GO:0042462,eye photoreceptor cell development,3/565,15/10364,0.04491559475973495,0.12179232470341361,0.08019698752100438,THY1/VEGFA/NTRK2,3
GO:0044539,long-chain fatty acid import into cell,3/565,15/10364,0.04491559475973495,0.12179232470341361,0.08019698752100438,FABP3/THBS1/CD36,3
GO:0048710,regulation of astrocyte differentiation,3/565,15/10364,0.04491559475973495,0.12179232470341361,0.08019698752100438,LDLR/SERPINE2/LIF,3
GO:0055093,response to hyperoxia,3/565,15/10364,0.04491559475973495,0.12179232470341361,0.08019698752100438,COL1A1/PDGFRB/CDKN1A,3
GO:0055119,relaxation of cardiac muscle,3/565,15/10364,0.04491559475973495,0.12179232470341361,0.08019698752100438,ATP1A2/RGS2/PLN,3
GO:0070233,negative regulation of T cell apoptotic process,3/565,15/10364,0.04491559475973495,0.12179232470341361,0.08019698752100438,CCL5/IL7R/TSC22D3,3
GO:0071305,cellular response to vitamin D,3/565,15/10364,0.04491559475973495,0.12179232470341361,0.08019698752100438,PTN/SFRP1/TNC,3
GO:0072010,glomerular epithelium development,3/565,15/10364,0.04491559475973495,0.12179232470341361,0.08019698752100438,KLF15/BASP1/CD24,3
GO:0090083,regulation of inclusion body assembly,3/565,15/10364,0.04491559475973495,0.12179232470341361,0.08019698752100438,HSPA1A/HSPA1B/CLU,3
GO:0140354,lipid import into cell,3/565,15/10364,0.04491559475973495,0.12179232470341361,0.08019698752100438,FABP3/THBS1/CD36,3
GO:0050848,regulation of calcium-mediated signaling,6/565,48/10364,0.044920960015181866,0.12179232470341361,0.08019698752100438,GBP1/CLEC7A/IGF1/CMKLR1/CD22/CD3E,6
GO:0051279,regulation of release of sequestered calcium ion into cytosol,6/565,48/10364,0.044920960015181866,0.12179232470341361,0.08019698752100438,ATP1A2/APLNR/THY1/CX3CL1/PLN/GPER1,6
GO:0010950,positive regulation of endopeptidase activity,12/565,128/10364,0.04633430338115674,0.12554112378719767,0.08266547142648117,CCN1/F3/S100A9/S100A8/CLEC7A/P2RX1/NGFR/TNFSF10/SFRP2/CCN2/GPER1/NLRP2,12
GO:0032635,interleukin-6 production,9/565,87/10364,0.04686404492408366,0.12672483482113506,0.08344491347464247,CLEC7A/CX3CL1/KLF2/TYROBP/LILRB2/SPON2/CD36/LPL/IL33,9
GO:0032675,regulation of interleukin-6 production,9/565,87/10364,0.04686404492408366,0.12672483482113506,0.08344491347464247,CLEC7A/CX3CL1/KLF2/TYROBP/LILRB2/SPON2/CD36/LPL/IL33,9
GO:0051048,negative regulation of secretion,9/565,87/10364,0.04686404492408366,0.12672483482113506,0.08344491347464247,FCGR2B/ADRA2A/APOE/INHBB/LIF/HMOX1/EDN1/SFRP1/CCN3,9
GO:0048609,multicellular organismal reproductive process,31/565,416/10364,0.04705828100636728,0.12716607421786644,0.08373545781296274,PTGS2/RGS2/MDK/BIRC3/ZBTB16/IGF1/TMEM119/TPPP3/P2RX1/ACE/SOX9/JUNB/CYP26B1/INHBB/SERPINE2/ADAMTS1/SPATC1L/GGT5/LIF/BCL6/SLIT2/SPP1/HPGD/EGR1/SLIT3/STC2/ADAMTS2/EDN1/PTN/ADAM28/TOP2A,31
GO:0120162,positive regulation of cold-induced thermogenesis,7/565,61/10364,0.0471266080514412,0.12726671066134584,0.0838017242186786,G0S2/SCD/CMKLR1/VEGFA/CD36/GADD45G/LCN2,7
GO:0051091,positive regulation of DNA-binding transcription factor activity,16/565,186/10364,0.04721715655993035,0.12742718454604804,0.08390739197861544,S100A9/S100A8/AGT/CLEC7A/CX3CL1/ICAM1/LTF/ANXA3/EDN1/HSPA1A/HSPA1B/VEGFA/ADCY1/CD36/RELN/CLU,16
GO:0015749,monosaccharide transmembrane transport,8/565,74/10364,0.047536459707250206,0.1282043913316748,0.08441916185442604,SLC2A3/IGF1/C3/HK2/KLF15/EDN1/NR4A3/GPC3,8
GO:0030522,intracellular receptor signaling pathway,17/565,201/10364,0.04768094425928328,0.12850940473831846,0.08462000502271194,AKR1C3/BIRC3/LMO3/NR4A1/OAS3/PLIN5/KLF2/CYP26B1/NR4A2/PTGIS/HSPA1A/HSPA1B/GPER1/SFRP1/NR4A3/RORC/PADI2,17
GO:1901215,negative regulation of neuron death,13/565,143/10364,0.04821871035425107,0.12987328959888414,0.0855180867155381,NES/MDK/CX3CL1/CCL2/APOE/C5AR1/NR4A2/HMOX1/GPNMB/ANGPT1/CNTFR/NTRK2/NR4A3,13
GO:0010976,positive regulation of neuron projection development,11/565,115/10364,0.048725229727985674,0.13085489118832702,0.08616444510151068,NEGR1/S100A9/RGS2/AGT/MDK/CNTN1/CX3CL1/APOE/RELN/PTN/NTRK2,11
GO:0051092,positive regulation of NF-kappaB transcription factor activity,11/565,115/10364,0.048725229727985674,0.13085489118832702,0.08616444510151068,S100A9/S100A8/AGT/CLEC7A/CX3CL1/ICAM1/LTF/HSPA1A/HSPA1B/CD36/CLU,11
GO:0032371,regulation of sterol transport,5/565,37/10364,0.048792436010200065,0.13085489118832702,0.08616444510151068,CES1/ABCA8/APOE/APOC1/ABCA1,5
GO:0032374,regulation of cholesterol transport,5/565,37/10364,0.048792436010200065,0.13085489118832702,0.08616444510151068,CES1/ABCA8/APOE/APOC1/ABCA1,5
GO:0048332,mesoderm morphogenesis,5/565,37/10364,0.048792436010200065,0.13085489118832702,0.08616444510151068,ITGA8/ITGB3/ITGB4/SFRP2/KLF4,5
GO:1902475,L-alpha-amino acid transmembrane transport,5/565,37/10364,0.048792436010200065,0.13085489118832702,0.08616444510151068,ATP1A2/RGS2/AGT/SLC7A5/SLC1A3,5
GO:0002381,immunoglobulin production involved in immunoglobulin-mediated immune response,6/565,49/10364,0.04893474313857564,0.13085489118832702,0.08616444510151068,BCL6/HLA-DRB5/HLA-DRB1/HLA-DQA1/HLA-DQB1/HLA-DQA1,6
GO:0014032,neural crest cell development,6/565,49/10364,0.04893474313857564,0.13085489118832702,0.08616444510151068,SOX9/SEMA6B/FN1/SEMA3G/EDN1/SEMA3C,6
GO:0045913,positive regulation of carbohydrate metabolic process,6/565,49/10364,0.04893474313857564,0.13085489118832702,0.08616444510151068,IGF2/DGAT2/NNMT/IGF1/GPER1/MLXIPL,6
GO:0046425,regulation of receptor signaling pathway via JAK-STAT,6/565,49/10364,0.04893474313857564,0.13085489118832702,0.08616444510151068,AGT/CCL5/SOCS3/BCL3/CYP1B1/LIF,6
GO:1904063,negative regulation of cation transmembrane transport,6/565,49/10364,0.04893474313857564,0.13085489118832702,0.08616444510151068,ATP1A2/RGS2/ADRA2A/RRAD/PLN/GEM,6
GO:1903825,organic acid transmembrane transport,9/565,88/10364,0.04980290864329803,0.13300267970362828,0.087578706379295,ATP1A2/RGS2/AGT/FOLR2/THBS1/SLC7A5/SLC16A3/SLC1A3/CD36,9
GO:1905039,carboxylic acid transmembrane transport,9/565,88/10364,0.04980290864329803,0.13300267970362828,0.087578706379295,ATP1A2/RGS2/AGT/FOLR2/THBS1/SLC7A5/SLC16A3/SLC1A3/CD36,9
GO:0001658,branching involved in ureteric bud morphogenesis,4/565,26/10364,0.05035063390889209,0.13368060650000274,0.0880251030382092,AGT/SOX9/VEGFA/GPC3,4
GO:0001912,positive regulation of leukocyte mediated cytotoxicity,4/565,26/10364,0.05035063390889209,0.13368060650000274,0.0880251030382092,TYROBP/HLA-G/HLA-DRB1/AZGP1,4
GO:0010659,cardiac muscle cell apoptotic process,4/565,26/10364,0.05035063390889209,0.13368060650000274,0.0880251030382092,AGT/MDK/HSPB6/SFRP2,4
GO:0042304,regulation of fatty acid biosynthetic process,4/565,26/10364,0.05035063390889209,0.13368060650000274,0.0880251030382092,PTGS2/APOC1/MLXIPL/PDK4,4
GO:0045103,intermediate filament-based process,4/565,26/10364,0.05035063390889209,0.13368060650000274,0.0880251030382092,NES/PPL/DES/EPPK1,4
GO:0045104,intermediate filament cytoskeleton organization,4/565,26/10364,0.05035063390889209,0.13368060650000274,0.0880251030382092,NES/PPL/DES/EPPK1,4
GO:0070741,response to interleukin-6,4/565,26/10364,0.05035063390889209,0.13368060650000274,0.0880251030382092,CHI3L1/ICAM1/PTGIS/LCN2,4
GO:0097009,energy homeostasis,4/565,26/10364,0.05035063390889209,0.13368060650000274,0.0880251030382092,MFSD2A/MLXIPL/CD36/NR4A3,4
GO:1900181,negative regulation of protein localization to nucleus,4/565,26/10364,0.05035063390889209,0.13368060650000274,0.0880251030382092,DCLK1/APOD/CD36/ANGPT1,4
GO:0002275,myeloid cell activation involved in immune response,7/565,62/10364,0.05074390353312554,0.134550220896772,0.08859772085378682,FCER1G/TYROBP/DYSF/HMOX1/ANXA3/NR4A3/PTGDS,7
GO:1902807,negative regulation of cell cycle G1/S phase transition,7/565,62/10364,0.05074390353312554,0.134550220896772,0.08859772085378682,MUC1/CCL2/SUSD2/FAM107A/CDKN1A/GPNMB/KLF4,7
GO:0006836,neurotransmitter transport,10/565,102/10364,0.050953652165423136,0.13493159894258883,0.08884884809399378,ATP1A2/SNCG/ADRA2A/SYT7/NR4A1/P2RX1/ITGB3/SLC1A3/GPER1/ADCY1,10
GO:0050796,regulation of insulin secretion,10/565,102/10364,0.050953652165423136,0.13493159894258883,0.08884884809399378,ALOX5/ADRA2A/SYT7/CCL5/INHBB/CD38/HLA-DRB1/GPER1/SFRP1/CCN3,10
GO:0071901,negative regulation of protein serine/threonine kinase activity,9/565,89/10364,0.05286074543639252,0.13840401414722991,0.09113534060912139,RGS2/AGT/CDKN1C/APOE/UCHL1/SFRP2/DUSP1/CDKN1A/SFRP1,9
GO:1904950,negative regulation of establishment of protein localization,9/565,89/10364,0.05286074543639252,0.13840401414722991,0.09113534060912139,ADRA2A/APOE/INHBB/APOD/CD36/SFRP1/ANGPT1/CCN3/DERL3,9
GO:0030098,lymphocyte differentiation,20/565,249/10364,0.05300202078245622,0.13840401414722991,0.09113534060912139,VCAM1/FCER1G/FCGR2B/MDK/ZBTB16/BCL3/LILRB2/CYP26B1/CD8A/NFKBIZ/BCL6/IL7R/EGR1/HLA-G/HLA-DRB1/FGL2/EGR3/SFRP1/RORC/CD3E,20
GO:0001504,neurotransmitter uptake,3/565,16/10364,0.05311008945415197,0.13840401414722991,0.09113534060912139,ATP1A2/ITGB3/SLC1A3,3
GO:0001662,behavioral fear response,3/565,16/10364,0.05311008945415197,0.13840401414722991,0.09113534060912139,ATP1A2/MDK/APOE,3
GO:0001916,positive regulation of T cell mediated cytotoxicity,3/565,16/10364,0.05311008945415197,0.13840401414722991,0.09113534060912139,HLA-G/HLA-DRB1/AZGP1,3
GO:0002673,regulation of acute inflammatory response,3/565,16/10364,0.05311008945415197,0.13840401414722991,0.09113534060912139,FCGR2B/PTGS2/C3,3
GO:0009309,amine biosynthetic process,3/565,16/10364,0.05311008945415197,0.13840401414722991,0.09113534060912139,NNMT/NR4A2/MOXD1,3
GO:0010664,negative regulation of striated muscle cell apoptotic process,3/565,16/10364,0.05311008945415197,0.13840401414722991,0.09113534060912139,MDK/HSPB6/SFRP2,3
GO:0010934,macrophage cytokine production,3/565,16/10364,0.05311008945415197,0.13840401414722991,0.09113534060912139,SPON2/HLA-G/CD36,3
GO:0010935,regulation of macrophage cytokine production,3/565,16/10364,0.05311008945415197,0.13840401414722991,0.09113534060912139,SPON2/HLA-G/CD36,3
GO:0019430,removal of superoxide radicals,3/565,16/10364,0.05311008945415197,0.13840401414722991,0.09113534060912139,H19/NQO1/CD36,3
GO:0019885,antigen processing and presentation of endogenous peptide antigen via MHC class I,3/565,16/10364,0.05311008945415197,0.13840401414722991,0.09113534060912139,ERAP2/HLA-G/AZGP1,3
GO:0032692,negative regulation of interleukin-1 production,3/565,16/10364,0.05311008945415197,0.13840401414722991,0.09113534060912139,IGF1/CX3CL1/ACP5,3
GO:0032703,negative regulation of interleukin-2 production,3/565,16/10364,0.05311008945415197,0.13840401414722991,0.09113534060912139,GBP1/ZFP36/VSIG4,3
GO:0032930,positive regulation of superoxide anion generation,3/565,16/10364,0.05311008945415197,0.13840401414722991,0.09113534060912139,AGT/CLEC7A/TYROBP,3
GO:0032967,positive regulation of collagen biosynthetic process,3/565,16/10364,0.05311008945415197,0.13840401414722991,0.09113534060912139,CREB3L1/PDGFRB/CCN2,3
GO:0033194,response to hydroperoxide,3/565,16/10364,0.05311008945415197,0.13840401414722991,0.09113534060912139,CD38/GPX3/CD36,3
GO:0036303,lymph vessel morphogenesis,3/565,16/10364,0.05311008945415197,0.13840401414722991,0.09113534060912139,SOX18/VEGFA/SVEP1,3
GO:0042401,cellular biogenic amine biosynthetic process,3/565,16/10364,0.05311008945415197,0.13840401414722991,0.09113534060912139,NNMT/NR4A2/MOXD1,3
GO:0044321,response to leptin,3/565,16/10364,0.05311008945415197,0.13840401414722991,0.09113534060912139,INHBB/EDN1/NR4A3,3
GO:0046885,regulation of hormone biosynthetic process,3/565,16/10364,0.05311008945415197,0.13840401414722991,0.09113534060912139,ADM/EGR1/STC2,3
GO:0110110,positive regulation of animal organ morphogenesis,3/565,16/10364,0.05311008945415197,0.13840401414722991,0.09113534060912139,NGFR/SOX9/EDN1,3
GO:1900273,positive regulation of long-term synaptic potentiation,3/565,16/10364,0.05311008945415197,0.13840401414722991,0.09113534060912139,MME/ADCY1/RELN,3
GO:1903901,negative regulation of viral life cycle,3/565,16/10364,0.05311008945415197,0.13840401414722991,0.09113534060912139,IFITM2/IFITM1/IFITM3,3
GO:0001836,release of cytochrome c from mitochondria,6/565,50/10364,0.05316240131387137,0.13845220800190164,0.09116707497309802,IFI6/JUN/IGF1/TNFSF10/GPER1/CLU,6
GO:0030072,peptide hormone secretion,12/565,131/10364,0.053614737867330786,0.13945281882392135,0.09182595043017062,ALOX5/ADRA2A/SYT7/CCL5/IL1RN/INHBB/CD38/EDN1/HLA-DRB1/GPER1/SFRP1/CCN3,12
GO:0050777,negative regulation of immune response,12/565,131/10364,0.053614737867330786,0.13945281882392135,0.09182595043017062,ISG15/FCGR2B/OAS1/OAS3/COL3A1/HMOX1/BCL6/IL7R/HLA-G/HLA-DRB1/FGL2/VSIG4,12
GO:0071677,positive regulation of mononuclear cell migration,5/565,38/10364,0.053774380509649146,0.13953514421723356,0.09188015949922484,CXCL12/CCL5/CCR1/SERPINE1/CCL21,5
GO:1903409,reactive oxygen species biosynthetic process,5/565,38/10364,0.053774380509649146,0.13953514421723356,0.09188015949922484,MTCO2P12/ALOX5/H19/CD36/LCN2,5
GO:0048736,appendage development,10/565,103/10364,0.05381680330215237,0.13953514421723356,0.09188015949922484,PRRX1/ZBTB16/SMOC1/SOX9/ITGB4/CYP26B1/FRAS1/SFRP2/SEMA3C/GPC3,10
GO:0060173,limb development,10/565,103/10364,0.05381680330215237,0.13953514421723356,0.09188015949922484,PRRX1/ZBTB16/SMOC1/SOX9/ITGB4/CYP26B1/FRAS1/SFRP2/SEMA3C/GPC3,10
GO:0060401,cytosolic calcium ion transport,10/565,103/10364,0.05381680330215237,0.13953514421723356,0.09188015949922484,ATP1A2/APLNR/THY1/CX3CL1/P2RX1/PLN/CCN2/GPER1/RAMP3/CCL21,10
GO:0007219,Notch signaling pathway,11/565,117/10364,0.05399247424802983,0.13990201871609756,0.09212173654177509,CNTN1/POSTN/KRT19/SOX9/CFD/NOTCH3/BCL6/PLN/TCIM/CCN3/S1PR3,11
GO:0034219,carbohydrate transmembrane transport,8/565,76/10364,0.05419270695285242,0.14033203179315484,0.09240488864892643,SLC2A3/IGF1/C3/HK2/KLF15/EDN1/NR4A3/GPC3,8
GO:0062197,cellular response to chemical stress,21/565,265/10364,0.05430160485983339,0.1405251392516801,0.09253204474418346,JUN/PTGS2/AKR1C3/ALOX5/H19/FOS/MMP2/NQO1/KLF2/CYP1B1/NR4A2/HMOX1/MYLK/HSPA1A/HSPA1B/AQP1/HSPB1/CD36/NR4A3/KLF4/LCN2,21
GO:0097193,intrinsic apoptotic signaling pathway,19/565,235/10364,0.05520327801808939,0.14274773053445944,0.09399556164316217,IFI6/S100A9/S100A8/MUC1/PTGS2/CXCL12/DDIT4/CREB3L1/CRIP1/BCL3/CYP1B1/ACKR3/HMOX1/SFRP2/HSPA1A/CDKN1A/HSPB1/CLU/CD24,19
GO:0045088,regulation of innate immune response,13/565,146/10364,0.055265059330023986,0.14274773053445944,0.09399556164316217,ISG15/GBP5/MNDA/FCGR2B/BIRC3/CLEC7A/OAS1/OAS3/CCL5/TYROBP/APOE/HLA-G/VSIG4,13
GO:0071383,cellular response to steroid hormone stimulus,13/565,146/10364,0.055265059330023986,0.14274773053445944,0.09399556164316217,ATP1A2/AKR1C3/DDIT4/LMO3/ICAM1/ZFP36/FAM107A/EDN1/GPER1/AQP1/SFRP1/NR4A3/PADI2,13
GO:0030879,mammary gland development,9/565,90/10364,0.05603878311083361,0.14465496724826785,0.09525142599511839,MTCO2P12/OAS2/NTN1/SOX9/HK2/IGFBP5/CSF1R/VEGFA/ELF3,9
GO:0010658,striated muscle cell apoptotic process,4/565,27/10364,0.05665999524368896,0.1455538676533212,0.09584332786366585,AGT/MDK/HSPB6/SFRP2,4
GO:0010874,regulation of cholesterol efflux,4/565,27/10364,0.05665999524368896,0.1455538676533212,0.09584332786366585,CES1/ABCA8/APOE/ABCA1,4
GO:0030104,water homeostasis,4/565,27/10364,0.05665999524368896,0.1455538676533212,0.09584332786366585,CYP4F12/CYP26B1/AQP1/AQP3,4
GO:0030224,monocyte differentiation,4/565,27/10364,0.05665999524368896,0.1455538676533212,0.09584332786366585,JUN/CSF1R/HLA-DRB1/VEGFA,4
GO:0042551,neuron maturation,4/565,27/10364,0.05665999524368896,0.1455538676533212,0.09584332786366585,C1QA/CX3CL1/C3/NR4A2,4
GO:0045880,positive regulation of smoothened signaling pathway,4/565,27/10364,0.05665999524368896,0.1455538676533212,0.09584332786366585,PRRX1/SCUBE1/SFRP1/GPC3,4
GO:0048168,regulation of neuronal synaptic plasticity,4/565,27/10364,0.05665999524368896,0.1455538676533212,0.09584332786366585,AGT/EGR2/APOE/S100B,4
GO:0006820,anion transport,20/565,251/10364,0.05667143747908989,0.1455538676533212,0.09584332786366585,PLA2G2A/MFSD2A/ATP1A2/RGS2/AGT/FOLR2/SLC2A3/CES1/SLC7A5/ABCC3/ACE/SLC16A3/SLC11A1/CLIC6/ABCG2/SLC1A3/EDN1/CD36/CA2/NTRK2,20
GO:0030073,insulin secretion,11/565,118/10364,0.05676362505457071,0.14566122546086374,0.09591402010780142,ALOX5/ADRA2A/SYT7/CCL5/IL1RN/INHBB/CD38/HLA-DRB1/GPER1/SFRP1/CCN3,11
GO:0002822,regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,10/565,104/10364,0.05678439566085455,0.14566122546086374,0.09591402010780142,FCGR2B/CLEC7A/C3/SLC11A1/NFKBIZ/BCL6/IL7R/HLA-G/HLA-DRB1/AZGP1,10
GO:0032535,regulation of cellular component size,22/565,282/10364,0.05716574837356869,0.1465476354673702,0.09649769738305997,LMOD1/CXCL12/KCNMA1/NTN1/SEMA6B/ICAM1/APOE/FN1/SEMA3G/SLIT2/SPP1/IL7R/MAP1B/EDN1/VEGFA/AQP1/ELN/SEMA3C/PLXNA4/CCL21/TENM1/KCNN4,22
GO:0043535,regulation of blood vessel endothelial cell migration,8/565,77/10364,0.05773336406258723,0.14791013296134675,0.09739486553210322,PTGS2/THBS1/APOE/HMOX1/VEGFA/HSPB1/ANGPT1/KLF4,8
GO:0008589,regulation of smoothened signaling pathway,7/565,64/10364,0.058491729336021356,0.14966571243854462,0.0985508676510202,PRRX1/SERPINE2/SCUBE1/SFRP1/GAS1/GPC3/CD3E,7
GO:0071260,cellular response to mechanical stimulus,7/565,64/10364,0.058491729336021356,0.14966571243854462,0.0985508676510202,ATP1A2/PTGS2/AGT/COL1A1/SOX9/TNFSF14/AQP1,7
GO:0007585,respiratory gaseous exchange by respiratory system,5/565,39/10364,0.05904046913602234,0.150693067732466,0.09922735362734822,ATP1A2/NR4A2/CSF2RB/EDN1/ELN,5
GO:0038066,p38MAPK cascade,5/565,39/10364,0.05904046913602234,0.150693067732466,0.09922735362734822,GADD45B/ZFP36/DUSP1/VEGFA/GADD45G,5
GO:0051149,positive regulation of muscle cell differentiation,5/565,39/10364,0.05904046913602234,0.150693067732466,0.09922735362734822,IGF1/CYP26B1/HOPX/EDN1/GPER1,5
GO:1903018,regulation of glycoprotein metabolic process,5/565,39/10364,0.05904046913602234,0.150693067732466,0.09922735362734822,IGF1/RAMP1/HBEGF/IL33/CCL21,5
GO:0017015,regulation of transforming growth factor beta receptor signaling pathway,9/565,91/10364,0.05933810760840473,0.15135838788087785,0.09966544914584326,CDKN1C/THBS1/FBN1/LRG1/EMILIN1/LTBP1/HTRA3/HSPA1A/PEG10,9
GO:0006986,response to unfolded protein,11/565,119/10364,0.05962765441996467,0.15190766471396103,0.10002713324568795,HSPB7/HSPA6/ATF3/CREB3L1/HSPB8/THBS1/THBS4/HSPA1A/HSPA1B/HSPB1/DERL3,11
GO:0043433,negative regulation of DNA-binding transcription factor activity,11/565,119/10364,0.05962765441996467,0.15190766471396103,0.10002713324568795,ID3/CMKLR1/BCL3/CYP1B1/ID1/PTGIS/SIK1/HMOX1/BHLHE40/KLF4/NLRP2,11
GO:0009416,response to light stimulus,17/565,207/10364,0.059708476153204744,0.15201896851444044,0.10010042382060576,ATP1A2/PTGS2/FOS/CRIP1/MMP2/MFAP4/BCL3/SIK1/BHLHE40/MME/SLC1A3/DUSP1/CDKN1A/AQP1/PTN/TIMP1/LCN2,17
GO:0051651,maintenance of location in cell,13/565,148/10364,0.06033299463642539,0.15351353638379464,0.10108455677857149,S100A9/S100A8/ATP1A2/SRGN/APLNR/THY1/CX3CL1/APOE/HK2/PLN/GPER1/CCL21/LCN2,13
GO:0002209,behavioral defense response,3/565,17/10364,0.061966605559907656,0.1558300265124459,0.10260990355549174,ATP1A2/MDK/APOE,3
GO:0002507,tolerance induction,3/565,17/10364,0.061966605559907656,0.1558300265124459,0.10260990355549174,LILRB2/HLA-G/CD3E,3
GO:0006691,leukotriene metabolic process,3/565,17/10364,0.061966605559907656,0.1558300265124459,0.10260990355549174,ALOX5/CYP4F12/GGT5,3
GO:0010714,positive regulation of collagen metabolic process,3/565,17/10364,0.061966605559907656,0.1558300265124459,0.10260990355549174,CREB3L1/PDGFRB/CCN2,3
GO:0010888,negative regulation of lipid storage,3/565,17/10364,0.061966605559907656,0.1558300265124459,0.10260990355549174,CES1/ITGB3/ABCA1,3
GO:0017158,regulation of calcium ion-dependent exocytosis,3/565,17/10364,0.061966605559907656,0.1558300265124459,0.10260990355549174,ADRA2A/SYT7/CACNA1H,3
GO:0031664,regulation of lipopolysaccharide-mediated signaling pathway,3/565,17/10364,0.061966605559907656,0.1558300265124459,0.10260990355549174,CX3CL1/LTF/CD36,3
GO:0032941,secretion by tissue,3/565,17/10364,0.061966605559907656,0.1558300265124459,0.10260990355549174,NPR3/AQP1/KCNN4,3
GO:0036315,cellular response to sterol,3/565,17/10364,0.061966605559907656,0.1558300265124459,0.10260990355549174,CES1/ABCA1/RORC,3
GO:0051955,regulation of amino acid transport,3/565,17/10364,0.061966605559907656,0.1558300265124459,0.10260990355549174,ATP1A2/RGS2/AGT,3
GO:0060339,negative regulation of type I interferon-mediated signaling pathway,3/565,17/10364,0.061966605559907656,0.1558300265124459,0.10260990355549174,ISG15/OAS1/OAS3,3
GO:0070168,negative regulation of biomineral tissue development,3/565,17/10364,0.061966605559907656,0.1558300265124459,0.10260990355549174,SRGN/SOX9/CCR1,3
GO:0071450,cellular response to oxygen radical,3/565,17/10364,0.061966605559907656,0.1558300265124459,0.10260990355549174,H19/NQO1/CD36,3
GO:0071451,cellular response to superoxide,3/565,17/10364,0.061966605559907656,0.1558300265124459,0.10260990355549174,H19/NQO1/CD36,3
GO:0101023,vascular endothelial cell proliferation,3/565,17/10364,0.061966605559907656,0.1558300265124459,0.10260990355549174,IGF2/MDK/CCL2,3
GO:0110150,negative regulation of biomineralization,3/565,17/10364,0.061966605559907656,0.1558300265124459,0.10260990355549174,SRGN/SOX9/CCR1,3
GO:1902692,regulation of neuroblast proliferation,3/565,17/10364,0.061966605559907656,0.1558300265124459,0.10260990355549174,CX3CL1/VEGFA/PTN,3
GO:1903306,negative regulation of regulated secretory pathway,3/565,17/10364,0.061966605559907656,0.1558300265124459,0.10260990355549174,FCGR2B/ADRA2A/HMOX1,3
GO:1905562,regulation of vascular endothelial cell proliferation,3/565,17/10364,0.061966605559907656,0.1558300265124459,0.10260990355549174,IGF2/MDK/CCL2,3
GO:0014031,mesenchymal cell development,6/565,52/10364,0.06226393929961534,0.15638562422860441,0.10297574978773967,SOX9/SEMA6B/FN1/SEMA3G/EDN1/SEMA3C,6
GO:0043903,regulation of biological process involved in symbiotic interaction,6/565,52/10364,0.06226393929961534,0.15638562422860441,0.10297574978773967,IFITM2/IFITM1/IFITM3/LTF/CXCL8/HLA-DRB1,6
GO:0022037,metencephalon development,7/565,65/10364,0.06262453770471951,0.1571948849559299,0.10350862632662343,FCGR2B/MDK/CNTN1/CKB/SERPINE2/PTN/CD3E,7
GO:0042326,negative regulation of phosphorylation,22/565,285/10364,0.06268056211699656,0.15723910619300485,0.10353774482819154,NIBAN1/RGS2/AGT/DDIT4/CDKN1C/THY1/GPRC5A/SOCS3/GADD45B/APOE/EMILIN1/FBLN1/SLIT2/UCHL1/SFRP2/DUSP1/CDKN1A/IGFBP3/MLXIPL/HSPB1/SFRP1/ANGPT1,22
GO:0030902,hindbrain development,9/565,92/10364,0.06275966040853218,0.15724482846544108,0.10354151279150352,FCGR2B/EGR2/MDK/CNTN1/CKB/C5AR1/SERPINE2/PTN/CD3E,9
GO:1903844,regulation of cellular response to transforming growth factor beta stimulus,9/565,92/10364,0.06275966040853218,0.15724482846544108,0.10354151279150352,CDKN1C/THBS1/FBN1/LRG1/EMILIN1/LTBP1/HTRA3/HSPA1A/PEG10,9
GO:0006006,glucose metabolic process,13/565,149/10364,0.06298017366120916,0.1577008140483121,0.10384176709889371,ATF3/IGF2/DGAT2/NNMT/IGF1/OAS1/C1QTNF1/HK2/SIK1/APOD/HK3/PDK4/RORC,13
GO:0001708,cell fate specification,4/565,28/10364,0.06337280901558565,0.15800747875140536,0.10404369760171477,SOX9/SOX18/MIAT/SFRP2,4
GO:0030517,negative regulation of axon extension,4/565,28/10364,0.06337280901558565,0.15800747875140536,0.10404369760171477,NTN1/SEMA6B/SEMA3G/SEMA3C,4
GO:0045668,negative regulation of osteoblast differentiation,4/565,28/10364,0.06337280901558565,0.15800747875140536,0.10404369760171477,ID3/SOX9/IGFBP5/SFRP1,4
GO:0046622,positive regulation of organ growth,4/565,28/10364,0.06337280901558565,0.15800747875140536,0.10404369760171477,IGF2/IGF1/BASP1/EDN1,4
GO:0060711,labyrinthine layer development,4/565,28/10364,0.06337280901558565,0.15800747875140536,0.10404369760171477,CCN1/ADM/SOCS3/JUNB,4
GO:0061383,trabecula morphogenesis,4/565,28/10364,0.06337280901558565,0.15800747875140536,0.10404369760171477,MMP2/COL1A1/ADAMTS1/SFRP1,4
GO:1903725,regulation of phospholipid metabolic process,4/565,28/10364,0.06337280901558565,0.15800747875140536,0.10404369760171477,FABP3/MFSD2A/LDLR/APOC1,4
GO:0016042,lipid catabolic process,16/565,194/10364,0.06431875989202669,0.1602618283474497,0.10552812650035191,PLA2G2A/MFSD2A/AKR1C3/ADRA2A/CES1/PLIN5/LDLR/CYP4F12/APOE/APOC1/CYP1B1/CYP26B1/SPP1/LPL/ENPP2/PLCH2,16
GO:0008344,adult locomotory behavior,5/565,40/10364,0.06459013599738446,0.1602618283474497,0.10552812650035191,ATP1A2/CXCL12/SNCG/NR4A2/UCHL1,5
GO:0015807,L-amino acid transport,5/565,40/10364,0.06459013599738446,0.1602618283474497,0.10552812650035191,ATP1A2/AGT/SLC7A5/SLC11A1/SLC1A3,5
GO:0032413,negative regulation of ion transmembrane transporter activity,5/565,40/10364,0.06459013599738446,0.1602618283474497,0.10552812650035191,ATP1A2/ADRA2A/RRAD/PLN/GEM,5
GO:0035904,aorta development,5/565,40/10364,0.06459013599738446,0.1602618283474497,0.10552812650035191,APLNR/NGFR/ADAMTS9/MYLK/PDGFRB,5
GO:0050709,negative regulation of protein secretion,5/565,40/10364,0.06459013599738446,0.1602618283474497,0.10552812650035191,ADRA2A/APOE/INHBB/SFRP1/CCN3,5
GO:0050810,regulation of steroid biosynthetic process,5/565,40/10364,0.06459013599738446,0.1602618283474497,0.10552812650035191,AKR1C3/ADM/CES1/APOE/EGR1,5
GO:0061028,establishment of endothelial barrier,5/565,40/10364,0.06459013599738446,0.1602618283474497,0.10552812650035191,ICAM1/SOX18/CLDN5/VEGFA/S1PR3,5
GO:0002824,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,7/565,66/10364,0.06693094495960639,0.16586881880425458,0.10922017971298072,CLEC7A/C3/SLC11A1/NFKBIZ/HLA-G/HLA-DRB1/AZGP1,7
GO:0007498,mesoderm development,7/565,66/10364,0.06693094495960639,0.16586881880425458,0.10922017971298072,ITGA8/ITGB3/ITGB4/SECTM1/SFRP2/VEGFA/KLF4,7
GO:0014013,regulation of gliogenesis,6/565,53/10364,0.06713886932416638,0.1661829087141095,0.10942699951580863,EGR2/MDK/LDLR/SERPINE2/LIF/PTN,6
GO:0048864,stem cell development,6/565,53/10364,0.06713886932416638,0.1661829087141095,0.10942699951580863,SOX9/SEMA6B/FN1/SEMA3G/EDN1/SEMA3C,6
GO:0010675,regulation of cellular carbohydrate metabolic process,10/565,108/10364,0.06971684752695491,0.17245968203948844,0.11356008682876866,DDIT4/IGF2/DGAT2/NNMT/IGF1/C1QTNF1/SIK1/GPER1/PDK4/RORC,10
GO:0051148,negative regulation of muscle cell differentiation,5/565,41/10364,0.07042195691459378,0.17299627023150974,0.11391341579793188,RGS2/IGF2/TMEM119/PI16/CCN3,5
GO:0060420,regulation of heart growth,5/565,41/10364,0.07042195691459378,0.17299627023150974,0.11391341579793188,RGS2/IGF1/BASP1/EDN1/PI16,5
GO:0070613,regulation of protein processing,5/565,41/10364,0.07042195691459378,0.17299627023150974,0.11391341579793188,THBS1/SERPINE2/CLEC3B/SERPINE1/GAS1,5
GO:0072089,stem cell proliferation,5/565,41/10364,0.07042195691459378,0.17299627023150974,0.11391341579793188,NES/ACE/SOX18/FBLN1/SFRP2,5
GO:0002707,negative regulation of lymphocyte mediated immunity,4/565,29/10364,0.07048309202397612,0.17299627023150974,0.11391341579793188,FCGR2B/BCL6/IL7R/HLA-G,4
GO:0002823,negative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,4/565,29/10364,0.07048309202397612,0.17299627023150974,0.11391341579793188,FCGR2B/BCL6/IL7R/HLA-G,4
GO:0003407,neural retina development,4/565,29/10364,0.07048309202397612,0.17299627023150974,0.11391341579793188,THY1/SOX9/PTN/NTRK2,4
GO:0010907,positive regulation of glucose metabolic process,4/565,29/10364,0.07048309202397612,0.17299627023150974,0.11391341579793188,IGF2/DGAT2/NNMT/IGF1,4
GO:0019748,secondary metabolic process,4/565,29/10364,0.07048309202397612,0.17299627023150974,0.11391341579793188,FMO2/AKR1C2/AKR1C3/CYP1B1,4
GO:0046596,regulation of viral entry into host cell,4/565,29/10364,0.07048309202397612,0.17299627023150974,0.11391341579793188,IFITM2/IFITM1/IFITM3/HLA-DRB1,4
GO:0051785,positive regulation of nuclear division,4/565,29/10364,0.07048309202397612,0.17299627023150974,0.11391341579793188,IGF2/IGF1/PDGFRB/EDN1,4
GO:0072132,mesenchyme morphogenesis,4/565,29/10364,0.07048309202397612,0.17299627023150974,0.11391341579793188,ACTA2/APLNR/SOX9/ACTG2,4
GO:2000404,regulation of T cell migration,4/565,29/10364,0.07048309202397612,0.17299627023150974,0.11391341579793188,CXCL12/CCL5/APOD/CCL21,4
GO:0001709,cell fate determination,3/565,18/10364,0.07145880730348506,0.17393124678981442,0.1145290728482541,PRRX1/CYP26B1/KLF4,3
GO:0001911,negative regulation of leukocyte mediated cytotoxicity,3/565,18/10364,0.07145880730348506,0.17393124678981442,0.1145290728482541,FCGR2B/IL7R/HLA-G,3
GO:0006026,aminoglycan catabolic process,3/565,18/10364,0.07145880730348506,0.17393124678981442,0.1145290728482541,CHI3L2/CHI3L1/LYVE1,3
GO:0006884,cell volume homeostasis,3/565,18/10364,0.07145880730348506,0.17393124678981442,0.1145290728482541,KCNMA1/AQP1/KCNN4,3
GO:0009435,"NAD biosynthetic process",3/565,18/10364,0.07145880730348506,0.17393124678981442,0.1145290728482541,NNMT/PTGIS/NAMPT,3
GO:0030574,collagen catabolic process,3/565,18/10364,0.07145880730348506,0.17393124678981442,0.1145290728482541,MMP2/MRC2/ADAMTS2,3
GO:0031065,positive regulation of histone deacetylation,3/565,18/10364,0.07145880730348506,0.17393124678981442,0.1145290728482541,APLNR/BCL6/VEGFA,3
GO:0032369,negative regulation of lipid transport,3/565,18/10364,0.07145880730348506,0.17393124678981442,0.1145290728482541,THBS1/ITGB3/APOC1,3
GO:0045671,negative regulation of osteoclast differentiation,3/565,18/10364,0.07145880730348506,0.17393124678981442,0.1145290728482541,FBN1/LTF/SFRP1,3
GO:0051131,chaperone-mediated protein complex assembly,3/565,18/10364,0.07145880730348506,0.17393124678981442,0.1145290728482541,HOPX/HSPA1A/CLU,3
GO:0051895,negative regulation of focal adhesion assembly,3/565,18/10364,0.07145880730348506,0.17393124678981442,0.1145290728482541,THBS1/FAM107A/APOD,3
GO:0086010,membrane depolarization during action potential,3/565,18/10364,0.07145880730348506,0.17393124678981442,0.1145290728482541,ATP1A2/CACNA1H/SCN7A,3
GO:0150118,negative regulation of cell-substrate junction organization,3/565,18/10364,0.07145880730348506,0.17393124678981442,0.1145290728482541,THBS1/FAM107A/APOD,3
GO:2000191,regulation of fatty acid transport,3/565,18/10364,0.07145880730348506,0.17393124678981442,0.1145290728482541,FABP3/THBS1/EDN1,3
GO:0042058,regulation of epidermal growth factor receptor signaling pathway,6/565,54/10364,0.07222978524076316,0.17559901471240166,0.1156272534076725,IFI6/AGT/ADRA2A/GPRC5A/HBEGF/GPER1,6
GO:0060419,heart growth,6/565,54/10364,0.07222978524076316,0.17559901471240166,0.1156272534076725,RGS2/AGT/IGF1/BASP1/EDN1/PI16,6
GO:0035107,appendage morphogenesis,8/565,81/10364,0.07333538019484644,0.17796979639460658,0.1171883497201521,PRRX1/ZBTB16/SOX9/CYP26B1/FRAS1/SFRP2/SEMA3C/GPC3,8
GO:0035108,limb morphogenesis,8/565,81/10364,0.07333538019484644,0.17796979639460658,0.1171883497201521,PRRX1/ZBTB16/SOX9/CYP26B1/FRAS1/SFRP2/SEMA3C/GPC3,8
GO:0051606,detection of stimulus,8/565,81/10364,0.07333538019484644,0.17796979639460658,0.1171883497201521,CXCL12/CLEC7A/NGFR/SSC5D/SERPINE2/C4B/HLA-DRB1/AZGP1,8
GO:0002699,positive regulation of immune effector process,12/565,138/10364,0.07350238956802137,0.1782694211442414,0.11738564460195978,CLEC7A/SLC7A5/C3/TYROBP/HMOX1/NFKBIZ/SPON2/HLA-G/HLA-DRB1/CD36/AZGP1/NR4A3,12
GO:0010977,negative regulation of neuron projection development,9/565,95/10364,0.07376489309406403,0.1788001612357005,0.1177351227533564,THY1/NTN1/SEMA6B/APOE/SEMA3G/CD38/SPP1/SPOCK1/SEMA3C,9
GO:0051209,release of sequestered calcium ion into cytosol,7/565,68/10364,0.07606570149157633,0.18426803663107308,0.12133557241976144,ATP1A2/APLNR/THY1/CX3CL1/PLN/GPER1/CCL21,7
GO:0032623,interleukin-2 production,5/565,42/10364,0.07653368007333214,0.18485480012992436,0.12172194048613792,GBP1/CLEC7A/ZFP36/VSIG4/CD3E,5
GO:0032663,regulation of interleukin-2 production,5/565,42/10364,0.07653368007333214,0.18485480012992436,0.12172194048613792,GBP1/CLEC7A/ZFP36/VSIG4/CD3E,5
GO:0048010,vascular endothelial growth factor receptor signaling pathway,5/565,42/10364,0.07653368007333214,0.18485480012992436,0.12172194048613792,ITGB3/EMILIN1/VEGFA/HSPB1/SULF1,5
GO:0050854,regulation of antigen receptor-mediated signaling pathway,5/565,42/10364,0.07653368007333214,0.18485480012992436,0.12172194048613792,GBP1/FCGR2B/THY1/CD22/KCNN4,5
GO:1903317,regulation of protein maturation,5/565,42/10364,0.07653368007333214,0.18485480012992436,0.12172194048613792,THBS1/SERPINE2/CLEC3B/SERPINE1/GAS1,5
GO:0035966,response to topologically incorrect protein,12/565,139/10364,0.07668438601403149,0.18510959689943687,0.12188971734231298,HSPB7/HSPA6/ATF3/CREB3L1/HSPB8/THBS1/THBS4/HSPA1A/HSPA1B/HSPB1/CLU/DERL3,12
GO:0030178,negative regulation of Wnt signaling pathway,10/565,110/10364,0.07682965450306874,0.18524181715875346,0.12197678084579942,MDK/IGFBP6/SOX9/APOE/FRZB/IGFBP2/SFRP2/EGR1/SFRP1/GPC3,10
GO:0090276,regulation of peptide hormone secretion,10/565,110/10364,0.07682965450306874,0.18524181715875346,0.12197678084579942,ALOX5/ADRA2A/SYT7/CCL5/INHBB/CD38/HLA-DRB1/GPER1/SFRP1/CCN3,10
GO:0030512,negative regulation of transforming growth factor beta receptor signaling pathway,6/565,55/10364,0.0775359911030085,0.18650549211264206,0.1228088769959829,FBN1/EMILIN1/LTBP1/HTRA3/HSPA1A/PEG10,6
GO:0034766,negative regulation of ion transmembrane transport,6/565,55/10364,0.0775359911030085,0.18650549211264206,0.1228088769959829,ATP1A2/RGS2/ADRA2A/RRAD/PLN/GEM,6
GO:0045638,negative regulation of myeloid cell differentiation,6/565,55/10364,0.0775359911030085,0.18650549211264206,0.1228088769959829,C1QC/ZBTB16/FBN1/ZFP36/LTF/SFRP1,6
GO:0051702,biological process involved in interaction with symbiont,6/565,55/10364,0.0775359911030085,0.18650549211264206,0.1228088769959829,JUN/IFI27/CCL5/APOE/FN1/LTF,6
GO:0000768,syncytium formation by plasma membrane fusion,4/565,30/10364,0.0779833014601575,0.1867038808057806,0.1229395106429445,CACNA1H/GDF15/TYROBP/ADAMTS5,4
GO:0001755,neural crest cell migration,4/565,30/10364,0.0779833014601575,0.1867038808057806,0.1229395106429445,SEMA6B/FN1/SEMA3G/SEMA3C,4
GO:0060443,mammary gland morphogenesis,4/565,30/10364,0.0779833014601575,0.1867038808057806,0.1229395106429445,NTN1/IGFBP5/CSF1R/ELF3,4
GO:0060675,ureteric bud morphogenesis,4/565,30/10364,0.0779833014601575,0.1867038808057806,0.1229395106429445,AGT/SOX9/VEGFA/GPC3,4
GO:0072171,mesonephric tubule morphogenesis,4/565,30/10364,0.0779833014601575,0.1867038808057806,0.1229395106429445,AGT/SOX9/VEGFA/GPC3,4
GO:0140253,cell-cell fusion,4/565,30/10364,0.0779833014601575,0.1867038808057806,0.1229395106429445,CACNA1H/GDF15/TYROBP/ADAMTS5,4
GO:1902003,regulation of amyloid-beta formation,4/565,30/10364,0.0779833014601575,0.1867038808057806,0.1229395106429445,IGF1/APOE/CLU/NTRK2,4
GO:2000243,positive regulation of reproductive process,4/565,30/10364,0.0779833014601575,0.1867038808057806,0.1229395106429445,CACNA1H/SOX9/INHBB/VEGFA,4
GO:0008610,lipid biosynthetic process,34/565,486/10364,0.07941972771744486,0.19003177397733445,0.1251308392656657,FABP3/MFSD2A/CCN1/GSTM1/PTGS2/AKR1C3/CCDC3/ALOX5/SCD/ADM/FADS2/DGAT2/ALDH1A3/CACNA1H/CES1/P2RX1/ABCA8/SOCS3/PLIN5/C3/LDLR/APOE/APOC1/THNSL2/PTGIS/SIK1/EGR1/EDN1/GPER1/MLXIPL/PDK4/LPL/PTGDS/PLPP2,34
GO:0031334,positive regulation of protein-containing complex assembly,15/565,185/10364,0.08021746284727485,0.19182844211258365,0.12631389716666927,ISG15/GBP5/LMOD1/CLEC7A/TPPP3/ICAM1/MAP1B/HSPA1A/HSPA1B/VEGFA/CD36/CLU/CCL21/ABCA1/TENM1,15
GO:0071692,protein localization to extracellular region,18/565,231/10364,0.08030088776292033,0.1919158403394021,0.1263714465608744,ALOX5/SNCG/ADRA2A/SYT7/IGF1/FBN1/CCL5/APOE/LTBP1/IL1RN/INHBB/CD38/HLA-DRB1/GPER1/SFRP1/CCN3/ABCA1/KCNN4,18
GO:0030100,regulation of endocytosis,13/565,155/10364,0.08048265495865936,0.19223803348935323,0.12658360213052056,ITGB3/C3/APOE/APOC1/CD14/VEGFA/CD36/SERPINE1/CLU/ANGPT1/CCL21/GPC3/CD22,13
GO:1903532,positive regulation of secretion by cell,14/565,170/10364,0.0805347901960545,0.19225039712107705,0.12659174325124786,AGT/CXCL12/SYT7/IGF1/CACNA1H/C1QTNF1/INHBB/CD38/SPP1/EDN1/HLA-DRB1/GPER1/KCNN4/RAB27B,14
GO:0001508,action potential,7/565,69/10364,0.08089385348258579,0.19277033536537036,0.12693410867526636,ATP1A2/CACNA1H/P2RX1/SCN7A/GPER1/CD36/NTRK2,7
GO:0007601,visual perception,7/565,69/10364,0.08089385348258579,0.19277033536537036,0.12693410867526636,RGS16/HMCN1/LUM/COL1A1/TIMP3/TGFBI/LAMC3,7
GO:0051283,negative regulation of sequestering of calcium ion,7/565,69/10364,0.08089385348258579,0.19277033536537036,0.12693410867526636,ATP1A2/APLNR/THY1/CX3CL1/PLN/GPER1/CCL21,7
GO:0000303,response to superoxide,3/565,19/10364,0.0815574603666549,0.19278074061263578,0.12694096025222024,H19/NQO1/CD36,3
GO:0003171,atrioventricular valve development,3/565,19/10364,0.0815574603666549,0.19278074061263578,0.12694096025222024,CCN1/APLNR/SLIT3,3
GO:0010464,regulation of mesenchymal cell proliferation,3/565,19/10364,0.0815574603666549,0.19278074061263578,0.12694096025222024,PRRX1/SOX9/PTN,3
GO:0031342,negative regulation of cell killing,3/565,19/10364,0.0815574603666549,0.19278074061263578,0.12694096025222024,FCGR2B/IL7R/HLA-G,3
GO:0032892,positive regulation of organic acid transport,3/565,19/10364,0.0815574603666549,0.19278074061263578,0.12694096025222024,FABP3/AGT/EDN1,3
GO:0046823,negative regulation of nucleocytoplasmic transport,3/565,19/10364,0.0815574603666549,0.19278074061263578,0.12694096025222024,APOD/CD36/ANGPT1,3
GO:0046835,carbohydrate phosphorylation,3/565,19/10364,0.0815574603666549,0.19278074061263578,0.12694096025222024,PFKFB3/HK2/HK3,3
GO:0048679,regulation of axon regeneration,3/565,19/10364,0.0815574603666549,0.19278074061263578,0.12694096025222024,SPP1/PTN/KLF4,3
GO:0050850,positive regulation of calcium-mediated signaling,3/565,19/10364,0.0815574603666549,0.19278074061263578,0.12694096025222024,CLEC7A/IGF1/CD3E,3
GO:0050892,intestinal absorption,3/565,19/10364,0.0815574603666549,0.19278074061263578,0.12694096025222024,ADRA2A/LDLR/CD36,3
GO:0070528,protein kinase C signaling,3/565,19/10364,0.0815574603666549,0.19278074061263578,0.12694096025222024,FIBIN/VEGFA/AKAP12,3
GO:0070841,inclusion body assembly,3/565,19/10364,0.0815574603666549,0.19278074061263578,0.12694096025222024,HSPA1A/HSPA1B/CLU,3
GO:0090050,positive regulation of cell migration involved in sprouting angiogenesis,3/565,19/10364,0.0815574603666549,0.19278074061263578,0.12694096025222024,PTGS2/HMOX1/VEGFA,3
GO:1903959,regulation of anion transmembrane transport,3/565,19/10364,0.0815574603666549,0.19278074061263578,0.12694096025222024,ATP1A2/RGS2/AGT,3
GO:0006022,aminoglycan metabolic process,8/565,83/10364,0.08200694561690372,0.19373135335003105,0.12756691330816072,CHI3L2/CHI3L1/ITIH5/LYVE1/DCN/PDGFRB/ANGPT1/BGN,8
GO:0045936,negative regulation of phosphate metabolic process,24/565,326/10364,0.08209002361640486,0.1938157766352719,0.12762250378292528,NIBAN1/RGS2/AGT/DDIT4/H19/CDKN1C/THY1/GPRC5A/SOCS3/GADD45B/APOE/APOC1/EMILIN1/FBLN1/SLIT2/UCHL1/SFRP2/DUSP1/CDKN1A/IGFBP3/MLXIPL/HSPB1/SFRP1/ANGPT1,24
GO:0042391,regulation of membrane potential,16/565,201/10364,0.08237439754495826,0.194375091382743,0.12799079758085127,IFI6/JUN/ATP1A2/KCNMA1/DCN/CACNA1H/P2RX1/SCN7A/EDN1/PLN/GPER1/CD36/RELN/PTN/NTRK2/KCNN4,16
GO:0043551,regulation of phosphatidylinositol 3-kinase activity,5/565,43/10364,0.08292225975998843,0.19544256272734178,0.12869369890333024,SOCS3/FGFR3/PDGFRB/CCL21/KLF4,5
GO:0051145,smooth muscle cell differentiation,5/565,43/10364,0.08292225975998843,0.19544256272734178,0.12869369890333024,ADM/APLNR/SOX9/VEGFA/GPER1,5
GO:2000106,regulation of leukocyte apoptotic process,6/565,56/10364,0.08305631876549575,0.19564589702298021,0.12882758909722888,CXCL12/CCL5/BCL6/IL7R/CCL21/TSC22D3,6
GO:0009746,response to hexose,12/565,141/10364,0.08330836968257005,0.196126777159541,0.12914423580222262,PTGS2/ADRA2A/THBS1/ICAM1/COL6A2/EGR1/HLA-DRB1/CCN2/GPER1/MLXIPL/NAMPT/LPL,12
GO:0070588,calcium ion transmembrane transport,13/565,156/10364,0.08367348356300135,0.19687312741777444,0.1296356874802459,ATP1A2/ADRA2A/APLNR/THY1/CACNA1H/CX3CL1/RRAD/P2RX1/PLN/GPER1/RAMP3/GEM/CCL21,13
GO:0010563,negative regulation of phosphorus metabolic process,24/565,327/10364,0.08427494070779891,0.1981743867074835,0.1304925319100777,NIBAN1/RGS2/AGT/DDIT4/H19/CDKN1C/THY1/GPRC5A/SOCS3/GADD45B/APOE/APOC1/EMILIN1/FBLN1/SLIT2/UCHL1/SFRP2/DUSP1/CDKN1A/IGFBP3/MLXIPL/HSPB1/SFRP1/ANGPT1,24
GO:0006949,syncytium formation,4/565,31/10364,0.08586446469906663,0.20094572134580763,0.13231738162821416,CACNA1H/GDF15/TYROBP/ADAMTS5,4
GO:0032330,regulation of chondrocyte differentiation,4/565,31/10364,0.08586446469906663,0.20094572134580763,0.13231738162821416,MDK/ZBTB16/SOX9/CCN2,4
GO:0045620,negative regulation of lymphocyte differentiation,4/565,31/10364,0.08586446469906663,0.20094572134580763,0.13231738162821416,MDK/BCL6/FGL2/SFRP1,4
GO:1900744,regulation of p38MAPK cascade,4/565,31/10364,0.08586446469906663,0.20094572134580763,0.13231738162821416,GADD45B/DUSP1/VEGFA/GADD45G,4
GO:0042552,myelination,9/565,98/10364,0.08588982120394904,0.20094572134580763,0.13231738162821416,EGR2/ITGAX/ITGB4/S100B/CLDN5/TYMP/PTN/CLU/NTRK2,9
GO:0002821,positive regulation of adaptive immune response,7/565,70/10364,0.08589521552397737,0.20094572134580763,0.13231738162821416,CLEC7A/C3/SLC11A1/NFKBIZ/HLA-G/HLA-DRB1/AZGP1,7
GO:0003206,cardiac chamber morphogenesis,7/565,70/10364,0.08589521552397737,0.20094572134580763,0.13231738162821416,CCN1/APLNR/ADAMTS1/SLIT2/SFRP2/SLIT3/SEMA3C,7
GO:0030004,cellular monovalent inorganic cation homeostasis,7/565,70/10364,0.08589521552397737,0.20094572134580763,0.13231738162821416,ATP1A2/AGT/KCNMA1/SLC11A1/SLC1A3/C7/CA2,7
GO:0050953,sensory perception of light stimulus,7/565,70/10364,0.08589521552397737,0.20094572134580763,0.13231738162821416,RGS16/HMCN1/LUM/COL1A1/TIMP3/TGFBI/LAMC3,7
GO:1902903,regulation of supramolecular fiber organization,22/565,296/10364,0.08604948225670377,0.2011916506904313,0.1324793195223291,LMOD1/CXCL12/CRYAB/CX3CL1/ICAM1/LDLR/APOE/EMILIN1/ID1/SLIT2/SYNPO2/MAP1B/EDN1/HSPA1A/HSPA1B/CCN2/AEBP1/ELN/CLU/SFRP1/CCL21/TENM1,22
GO:0003002,regionalization,13/565,157/10364,0.08694329101014917,0.2031654300202915,0.1337790004067484,C1QA/EGR2/ZBTB16/C3/CYP26B1/BHLHE40/SFRP2/BASP1/EDN1/SEMA3C/RELN/SFRP1/GPC3,13
GO:1902806,regulation of cell cycle G1/S phase transition,10/565,113/10364,0.08831581208802704,0.2062549541861852,0.1358133694163012,MUC1/CCL2/ADAMTS1/SUSD2/FAM107A/CDKN1A/GPNMB/TCIM/KLF4/PLPP2,10
GO:0071230,cellular response to amino acid stimulus,6/565,57/10364,0.08878913958117472,0.20712406692041557,0.1363856569005179,COL4A1/MMP2/COL1A1/COL1A2/NTRK2/CYBB,6
GO:2000134,negative regulation of G1/S transition of mitotic cell cycle,6/565,57/10364,0.08878913958117472,0.20712406692041557,0.1363856569005179,MUC1/CCL2/FAM107A/CDKN1A/GPNMB/KLF4,6
GO:0042093,T-helper cell differentiation,5/565,44/10364,0.08958389270606654,0.2085028179298672,0.13729352755467306,BCL3/NFKBIZ/BCL6/HLA-DRB1/RORC,5
GO:0051057,positive regulation of small GTPase mediated signal transduction,5/565,44/10364,0.08958389270606654,0.2085028179298672,0.13729352755467306,IGF1/COL3A1/TGM2/PDGFRB/RELN,5
GO:0060411,cardiac septum morphogenesis,5/565,44/10364,0.08958389270606654,0.2085028179298672,0.13729352755467306,CCN1/APLNR/SLIT2/SLIT3/SEMA3C,5
GO:2000177,regulation of neural precursor cell proliferation,5/565,44/10364,0.08958389270606654,0.2085028179298672,0.13729352755467306,NES/MDK/CX3CL1/VEGFA/PTN,5
GO:0002285,lymphocyte activation involved in immune response,11/565,128/10364,0.08968703350428091,0.20850580077599432,0.13729549167904803,FCER1G/FCGR2B/MDK/ICAM1/BCL3/SLC11A1/NFKBIZ/BCL6/HLA-DRB1/FGL2/RORC,11
GO:0048738,cardiac muscle tissue development,11/565,128/10364,0.08968703350428091,0.20850580077599432,0.13729549167904803,RGS2/AGT/IGF1/SIK1/ADAMTS9/HOPX/PDGFRB/EDN1/PI16/VEGFA/PLN,11
GO:0007272,ensheathment of neurons,9/565,99/10364,0.09018083644935675,0.20941596393855164,0.13789480977210058,EGR2/ITGAX/ITGB4/S100B/CLDN5/TYMP/PTN/CLU/NTRK2,9
GO:0008366,axon ensheathment,9/565,99/10364,0.09018083644935675,0.20941596393855164,0.13789480977210058,EGR2/ITGAX/ITGB4/S100B/CLDN5/TYMP/PTN/CLU/NTRK2,9
GO:0016485,protein processing,12/565,143/10364,0.09028050098407105,0.20943706147271954,0.13790870193393018,F3/SRGN/CPXM2/THBS1/ACE/SERPINE2/CLEC3B/MME/ADAMTS2/SERPINE1/PLAT/GAS1,12
GO:0042593,glucose homeostasis,13/565,158/10364,0.09029223583276745,0.20943706147271954,0.13790870193393018,ALOX5/ADRA2A/OAS1/NGFR/ICAM1/HK2/IGFBP5/KLF15/HK3/HLA-DRB1/GPER1/MLXIPL/PDK4,13
GO:0051282,regulation of sequestering of calcium ion,7/565,71/10364,0.09106893361590124,0.21111903410164196,0.1390162359124534,ATP1A2/APLNR/THY1/CX3CL1/PLN/GPER1/CCL21,7
GO:0007044,cell-substrate junction assembly,8/565,85/10364,0.09125912212924418,0.21144020712910339,0.13922771975873136,THY1/THBS1/ITGB4/FN1/FAM107A/APOD/VEGFA/SFRP1,8
GO:0000305,response to oxygen radical,3/565,20/10364,0.0922310300674074,0.21201226114315888,0.13960440202289096,H19/NQO1/CD36,3
GO:0001945,lymph vessel development,3/565,20/10364,0.0922310300674074,0.21201226114315888,0.13960440202289096,SOX18/VEGFA/SVEP1,3
GO:0007435,salivary gland morphogenesis,3/565,20/10364,0.0922310300674074,0.21201226114315888,0.13960440202289096,FGF7/TGM2/SEMA3C,3
GO:0007606,sensory perception of chemical stimulus,3/565,20/10364,0.0922310300674074,0.21201226114315888,0.13960440202289096,C5AR1/CD36/AZGP1,3
GO:0042026,protein refolding,3/565,20/10364,0.0922310300674074,0.21201226114315888,0.13960440202289096,HSPA6/HSPA1A/HSPA1B,3
GO:0046475,glycerophospholipid catabolic process,3/565,20/10364,0.0922310300674074,0.21201226114315888,0.13960440202289096,LDLR/APOC1/ENPP2,3
GO:0048843,negative regulation of axon extension involved in axon guidance,3/565,20/10364,0.0922310300674074,0.21201226114315888,0.13960440202289096,SEMA6B/SEMA3G/SEMA3C,3
GO:0070050,neuron cellular homeostasis,3/565,20/10364,0.0922310300674074,0.21201226114315888,0.13960440202289096,CX3CL1/P2RX1/NELL2,3
GO:0070423,nucleotide-binding oligomerization domain containing signaling pathway,3/565,20/10364,0.0922310300674074,0.21201226114315888,0.13960440202289096,BIRC3/HSPA1A/HSPA1B,3
GO:0071549,cellular response to dexamethasone stimulus,3/565,20/10364,0.0922310300674074,0.21201226114315888,0.13960440202289096,DDIT4/ICAM1/AQP1,3
GO:0097106,postsynaptic density organization,3/565,20/10364,0.0922310300674074,0.21201226114315888,0.13960440202289096,LILRB2/RELN/LRRC4,3
GO:0099084,postsynaptic specialization organization,3/565,20/10364,0.0922310300674074,0.21201226114315888,0.13960440202289096,LILRB2/RELN/LRRC4,3
GO:2000050,regulation of non-canonical Wnt signaling pathway,3/565,20/10364,0.0922310300674074,0.21201226114315888,0.13960440202289096,SFRP2/SFRP1/GPC3,3
GO:2000406,positive regulation of T cell migration,3/565,20/10364,0.0922310300674074,0.21201226114315888,0.13960440202289096,CXCL12/CCL5/CCL21,3
GO:0033500,carbohydrate homeostasis,13/565,159/10364,0.09372041849202421,0.21507365095647263,0.14162024531394504,ALOX5/ADRA2A/OAS1/NGFR/ICAM1/HK2/IGFBP5/KLF15/HK3/HLA-DRB1/GPER1/MLXIPL/PDK4,13
GO:0042594,response to starvation,13/565,159/10364,0.09372041849202421,0.21507365095647263,0.14162024531394504,MFSD2A/JUN/ATF3/AKR1C3/ADM/ZFP36/INHBB/LOC102724428/SIK1/CDKN1A/PDK4/SFRP1/ELAPOR1,13
GO:0043123,positive regulation of I-kappaB kinase/NF-kappaB signaling,13/565,159/10364,0.09372041849202421,0.21507365095647263,0.14162024531394504,S100A4/BIRC3/CLEC7A/CX3CL1/SECTM1/TGM2/S100B/HMOX1/LTF/TNFSF10/HLA-DRB1/CD36/CCL21,13
GO:0002762,negative regulation of myeloid leukocyte differentiation,4/565,32/10364,0.09411630879872401,0.21513800570741268,0.14166262119576373,C1QC/FBN1/LTF/SFRP1,4
GO:0002820,negative regulation of adaptive immune response,4/565,32/10364,0.09411630879872401,0.21513800570741268,0.14166262119576373,FCGR2B/BCL6/IL7R/HLA-G,4
GO:0007595,lactation,4/565,32/10364,0.09411630879872401,0.21513800570741268,0.14166262119576373,MTCO2P12/OAS2/HK2/VEGFA,4
GO:0009409,response to cold,4/565,32/10364,0.09411630879872401,0.21513800570741268,0.14166262119576373,MTCO2P12/ADM/FOS/LPL,4
GO:0014037,Schwann cell differentiation,4/565,32/10364,0.09411630879872401,0.21513800570741268,0.14166262119576373,EGR2/ITGB4/LAMA2/NTRK2,4
GO:0042181,ketone biosynthetic process,4/565,32/10364,0.09411630879872401,0.21513800570741268,0.14166262119576373,AKR1C3/ADM/CACNA1H/EGR1,4
GO:0060425,lung morphogenesis,4/565,32/10364,0.09411630879872401,0.21513800570741268,0.14166262119576373,FGF7/SOX9/LIF/TNC,4
GO:0006720,isoprenoid metabolic process,6/565,58/10364,0.09473237760973728,0.2160637069271668,0.14227217068379253,AKR1C3/DGAT2/ALDH1A3/CYP1B1/CYP26B1/ADH1B,6
GO:0042303,molting cycle,6/565,58/10364,0.09473237760973728,0.2160637069271668,0.14227217068379253,PTGS2/FGF7/NGFR/SOX9/IGFBP5/SOX18,6
GO:0042633,hair cycle,6/565,58/10364,0.09473237760973728,0.2160637069271668,0.14227217068379253,PTGS2/FGF7/NGFR/SOX9/IGFBP5/SOX18,6
GO:1901184,regulation of ERBB signaling pathway,6/565,58/10364,0.09473237760973728,0.2160637069271668,0.14227217068379253,IFI6/AGT/ADRA2A/GPRC5A/HBEGF/GPER1,6
GO:0034763,negative regulation of transmembrane transport,7/565,72/10364,0.09641386009971994,0.2192722240233813,0.14438489335455726,ATP1A2/RGS2/ADRA2A/THBS1/RRAD/PLN/GEM,7
GO:0046887,positive regulation of hormone secretion,7/565,72/10364,0.09641386009971994,0.2192722240233813,0.14438489335455726,C1QTNF1/INHBB/CD38/SPP1/EDN1/HLA-DRB1/GPER1,7
GO:0002287,alpha-beta T cell activation involved in immune response,5/565,45/10364,0.09651405659260702,0.2192722240233813,0.14438489335455726,BCL3/NFKBIZ/BCL6/HLA-DRB1/RORC,5
GO:0002293,alpha-beta T cell differentiation involved in immune response,5/565,45/10364,0.09651405659260702,0.2192722240233813,0.14438489335455726,BCL3/NFKBIZ/BCL6/HLA-DRB1/RORC,5
GO:0002294,"CD4-positive, alpha-beta T cell differentiation involved in immune response",5/565,45/10364,0.09651405659260702,0.2192722240233813,0.14438489335455726,BCL3/NFKBIZ/BCL6/HLA-DRB1/RORC,5
GO:0051851,modulation by host of symbiont process,5/565,45/10364,0.09651405659260702,0.2192722240233813,0.14438489335455726,JUN/IFI27/CCL5/APOE/LTF,5
GO:1901568,fatty acid derivative metabolic process,5/565,45/10364,0.09651405659260702,0.2192722240233813,0.14438489335455726,ALOX5/DGAT2/CYP4F12/GGT5/HPGD,5
GO:0051495,positive regulation of cytoskeleton organization,14/565,176/10364,0.09984601985745158,0.2210366429565158,0.14554671601872754,NES/LMOD1/CX3CL1/ICAM1/ID1/SYNPO2/MAP1B/EDN1/HSPA1A/HSPA1B/CCN2/SFRP1/CCL21/TENM1,14
GO:0001768,establishment of T cell polarity,2/565,10/10364,0.09988221530765858,0.2210366429565158,0.14554671601872754,CYP26B1/CCL21,2
GO:0001771,immunological synapse formation,2/565,10/10364,0.09988221530765858,0.2210366429565158,0.14554671601872754,PRF1/CCL21,2
GO:0002291,T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell,2/565,10/10364,0.09988221530765858,0.2210366429565158,0.14554671601872754,ICAM1/FGL2,2
GO:0006002,fructose 6-phosphate metabolic process,2/565,10/10364,0.09988221530765858,0.2210366429565158,0.14554671601872754,HK2/HK3,2
GO:0006706,steroid catabolic process,2/565,10/10364,0.09988221530765858,0.2210366429565158,0.14554671601872754,APOE/SPP1,2
GO:0010745,negative regulation of macrophage derived foam cell differentiation,2/565,10/10364,0.09988221530765858,0.2210366429565158,0.14554671601872754,ITGB3/ABCA1,2
GO:0010968,regulation of microtubule nucleation,2/565,10/10364,0.09988221530765858,0.2210366429565158,0.14554671601872754,HSPA1A/HSPA1B,2
GO:0014029,neural crest formation,2/565,10/10364,0.09988221530765858,0.2210366429565158,0.14554671601872754,SOX9/SFRP1,2
GO:0014745,negative regulation of muscle adaptation,2/565,10/10364,0.09988221530765858,0.2210366429565158,0.14554671601872754,IGFBP5/KLF4,2
GO:0015911,long-chain fatty acid import across plasma membrane,2/565,10/10364,0.09988221530765858,0.2210366429565158,0.14554671601872754,THBS1/CD36,2
GO:0016114,terpenoid biosynthetic process,2/565,10/10364,0.09988221530765858,0.2210366429565158,0.14554671601872754,AKR1C3/ALDH1A3,2
GO:0019433,triglyceride catabolic process,2/565,10/10364,0.09988221530765858,0.2210366429565158,0.14554671601872754,PLIN5/LPL,2
GO:0021783,preganglionic parasympathetic fiber development,2/565,10/10364,0.09988221530765858,0.2210366429565158,0.14554671601872754,EGR2/PLXNA4,2
GO:0030431,sleep,2/565,10/10364,0.09988221530765858,0.2210366429565158,0.14554671601872754,FOS/PTGDS,2
GO:0030449,regulation of complement activation,2/565,10/10364,0.09988221530765858,0.2210366429565158,0.14554671601872754,C3/VSIG4,2
GO:0032780,negative regulation of ATPase activity,2/565,10/10364,0.09988221530765858,0.2210366429565158,0.14554671601872754,LTF/PLN,2
GO:0033212,iron import into cell,2/565,10/10364,0.09988221530765858,0.2210366429565158,0.14554671601872754,STEAP4/LCN2,2
GO:0034350,regulation of glial cell apoptotic process,2/565,10/10364,0.09988221530765858,0.2210366429565158,0.14554671601872754,CCL2/AKAP12,2
GO:0035641,locomotory exploration behavior,2/565,10/10364,0.09988221530765858,0.2210366429565158,0.14554671601872754,ATP1A2/APOE,2
GO:0035812,renal sodium excretion,2/565,10/10364,0.09988221530765858,0.2210366429565158,0.14554671601872754,AGT/EDN1,2
GO:0035929,steroid hormone secretion,2/565,10/10364,0.09988221530765858,0.2210366429565158,0.14554671601872754,AGT/C1QTNF1,2
GO:0036462,TRAIL-activated apoptotic signaling pathway,2/565,10/10364,0.09988221530765858,0.2210366429565158,0.14554671601872754,ATF3/TIMP3,2
GO:0042755,eating behavior,2/565,10/10364,0.09988221530765858,0.2210366429565158,0.14554671601872754,GDF15/UCHL1,2
GO:0043508,negative regulation of JUN kinase activity,2/565,10/10364,0.09988221530765858,0.2210366429565158,0.14554671601872754,SFRP2/SFRP1,2
GO:0043922,negative regulation by host of viral transcription,2/565,10/10364,0.09988221530765858,0.2210366429565158,0.14554671601872754,JUN/CCL5,2
GO:0044062,regulation of excretion,2/565,10/10364,0.09988221530765858,0.2210366429565158,0.14554671601872754,AGT/EDN1,2
GO:0045064,T-helper 2 cell differentiation,2/565,10/10364,0.09988221530765858,0.2210366429565158,0.14554671601872754,BCL3/BCL6,2
GO:0048486,parasympathetic nervous system development,2/565,10/10364,0.09988221530765858,0.2210366429565158,0.14554671601872754,EGR2/PLXNA4,2
GO:0048532,anatomical structure arrangement,2/565,10/10364,0.09988221530765858,0.2210366429565158,0.14554671601872754,EGR2/PLXNA4,2
GO:0050482,arachidonic acid secretion,2/565,10/10364,0.09988221530765858,0.2210366429565158,0.14554671601872754,PLA2G2A/ACE,2
GO:0051004,regulation of lipoprotein lipase activity,2/565,10/10364,0.09988221530765858,0.2210366429565158,0.14554671601872754,ANGPTL4/APOC1,2
GO:0051450,myoblast proliferation,2/565,10/10364,0.09988221530765858,0.2210366429565158,0.14554671601872754,IGF1/ATOH8,2
GO:0051930,regulation of sensory perception of pain,2/565,10/10364,0.09988221530765858,0.2210366429565158,0.14554671601872754,EDN1/CCN3,2
GO:0055064,chloride ion homeostasis,2/565,10/10364,0.09988221530765858,0.2210366429565158,0.14554671601872754,CKB/CA12,2
GO:0055083,monovalent inorganic anion homeostasis,2/565,10/10364,0.09988221530765858,0.2210366429565158,0.14554671601872754,CKB/CA12,2
GO:0070207,protein homotrimerization,2/565,10/10364,0.09988221530765858,0.2210366429565158,0.14554671601872754,HLA-G/STEAP4,2
GO:0072170,metanephric tubule development,2/565,10/10364,0.09988221530765858,0.2210366429565158,0.14554671601872754,SOX9/LIF,2
GO:0072234,metanephric nephron tubule development,2/565,10/10364,0.09988221530765858,0.2210366429565158,0.14554671601872754,SOX9/LIF,2
GO:0072683,T cell extravasation,2/565,10/10364,0.09988221530765858,0.2210366429565158,0.14554671601872754,CCL2/ICAM1,2
GO:0090084,negative regulation of inclusion body assembly,2/565,10/10364,0.09988221530765858,0.2210366429565158,0.14554671601872754,HSPA1A/HSPA1B,2
GO:1901203,positive regulation of extracellular matrix assembly,2/565,10/10364,0.09988221530765858,0.2210366429565158,0.14554671601872754,SOX9/EMILIN1,2
GO:1901569,fatty acid derivative catabolic process,2/565,10/10364,0.09988221530765858,0.2210366429565158,0.14554671601872754,CYP4F12/HPGD,2
GO:1901841,regulation of high voltage-gated calcium channel activity,2/565,10/10364,0.09988221530765858,0.2210366429565158,0.14554671601872754,RRAD/GEM,2
GO:1903265,positive regulation of tumor necrosis factor-mediated signaling pathway,2/565,10/10364,0.09988221530765858,0.2210366429565158,0.14554671601872754,HSPA1A/HSPA1B,2
GO:1903963,arachidonate transport,2/565,10/10364,0.09988221530765858,0.2210366429565158,0.14554671601872754,PLA2G2A/ACE,2
GO:1990440,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress,2/565,10/10364,0.09988221530765858,0.2210366429565158,0.14554671601872754,ATF3/CREB3L1,2
GO:2000345,regulation of hepatocyte proliferation,2/565,10/10364,0.09988221530765858,0.2210366429565158,0.14554671601872754,MDK/PTN,2
GO:0002819,regulation of adaptive immune response,10/565,116/10364,0.10078342069701503,0.22229211724939665,0.14637341225302877,FCGR2B/CLEC7A/C3/SLC11A1/NFKBIZ/BCL6/IL7R/HLA-G/HLA-DRB1/AZGP1,10
GO:0006140,regulation of nucleotide metabolic process,6/565,59/10364,0.1008835241880912,0.22229211724939665,0.14637341225302877,MTCO2P12/DDIT4/H19/IGF1/MLXIPL/PDK4,6
GO:0015914,phospholipid transport,6/565,59/10364,0.1008835241880912,0.22229211724939665,0.14637341225302877,MFSD2A/LDLR/APOE/APOC1/ABCA1/KCNN4,6
GO:0030901,midbrain development,6/565,59/10364,0.1008835241880912,0.22229211724939665,0.14637341225302877,CKB/NR4A2/SFRP2/BASP1/SFRP1/PADI2,6
GO:0046620,regulation of organ growth,6/565,59/10364,0.1008835241880912,0.22229211724939665,0.14637341225302877,RGS2/IGF2/IGF1/BASP1/EDN1/PI16,6
GO:0098586,cellular response to virus,6/565,59/10364,0.1008835241880912,0.22229211724939665,0.14637341225302877,IFI6/H19/BIRC3/OAS1/OAS3/CCL5,6
GO:1900542,regulation of purine nucleotide metabolic process,6/565,59/10364,0.1008835241880912,0.22229211724939665,0.14637341225302877,MTCO2P12/DDIT4/H19/IGF1/MLXIPL/PDK4,6
GO:0045862,positive regulation of proteolysis,21/565,286/10364,0.10088391642632608,0.22229211724939665,0.14637341225302877,CCN1/F3/S100A9/S100A8/ADRA2A/CLEC7A/P2RX1/NGFR/APOE/FN1/FBLN1/CLEC3B/PCOLCE2/TNFSF10/SFRP2/HSPA1A/HSPA1B/CCN2/GPER1/CLU/NLRP2,21
GO:0008637,apoptotic mitochondrial changes,8/565,87/10364,0.10108792722635423,0.22262182574754935,0.14659051647840843,IFI6/JUN/IGF1/HK2/TNFSF10/HSPA1A/GPER1/CLU,8
GO:0034284,response to monosaccharide,12/565,146/10364,0.1013929084749493,0.22316929796859247,0.14695101228950333,PTGS2/ADRA2A/THBS1/ICAM1/COL6A2/EGR1/HLA-DRB1/CCN2/GPER1/MLXIPL/NAMPT/LPL,12
GO:0009267,cellular response to starvation,11/565,131/10364,0.10144554555924537,0.22316929796859247,0.14695101228950333,MFSD2A/JUN/ATF3/AKR1C3/INHBB/LOC102724428/SIK1/CDKN1A/PDK4/SFRP1/ELAPOR1,11
GO:0005996,monosaccharide metabolic process,15/565,192/10364,0.1018817403934124,0.22400850975866293,0.14750361080192725,ATF3/PFKFB3/IGF2/DGAT2/NNMT/SLC2A3/IGF1/OAS1/C1QTNF1/HK2/SIK1/APOD/HK3/PDK4/RORC,15
GO:0042446,hormone biosynthetic process,4/565,33/10364,0.10272738853202022,0.2255045193834267,0.1484886931172591,ADM/CACNA1H/EGR1/STC2,4
GO:0071526,semaphorin-plexin signaling pathway,4/565,33/10364,0.10272738853202022,0.2255045193834267,0.1484886931172591,SEMA6B/SEMA3G/SEMA3C/PLXNA4,4
GO:0072078,nephron tubule morphogenesis,4/565,33/10364,0.10272738853202022,0.2255045193834267,0.1484886931172591,AGT/SOX9/VEGFA/GPC3,4
GO:0007176,regulation of epidermal growth factor-activated receptor activity,3/565,21/10364,0.10344621211741617,0.22563068322253693,0.14857176863006635,ADRA2A/GPRC5A/HBEGF,3
GO:0007431,salivary gland development,3/565,21/10364,0.10344621211741617,0.22563068322253693,0.14857176863006635,FGF7/TGM2/SEMA3C,3
GO:0014741,negative regulation of muscle hypertrophy,3/565,21/10364,0.10344621211741617,0.22563068322253693,0.14857176863006635,RGS2/IGFBP5/PI16,3
GO:0019359,nicotinamide nucleotide biosynthetic process,3/565,21/10364,0.10344621211741617,0.22563068322253693,0.14857176863006635,NNMT/PTGIS/NAMPT,3
GO:0019363,pyridine nucleotide biosynthetic process,3/565,21/10364,0.10344621211741617,0.22563068322253693,0.14857176863006635,NNMT/PTGIS/NAMPT,3
GO:0031646,positive regulation of nervous system process,3/565,21/10364,0.10344621211741617,0.22563068322253693,0.14857176863006635,EGR2/ITGAX/S100B,3
GO:0035872,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway",3/565,21/10364,0.10344621211741617,0.22563068322253693,0.14857176863006635,BIRC3/HSPA1A/HSPA1B,3
GO:0035909,aorta morphogenesis,3/565,21/10364,0.10344621211741617,0.22563068322253693,0.14857176863006635,ADAMTS9/MYLK/PDGFRB,3
GO:0046427,positive regulation of receptor signaling pathway via JAK-STAT,3/565,21/10364,0.10344621211741617,0.22563068322253693,0.14857176863006635,AGT/CCL5/CYP1B1,3
GO:0060421,positive regulation of heart growth,3/565,21/10364,0.10344621211741617,0.22563068322253693,0.14857176863006635,IGF1/BASP1/EDN1,3
GO:0060428,lung epithelium development,3/565,21/10364,0.10344621211741617,0.22563068322253693,0.14857176863006635,FGF7/SOX9/KLF2,3
GO:2000209,regulation of anoikis,3/565,21/10364,0.10344621211741617,0.22563068322253693,0.14857176863006635,SIK1/PDK4/NTRK2,3
GO:0021954,central nervous system neuron development,5/565,46/10364,0.10370755029376827,0.22595993129467126,0.14878856967723064,DCLK1/NR4A2/SLIT2/PLXNA4/NTRK2,5
GO:0032410,negative regulation of transporter activity,5/565,46/10364,0.10370755029376827,0.22595993129467126,0.14878856967723064,ATP1A2/ADRA2A/RRAD/PLN/GEM,5
GO:0051100,negative regulation of binding,10/565,117/10364,0.10515640634645286,0.22899485509700956,0.15078698580809954,JUN/NES/IFIT1/ACE/ID1/SLPI/HMOX1/CDKN1A/PLN/RAP1GAP,10
GO:0032874,positive regulation of stress-activated MAPK cascade,8/565,88/10364,0.10621642908465989,0.23118025554098756,0.15222601353468984,FCGR2B/CLEC7A/IGFBP6/GADD45B/VEGFA/CCN2/CCL21/GADD45G,8
GO:0051403,stress-activated MAPK cascade,14/565,178/10364,0.10686358089549247,0.23246519669827106,0.15307211291087658,FCGR2B/AGT/CRYAB/CLEC7A/IGFBP6/GADD45B/ZFP36/SFRP2/DUSP1/VEGFA/CCN2/SFRP1/CCL21/GADD45G,14
GO:0051893,regulation of focal adhesion assembly,6/565,60/10364,0.10723965371637739,0.2330356381713636,0.15344773335995224,THY1/THBS1/FAM107A/APOD/VEGFA/SFRP1,6
GO:0090109,regulation of cell-substrate junction assembly,6/565,60/10364,0.10723965371637739,0.2330356381713636,0.15344773335995224,THY1/THBS1/FAM107A/APOD/VEGFA/SFRP1,6
GO:0050954,sensory perception of mechanical stimulus,7/565,74/10364,0.10761131643102567,0.2337192198772515,0.1538978536254959,CXCL12/COL1A1/ICAM1/MYO7B/SERPINE2/SLC1A3/ESPN,7
GO:0048762,mesenchymal cell differentiation,12/565,148/10364,0.10923639593333431,0.2371229082455306,0.15613909135752035,S100A4/MDK/COL1A1/SOX9/SEMA6B/FRZB/FN1/SEMA3G/SFRP2/EDN1/SEMA3C/SFRP1,12
GO:0001942,hair follicle development,5/565,47/10364,0.11115853546681961,0.24103974798790226,0.1587182255411045,FGF7/NGFR/SOX9/IGFBP5/SOX18,5
GO:0050732,negative regulation of peptidyl-tyrosine phosphorylation,5/565,47/10364,0.11115853546681961,0.24103974798790226,0.1587182255411045,THY1/GPRC5A/SOCS3/SFRP2/SFRP1,5
GO:0022029,telencephalon cell migration,4/565,34/10364,0.11168521196573748,0.2417975979839922,0.15921724948885507,CXCL12/SLIT2/MDGA1/RELN,4
GO:0030239,myofibril assembly,4/565,34/10364,0.11168521196573748,0.2417975979839922,0.15921724948885507,LMOD1/KRT19/PDGFRB/EDN1,4
GO:0032728,positive regulation of interferon-beta production,4/565,34/10364,0.11168521196573748,0.2417975979839922,0.15921724948885507,ISG15/OAS1/OAS3/OAS2,4
GO:0071902,positive regulation of protein serine/threonine kinase activity,12/565,149/10364,0.11328803584038152,0.24513806486814058,0.16141685756493662,ADRA2A/IGF2/THBS1/SPATC1L/LTF/CSF1R/PDGFRB/EDN1/VEGFA/TCIM/TENM1/CD24,12
GO:0006865,amino acid transport,7/565,75/10364,0.11346014101721803,0.2452512235081788,0.1614913695020816,ATP1A2/RGS2/AGT/SLC7A5/SLC11A1/SLC1A3/NTRK2,7
GO:0051208,sequestering of calcium ion,7/565,75/10364,0.11346014101721803,0.2452512235081788,0.1614913695020816,ATP1A2/APLNR/THY1/CX3CL1/PLN/GPER1/CCL21,7
GO:0009308,amine metabolic process,6/565,61/10364,0.11379744051618869,0.2455913133754752,0.1617153095813108,VCAM1/NNMT/AOC3/NR4A2/INMT/MOXD1,6
GO:0030216,keratinocyte differentiation,6/565,61/10364,0.11379744051618869,0.2455913133754752,0.1617153095813108,AKR1C3/PPL/ZFP36/FOSL2/CYP26B1/AQP3,6
GO:0071479,cellular response to ionizing radiation,6/565,61/10364,0.11379744051618869,0.2455913133754752,0.1617153095813108,CRYAB/SFRP2/EGR1/CDKN1A/NAMPT/SFRP1,6
GO:0002703,regulation of leukocyte mediated immunity,11/565,134/10364,0.11407219924485497,0.24579557037286118,0.16184980734962526,FCGR2B/CLEC7A/C3/ICAM1/TYROBP/HMOX1/BCL6/IL7R/HLA-G/HLA-DRB1/AZGP1,11
GO:0006109,regulation of carbohydrate metabolic process,11/565,134/10364,0.11407219924485497,0.24579557037286118,0.16184980734962526,DDIT4/IGF2/DGAT2/NNMT/IGF1/C1QTNF1/SIK1/GPER1/MLXIPL/PDK4/RORC,11
GO:2001242,regulation of intrinsic apoptotic signaling pathway,11/565,134/10364,0.11407219924485497,0.24579557037286118,0.16184980734962526,S100A9/S100A8/MUC1/PTGS2/CXCL12/CREB3L1/ACKR3/SFRP2/HSPA1A/HSPB1/CLU,11
GO:0019318,hexose metabolic process,14/565,180/10364,0.11417082410894934,0.24587867117413917,0.16190452700408056,ATF3/PFKFB3/IGF2/DGAT2/NNMT/IGF1/OAS1/C1QTNF1/HK2/SIK1/APOD/HK3/PDK4/RORC,14
GO:0002063,chondrocyte development,3/565,22/10364,0.11516840209718297,0.24621380584118385,0.1621252042165099,SOX9/SFRP2/SULF1,3
GO:0006734,"NADH metabolic process",3/565,22/10364,0.11516840209718297,0.24621380584118385,0.1621252042165099,NQO1/HK2/HK3,3
GO:0007520,myoblast fusion,3/565,22/10364,0.11516840209718297,0.24621380584118385,0.1621252042165099,CACNA1H/GDF15/ADAMTS5,3
GO:0010039,response to iron ion,3/565,22/10364,0.11516840209718297,0.24621380584118385,0.1621252042165099,C1QA/HMOX1/LCN2,3
GO:0022602,ovulation cycle process,3/565,22/10364,0.11516840209718297,0.24621380584118385,0.1621252042165099,ADAMTS1/SLIT2/SLIT3,3
GO:0032733,positive regulation of interleukin-10 production,3/565,22/10364,0.11516840209718297,0.24621380584118385,0.1621252042165099,ISG15/CLEC7A/BCL3,3
GO:0044788,modulation by host of viral process,3/565,22/10364,0.11516840209718297,0.24621380584118385,0.1621252042165099,IFI27/APOE/LTF,3
GO:0045622,regulation of T-helper cell differentiation,3/565,22/10364,0.11516840209718297,0.24621380584118385,0.1621252042165099,NFKBIZ/BCL6/HLA-DRB1,3
GO:0048384,retinoic acid receptor signaling pathway,3/565,22/10364,0.11516840209718297,0.24621380584118385,0.1621252042165099,AKR1C3/KLF2/CYP26B1,3
GO:0060986,endocrine hormone secretion,3/565,22/10364,0.11516840209718297,0.24621380584118385,0.1621252042165099,AGT/C1QTNF1/INHBB,3
GO:0072538,T-helper 17 type immune response,3/565,22/10364,0.11516840209718297,0.24621380584118385,0.1621252042165099,CLEC7A/NFKBIZ/RORC,3
GO:1900745,positive regulation of p38MAPK cascade,3/565,22/10364,0.11516840209718297,0.24621380584118385,0.1621252042165099,GADD45B/VEGFA/GADD45G,3
GO:1903055,positive regulation of extracellular matrix organization,3/565,22/10364,0.11516840209718297,0.24621380584118385,0.1621252042165099,AGT/SOX9/EMILIN1,3
GO:2000403,positive regulation of lymphocyte migration,3/565,22/10364,0.11516840209718297,0.24621380584118385,0.1621252042165099,CXCL12/CCL5/CCL21,3
GO:0006469,negative regulation of protein kinase activity,13/565,165/10364,0.11595174726327259,0.24648565993555688,0.16230421286477287,RGS2/AGT/CDKN1C/THY1/GPRC5A/GADD45B/APOE/UCHL1/SFRP2/DUSP1/CDKN1A/HSPB1/SFRP1,13
GO:0009913,epidermal cell differentiation,8/565,90/10364,0.11689562312527899,0.24648565993555688,0.16230421286477287,AKR1C3/PPL/ZFP36/FOSL2/CYP26B1/MAFF/AQP3/KLF4,8
GO:0050852,T cell receptor signaling pathway,8/565,90/10364,0.11689562312527899,0.24648565993555688,0.16230421286477287,GBP1/THY1/NFKBIZ/BTNL9/HLA-DRB1/HLA-DQB1/CD3E/KCNN4,8
GO:0070304,positive regulation of stress-activated protein kinase signaling cascade,8/565,90/10364,0.11689562312527899,0.24648565993555688,0.16230421286477287,FCGR2B/CLEC7A/IGFBP6/GADD45B/VEGFA/CCN2/CCL21/GADD45G,8
GO:0001767,establishment of lymphocyte polarity,2/565,11/10364,0.11782423949533091,0.24648565993555688,0.16230421286477287,CYP26B1/CCL21,2
GO:0002029,desensitization of G protein-coupled receptor signaling pathway,2/565,11/10364,0.11782423949533091,0.24648565993555688,0.16230421286477287,ADM/APLNR,2
GO:0010460,positive regulation of heart rate,2/565,11/10364,0.11782423949533091,0.24648565993555688,0.16230421286477287,ADM/EDN1,2
GO:0010889,regulation of sequestering of triglyceride,2/565,11/10364,0.11782423949533091,0.24648565993555688,0.16230421286477287,PLIN5/LPL,2
GO:0014067,negative regulation of phosphatidylinositol 3-kinase signaling,2/565,11/10364,0.11782423949533091,0.24648565993555688,0.16230421286477287,SERPINE2/KLF4,2
GO:0019370,leukotriene biosynthetic process,2/565,11/10364,0.11782423949533091,0.24648565993555688,0.16230421286477287,ALOX5/GGT5,2
GO:0022401,negative adaptation of signaling pathway,2/565,11/10364,0.11782423949533091,0.24648565993555688,0.16230421286477287,ADM/APLNR,2
GO:0023058,adaptation of signaling pathway,2/565,11/10364,0.11782423949533091,0.24648565993555688,0.16230421286477287,ADM/APLNR,2
GO:0032026,response to magnesium ion,2/565,11/10364,0.11782423949533091,0.24648565993555688,0.16230421286477287,THBS1/CD14,2
GO:0034111,negative regulation of homotypic cell-cell adhesion,2/565,11/10364,0.11782423949533091,0.24648565993555688,0.16230421286477287,C1QTNF1/SERPINE2,2
GO:0035116,embryonic hindlimb morphogenesis,2/565,11/10364,0.11782423949533091,0.24648565993555688,0.16230421286477287,ZBTB16/GPC3,2
GO:0042178,xenobiotic catabolic process,2/565,11/10364,0.11782423949533091,0.24648565993555688,0.16230421286477287,GSTM1/GSTM3,2
GO:0042249,establishment of planar polarity of embryonic epithelium,2/565,11/10364,0.11782423949533091,0.24648565993555688,0.16230421286477287,SFRP2/SFRP1,2
GO:0042759,long-chain fatty acid biosynthetic process,2/565,11/10364,0.11782423949533091,0.24648565993555688,0.16230421286477287,GSTM1/ALOX5,2
GO:0042953,lipoprotein transport,2/565,11/10364,0.11782423949533091,0.24648565993555688,0.16230421286477287,CD36/MSR1,2
GO:0043951,negative regulation of cAMP-mediated signaling,2/565,11/10364,0.11782423949533091,0.24648565993555688,0.16230421286477287,RGS2/APLNR,2
GO:0045723,positive regulation of fatty acid biosynthetic process,2/565,11/10364,0.11782423949533091,0.24648565993555688,0.16230421286477287,PTGS2/MLXIPL,2
GO:0045725,positive regulation of glycogen biosynthetic process,2/565,11/10364,0.11782423949533091,0.24648565993555688,0.16230421286477287,IGF2/IGF1,2
GO:0045822,negative regulation of heart contraction,2/565,11/10364,0.11782423949533091,0.24648565993555688,0.16230421286477287,ATP1A2/PLN,2
GO:0046348,amino sugar catabolic process,2/565,11/10364,0.11782423949533091,0.24648565993555688,0.16230421286477287,CHI3L2/CHI3L1,2
GO:0051931,regulation of sensory perception,2/565,11/10364,0.11782423949533091,0.24648565993555688,0.16230421286477287,EDN1/CCN3,2
GO:0060008,Sertoli cell differentiation,2/565,11/10364,0.11782423949533091,0.24648565993555688,0.16230421286477287,SOX9/ICAM1,2
GO:0060100,"positive regulation of phagocytosis, engulfment",2/565,11/10364,0.11782423949533091,0.24648565993555688,0.16230421286477287,C3/CD36,2
GO:0060602,branch elongation of an epithelium,2/565,11/10364,0.11782423949533091,0.24648565993555688,0.16230421286477287,SOX9/TNC,2
GO:0060977,coronary vasculature morphogenesis,2/565,11/10364,0.11782423949533091,0.24648565993555688,0.16230421286477287,PDGFRB/VEGFA,2
GO:0061615,glycolytic process through fructose-6-phosphate,2/565,11/10364,0.11782423949533091,0.24648565993555688,0.16230421286477287,HK2/HK3,2
GO:0061620,glycolytic process through glucose-6-phosphate,2/565,11/10364,0.11782423949533091,0.24648565993555688,0.16230421286477287,HK2/HK3,2
GO:0070571,negative regulation of neuron projection regeneration,2/565,11/10364,0.11782423949533091,0.24648565993555688,0.16230421286477287,THY1/SPP1,2
GO:0071481,cellular response to X-ray,2/565,11/10364,0.11782423949533091,0.24648565993555688,0.16230421286477287,SFRP2/SFRP1,2
GO:0072207,metanephric epithelium development,2/565,11/10364,0.11782423949533091,0.24648565993555688,0.16230421286477287,SOX9/LIF,2
GO:0072243,metanephric nephron epithelium development,2/565,11/10364,0.11782423949533091,0.24648565993555688,0.16230421286477287,SOX9/LIF,2
GO:0098703,calcium ion import across plasma membrane,2/565,11/10364,0.11782423949533091,0.24648565993555688,0.16230421286477287,P2RX1/RAMP3,2
GO:1900221,regulation of amyloid-beta clearance,2/565,11/10364,0.11782423949533091,0.24648565993555688,0.16230421286477287,APOE/CLU,2
GO:1901163,regulation of trophoblast cell migration,2/565,11/10364,0.11782423949533091,0.24648565993555688,0.16230421286477287,VEGFA/TIMP1,2
GO:1902656,calcium ion import into cytosol,2/565,11/10364,0.11782423949533091,0.24648565993555688,0.16230421286477287,P2RX1/RAMP3,2
GO:1905155,positive regulation of membrane invagination,2/565,11/10364,0.11782423949533091,0.24648565993555688,0.16230421286477287,C3/CD36,2
GO:2000052,positive regulation of non-canonical Wnt signaling pathway,2/565,11/10364,0.11782423949533091,0.24648565993555688,0.16230421286477287,SFRP1/GPC3,2
GO:2001014,regulation of skeletal muscle cell differentiation,2/565,11/10364,0.11782423949533091,0.24648565993555688,0.16230421286477287,CYP26B1/S100B,2
GO:0051341,regulation of oxidoreductase activity,6/565,62/10364,0.12055317662151702,0.25206573293589923,0.1659785416524408,AGT/H19/AOC3/APOE/NPR3/EDN1,6
GO:0006509,membrane protein ectodomain proteolysis,4/565,35/10364,0.12097636277051979,0.2524348772591784,0.16622161331364407,ADRA2A/APOE/TIMP3/TIMP1,4
GO:0055002,striated muscle cell development,4/565,35/10364,0.12097636277051979,0.2524348772591784,0.16622161331364407,LMOD1/KRT19/PDGFRB/EDN1,4
GO:0090317,negative regulation of intracellular protein transport,4/565,35/10364,0.12097636277051979,0.2524348772591784,0.16622161331364407,APOD/CD36/ANGPT1/DERL3,4
GO:1902991,regulation of amyloid precursor protein catabolic process,4/565,35/10364,0.12097636277051979,0.2524348772591784,0.16622161331364407,IGF1/APOE/CLU/NTRK2,4
GO:0010906,regulation of glucose metabolic process,8/565,91/10364,0.1224433354642548,0.2552357512172399,0.16806591388356554,IGF2/DGAT2/NNMT/IGF1/C1QTNF1/SIK1/PDK4/RORC,8
GO:0150115,cell-substrate junction organization,8/565,91/10364,0.1224433354642548,0.2552357512172399,0.16806591388356554,THY1/THBS1/ITGB4/FN1/FAM107A/APOD/VEGFA/SFRP1,8
GO:0007266,Rho protein signal transduction,9/565,106/10364,0.12366718056676722,0.2575246374569405,0.16957308423809545,ADRA2A/NTN1/NGFR/APOE/COL3A1/BCL6/PDGFRB/COL1A2/ABCA1,9
GO:0045165,cell fate commitment,9/565,106/10364,0.12366718056676722,0.2575246374569405,0.16957308423809545,PRRX1/SOX9/CYP26B1/SOX18/MIAT/SFRP2/SFRP1/GAS1/KLF4,9
GO:0070301,cellular response to hydrogen peroxide,7/565,77/10364,0.1256467207749364,0.26151381538006596,0.17219985117845085,NQO1/KLF2/CYP1B1/AQP1/NR4A3/KLF4/LCN2,7
GO:0006942,regulation of striated muscle contraction,5/565,49/10364,0.1268066968496016,0.26272602069952883,0.1729980559513263,ATP1A2/RGS2/NR4A1/PLN/CCN2,5
GO:0021766,hippocampus development,5/565,49/10364,0.1268066968496016,0.26272602069952883,0.1729980559513263,MFSD2A/MDK/SEMA6B/ANXA3/RELN,5
GO:0022404,molting cycle process,5/565,49/10364,0.1268066968496016,0.26272602069952883,0.1729980559513263,FGF7/NGFR/SOX9/IGFBP5/SOX18,5
GO:0022405,hair cycle process,5/565,49/10364,0.1268066968496016,0.26272602069952883,0.1729980559513263,FGF7/NGFR/SOX9/IGFBP5/SOX18,5
GO:0032481,positive regulation of type I interferon production,5/565,49/10364,0.1268066968496016,0.26272602069952883,0.1729980559513263,ISG15/OAS1/OAS3/OAS2/CD14,5
GO:0046928,regulation of neurotransmitter secretion,5/565,49/10364,0.1268066968496016,0.26272602069952883,0.1729980559513263,SNCG/ADRA2A/P2RX1/GPER1/ADCY1,5
GO:0060021,roof of mouth development,5/565,49/10364,0.1268066968496016,0.26272602069952883,0.1729980559513263,PRRX1/LRRC32/CLDN5/FRAS1/ITGB8,5
GO:0098773,skin epidermis development,5/565,49/10364,0.1268066968496016,0.26272602069952883,0.1729980559513263,FGF7/NGFR/SOX9/IGFBP5/SOX18,5
GO:1901019,regulation of calcium ion transmembrane transporter activity,5/565,49/10364,0.1268066968496016,0.26272602069952883,0.1729980559513263,ATP1A2/ADRA2A/RRAD/PLN/GEM,5
GO:0002861,regulation of inflammatory response to antigenic stimulus,3/565,23/10364,0.1273621092913748,0.2629452725360002,0.17314242742002328,FCGR2B/C3/HLA-DRB1,3
GO:0010863,positive regulation of phospholipase C activity,3/565,23/10364,0.1273621092913748,0.2629452725360002,0.17314242742002328,AGT/C5AR1/PDGFRB,3
GO:0031954,positive regulation of protein autophosphorylation,3/565,23/10364,0.1273621092913748,0.2629452725360002,0.17314242742002328,ACE/VEGFA/GPNMB,3
GO:0033363,secretory granule organization,3/565,23/10364,0.1273621092913748,0.2629452725360002,0.17314242742002328,SRGN/SERPINE2/ABCA1,3
GO:0050906,detection of stimulus involved in sensory perception,3/565,23/10364,0.1273621092913748,0.2629452725360002,0.17314242742002328,CXCL12/SERPINE2/AZGP1,3
GO:0071312,cellular response to alkaloid,3/565,23/10364,0.1273621092913748,0.2629452725360002,0.17314242742002328,ICAM1/TGM2/SLC1A3,3
GO:0072091,regulation of stem cell proliferation,3/565,23/10364,0.1273621092913748,0.2629452725360002,0.17314242742002328,ACE/SOX18/FBLN1,3
GO:0002448,mast cell mediated immunity,4/565,36/10364,0.13058661859495543,0.2690596962897572,0.17716861188338986,HMOX1/SPON2/NR4A3/PTGDS,4
GO:0021885,forebrain cell migration,4/565,36/10364,0.13058661859495543,0.2690596962897572,0.17716861188338986,CXCL12/SLIT2/MDGA1/RELN,4
GO:0043113,receptor clustering,4/565,36/10364,0.13058661859495543,0.2690596962897572,0.17716861188338986,THY1/APOE/RELN/PTN,4
GO:1903053,regulation of extracellular matrix organization,4/565,36/10364,0.13058661859495543,0.2690596962897572,0.17716861188338986,AGT/SOX9/EMILIN1/AEBP1,4
GO:0043406,positive regulation of MAP kinase activity,7/565,78/10364,0.13197920842471322,0.2717921928022012,0.1789678877346662,ADRA2A/THBS1/PDGFRB/EDN1/VEGFA/TENM1/CD24,7
GO:0032872,regulation of stress-activated MAPK cascade,11/565,138/10364,0.13223721927361629,0.27218661423136503,0.179227603693859,FCGR2B/CLEC7A/IGFBP6/GADD45B/SFRP2/DUSP1/VEGFA/CCN2/SFRP1/CCL21/GADD45G,11
GO:0050708,regulation of protein secretion,13/565,169/10364,0.13234046160087526,0.27226223607737854,0.1792773986563563,ALOX5/ADRA2A/SYT7/IGF1/CCL5/APOE/INHBB/CD38/HLA-DRB1/GPER1/SFRP1/CCN3/KCNN4,13
GO:0031098,stress-activated protein kinase signaling cascade,14/565,185/10364,0.13369441347912112,0.27490955740006123,0.18102058892385692,FCGR2B/AGT/CRYAB/CLEC7A/IGFBP6/GADD45B/ZFP36/SFRP2/DUSP1/VEGFA/CCN2/SFRP1/CCL21/GADD45G,14
GO:0009791,post-embryonic development,6/565,64/10364,0.1346418656465574,0.2765799287290546,0.18212048375674517,FBN1/NR4A2/SCUBE1/VEGFA/SEMA3C/KLF4,6
GO:0032088,negative regulation of NF-kappaB transcription factor activity,6/565,64/10364,0.1346418656465574,0.2765799287290546,0.18212048375674517,CMKLR1/BCL3/CYP1B1/PTGIS/KLF4/NLRP2,6
GO:0002709,regulation of T cell mediated immunity,5/565,50/10364,0.1349893963535716,0.27676008321918294,0.18223911066884213,FCGR2B/IL7R/HLA-G/HLA-DRB1/AZGP1,5
GO:0035282,segmentation,5/565,50/10364,0.1349893963535716,0.27676008321918294,0.18223911066884213,EGR2/SFRP2/BASP1/SEMA3C/SFRP1,5
GO:0002052,positive regulation of neuroblast proliferation,2/565,12/10364,0.1364872027404813,0.27676008321918294,0.18223911066884213,CX3CL1/VEGFA,2
GO:0002467,germinal center formation,2/565,12/10364,0.1364872027404813,0.27676008321918294,0.18223911066884213,BCL3/BCL6,2
GO:0010766,negative regulation of sodium ion transport,2/565,12/10364,0.1364872027404813,0.27676008321918294,0.18223911066884213,ATP1A2/SERPINE2,2
GO:0015802,basic amino acid transport,2/565,12/10364,0.1364872027404813,0.27676008321918294,0.18223911066884213,AGT/SLC11A1,2
GO:0016486,peptide hormone processing,2/565,12/10364,0.1364872027404813,0.27676008321918294,0.18223911066884213,ACE/MME,2
GO:0030730,sequestering of triglyceride,2/565,12/10364,0.1364872027404813,0.27676008321918294,0.18223911066884213,PLIN5/LPL,2
GO:0032891,negative regulation of organic acid transport,2/565,12/10364,0.1364872027404813,0.27676008321918294,0.18223911066884213,RGS2/THBS1,2
GO:0034505,tooth mineralization,2/565,12/10364,0.1364872027404813,0.27676008321918294,0.18223911066884213,ALPL/COL1A1,2
GO:0043576,regulation of respiratory gaseous exchange,2/565,12/10364,0.1364872027404813,0.27676008321918294,0.18223911066884213,ATP1A2/NR4A2,2
GO:0044872,lipoprotein localization,2/565,12/10364,0.1364872027404813,0.27676008321918294,0.18223911066884213,CD36/MSR1,2
GO:0045091,regulation of single stranded viral RNA replication via double stranded DNA intermediate,2/565,12/10364,0.1364872027404813,0.27676008321918294,0.18223911066884213,CXCL8/TOP2A,2
GO:0046321,positive regulation of fatty acid oxidation,2/565,12/10364,0.1364872027404813,0.27676008321918294,0.18223911066884213,PLIN5/NR4A3,2
GO:0048714,positive regulation of oligodendrocyte differentiation,2/565,12/10364,0.1364872027404813,0.27676008321918294,0.18223911066884213,MDK/PTN,2
GO:0050974,detection of mechanical stimulus involved in sensory perception,2/565,12/10364,0.1364872027404813,0.27676008321918294,0.18223911066884213,CXCL12/SERPINE2,2
GO:0051044,positive regulation of membrane protein ectodomain proteolysis,2/565,12/10364,0.1364872027404813,0.27676008321918294,0.18223911066884213,ADRA2A/APOE,2
GO:0051354,negative regulation of oxidoreductase activity,2/565,12/10364,0.1364872027404813,0.27676008321918294,0.18223911066884213,H19/AOC3,2
GO:0060099,"regulation of phagocytosis, engulfment",2/565,12/10364,0.1364872027404813,0.27676008321918294,0.18223911066884213,C3/CD36,2
GO:0060487,lung epithelial cell differentiation,2/565,12/10364,0.1364872027404813,0.27676008321918294,0.18223911066884213,SOX9/KLF2,2
GO:0061418,regulation of transcription from RNA polymerase II promoter in response to hypoxia,2/565,12/10364,0.1364872027404813,0.27676008321918294,0.18223911066884213,EGR1/VEGFA,2
GO:0070431,nucleotide-binding oligomerization domain containing 2 signaling pathway,2/565,12/10364,0.1364872027404813,0.27676008321918294,0.18223911066884213,HSPA1A/HSPA1B,2
GO:0090036,regulation of protein kinase C signaling,2/565,12/10364,0.1364872027404813,0.27676008321918294,0.18223911066884213,VEGFA/AKAP12,2
GO:0097201,negative regulation of transcription from RNA polymerase II promoter in response to stress,2/565,12/10364,0.1364872027404813,0.27676008321918294,0.18223911066884213,JUN/HSPA1A,2
GO:1903523,negative regulation of blood circulation,2/565,12/10364,0.1364872027404813,0.27676008321918294,0.18223911066884213,ATP1A2/PLN,2
GO:1905048,regulation of metallopeptidase activity,2/565,12/10364,0.1364872027404813,0.27676008321918294,0.18223911066884213,TIMP3/TIMP1,2
GO:0008584,male gonad development,7/565,79/10364,0.13846724814003328,0.2806360959828199,0.18479136137916896,AKR1C3/SOX9/ICAM1/TNFSF10/SFRP2/PDGFRB/SFRP1,7
GO:0009411,response to UV,10/565,124/10364,0.13874479899779815,0.28105947901879547,0.18507014778164071,PTGS2/CRIP1/MMP2/MFAP4/BCL3/MME/CDKN1A/AQP1/PTN/TIMP1,10
GO:0038061,NIK/NF-kappaB signaling,8/565,94/10364,0.13989719397213418,0.28204944111692587,0.18572201133891628,CHI3L1/BIRC3/TNFSF14/BCL3/CD14/EDN1/TCIM/CCN3,8
GO:0007622,rhythmic behavior,3/565,24/10364,0.13999132006585083,0.28204944111692587,0.18572201133891628,EGR2/EGR1/PTGDS,3
GO:0019362,pyridine nucleotide metabolic process,3/565,24/10364,0.13999132006585083,0.28204944111692587,0.18572201133891628,NNMT/PTGIS/NAMPT,3
GO:0021545,cranial nerve development,3/565,24/10364,0.13999132006585083,0.28204944111692587,0.18572201133891628,EGR2/SLC1A3/PLXNA4,3
GO:0036314,response to sterol,3/565,24/10364,0.13999132006585083,0.28204944111692587,0.18572201133891628,CES1/ABCA1/RORC,3
GO:0043552,positive regulation of phosphatidylinositol 3-kinase activity,3/565,24/10364,0.13999132006585083,0.28204944111692587,0.18572201133891628,FGFR3/PDGFRB/CCL21,3
GO:0046496,nicotinamide nucleotide metabolic process,3/565,24/10364,0.13999132006585083,0.28204944111692587,0.18572201133891628,NNMT/PTGIS/NAMPT,3
GO:0070232,regulation of T cell apoptotic process,3/565,24/10364,0.13999132006585083,0.28204944111692587,0.18572201133891628,CCL5/IL7R/TSC22D3,3
GO:0072525,pyridine-containing compound biosynthetic process,3/565,24/10364,0.13999132006585083,0.28204944111692587,0.18572201133891628,NNMT/PTGIS/NAMPT,3
GO:0120033,negative regulation of plasma membrane bounded cell projection assembly,3/565,24/10364,0.13999132006585083,0.28204944111692587,0.18572201133891628,SLIT2/CCL21/RAP1GAP,3
GO:0120178,steroid hormone biosynthetic process,3/565,24/10364,0.13999132006585083,0.28204944111692587,0.18572201133891628,ADM/CACNA1H/EGR1,3
GO:0070228,regulation of lymphocyte apoptotic process,4/565,37/10364,0.14050106496886502,0.2829372159284473,0.18630658730176475,CCL5/BCL6/IL7R/TSC22D3,4
GO:0150116,regulation of cell-substrate junction organization,6/565,65/10364,0.14196566170843902,0.28574602705720226,0.1881561142862456,THY1/THBS1/FAM107A/APOD/VEGFA/SFRP1,6
GO:0003333,amino acid transmembrane transport,5/565,51/10364,0.14340072107911614,0.28792670529568487,0.1895920325668498,ATP1A2/RGS2/AGT/SLC7A5/SLC1A3,5
GO:0014823,response to activity,5/565,51/10364,0.14340072107911614,0.28792670529568487,0.1895920325668498,AGT/POSTN/COL4A2/EDN1/PTN,5
GO:0055017,cardiac muscle tissue growth,5/565,51/10364,0.14340072107911614,0.28792670529568487,0.1895920325668498,RGS2/AGT/IGF1/EDN1/PI16,5
GO:0071868,cellular response to monoamine stimulus,5/565,51/10364,0.14340072107911614,0.28792670529568487,0.1895920325668498,ID1/TGM2/HRH2/NR4A3/NSG1,5
GO:0071870,cellular response to catecholamine stimulus,5/565,51/10364,0.14340072107911614,0.28792670529568487,0.1895920325668498,ID1/TGM2/HRH2/NR4A3/NSG1,5
GO:0046546,development of primary male sexual characteristics,7/565,80/10364,0.14510761923847101,0.29121107507955896,0.19175470220316013,AKR1C3/SOX9/ICAM1/TNFSF10/SFRP2/PDGFRB/SFRP1,7
GO:0021543,pallium development,9/565,110/10364,0.14542824076900585,0.29171152264003425,0.1920842335333165,MFSD2A/MDK/SEMA6B/COL3A1/SLIT2/ANXA3/MDGA1/RELN/NTRK2,9
GO:0070302,regulation of stress-activated protein kinase signaling cascade,11/565,141/10364,0.14683251485583362,0.29438409197834614,0.19384404894365173,FCGR2B/CLEC7A/IGFBP6/GADD45B/SFRP2/DUSP1/VEGFA/CCN2/SFRP1/CCL21/GADD45G,11
GO:0030326,embryonic limb morphogenesis,6/565,66/10364,0.1494691333833225,0.29923062692974195,0.19703536255034818,PRRX1/ZBTB16/CYP26B1/FRAS1/SFRP2/GPC3,6
GO:0035113,embryonic appendage morphogenesis,6/565,66/10364,0.1494691333833225,0.29923062692974195,0.19703536255034818,PRRX1/ZBTB16/CYP26B1/FRAS1/SFRP2/GPC3,6
GO:1990830,cellular response to leukemia inhibitory factor,6/565,66/10364,0.1494691333833225,0.29923062692974195,0.19703536255034818,SOCS3/ICAM1/HK2/PCOLCE2/KLF4/PADI2,6
GO:0008347,glial cell migration,4/565,38/10364,0.1507042043170081,0.3009673231579664,0.19817893055499758,CSPG4/CX3CL1/CCL2/RELN,4
GO:0018198,peptidyl-cysteine modification,4/565,38/10364,0.1507042043170081,0.3009673231579664,0.19817893055499758,S100A9/S100A8/ACE/ZDHHC11B,4
GO:0035418,protein localization to synapse,4/565,38/10364,0.1507042043170081,0.3009673231579664,0.19817893055499758,HSPB1/RELN/NSG1/RAB27B,4
GO:0055021,regulation of cardiac muscle tissue growth,4/565,38/10364,0.1507042043170081,0.3009673231579664,0.19817893055499758,RGS2/IGF1/EDN1/PI16,4
GO:0120163,negative regulation of cold-induced thermogenesis,4/565,38/10364,0.1507042043170081,0.3009673231579664,0.19817893055499758,ID1/ADAMTS5/NPR3/ARRDC3,4
GO:0007269,neurotransmitter secretion,7/565,81/10364,0.15189688509394905,0.30174994522779075,0.1986942662505778,SNCG/ADRA2A/SYT7/NR4A1/P2RX1/GPER1/ADCY1,7
GO:0021953,central nervous system neuron differentiation,7/565,81/10364,0.15189688509394905,0.30174994522779075,0.1986942662505778,DCLK1/NR4A2/SLIT2/SPOCK1/MDGA1/PLXNA4/NTRK2,7
GO:0051101,regulation of DNA binding,7/565,81/10364,0.15189688509394905,0.30174994522779075,0.1986942662505778,JUN/IGF1/BCL3/ID1/LIF/HMOX1/KLF4,7
GO:0051783,regulation of nuclear division,7/565,81/10364,0.15189688509394905,0.30174994522779075,0.1986942662505778,IGF2/IGF1/LIF/PDGFRB/DUSP1/EDN1/MKI67,7
GO:0099643,signal release from synapse,7/565,81/10364,0.15189688509394905,0.30174994522779075,0.1986942662505778,SNCG/ADRA2A/SYT7/NR4A1/P2RX1/GPER1/ADCY1,7
GO:0032233,positive regulation of actin filament bundle assembly,5/565,52/10364,0.15203229360885012,0.30174994522779075,0.1986942662505778,CX3CL1/ID1/SYNPO2/CCN2/SFRP1,5
GO:0046323,glucose import,5/565,52/10364,0.15203229360885012,0.30174994522779075,0.1986942662505778,SLC2A3/IGF1/HK2/KLF15/GPC3,5
GO:0002347,response to tumor cell,3/565,25/10364,0.1530198155417955,0.30174994522779075,0.1986942662505778,PRF1/HLA-DRB1/KLF4,3
GO:0006730,one-carbon metabolic process,3/565,25/10364,0.1530198155417955,0.30174994522779075,0.1986942662505778,CA12/ALDH1L1/CA2,3
GO:0009988,cell-cell recognition,3/565,25/10364,0.1530198155417955,0.30174994522779075,0.1986942662505778,PRF1/FOLR2/CCL21,3
GO:0030513,positive regulation of BMP signaling pathway,3/565,25/10364,0.1530198155417955,0.30174994522779075,0.1986942662505778,CCN1/SULF1/GPC3,3
GO:0030808,regulation of nucleotide biosynthetic process,3/565,25/10364,0.1530198155417955,0.30174994522779075,0.1986942662505778,MTCO2P12/H19/PDK4,3
GO:0034110,regulation of homotypic cell-cell adhesion,3/565,25/10364,0.1530198155417955,0.30174994522779075,0.1986942662505778,CCL5/C1QTNF1/SERPINE2,3
GO:0045920,negative regulation of exocytosis,3/565,25/10364,0.1530198155417955,0.30174994522779075,0.1986942662505778,FCGR2B/ADRA2A/HMOX1,3
GO:0048286,lung alveolus development,3/565,25/10364,0.1530198155417955,0.30174994522779075,0.1986942662505778,IGFBP5/LIF/HOPX,3
GO:0051180,vitamin transport,3/565,25/10364,0.1530198155417955,0.30174994522779075,0.1986942662505778,FOLR2/SLC2A3/ABCG2,3
GO:0051894,positive regulation of focal adhesion assembly,3/565,25/10364,0.1530198155417955,0.30174994522779075,0.1986942662505778,THY1/VEGFA/SFRP1,3
GO:0071354,cellular response to interleukin-6,3/565,25/10364,0.1530198155417955,0.30174994522779075,0.1986942662505778,ICAM1/PTGIS/LCN2,3
GO:0071392,cellular response to estradiol stimulus,3/565,25/10364,0.1530198155417955,0.30174994522779075,0.1986942662505778,GPER1/RAMP3/SFRP1,3
GO:1900274,regulation of phospholipase C activity,3/565,25/10364,0.1530198155417955,0.30174994522779075,0.1986942662505778,AGT/C5AR1/PDGFRB,3
GO:1900371,regulation of purine nucleotide biosynthetic process,3/565,25/10364,0.1530198155417955,0.30174994522779075,0.1986942662505778,MTCO2P12/H19/PDK4,3
GO:1903579,negative regulation of ATP metabolic process,3/565,25/10364,0.1530198155417955,0.30174994522779075,0.1986942662505778,DDIT4/H19/MLXIPL,3
GO:0043122,regulation of I-kappaB kinase/NF-kappaB signaling,15/565,206/10364,0.15497257515189097,0.30174994522779075,0.1986942662505778,S100A4/BIRC3/CLEC7A/CX3CL1/SECTM1/TGM2/S100B/HMOX1/LTF/TNFSF10/HLA-DRB1/HSPB1/CD36/ANGPT1/CCL21,15
GO:0071375,cellular response to peptide hormone stimulus,15/565,206/10364,0.15497257515189097,0.30174994522779075,0.1986942662505778,AGT/IGF2/NR4A1/FBN1/SOCS3/GDF15/INHBB/NR4A2/MAP1B/EDN1/GPER1/PDK4/LPL/CA2/NR4A3,15
GO:0001829,trophectodermal cell differentiation,2/565,13/10364,0.15573952962049875,0.30174994522779075,0.1986942662505778,JUNB/HOPX,2
GO:0001921,positive regulation of receptor recycling,2/565,13/10364,0.15573952962049875,0.30174994522779075,0.1986942662505778,RAMP3/NSG1,2
GO:0002281,macrophage activation involved in immune response,2/565,13/10364,0.15573952962049875,0.30174994522779075,0.1986942662505778,TYROBP/DYSF,2
GO:0003071,renal system process involved in regulation of systemic arterial blood pressure,2/565,13/10364,0.15573952962049875,0.30174994522779075,0.1986942662505778,AGT/CYP4F12,2
GO:0006978,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator",2/565,13/10364,0.15573952962049875,0.30174994522779075,0.1986942662505778,MUC1/CDKN1A,2
GO:0007202,activation of phospholipase C activity,2/565,13/10364,0.15573952962049875,0.30174994522779075,0.1986942662505778,AGT/C5AR1,2
GO:0009190,cyclic nucleotide biosynthetic process,2/565,13/10364,0.15573952962049875,0.30174994522779075,0.1986942662505778,GUCY1A2/ADCY1,2
GO:0010669,epithelial structure maintenance,2/565,13/10364,0.15573952962049875,0.30174994522779075,0.1986942662505778,SERPINA3/SOX9,2
GO:0010763,positive regulation of fibroblast migration,2/565,13/10364,0.15573952962049875,0.30174994522779075,0.1986942662505778,THBS1/AKAP12,2
GO:0010818,T cell chemotaxis,2/565,13/10364,0.15573952962049875,0.30174994522779075,0.1986942662505778,CCL5/CCL21,2
GO:0039692,single stranded viral RNA replication via double stranded DNA intermediate,2/565,13/10364,0.15573952962049875,0.30174994522779075,0.1986942662505778,CXCL8/TOP2A,2
GO:0042159,lipoprotein catabolic process,2/565,13/10364,0.15573952962049875,0.30174994522779075,0.1986942662505778,LDLR/APOE,2
GO:0044320,cellular response to leptin stimulus,2/565,13/10364,0.15573952962049875,0.30174994522779075,0.1986942662505778,INHBB/NR4A3,2
GO:0044546,NLRP3 inflammasome complex assembly,2/565,13/10364,0.15573952962049875,0.30174994522779075,0.1986942662505778,GBP5/CD36,2
GO:0045019,negative regulation of nitric oxide biosynthetic process,2/565,13/10364,0.15573952962049875,0.30174994522779075,0.1986942662505778,ACP5/PTGIS,2
GO:0045662,negative regulation of myoblast differentiation,2/565,13/10364,0.15573952962049875,0.30174994522779075,0.1986942662505778,ID3/SOX9,2
GO:0045722,positive regulation of gluconeogenesis,2/565,13/10364,0.15573952962049875,0.30174994522779075,0.1986942662505778,DGAT2/NNMT,2
GO:0045780,positive regulation of bone resorption,2/565,13/10364,0.15573952962049875,0.30174994522779075,0.1986942662505778,SPP1/CA2,2
GO:0048745,smooth muscle tissue development,2/565,13/10364,0.15573952962049875,0.30174994522779075,0.1986942662505778,SOX9/MYLK,2
GO:0051954,positive regulation of amine transport,2/565,13/10364,0.15573952962049875,0.30174994522779075,0.1986942662505778,AGT/CXCL12,2
GO:0052652,cyclic purine nucleotide metabolic process,2/565,13/10364,0.15573952962049875,0.30174994522779075,0.1986942662505778,GUCY1A2/ADCY1,2
GO:0055075,potassium ion homeostasis,2/565,13/10364,0.15573952962049875,0.30174994522779075,0.1986942662505778,ATP1A2/KCNMA1,2
GO:0060479,lung cell differentiation,2/565,13/10364,0.15573952962049875,0.30174994522779075,0.1986942662505778,SOX9/KLF2,2
GO:0060716,labyrinthine layer blood vessel development,2/565,13/10364,0.15573952962049875,0.30174994522779075,0.1986942662505778,CCN1/JUNB,2
GO:0060795,cell fate commitment involved in formation of primary germ layer,2/565,13/10364,0.15573952962049875,0.30174994522779075,0.1986942662505778,SFRP2/KLF4,2
GO:0061037,negative regulation of cartilage development,2/565,13/10364,0.15573952962049875,0.30174994522779075,0.1986942662505778,SOX9/FRZB,2
GO:0070875,positive regulation of glycogen metabolic process,2/565,13/10364,0.15573952962049875,0.30174994522779075,0.1986942662505778,IGF2/IGF1,2
GO:0071397,cellular response to cholesterol,2/565,13/10364,0.15573952962049875,0.30174994522779075,0.1986942662505778,CES1/ABCA1,2
GO:0090051,negative regulation of cell migration involved in sprouting angiogenesis,2/565,13/10364,0.15573952962049875,0.30174994522779075,0.1986942662505778,THBS1/KLF4,2
GO:0098810,neurotransmitter reuptake,2/565,13/10364,0.15573952962049875,0.30174994522779075,0.1986942662505778,ATP1A2/ITGB3,2
GO:0140448,signaling receptor ligand precursor processing,2/565,13/10364,0.15573952962049875,0.30174994522779075,0.1986942662505778,ACE/MME,2
GO:1900225,regulation of NLRP3 inflammasome complex assembly,2/565,13/10364,0.15573952962049875,0.30174994522779075,0.1986942662505778,GBP5/CD36,2
GO:1901032,negative regulation of response to reactive oxygen species,2/565,13/10364,0.15573952962049875,0.30174994522779075,0.1986942662505778,H19/NR4A3,2
GO:1903672,positive regulation of sprouting angiogenesis,2/565,13/10364,0.15573952962049875,0.30174994522779075,0.1986942662505778,VEGFA/KLF4,2
GO:1904406,negative regulation of nitric oxide metabolic process,2/565,13/10364,0.15573952962049875,0.30174994522779075,0.1986942662505778,ACP5/PTGIS,2
GO:1905153,regulation of membrane invagination,2/565,13/10364,0.15573952962049875,0.30174994522779075,0.1986942662505778,C3/CD36,2
GO:1905564,positive regulation of vascular endothelial cell proliferation,2/565,13/10364,0.15573952962049875,0.30174994522779075,0.1986942662505778,IGF2/MDK,2
GO:2000316,regulation of T-helper 17 type immune response,2/565,13/10364,0.15573952962049875,0.30174994522779075,0.1986942662505778,CLEC7A/NFKBIZ,2
GO:2000773,negative regulation of cellular senescence,2/565,13/10364,0.15573952962049875,0.30174994522779075,0.1986942662505778,BCL6/NAMPT,2
GO:1990823,response to leukemia inhibitory factor,6/565,67/10364,0.15714695161693054,0.30433283818340284,0.20039503216200721,SOCS3/ICAM1/HK2/PCOLCE2/KLF4/PADI2,6
GO:0006090,pyruvate metabolic process,7/565,82/10364,0.15883140413314834,0.3074495359437869,0.20244729425655986,DDIT4/IGF1/HK2/HK3/MLXIPL/PDK4/NR4A3,7
GO:0007389,pattern specification process,15/565,207/10364,0.15924841931312309,0.30811107214930333,0.20288289814988966,C1QA/EGR2/APLNR/ZBTB16/C3/CYP26B1/SOX18/BHLHE40/SFRP2/BASP1/EDN1/SEMA3C/RELN/SFRP1/GPC3,15
GO:0043299,leukocyte degranulation,5/565,53/10364,0.16087535863850466,0.31038154500615395,0.204377943784424,FCGR2B/HMOX1/ANXA3/NR4A3/PTGDS,5
GO:0043550,regulation of lipid kinase activity,5/565,53/10364,0.16087535863850466,0.31038154500615395,0.204377943784424,SOCS3/FGFR3/PDGFRB/CCL21/KLF4,5
GO:0071867,response to monoamine,5/565,53/10364,0.16087535863850466,0.31038154500615395,0.204377943784424,ID1/TGM2/HRH2/NR4A3/NSG1,5
GO:0071869,response to catecholamine,5/565,53/10364,0.16087535863850466,0.31038154500615395,0.204377943784424,ID1/TGM2/HRH2/NR4A3/NSG1,5
GO:0006749,glutathione metabolic process,4/565,39/10364,0.16118005976626362,0.31038154500615395,0.204377943784424,GSTM1/GSTM3/GSTM5/GGT5,4
GO:0034205,amyloid-beta formation,4/565,39/10364,0.16118005976626362,0.31038154500615395,0.204377943784424,IGF1/APOE/CLU/NTRK2,4
GO:0042771,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,4/565,39/10364,0.16118005976626362,0.31038154500615395,0.204377943784424,MUC1/DDIT4/BCL3/CDKN1A,4
GO:0043525,positive regulation of neuron apoptotic process,4/565,39/10364,0.16118005976626362,0.31038154500615395,0.204377943784424,JUN/NQO1/TYROBP/LCN2,4
GO:0051353,positive regulation of oxidoreductase activity,4/565,39/10364,0.16118005976626362,0.31038154500615395,0.204377943784424,AGT/APOE/NPR3/EDN1,4
GO:1903573,negative regulation of response to endoplasmic reticulum stress,4/565,39/10364,0.16118005976626362,0.31038154500615395,0.204377943784424,ALOX5/CREB3L1/HSPA1A/CLU,4
GO:0002064,epithelial cell development,11/565,144/10364,0.16223051730434493,0.3122575166168256,0.20561322090239645,GSTM3/ACTA2/SOX9/ICAM1/FOSL2/SOX18/CLDN5/CDKN1A/VEGFA/S1PR3/COL15A1,11
GO:0001678,cellular glucose homeostasis,9/565,113/10364,0.16293030449984056,0.31345708017967444,0.20640310141674498,ADRA2A/NGFR/ICAM1/HK2/KLF15/HK3/HLA-DRB1/GPER1/MLXIPL,9
GO:0007569,cell aging,8/565,98/10364,0.16497700703761878,0.317245592678258,0.20889773554341878,PRELP/ICAM1/MME/BCL6/HLA-G/CDKN1A/SERPINE1/NAMPT,8
GO:0007009,plasma membrane organization,7/565,83/10364,0.16590734110174996,0.3180618430532592,0.20943521457830375,S100A9/SYT7/FOLR2/DYSF/CAVIN2/CLU/COL5A1,7
GO:0007173,epidermal growth factor receptor signaling pathway,7/565,83/10364,0.16590734110174996,0.3180618430532592,0.20943521457830375,IFI6/AGT/ADRA2A/GPRC5A/SOX9/HBEGF/GPER1,7
GO:0019395,fatty acid oxidation,7/565,83/10364,0.16590734110174996,0.3180618430532592,0.20943521457830375,FABP3/MFSD2A/DGAT2/SOX9/PLIN5/PDK4/NR4A3,7
GO:0022604,regulation of cell morphogenesis,17/565,241/10364,0.16603329792371255,0.3180618430532592,0.20943521457830375,MFSD2A/GBP1/MDK/ITGA7/POSTN/CCL2/ICAM1/FN1/S100B/FBLN1/CSF1R/CPNE5/VEGFA/RELN/PLXNA4/PTN/ENPP2,17
GO:0030511,positive regulation of transforming growth factor beta receptor signaling pathway,3/565,26/10364,0.16641144792869594,0.3180618430532592,0.20943521457830375,CDKN1C/THBS1/LRG1,3
GO:0031063,regulation of histone deacetylation,3/565,26/10364,0.16641144792869594,0.3180618430532592,0.20943521457830375,APLNR/BCL6/VEGFA,3
GO:0045879,negative regulation of smoothened signaling pathway,3/565,26/10364,0.16641144792869594,0.3180618430532592,0.20943521457830375,SERPINE2/GPC3/CD3E,3
GO:0045981,positive regulation of nucleotide metabolic process,3/565,26/10364,0.16641144792869594,0.3180618430532592,0.20943521457830375,MTCO2P12/IGF1/MLXIPL,3
GO:0090218,positive regulation of lipid kinase activity,3/565,26/10364,0.16641144792869594,0.3180618430532592,0.20943521457830375,FGFR3/PDGFRB/CCL21,3
GO:1900544,positive regulation of purine nucleotide metabolic process,3/565,26/10364,0.16641144792869594,0.3180618430532592,0.20943521457830375,MTCO2P12/IGF1/MLXIPL,3
GO:1901031,regulation of response to reactive oxygen species,3/565,26/10364,0.16641144792869594,0.3180618430532592,0.20943521457830375,H19/CD36/NR4A3,3
GO:1903580,positive regulation of ATP metabolic process,3/565,26/10364,0.16641144792869594,0.3180618430532592,0.20943521457830375,MTCO2P12/IGF1/MLXIPL,3
GO:1903846,positive regulation of cellular response to transforming growth factor beta stimulus,3/565,26/10364,0.16641144792869594,0.3180618430532592,0.20943521457830375,CDKN1C/THBS1/LRG1,3
GO:0045824,negative regulation of innate immune response,5/565,54/10364,0.16992082531174355,0.324617759601623,0.21375211023571247,ISG15/OAS1/OAS3/HLA-G/VSIG4,5
GO:0046677,response to antibiotic,4/565,40/10364,0.17191227351836136,0.32811601295299364,0.2160556164792165,ALPL/CRIP1/AOC3/SLC1A3,4
GO:0048477,oogenesis,4/565,40/10364,0.17191227351836136,0.32811601295299364,0.2160556164792165,MDK/IGF1/INHBB/PTN,4
GO:0002832,negative regulation of response to biotic stimulus,7/565,84/10364,0.17312067854946156,0.3298166315318064,0.21717542831690953,ISG15/OAS1/OAS3/LTF/HLA-G/FGL2/VSIG4,7
GO:0034620,cellular response to unfolded protein,7/565,84/10364,0.17312067854946156,0.3298166315318064,0.21717542831690953,HSPA6/ATF3/CREB3L1/HSPB8/HSPA1A/HSPA1B/DERL3,7
GO:0002053,positive regulation of mesenchymal cell proliferation,2/565,14/10364,0.17546180348712123,0.3298166315318064,0.21717542831690953,PRRX1/SOX9,2
GO:0002220,innate immune response activating cell surface receptor signaling pathway,2/565,14/10364,0.17546180348712123,0.3298166315318064,0.21717542831690953,CLEC7A/TYROBP,2
GO:0002223,stimulatory C-type lectin receptor signaling pathway,2/565,14/10364,0.17546180348712123,0.3298166315318064,0.21717542831690953,CLEC7A/TYROBP,2
GO:0010042,response to manganese ion,2/565,14/10364,0.17546180348712123,0.3298166315318064,0.21717542831690953,PTGS2/FIBIN,2
GO:0021602,cranial nerve morphogenesis,2/565,14/10364,0.17546180348712123,0.3298166315318064,0.21717542831690953,EGR2/PLXNA4,2
GO:0032332,positive regulation of chondrocyte differentiation,2/565,14/10364,0.17546180348712123,0.3298166315318064,0.21717542831690953,ZBTB16/SOX9,2
GO:0032897,negative regulation of viral transcription,2/565,14/10364,0.17546180348712123,0.3298166315318064,0.21717542831690953,IFITM3/ZFP36,2
GO:0033631,cell-cell adhesion mediated by integrin,2/565,14/10364,0.17546180348712123,0.3298166315318064,0.21717542831690953,CCL5/CD3E,2
GO:0035137,hindlimb morphogenesis,2/565,14/10364,0.17546180348712123,0.3298166315318064,0.21717542831690953,ZBTB16/GPC3,2
GO:0035313,"wound healing, spreading of epidermal cells",2/565,14/10364,0.17546180348712123,0.3298166315318064,0.21717542831690953,HBEGF/COL5A1,2
GO:0035584,calcium-mediated signaling using intracellular calcium source,2/565,14/10364,0.17546180348712123,0.3298166315318064,0.21717542831690953,VCAM1/SELP,2
GO:0035640,exploration behavior,2/565,14/10364,0.17546180348712123,0.3298166315318064,0.21717542831690953,ATP1A2/APOE,2
GO:0038083,peptidyl-tyrosine autophosphorylation,2/565,14/10364,0.17546180348712123,0.3298166315318064,0.21717542831690953,ACE/VEGFA,2
GO:0042219,cellular modified amino acid catabolic process,2/565,14/10364,0.17546180348712123,0.3298166315318064,0.21717542831690953,GGT5/ALDH1L1,2
GO:0042537,benzene-containing compound metabolic process,2/565,14/10364,0.17546180348712123,0.3298166315318064,0.21717542831690953,GSTM1/GSTM3,2
GO:0042772,"DNA damage response, signal transduction resulting in transcription",2/565,14/10364,0.17546180348712123,0.3298166315318064,0.21717542831690953,MUC1/CDKN1A,2
GO:0043032,positive regulation of macrophage activation,2/565,14/10364,0.17546180348712123,0.3298166315318064,0.21717542831690953,THBS1/IL33,2
GO:0043949,regulation of cAMP-mediated signaling,2/565,14/10364,0.17546180348712123,0.3298166315318064,0.21717542831690953,RGS2/APLNR,2
GO:0045821,positive regulation of glycolytic process,2/565,14/10364,0.17546180348712123,0.3298166315318064,0.21717542831690953,IGF1/MLXIPL,2
GO:0048535,lymph node development,2/565,14/10364,0.17546180348712123,0.3298166315318064,0.21717542831690953,CD248/IL7R,2
GO:0050855,regulation of B cell receptor signaling pathway,2/565,14/10364,0.17546180348712123,0.3298166315318064,0.21717542831690953,FCGR2B/CD22,2
GO:0060143,positive regulation of syncytium formation by plasma membrane fusion,2/565,14/10364,0.17546180348712123,0.3298166315318064,0.21717542831690953,GDF15/TYROBP,2
GO:0061684,chaperone-mediated autophagy,2/565,14/10364,0.17546180348712123,0.3298166315318064,0.21717542831690953,SYNPO2/CLU,2
GO:0062009,secondary palate development,2/565,14/10364,0.17546180348712123,0.3298166315318064,0.21717542831690953,LRRC32/ITGB8,2
GO:0072574,hepatocyte proliferation,2/565,14/10364,0.17546180348712123,0.3298166315318064,0.21717542831690953,MDK/PTN,2
GO:0072575,epithelial cell proliferation involved in liver morphogenesis,2/565,14/10364,0.17546180348712123,0.3298166315318064,0.21717542831690953,MDK/PTN,2
GO:0097062,dendritic spine maintenance,2/565,14/10364,0.17546180348712123,0.3298166315318064,0.21717542831690953,FCGR2B/APOE,2
GO:0140632,inflammasome complex assembly,2/565,14/10364,0.17546180348712123,0.3298166315318064,0.21717542831690953,GBP5/CD36,2
GO:1990840,response to lectin,2/565,14/10364,0.17546180348712123,0.3298166315318064,0.21717542831690953,CLEC7A/TYROBP,2
GO:1990858,cellular response to lectin,2/565,14/10364,0.17546180348712123,0.3298166315318064,0.21717542831690953,CLEC7A/TYROBP,2
GO:2000310,regulation of NMDA receptor activity,2/565,14/10364,0.17546180348712123,0.3298166315318064,0.21717542831690953,CCL2/RELN,2
GO:0009306,protein secretion,16/565,227/10364,0.17573935849586936,0.3300352906798574,0.21731940951613782,ALOX5/SNCG/ADRA2A/SYT7/IGF1/CCL5/APOE/IL1RN/INHBB/CD38/HLA-DRB1/GPER1/SFRP1/CCN3/ABCA1/KCNN4,16
GO:0035592,establishment of protein localization to extracellular region,16/565,227/10364,0.17573935849586936,0.3300352906798574,0.21731940951613782,ALOX5/SNCG/ADRA2A/SYT7/IGF1/CCL5/APOE/IL1RN/INHBB/CD38/HLA-DRB1/GPER1/SFRP1/CCN3/ABCA1/KCNN4,16
GO:0031116,positive regulation of microtubule polymerization,3/565,27/10364,0.18013037951432176,0.33735305294219275,0.22213796019462517,MAP1B/HSPA1A/HSPA1B,3
GO:0038179,neurotrophin signaling pathway,3/565,27/10364,0.18013037951432176,0.33735305294219275,0.22213796019462517,AGT/DDIT4/NTRK2,3
GO:0044319,"wound healing, spreading of cells",3/565,27/10364,0.18013037951432176,0.33735305294219275,0.22213796019462517,CCN1/HBEGF/COL5A1,3
GO:0045070,positive regulation of viral genome replication,3/565,27/10364,0.18013037951432176,0.33735305294219275,0.22213796019462517,IFIT1/CCL5/TOP2A,3
GO:0060412,ventricular septum morphogenesis,3/565,27/10364,0.18013037951432176,0.33735305294219275,0.22213796019462517,APLNR/SLIT2/SLIT3,3
GO:0090505,epiboly involved in wound healing,3/565,27/10364,0.18013037951432176,0.33735305294219275,0.22213796019462517,CCN1/HBEGF/COL5A1,3
GO:1903305,regulation of regulated secretory pathway,7/565,85/10364,0.18046722848460928,0.3378293705605809,0.22245160260346275,FCGR2B/ADRA2A/SYT7/CACNA1H/P2RX1/HMOX1/ADCY1,7
GO:0003231,cardiac ventricle development,6/565,70/10364,0.18116937301640235,0.33883390275429476,0.22311306017888796,CCN1/APLNR/SLIT2/SFRP2/SLIT3/SEMA3C,6
GO:0007088,regulation of mitotic nuclear division,6/565,70/10364,0.18116937301640235,0.33883390275429476,0.22311306017888796,IGF2/IGF1/PDGFRB/DUSP1/EDN1/MKI67,6
GO:0002886,regulation of myeloid leukocyte mediated immunity,4/565,41/10364,0.18288419963768746,0.34004471464082714,0.223910347413457,FCGR2B/C3/TYROBP/HMOX1,4
GO:0006081,cellular aldehyde metabolic process,4/565,41/10364,0.18288419963768746,0.34004471464082714,0.223910347413457,AKR1C3/ALDH1A3/CACNA1H/CYP1B1,4
GO:0006826,iron ion transport,4/565,41/10364,0.18288419963768746,0.34004471464082714,0.223910347413457,SLC11A1/LTF/STEAP4/LCN2,4
GO:0008306,associative learning,4/565,41/10364,0.18288419963768746,0.34004471464082714,0.223910347413457,ATP1A2/AGT/FOS/RELN,4
GO:0040014,regulation of multicellular organism growth,4/565,41/10364,0.18288419963768746,0.34004471464082714,0.223910347413457,MFSD2A/IGF2/IGF1/GDF15,4
GO:0045646,regulation of erythrocyte differentiation,4/565,41/10364,0.18288419963768746,0.34004471464082714,0.223910347413457,ISG15/ZFP36/HSPA1A/HSPA1B,4
GO:0046324,regulation of glucose import,4/565,41/10364,0.18288419963768746,0.34004471464082714,0.223910347413457,IGF1/HK2/KLF15/GPC3,4
GO:0061053,somite development,4/565,41/10364,0.18288419963768746,0.34004471464082714,0.223910347413457,FRZB/SFRP2/SEMA3C/SFRP1,4
GO:0071364,cellular response to epidermal growth factor stimulus,4/565,41/10364,0.18288419963768746,0.34004471464082714,0.223910347413457,COL1A1/SOX9/ZFP36/ID1,4
GO:0090311,regulation of protein deacetylation,4/565,41/10364,0.18288419963768746,0.34004471464082714,0.223910347413457,APLNR/NNMT/BCL6/VEGFA,4
GO:1903351,cellular response to dopamine,4/565,41/10364,0.18288419963768746,0.34004471464082714,0.223910347413457,ID1/TGM2/HRH2/NSG1,4
GO:1990089,response to nerve growth factor,4/565,41/10364,0.18288419963768746,0.34004471464082714,0.223910347413457,ID1/PTN/NTRK2/LCN2,4
GO:0051098,regulation of binding,19/565,278/10364,0.1828965465654864,0.34004471464082714,0.223910347413457,JUN/NES/IFIT1/IGF1/ACE/BCL3/APOE/RAMP1/ID1/SLPI/CLDN5/LIF/HMOX1/HOPX/CDKN1A/PLN/ANGPT1/KLF4/RAP1GAP,19
GO:0051302,regulation of cell division,8/565,101/10364,0.18504939768369902,0.3438911639205918,0.2264431313605625,IGF2/MDK/FGF7/SUSD2/SFRP2/THBS4/VEGFA/PTN,8
GO:0031400,negative regulation of protein modification process,26/565,396/10364,0.18659780919980187,0.3466113570163289,0.22823430574108922,ISG15/NIBAN1/RGS2/AGT/DDIT4/CDKN1C/THY1/GPRC5A/SOCS3/GADD45B/APOE/EMILIN1/FBLN1/KLF15/SLIT2/UCHL1/SFRP2/DUSP1/HSPA1A/HSPA1B/CDKN1A/IGFBP3/MLXIPL/HSPB1/SFRP1/ANGPT1,26
GO:0043367,"CD4-positive, alpha-beta T cell differentiation",5/565,56/10364,0.1885811704940997,0.35011092979828196,0.2305386807943332,BCL3/NFKBIZ/BCL6/HLA-DRB1/RORC,5
GO:0033673,negative regulation of kinase activity,13/565,181/10364,0.18865283613458964,0.35011092979828196,0.2305386807943332,RGS2/AGT/CDKN1C/THY1/GPRC5A/GADD45B/APOE/UCHL1/SFRP2/DUSP1/CDKN1A/HSPB1/SFRP1,13
GO:0032868,response to insulin,14/565,198/10364,0.19246681013041778,0.35564844555416114,0.23418498677505123,FABP3/AGT/EGR2/IGF2/ADM/SOCS3/ICAM1/INHBB/KLF15/TNFSF10/EGR1/PLN/PDK4/LPL,14
GO:0007249,I-kappaB kinase/NF-kappaB signaling,16/565,231/10364,0.19362523966020204,0.35564844555416114,0.23418498677505123,S100A4/BIRC3/CLEC7A/CX3CL1/SECTM1/BCL3/TGM2/S100B/HMOX1/LTF/TNFSF10/HLA-DRB1/HSPB1/CD36/ANGPT1/CCL21,16
GO:0046635,positive regulation of alpha-beta T cell activation,4/565,42/10364,0.19407899117077762,0.35564844555416114,0.23418498677505123,ZBTB16/NFKBIZ/HLA-DRB1/CD3E,4
GO:0048857,neural nucleus development,4/565,42/10364,0.19407899117077762,0.35564844555416114,0.23418498677505123,CKB/ALDH1A3/BASP1/PADI2,4
GO:0090199,regulation of release of cytochrome c from mitochondria,4/565,42/10364,0.19407899117077762,0.35564844555416114,0.23418498677505123,IGF1/TNFSF10/GPER1/CLU,4
GO:1903350,response to dopamine,4/565,42/10364,0.19407899117077762,0.35564844555416114,0.23418498677505123,ID1/TGM2/HRH2/NSG1,4
GO:0001541,ovarian follicle development,3/565,28/10364,0.1941412879741701,0.35564844555416114,0.23418498677505123,ICAM1/INHBB/VEGFA,3
GO:0021795,cerebral cortex cell migration,3/565,28/10364,0.1941412879741701,0.35564844555416114,0.23418498677505123,SLIT2/MDGA1/RELN,3
GO:0030261,chromosome condensation,3/565,28/10364,0.1941412879741701,0.35564844555416114,0.23418498677505123,H1-2/GPER1/TOP2A,3
GO:0030890,positive regulation of B cell proliferation,3/565,28/10364,0.1941412879741701,0.35564844555416114,0.23418498677505123,BCL6/CD38/CDKN1A,3
GO:0034142,toll-like receptor 4 signaling pathway,3/565,28/10364,0.1941412879741701,0.35564844555416114,0.23418498677505123,OAS1/LTF/CD14,3
GO:0042088,T-helper 1 type immune response,3/565,28/10364,0.1941412879741701,0.35564844555416114,0.23418498677505123,BCL3/SLC11A1/HLA-DRB1,3
GO:0043537,negative regulation of blood vessel endothelial cell migration,3/565,28/10364,0.1941412879741701,0.35564844555416114,0.23418498677505123,THBS1/APOE/KLF4,3
GO:0045332,phospholipid translocation,3/565,28/10364,0.1941412879741701,0.35564844555416114,0.23418498677505123,MFSD2A/ABCA1/KCNN4,3
GO:0045581,negative regulation of T cell differentiation,3/565,28/10364,0.1941412879741701,0.35564844555416114,0.23418498677505123,MDK/BCL6/FGL2,3
GO:0045648,positive regulation of erythrocyte differentiation,3/565,28/10364,0.1941412879741701,0.35564844555416114,0.23418498677505123,ISG15/HSPA1A/HSPA1B,3
GO:0046326,positive regulation of glucose import,3/565,28/10364,0.1941412879741701,0.35564844555416114,0.23418498677505123,IGF1/KLF15/GPC3,3
GO:0071480,cellular response to gamma radiation,3/565,28/10364,0.1941412879741701,0.35564844555416114,0.23418498677505123,CRYAB/EGR1/CDKN1A,3
GO:0090504,epiboly,3/565,28/10364,0.1941412879741701,0.35564844555416114,0.23418498677505123,CCN1/HBEGF/COL5A1,3
GO:0098751,bone cell development,3/565,28/10364,0.1941412879741701,0.35564844555416114,0.23418498677505123,FBN1/TYROBP/LTF,3
GO:0002418,immune response to tumor cell,2/565,15/10364,0.19554583559902705,0.35564844555416114,0.23418498677505123,PRF1/HLA-DRB1,2
GO:0002758,innate immune response-activating signal transduction,2/565,15/10364,0.19554583559902705,0.35564844555416114,0.23418498677505123,CLEC7A/TYROBP,2
GO:0003159,morphogenesis of an endothelium,2/565,15/10364,0.19554583559902705,0.35564844555416114,0.23418498677505123,ITGAX/LCN2,2
GO:0006007,glucose catabolic process,2/565,15/10364,0.19554583559902705,0.35564844555416114,0.23418498677505123,HK2/HK3,2
GO:0015813,L-glutamate transmembrane transport,2/565,15/10364,0.19554583559902705,0.35564844555416114,0.23418498677505123,ATP1A2/SLC1A3,2
GO:0016137,glycoside metabolic process,2/565,15/10364,0.19554583559902705,0.35564844555416114,0.23418498677505123,AKR1C2/AKR1C3,2
GO:0016339,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules,2/565,15/10364,0.19554583559902705,0.35564844555416114,0.23418498677505123,SELP/SELL,2
GO:0030033,microvillus assembly,2/565,15/10364,0.19554583559902705,0.35564844555416114,0.23418498677505123,ESPN/RAP1GAP,2
GO:0033238,regulation of cellular amine metabolic process,2/565,15/10364,0.19554583559902705,0.35564844555416114,0.23418498677505123,NNMT/NR4A2,2
GO:0034695,response to prostaglandin E,2/565,15/10364,0.19554583559902705,0.35564844555416114,0.23418498677505123,SFRP1/CCL21,2
GO:0035970,peptidyl-threonine dephosphorylation,2/565,15/10364,0.19554583559902705,0.35564844555416114,0.23418498677505123,DUSP5/DUSP1,2
GO:0045655,regulation of monocyte differentiation,2/565,15/10364,0.19554583559902705,0.35564844555416114,0.23418498677505123,JUN/HLA-DRB1,2
GO:0045777,positive regulation of blood pressure,2/565,15/10364,0.19554583559902705,0.35564844555416114,0.23418498677505123,AGT/ACE,2
GO:0045980,negative regulation of nucleotide metabolic process,2/565,15/10364,0.19554583559902705,0.35564844555416114,0.23418498677505123,DDIT4/H19,2
GO:0048048,embryonic eye morphogenesis,2/565,15/10364,0.19554583559902705,0.35564844555416114,0.23418498677505123,FBN1/ALDH1A3,2
GO:0051000,positive regulation of nitric-oxide synthase activity,2/565,15/10364,0.19554583559902705,0.35564844555416114,0.23418498677505123,APOE/NPR3,2
GO:0061154,endothelial tube morphogenesis,2/565,15/10364,0.19554583559902705,0.35564844555416114,0.23418498677505123,ITGAX/LCN2,2
GO:0072539,T-helper 17 cell differentiation,2/565,15/10364,0.19554583559902705,0.35564844555416114,0.23418498677505123,NFKBIZ/RORC,2
GO:0072576,liver morphogenesis,2/565,15/10364,0.19554583559902705,0.35564844555416114,0.23418498677505123,MDK/PTN,2
GO:1900543,negative regulation of purine nucleotide metabolic process,2/565,15/10364,0.19554583559902705,0.35564844555416114,0.23418498677505123,DDIT4/H19,2
GO:1900746,regulation of vascular endothelial growth factor signaling pathway,2/565,15/10364,0.19554583559902705,0.35564844555416114,0.23418498677505123,DCN/SMOC2,2
GO:1901673,regulation of mitotic spindle assembly,2/565,15/10364,0.19554583559902705,0.35564844555416114,0.23418498677505123,HSPA1A/HSPA1B,2
GO:2000679,positive regulation of transcription regulatory region DNA binding,2/565,15/10364,0.19554583559902705,0.35564844555416114,0.23418498677505123,IGF1/KLF4,2
GO:2000811,negative regulation of anoikis,2/565,15/10364,0.19554583559902705,0.35564844555416114,0.23418498677505123,PDK4/NTRK2,2
GO:2001224,positive regulation of neuron migration,2/565,15/10364,0.19554583559902705,0.35564844555416114,0.23418498677505123,MDK/RELN,2
GO:0032091,negative regulation of protein binding,6/565,72/10364,0.19794747088552153,0.3596968245917999,0.23685073606551293,NES/IFIT1/ACE/ID1/SLPI/CDKN1A,6
GO:1901222,regulation of NIK/NF-kappaB signaling,6/565,72/10364,0.19794747088552153,0.3596968245917999,0.23685073606551293,TNFSF14/BCL3/CD14/EDN1/TCIM/CCN3,6
GO:0002028,regulation of sodium ion transport,5/565,57/10364,0.19817655808188095,0.3599533401895389,0.2370196447240915,ATP1A2/CNTN1/SERPINE2/SIK1/PRSS8,5
GO:0043009,chordate embryonic development,26/565,401/10364,0.20406302281674493,0.37048071636884866,0.2439516403004709,CCN1/TENT5C/PHGDH/PRRX1/IGF2/ADM/IGF1/KRT19/COL1A1/SOX9/SOCS3/JUNB/KLF2/SOX18/LIF/MAFF/HOPX/SFRP2/EDN1/VEGFA/SEMA3C/SFRP1/SULF1/ANGPT1/KLF4/ELF3,26
GO:0038034,signal transduction in absence of ligand,4/565,43/10364,0.20547968157188437,0.37239212764731944,0.24521025349157563,IFI6/CX3CL1/HSPA1A/HSPA1B,4
GO:0043506,regulation of JUN kinase activity,4/565,43/10364,0.20547968157188437,0.37239212764731944,0.24521025349157563,SFRP2/EDN1/TNXB/SFRP1,4
GO:0097192,extrinsic apoptotic signaling pathway in absence of ligand,4/565,43/10364,0.20547968157188437,0.37239212764731944,0.24521025349157563,IFI6/CX3CL1/HSPA1A/HSPA1B,4
GO:1901616,organic hydroxy compound catabolic process,4/565,43/10364,0.20547968157188437,0.37239212764731944,0.24521025349157563,AKR1C3/CYP4F12/APOE/MOXD1,4
GO:0001701,in utero embryonic development,18/565,267/10364,0.20654362443241245,0.37415468956915776,0.2463708533634878,CCN1/TENT5C/IGF2/ADM/IGF1/KRT19/SOCS3/JUNB/KLF2/SOX18/LIF/MAFF/HOPX/EDN1/VEGFA/ANGPT1/KLF4/ELF3,18
GO:0009749,response to glucose,10/565,136/10364,0.2075292587810945,0.375706148084254,0.24739244728968568,ADRA2A/THBS1/ICAM1/COL6A2/EGR1/HLA-DRB1/CCN2/GPER1/MLXIPL/LPL,10
GO:0006970,response to osmotic stress,5/565,58/10364,0.20793544303208303,0.375706148084254,0.24739244728968568,PTGS2/KCNMA1/MYLK/AQP1/TSC22D3,5
GO:0048709,oligodendrocyte differentiation,5/565,58/10364,0.20793544303208303,0.375706148084254,0.24739244728968568,MDK/SOX9/PTN/CLU/NTRK2,5
GO:0061515,myeloid cell development,5/565,58/10364,0.20793544303208303,0.375706148084254,0.24739244728968568,FBN1/KLF2/TYROBP/LTF/BCL6,5
GO:0099175,regulation of postsynapse organization,5/565,58/10364,0.20793544303208303,0.375706148084254,0.24739244728968568,FCGR2B/SRGN/APOE/LILRB2/RELN,5
GO:0017156,calcium-ion regulated exocytosis,3/565,29/10364,0.2084095413530388,0.375706148084254,0.24739244728968568,ADRA2A/SYT7/CACNA1H,3
GO:0031112,positive regulation of microtubule polymerization or depolymerization,3/565,29/10364,0.2084095413530388,0.375706148084254,0.24739244728968568,MAP1B/HSPA1A/HSPA1B,3
GO:0046685,response to arsenic-containing substance,3/565,29/10364,0.2084095413530388,0.375706148084254,0.24739244728968568,ATF3/HMOX1/CDKN1A,3
GO:0050856,regulation of T cell receptor signaling pathway,3/565,29/10364,0.2084095413530388,0.375706148084254,0.24739244728968568,GBP1/THY1/KCNN4,3
GO:0051085,chaperone cofactor-dependent protein refolding,3/565,29/10364,0.2084095413530388,0.375706148084254,0.24739244728968568,HSPA6/HSPA1A/HSPA1B,3
GO:0072524,pyridine-containing compound metabolic process,3/565,29/10364,0.2084095413530388,0.375706148084254,0.24739244728968568,NNMT/PTGIS/NAMPT,3
GO:0046661,male sex differentiation,7/565,89/10364,0.21109648563748376,0.3803824877640222,0.25047169186323015,AKR1C3/SOX9/ICAM1/TNFSF10/SFRP2/PDGFRB/SFRP1,7
GO:0042157,lipoprotein metabolic process,8/565,105/10364,0.21333447612342668,0.3842460823798103,0.2530157655554198,DGAT2/ITGB3/LDLR/APOE/APOC1/APOD/ZDHHC11B/ABCA1,8
GO:0002702,positive regulation of production of molecular mediator of immune response,6/565,74/10364,0.21527572607667678,0.3849604592654323,0.2534861636229584,CLEC7A/SLC7A5/SPON2/HLA-G/CD36/NR4A3,6
GO:0043255,regulation of carbohydrate biosynthetic process,6/565,74/10364,0.21527572607667678,0.3849604592654323,0.2534861636229584,IGF2/DGAT2/NNMT/IGF1/SIK1/GPER1,6
GO:0002092,positive regulation of receptor internalization,2/565,16/10364,0.21589379933400893,0.3849604592654323,0.2534861636229584,VEGFA/ANGPT1,2
GO:0002888,positive regulation of myeloid leukocyte mediated immunity,2/565,16/10364,0.21589379933400893,0.3849604592654323,0.2534861636229584,C3/TYROBP,2
GO:0006775,fat-soluble vitamin metabolic process,2/565,16/10364,0.21589379933400893,0.3849604592654323,0.2534861636229584,CYP4F12/CYP26B1,2
GO:0006977,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest",2/565,16/10364,0.21589379933400893,0.3849604592654323,0.2534861636229584,MUC1/CDKN1A,2
GO:0008209,androgen metabolic process,2/565,16/10364,0.21589379933400893,0.3849604592654323,0.2534861636229584,ADM/SPP1,2
GO:0010881,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion,2/565,16/10364,0.21589379933400893,0.3849604592654323,0.2534861636229584,ATP1A2/PLN,2
GO:0021988,olfactory lobe development,2/565,16/10364,0.21589379933400893,0.3849604592654323,0.2534861636229584,ATP1A2/SLIT2,2
GO:0031998,regulation of fatty acid beta-oxidation,2/565,16/10364,0.21589379933400893,0.3849604592654323,0.2534861636229584,MFSD2A/PLIN5,2
GO:0033081,regulation of T cell differentiation in thymus,2/565,16/10364,0.21589379933400893,0.3849604592654323,0.2534861636229584,IL7R/EGR3,2
GO:0034349,glial cell apoptotic process,2/565,16/10364,0.21589379933400893,0.3849604592654323,0.2534861636229584,CCL2/AKAP12,2
GO:0034390,smooth muscle cell apoptotic process,2/565,16/10364,0.21589379933400893,0.3849604592654323,0.2534861636229584,IGF1/EDN1,2
GO:0034391,regulation of smooth muscle cell apoptotic process,2/565,16/10364,0.21589379933400893,0.3849604592654323,0.2534861636229584,IGF1/EDN1,2
GO:0035994,response to muscle stretch,2/565,16/10364,0.21589379933400893,0.3849604592654323,0.2534861636229584,FOS/EDN1,2
GO:0045649,regulation of macrophage differentiation,2/565,16/10364,0.21589379933400893,0.3849604592654323,0.2534861636229584,C1QC/LIF,2
GO:0050860,negative regulation of T cell receptor signaling pathway,2/565,16/10364,0.21589379933400893,0.3849604592654323,0.2534861636229584,GBP1/THY1,2
GO:0051900,regulation of mitochondrial depolarization,2/565,16/10364,0.21589379933400893,0.3849604592654323,0.2534861636229584,IFI6/DCN,2
GO:0060142,regulation of syncytium formation by plasma membrane fusion,2/565,16/10364,0.21589379933400893,0.3849604592654323,0.2534861636229584,GDF15/TYROBP,2
GO:0060292,long-term synaptic depression,2/565,16/10364,0.21589379933400893,0.3849604592654323,0.2534861636229584,LILRB2/CD38,2
GO:0060561,apoptotic process involved in morphogenesis,2/565,16/10364,0.21589379933400893,0.3849604592654323,0.2534861636229584,CCN1/CRYAB,2
GO:1902547,regulation of cellular response to vascular endothelial growth factor stimulus,2/565,16/10364,0.21589379933400893,0.3849604592654323,0.2534861636229584,DCN/SMOC2,2
GO:1904385,cellular response to angiotensin,2/565,16/10364,0.21589379933400893,0.3849604592654323,0.2534861636229584,AGT/CA2,2
GO:0006835,dicarboxylic acid transport,4/565,44/10364,0.21706926045846564,0.38655134942016456,0.25453372222894644,ATP1A2/FOLR2/SLC1A3/NTRK2,4
GO:0019083,viral transcription,4/565,44/10364,0.21706926045846564,0.38655134942016456,0.25453372222894644,JUN/IFITM3/CCL5/ZFP36,4
GO:0070849,response to epidermal growth factor,4/565,44/10364,0.21706926045846564,0.38655134942016456,0.25453372222894644,COL1A1/SOX9/ZFP36/ID1,4
GO:0006919,activation of cysteine-type endopeptidase activity involved in apoptotic process,5/565,59/10364,0.21784765773986015,0.38776883077695107,0.2553354011312503,F3/S100A9/S100A8/P2RX1/NGFR,5
GO:0022412,cellular process involved in reproduction in multicellular organism,12/565,171/10364,0.22284799004357655,0.39556051566804007,0.26046601718197376,MDK/FOLR2/ZBTB16/IGF1/TMEM119/CYP26B1/INHBB/SLIT2/SLIT3/PTN/SFRP1/TOP2A,12
GO:0002431,Fc receptor mediated stimulatory signaling pathway,3/565,30/10364,0.22290134578558096,0.39556051566804007,0.26046601718197376,FCER1G/FCGR2B/NR4A3,3
GO:0014009,glial cell proliferation,3/565,30/10364,0.22290134578558096,0.39556051566804007,0.26046601718197376,CX3CL1/PTN/CLU,3
GO:0043276,anoikis,3/565,30/10364,0.22290134578558096,0.39556051566804007,0.26046601718197376,SIK1/PDK4/NTRK2,3
GO:0045604,regulation of epidermal cell differentiation,3/565,30/10364,0.22290134578558096,0.39556051566804007,0.26046601718197376,ZFP36/MAFF/AQP3,3
GO:0045661,regulation of myoblast differentiation,3/565,30/10364,0.22290134578558096,0.39556051566804007,0.26046601718197376,ID3/SOX9/IGFBP3,3
GO:0150117,positive regulation of cell-substrate junction organization,3/565,30/10364,0.22290134578558096,0.39556051566804007,0.26046601718197376,THY1/VEGFA/SFRP1,3
GO:0046632,alpha-beta T cell differentiation,6/565,75/10364,0.22412925521228186,0.3975672317327045,0.2617873860251089,ZBTB16/BCL3/NFKBIZ/BCL6/HLA-DRB1/RORC,6
GO:0043393,regulation of protein binding,11/565,155/10364,0.2249483412467307,0.3988473404348703,0.2626303033588828,NES/IFIT1/ACE/APOE/RAMP1/ID1/SLPI/CLDN5/HOPX/CDKN1A/ANGPT1,11
GO:0002706,regulation of lymphocyte mediated immunity,7/565,91/10364,0.22709095346176975,0.4022978638998206,0.2649023807490912,FCGR2B/C3/BCL6/IL7R/HLA-G/HLA-DRB1/AZGP1,7
GO:0038127,ERBB signaling pathway,7/565,91/10364,0.22709095346176975,0.4022978638998206,0.2649023807490912,IFI6/AGT/ADRA2A/GPRC5A/SOX9/HBEGF/GPER1,7
GO:0033619,membrane protein proteolysis,4/565,45/10364,0.22883074376245202,0.404854392810492,0.2665857866422416,ADRA2A/APOE/TIMP3/TIMP1,4
GO:0046637,regulation of alpha-beta T cell differentiation,4/565,45/10364,0.22883074376245202,0.404854392810492,0.2665857866422416,ZBTB16/NFKBIZ/BCL6/HLA-DRB1,4
GO:0055117,regulation of cardiac muscle contraction,4/565,45/10364,0.22883074376245202,0.404854392810492,0.2665857866422416,ATP1A2/RGS2/PLN/CCN2,4
GO:0002705,positive regulation of leukocyte mediated immunity,6/565,76/10364,0.23309981029428042,0.41222921094807086,0.2714419070881674,CLEC7A/C3/TYROBP/HLA-G/HLA-DRB1/AZGP1,6
GO:0010212,response to ionizing radiation,9/565,124/10364,0.2347448757880455,0.4149592061641875,0.2732395359027291,VCAM1/CRYAB/ICAM1/THBD/SFRP2/EGR1/CDKN1A/NAMPT/SFRP1,9
GO:0034101,erythrocyte homeostasis,8/565,108/10364,0.23556597145559088,0.4154046946988221,0.2735328781846819,ISG15/KLF2/ZFP36/HMOX1/BCL6/HSPA1A/HSPA1B/VEGFA,8
GO:0002862,negative regulation of inflammatory response to antigenic stimulus,2/565,17/10364,0.23641742517055578,0.4154046946988221,0.2735328781846819,FCGR2B/HLA-DRB1,2
GO:0006614,SRP-dependent cotranslational protein targeting to membrane,2/565,17/10364,0.23641742517055578,0.4154046946988221,0.2735328781846819,RN7SL1/RN7SL2,2
GO:0007618,mating,2/565,17/10364,0.23641742517055578,0.4154046946988221,0.2735328781846819,P2RX1/SERPINE2,2
GO:0032402,melanosome transport,2/565,17/10364,0.23641742517055578,0.4154046946988221,0.2735328781846819,MLPH/RAB27B,2
GO:0034755,iron ion transmembrane transport,2/565,17/10364,0.23641742517055578,0.4154046946988221,0.2735328781846819,SLC11A1/LCN2,2
GO:0035025,positive regulation of Rho protein signal transduction,2/565,17/10364,0.23641742517055578,0.4154046946988221,0.2735328781846819,COL3A1/PDGFRB,2
GO:0046461,neutral lipid catabolic process,2/565,17/10364,0.23641742517055578,0.4154046946988221,0.2735328781846819,PLIN5/LPL,2
GO:0046464,acylglycerol catabolic process,2/565,17/10364,0.23641742517055578,0.4154046946988221,0.2735328781846819,PLIN5/LPL,2
GO:0055022,negative regulation of cardiac muscle tissue growth,2/565,17/10364,0.23641742517055578,0.4154046946988221,0.2735328781846819,RGS2/PI16,2
GO:0061117,negative regulation of heart growth,2/565,17/10364,0.23641742517055578,0.4154046946988221,0.2735328781846819,RGS2/PI16,2
GO:1902001,fatty acid transmembrane transport,2/565,17/10364,0.23641742517055578,0.4154046946988221,0.2735328781846819,THBS1/CD36,2
GO:1902236,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,2/565,17/10364,0.23641742517055578,0.4154046946988221,0.2735328781846819,CREB3L1/HSPA1A,2
GO:1902883,negative regulation of response to oxidative stress,2/565,17/10364,0.23641742517055578,0.4154046946988221,0.2735328781846819,H19/NR4A3,2
GO:0009395,phospholipid catabolic process,3/565,31/10364,0.23758386875913634,0.41673879978573447,0.27441135069325223,LDLR/APOC1/ENPP2,3
GO:0022617,extracellular matrix disassembly,3/565,31/10364,0.23758386875913634,0.41673879978573447,0.27441135069325223,ADAMTS4/MMP2/ADAMTS5,3
GO:0060338,regulation of type I interferon-mediated signaling pathway,3/565,31/10364,0.23758386875913634,0.41673879978573447,0.27441135069325223,ISG15/OAS1/OAS3,3
GO:1901661,quinone metabolic process,3/565,31/10364,0.23758386875913634,0.41673879978573447,0.27441135069325223,AKR1C2/AKR1C3/CYP4F12,3
GO:0030534,adult behavior,5/565,61/10364,0.23809092103975368,0.4172706467194998,0.27476155767069627,ATP1A2/CXCL12/SNCG/NR4A2/UCHL1,5
GO:1900407,regulation of cellular response to oxidative stress,5/565,61/10364,0.23809092103975368,0.4172706467194998,0.27476155767069627,ALOX5/H19/HSPB1/CD36/NR4A3,5
GO:0051348,negative regulation of transferase activity,14/565,207/10364,0.23920810838894863,0.41904920656583466,0.2759326917478988,RGS2/AGT/CDKN1C/THY1/GPRC5A/GADD45B/ZFP36/APOE/UCHL1/SFRP2/DUSP1/CDKN1A/HSPB1/SFRP1,14
GO:0031529,ruffle organization,4/565,46/10364,0.24074723837851722,0.4213848627283666,0.2774706588453827,CSPG4/ICAM1/CSF1R/CCL21,4
GO:1900024,regulation of substrate adhesion-dependent cell spreading,4/565,46/10364,0.24074723837851722,0.4213848627283666,0.2774706588453827,GBP1/MDK/POSTN/FBLN1,4
GO:0071887,leukocyte apoptotic process,6/565,77/10364,0.2421803530705629,0.4237121219961045,0.2790030968122859,CXCL12/CCL5/BCL6/IL7R/CCL21/TSC22D3,6
GO:0032273,positive regulation of protein polymerization,8/565,109/10364,0.2431501569835243,0.42522714339621887,0.2800006978730663,LMOD1/TPPP3/ICAM1/MAP1B/HSPA1A/HSPA1B/CCL21/TENM1,8
GO:0009952,anterior/posterior pattern specification,7/565,93/10364,0.24348580527660793,0.4256323171658552,0.280267493960804,ZBTB16/BHLHE40/SFRP2/BASP1/SEMA3C/SFRP1/GPC3,7
GO:0048872,homeostasis of number of cells,14/565,208/10364,0.24466536696825994,0.4275117423679284,0.28150504517632086,ISG15/PLA2G2A/SOX9/TNFSF14/KLF2/ZFP36/HMOX1/BCL6/IL7R/HSPA1A/HSPA1B/VEGFA/CCN3/TSC22D3,14
GO:0045055,regulated exocytosis,10/565,142/10364,0.2464188236613233,0.4303919215313386,0.2834015661023213,FCGR2B/ADRA2A/SYT7/CACNA1H/P2RX1/HMOX1/ANXA3/ADCY1/NR4A3/PTGDS,10
GO:0035023,regulation of Rho protein signal transduction,5/565,62/10364,0.2484012494974938,0.4332998361494416,0.2853163500832335,APOE/COL3A1/BCL6/PDGFRB/ABCA1,5
GO:0042982,amyloid precursor protein metabolic process,5/565,62/10364,0.2484012494974938,0.4332998361494416,0.2853163500832335,IGF1/APOE/CLU/NTRK2/NSG1,5
GO:0051817,modulation of process of other organism involved in symbiotic interaction,5/565,62/10364,0.2484012494974938,0.4332998361494416,0.2853163500832335,JUN/IFI27/CCL5/APOE/LTF,5
GO:0009792,embryo development ending in birth or egg hatching,26/565,413/10364,0.24907914972368664,0.43429729087256097,0.28597314733361495,CCN1/TENT5C/PHGDH/PRRX1/IGF2/ADM/IGF1/KRT19/COL1A1/SOX9/SOCS3/JUNB/KLF2/SOX18/LIF/MAFF/HOPX/SFRP2/EDN1/VEGFA/SEMA3C/SFRP1/SULF1/ANGPT1/KLF4/ELF3,26
GO:0006814,sodium ion transport,8/565,110/10364,0.2508146210003494,0.4371371044595277,0.287843088607423,ATP1A2/CNTN1/CACNA1H/SCN7A/SERPINE2/SIK1/SGK1/PRSS8,8
GO:0030203,glycosaminoglycan metabolic process,6/565,78/10364,0.2513637817910503,0.4376200397021769,0.288161088544796,ITIH5/LYVE1/DCN/PDGFRB/ANGPT1/BGN,6
GO:0048041,focal adhesion assembly,6/565,78/10364,0.2513637817910503,0.4376200397021769,0.288161088544796,THY1/THBS1/FAM107A/APOD/VEGFA/SFRP1,6
GO:0001756,somitogenesis,3/565,32/10364,0.2524253404791791,0.4376200397021769,0.288161088544796,SFRP2/SEMA3C/SFRP1,3
GO:0007528,neuromuscular junction development,3/565,32/10364,0.2524253404791791,0.4376200397021769,0.288161088544796,COL4A1/PTN/TNC,3
GO:0015800,acidic amino acid transport,3/565,32/10364,0.2524253404791791,0.4376200397021769,0.288161088544796,ATP1A2/SLC1A3/NTRK2,3
GO:0034204,lipid translocation,3/565,32/10364,0.2524253404791791,0.4376200397021769,0.288161088544796,MFSD2A/ABCA1/KCNN4,3
GO:0043370,"regulation of CD4-positive, alpha-beta T cell differentiation",3/565,32/10364,0.2524253404791791,0.4376200397021769,0.288161088544796,NFKBIZ/BCL6/HLA-DRB1,3
GO:0050805,negative regulation of synaptic transmission,3/565,32/10364,0.2524253404791791,0.4376200397021769,0.288161088544796,PTGS2/LILRB2/CD38,3
GO:0051898,negative regulation of protein kinase B signaling,3/565,32/10364,0.2524253404791791,0.4376200397021769,0.288161088544796,HLA-G/GPER1/KLF4,3
GO:0060393,regulation of pathway-restricted SMAD protein phosphorylation,3/565,32/10364,0.2524253404791791,0.4376200397021769,0.288161088544796,GDF15/EMILIN1/INHBB,3
GO:0071470,cellular response to osmotic stress,3/565,32/10364,0.2524253404791791,0.4376200397021769,0.288161088544796,PTGS2/MYLK/AQP1,3
GO:2000677,regulation of transcription regulatory region DNA binding,3/565,32/10364,0.2524253404791791,0.4376200397021769,0.288161088544796,IGF1/LIF/KLF4,3
GO:0002027,regulation of heart rate,4/565,47/10364,0.2528020014400704,0.4376200397021769,0.288161088544796,AGT/ADM/EDN1/PLN,4
GO:0003281,ventricular septum development,4/565,47/10364,0.2528020014400704,0.4376200397021769,0.288161088544796,CCN1/APLNR/SLIT2/SLIT3,4
GO:0098659,inorganic cation import across plasma membrane,4/565,47/10364,0.2528020014400704,0.4376200397021769,0.288161088544796,ATP1A2/P2RX1/RAMP3/LCN2,4
GO:0099587,inorganic ion import across plasma membrane,4/565,47/10364,0.2528020014400704,0.4376200397021769,0.288161088544796,ATP1A2/P2RX1/RAMP3/LCN2,4
GO:0043254,regulation of protein-containing complex assembly,21/565,329/10364,0.2567232735542145,0.43992914353751245,0.2896815716451725,ISG15/GBP5/SELP/LMOD1/CRYAB/CLEC7A/TPPP3/SOX9/ICAM1/APOE/SLIT2/MAP1B/HSPA1A/HSPA1B/VEGFA/ELN/CD36/CLU/CCL21/ABCA1/TENM1,21
GO:0003181,atrioventricular valve morphogenesis,2/565,18/10364,0.2570372524039399,0.43992914353751245,0.2896815716451725,CCN1/SLIT3,2
GO:0003416,endochondral bone growth,2/565,18/10364,0.2570372524039399,0.43992914353751245,0.2896815716451725,SOX9/FGFR3,2
GO:0010640,regulation of platelet-derived growth factor receptor signaling pathway,2/565,18/10364,0.2570372524039399,0.43992914353751245,0.2896815716451725,F3/APOD,2
GO:0030262,apoptotic nuclear changes,2/565,18/10364,0.2570372524039399,0.43992914353751245,0.2896815716451725,GPER1/TOP2A,2
GO:0032401,establishment of melanosome localization,2/565,18/10364,0.2570372524039399,0.43992914353751245,0.2896815716451725,MLPH/RAB27B,2
GO:0032528,microvillus organization,2/565,18/10364,0.2570372524039399,0.43992914353751245,0.2896815716451725,ESPN/RAP1GAP,2
GO:0036120,cellular response to platelet-derived growth factor stimulus,2/565,18/10364,0.2570372524039399,0.43992914353751245,0.2896815716451725,PDGFRB/PTN,2
GO:0042417,dopamine metabolic process,2/565,18/10364,0.2570372524039399,0.43992914353751245,0.2896815716451725,NR4A2/MOXD1,2
GO:0043372,"positive regulation of CD4-positive, alpha-beta T cell differentiation",2/565,18/10364,0.2570372524039399,0.43992914353751245,0.2896815716451725,NFKBIZ/HLA-DRB1,2
GO:0044766,multi-organism transport,2/565,18/10364,0.2570372524039399,0.43992914353751245,0.2896815716451725,IFIT1/SIGLEC1,2
GO:0046628,positive regulation of insulin receptor signaling pathway,2/565,18/10364,0.2570372524039399,0.43992914353751245,0.2896815716451725,AGT/IGF2,2
GO:0046782,regulation of viral transcription,2/565,18/10364,0.2570372524039399,0.43992914353751245,0.2896815716451725,IFITM3/ZFP36,2
GO:0050765,negative regulation of phagocytosis,2/565,18/10364,0.2570372524039399,0.43992914353751245,0.2896815716451725,FCGR2B/DYSF,2
GO:0051156,glucose 6-phosphate metabolic process,2/565,18/10364,0.2570372524039399,0.43992914353751245,0.2896815716451725,HK2/HK3,2
GO:0051445,regulation of meiotic cell cycle,2/565,18/10364,0.2570372524039399,0.43992914353751245,0.2896815716451725,LIF/DUSP1,2
GO:0051904,pigment granule transport,2/565,18/10364,0.2570372524039399,0.43992914353751245,0.2896815716451725,MLPH/RAB27B,2
GO:0060351,cartilage development involved in endochondral bone morphogenesis,2/565,18/10364,0.2570372524039399,0.43992914353751245,0.2896815716451725,COL1A1/SOX9,2
GO:0060441,epithelial tube branching involved in lung morphogenesis,2/565,18/10364,0.2570372524039399,0.43992914353751245,0.2896815716451725,SOX9/TNC,2
GO:0090201,negative regulation of release of cytochrome c from mitochondria,2/565,18/10364,0.2570372524039399,0.43992914353751245,0.2896815716451725,IGF1/CLU,2
GO:0090330,regulation of platelet aggregation,2/565,18/10364,0.2570372524039399,0.43992914353751245,0.2896815716451725,C1QTNF1/SERPINE2,2
GO:0090344,negative regulation of cell aging,2/565,18/10364,0.2570372524039399,0.43992914353751245,0.2896815716451725,BCL6/NAMPT,2
GO:0098801,regulation of renal system process,2/565,18/10364,0.2570372524039399,0.43992914353751245,0.2896815716451725,AGT/EDN1,2
GO:0140058,neuron projection arborization,2/565,18/10364,0.2570372524039399,0.43992914353751245,0.2896815716451725,MFSD2A/PTN,2
GO:1901071,glucosamine-containing compound metabolic process,2/565,18/10364,0.2570372524039399,0.43992914353751245,0.2896815716451725,CHI3L2/CHI3L1,2
GO:1901385,regulation of voltage-gated calcium channel activity,2/565,18/10364,0.2570372524039399,0.43992914353751245,0.2896815716451725,RRAD/GEM,2
GO:1902579,multi-organism localization,2/565,18/10364,0.2570372524039399,0.43992914353751245,0.2896815716451725,IFIT1/SIGLEC1,2
GO:2000045,regulation of G1/S transition of mitotic cell cycle,7/565,95/10364,0.26023978672288883,0.4452242736496059,0.29316827316397315,MUC1/CCL2/ADAMTS1/FAM107A/CDKN1A/GPNMB/KLF4,7
GO:0021987,cerebral cortex development,6/565,79/10364,0.260642948940449,0.4457277497753543,0.293499798723339,MDK/COL3A1/SLIT2/MDGA1/RELN/NTRK2,6
GO:0008360,regulation of cell shape,9/565,128/10364,0.2633454342449356,0.45016125586587324,0.2964191438748622,ITGA7/CCL2/ICAM1/FN1/S100B/CSF1R/VEGFA/PLXNA4/PTN,9
GO:0042987,amyloid precursor protein catabolic process,4/565,48/10364,0.2649784943778966,0.4527637545839352,0.2981328196563541,IGF1/APOE/CLU/NTRK2,4
GO:0032970,regulation of actin filament-based process,19/565,297/10364,0.2669572296044235,0.4559544839384688,0.3002338295750954,ATP1A2/LMOD1/CXCL12/MDK/CX3CL1/ICAM1/ID1/FAM107A/SLIT2/SYNPO2/CSF1R/PDGFRB/EDN1/PLN/CCN2/ELN/SFRP1/CCL21/TENM1,19
GO:0043462,regulation of ATPase activity,3/565,33/10364,0.26739513567389483,0.45613153560371894,0.30035041336001955,LTF/PLN/TPM2,3
GO:0046638,positive regulation of alpha-beta T cell differentiation,3/565,33/10364,0.26739513567389483,0.45613153560371894,0.30035041336001955,ZBTB16/NFKBIZ/HLA-DRB1,3
GO:0060612,adipose tissue development,3/565,33/10364,0.26739513567389483,0.45613153560371894,0.30035041336001955,DGAT2/ARRDC3/RORC,3
GO:0002833,positive regulation of response to biotic stimulus,7/565,96/10364,0.2687383127520292,0.4580410709437167,0.30160779129582665,GBP5/MNDA/CLEC7A/CCL5/TYROBP/HLA-G/HLA-DRB1,7
GO:0003205,cardiac chamber development,7/565,96/10364,0.2687383127520292,0.4580410709437167,0.30160779129582665,CCN1/APLNR/ADAMTS1/SLIT2/SFRP2/SLIT3/SEMA3C,7
GO:0006096,glycolytic process,5/565,64/10364,0.2693474003561692,0.45812557418286526,0.3016634344181004,DDIT4/IGF1/HK2/HK3/MLXIPL,5
GO:0007605,sensory perception of sound,5/565,64/10364,0.2693474003561692,0.45812557418286526,0.3016634344181004,COL1A1/ICAM1/MYO7B/SLC1A3/ESPN,5
GO:0010927,cellular component assembly involved in morphogenesis,5/565,64/10364,0.2693474003561692,0.45812557418286526,0.3016634344181004,LMOD1/KRT19/ITGB4/PDGFRB/EDN1,5
GO:0046330,positive regulation of JNK cascade,5/565,64/10364,0.2693474003561692,0.45812557418286526,0.3016634344181004,FCGR2B/GADD45B/CCN2/CCL21/GADD45G,5
GO:0055072,iron ion homeostasis,5/565,64/10364,0.2693474003561692,0.45812557418286526,0.3016634344181004,SLC11A1/HMOX1/LTF/STEAP4/LCN2,5
GO:0045089,positive regulation of innate immune response,6/565,80/10364,0.27001067837574483,0.4588724438647984,0.3021552281227338,GBP5/MNDA/CLEC7A/CCL5/TYROBP/HLA-G,6
GO:0061351,neural precursor cell proliferation,6/565,80/10364,0.27001067837574483,0.4588724438647984,0.3021552281227338,NES/MDK/CX3CL1/C5AR1/VEGFA/PTN,6
GO:0019953,sexual reproduction,25/565,401/10364,0.27026462918497013,0.4591134406154638,0.30231391803568836,PTGS2/RGS2/MDK/FOLR2/BIRC3/ZBTB16/IGF1/TMEM119/CACNA1H/P2RX1/ACE/SOX9/CYP26B1/INHBB/SERPINE2/ADAMTS1/SPATC1L/GGT5/BCL6/HPGD/ADAMTS2/PTN/ADAM28/PLAT/TOP2A,25
GO:0006066,alcohol metabolic process,15/565,230/10364,0.2729449268355953,0.4634742971650465,0.3051854254080899,AKR1C2/AKR1C3/DGAT2/IGF1/ALDH1A3/CACNA1H/CES1/LDLR/APOE/CYP1B1/ADH1B/GPER1/ABCA1/PLPP2/MOXD1,15
GO:0006879,cellular iron ion homeostasis,4/565,49/10364,0.27726043193596717,0.46667891504903897,0.30729558055192163,SLC11A1/HMOX1/STEAP4/LCN2,4
GO:0032608,interferon-beta production,4/565,49/10364,0.27726043193596717,0.46667891504903897,0.30729558055192163,ISG15/OAS1/OAS3/OAS2,4
GO:0032648,regulation of interferon-beta production,4/565,49/10364,0.27726043193596717,0.46667891504903897,0.30729558055192163,ISG15/OAS1/OAS3/OAS2,4
GO:1900076,regulation of cellular response to insulin stimulus,4/565,49/10364,0.27726043193596717,0.46667891504903897,0.30729558055192163,AGT/IGF2/SOCS3/LPL,4
GO:1901224,positive regulation of NIK/NF-kappaB signaling,4/565,49/10364,0.27726043193596717,0.46667891504903897,0.30729558055192163,TNFSF14/CD14/EDN1/TCIM,4
GO:0043583,ear development,7/565,97/10364,0.2773107773922525,0.46667891504903897,0.30729558055192163,PRRX1/ALDH1A3/NTN1/SOX9/FRZB/PDGFRB/EDN1,7
GO:0046328,regulation of JNK cascade,7/565,97/10364,0.2773107773922525,0.46667891504903897,0.30729558055192163,FCGR2B/GADD45B/SFRP2/CCN2/SFRP1/CCL21/GADD45G,7
GO:0001919,regulation of receptor recycling,2/565,19/10364,0.27768193382009254,0.46667891504903897,0.30729558055192163,RAMP3/NSG1,2
GO:0002313,mature B cell differentiation involved in immune response,2/565,19/10364,0.27768193382009254,0.46667891504903897,0.30729558055192163,FCGR2B/BCL3,2
GO:0006656,phosphatidylcholine biosynthetic process,2/565,19/10364,0.27768193382009254,0.46667891504903897,0.30729558055192163,FABP3/MFSD2A,2
GO:0010259,multicellular organism aging,2/565,19/10364,0.27768193382009254,0.46667891504903897,0.30729558055192163,CRYAB/EDN1,2
GO:0014850,response to muscle activity,2/565,19/10364,0.27768193382009254,0.46667891504903897,0.30729558055192163,AGT/POSTN,2
GO:0032770,positive regulation of monooxygenase activity,2/565,19/10364,0.27768193382009254,0.46667891504903897,0.30729558055192163,APOE/NPR3,2
GO:0036119,response to platelet-derived growth factor,2/565,19/10364,0.27768193382009254,0.46667891504903897,0.30729558055192163,PDGFRB/PTN,2
GO:0045214,sarcomere organization,2/565,19/10364,0.27768193382009254,0.46667891504903897,0.30729558055192163,KRT19/EDN1,2
GO:0046189,phenol-containing compound biosynthetic process,2/565,19/10364,0.27768193382009254,0.46667891504903897,0.30729558055192163,NR4A2/MOXD1,2
GO:0046337,phosphatidylethanolamine metabolic process,2/565,19/10364,0.27768193382009254,0.46667891504903897,0.30729558055192163,PLA2G2A/MFSD2A,2
GO:0046426,negative regulation of receptor signaling pathway via JAK-STAT,2/565,19/10364,0.27768193382009254,0.46667891504903897,0.30729558055192163,SOCS3/BCL3,2
GO:0048011,neurotrophin TRK receptor signaling pathway,2/565,19/10364,0.27768193382009254,0.46667891504903897,0.30729558055192163,AGT/DDIT4,2
GO:0050982,detection of mechanical stimulus,2/565,19/10364,0.27768193382009254,0.46667891504903897,0.30729558055192163,CXCL12/SERPINE2,2
GO:0051882,mitochondrial depolarization,2/565,19/10364,0.27768193382009254,0.46667891504903897,0.30729558055192163,IFI6/DCN,2
GO:0051905,establishment of pigment granule localization,2/565,19/10364,0.27768193382009254,0.46667891504903897,0.30729558055192163,MLPH/RAB27B,2
GO:0055023,positive regulation of cardiac muscle tissue growth,2/565,19/10364,0.27768193382009254,0.46667891504903897,0.30729558055192163,IGF1/EDN1,2
GO:0055081,anion homeostasis,2/565,19/10364,0.27768193382009254,0.46667891504903897,0.30729558055192163,CKB/CA12,2
GO:2001169,regulation of ATP biosynthetic process,2/565,19/10364,0.27768193382009254,0.46667891504903897,0.30729558055192163,MTCO2P12/H19,2
GO:0006757,ATP generation from ADP,5/565,65/10364,0.27996254524348013,0.46993303002329134,0.3094383282054995,DDIT4/IGF1/HK2/HK3/MLXIPL,5
GO:0006766,vitamin metabolic process,5/565,65/10364,0.27996254524348013,0.46993303002329134,0.3094383282054995,AKR1C3/NNMT/SLC2A3/CYP4F12/CYP26B1,5
GO:2001021,negative regulation of response to DNA damage stimulus,5/565,65/10364,0.27996254524348013,0.46993303002329134,0.3094383282054995,MUC1/CXCL12/ACKR3/SFRP2/CLU,5
GO:0002279,mast cell activation involved in immune response,3/565,34/10364,0.28246383796823227,0.4718102621958151,0.3106744353697279,HMOX1/NR4A3/PTGDS,3
GO:0002711,positive regulation of T cell mediated immunity,3/565,34/10364,0.28246383796823227,0.4718102621958151,0.3106744353697279,HLA-G/HLA-DRB1/AZGP1,3
GO:0002712,regulation of B cell mediated immunity,3/565,34/10364,0.28246383796823227,0.4718102621958151,0.3106744353697279,FCGR2B/C3/BCL6,3
GO:0002889,regulation of immunoglobulin mediated immune response,3/565,34/10364,0.28246383796823227,0.4718102621958151,0.3106744353697279,FCGR2B/C3/BCL6,3
GO:0007405,neuroblast proliferation,3/565,34/10364,0.28246383796823227,0.4718102621958151,0.3106744353697279,CX3CL1/VEGFA/PTN,3
GO:0021762,substantia nigra development,3/565,34/10364,0.28246383796823227,0.4718102621958151,0.3106744353697279,CKB/BASP1/PADI2,3
GO:0043303,mast cell degranulation,3/565,34/10364,0.28246383796823227,0.4718102621958151,0.3106744353697279,HMOX1/NR4A3/PTGDS,3
GO:0043392,negative regulation of DNA binding,3/565,34/10364,0.28246383796823227,0.4718102621958151,0.3106744353697279,JUN/ID1/HMOX1,3
GO:0051084,'de novo' posttranslational protein folding,3/565,34/10364,0.28246383796823227,0.4718102621958151,0.3106744353697279,HSPA6/HSPA1A/HSPA1B,3
GO:0062208,positive regulation of pattern recognition receptor signaling pathway,3/565,34/10364,0.28246383796823227,0.4718102621958151,0.3106744353697279,LTF/HSPA1A/HSPA1B,3
GO:0140115,export across plasma membrane,3/565,34/10364,0.28246383796823227,0.4718102621958151,0.3106744353697279,ATP1A2/ABCG2/ABCA1,3
GO:2000772,regulation of cellular senescence,3/565,34/10364,0.28246383796823227,0.4718102621958151,0.3106744353697279,BCL6/HLA-G/NAMPT,3
GO:0007224,smoothened signaling pathway,7/565,98/10364,0.2859518366503013,0.4774416065441818,0.31438252496841324,PRRX1/SERPINE2/SCUBE1/SFRP1/GAS1/GPC3/CD3E,7
GO:0045786,negative regulation of cell cycle,17/565,267/10364,0.28824556492818937,0.481075149945376,0.31677511609032677,MUC1/PTGS2/CDKN1C/NR4A1/CCL2/SUSD2/LIF/FAM107A/BCL6/HPGD/DUSP1/HLA-G/CDKN1A/GPER1/GPNMB/GAS1/KLF4,17
GO:0035710,"CD4-positive, alpha-beta T cell activation",5/565,66/10364,0.2906587265434929,0.4849049822612306,0.31929695821124926,BCL3/NFKBIZ/BCL6/HLA-DRB1/RORC,5
GO:0016125,sterol metabolic process,7/565,99/10364,0.29465613441789984,0.49117354002723207,0.3234246357981491,DGAT2/CES1/LDLR/APOE/CYP1B1/CYP26B1/ABCA1,7
GO:0045664,regulation of neuron differentiation,7/565,99/10364,0.29465613441789984,0.49117354002723207,0.3234246357981491,CXCL12/SOX9/BCL6/SFRP2/MAP1B/SFRP1/RAP1GAP,7
GO:0002090,regulation of receptor internalization,3/565,35/10364,0.2976032887680181,0.49261371222708883,0.324372950662992,ITGB3/VEGFA/ANGPT1,3
GO:0031952,regulation of protein autophosphorylation,3/565,35/10364,0.2976032887680181,0.49261371222708883,0.324372950662992,ACE/VEGFA/GPNMB,3
GO:0060389,pathway-restricted SMAD protein phosphorylation,3/565,35/10364,0.2976032887680181,0.49261371222708883,0.324372950662992,GDF15/EMILIN1/INHBB,3
GO:2000300,regulation of synaptic vesicle exocytosis,3/565,35/10364,0.2976032887680181,0.49261371222708883,0.324372950662992,ADRA2A/P2RX1/ADCY1,3
GO:0002446,neutrophil mediated immunity,2/565,20/10364,0.29828758979261194,0.49261371222708883,0.324372950662992,ACE/ANXA3,2
GO:0006921,cellular component disassembly involved in execution phase of apoptosis,2/565,20/10364,0.29828758979261194,0.49261371222708883,0.324372950662992,GPER1/TOP2A,2
GO:0008299,isoprenoid biosynthetic process,2/565,20/10364,0.29828758979261194,0.49261371222708883,0.324372950662992,AKR1C3/ALDH1A3,2
GO:0010614,negative regulation of cardiac muscle hypertrophy,2/565,20/10364,0.29828758979261194,0.49261371222708883,0.324372950662992,RGS2/PI16,2
GO:0010719,negative regulation of epithelial to mesenchymal transition,2/565,20/10364,0.29828758979261194,0.49261371222708883,0.324372950662992,SFRP2/SFRP1,2
GO:0010880,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum,2/565,20/10364,0.29828758979261194,0.49261371222708883,0.324372950662992,ATP1A2/PLN,2
GO:0010882,regulation of cardiac muscle contraction by calcium ion signaling,2/565,20/10364,0.29828758979261194,0.49261371222708883,0.324372950662992,ATP1A2/PLN,2
GO:0014014,negative regulation of gliogenesis,2/565,20/10364,0.29828758979261194,0.49261371222708883,0.324372950662992,LDLR/PTN,2
GO:0030947,regulation of vascular endothelial growth factor receptor signaling pathway,2/565,20/10364,0.29828758979261194,0.49261371222708883,0.324372950662992,ITGB3/EMILIN1,2
GO:0032400,melanosome localization,2/565,20/10364,0.29828758979261194,0.49261371222708883,0.324372950662992,MLPH/RAB27B,2
GO:0033198,response to ATP,2/565,20/10364,0.29828758979261194,0.49261371222708883,0.324372950662992,PTGS2/P2RX1,2
GO:0045616,regulation of keratinocyte differentiation,2/565,20/10364,0.29828758979261194,0.49261371222708883,0.324372950662992,ZFP36/AQP3,2
GO:0048261,negative regulation of receptor-mediated endocytosis,2/565,20/10364,0.29828758979261194,0.49261371222708883,0.324372950662992,ITGB3/APOC1,2
GO:0060603,mammary gland duct morphogenesis,2/565,20/10364,0.29828758979261194,0.49261371222708883,0.324372950662992,NTN1/CSF1R,2
GO:0070723,response to cholesterol,2/565,20/10364,0.29828758979261194,0.49261371222708883,0.324372950662992,CES1/ABCA1,2
GO:0071243,cellular response to arsenic-containing substance,2/565,20/10364,0.29828758979261194,0.49261371222708883,0.324372950662992,ATF3/HMOX1,2
GO:0098868,bone growth,2/565,20/10364,0.29828758979261194,0.49261371222708883,0.324372950662992,SOX9/FGFR3,2
GO:1903793,positive regulation of anion transport,2/565,20/10364,0.29828758979261194,0.49261371222708883,0.324372950662992,AGT/EDN1,2
GO:1904893,negative regulation of receptor signaling pathway via STAT,2/565,20/10364,0.29828758979261194,0.49261371222708883,0.324372950662992,SOCS3/BCL3,2
GO:0042752,regulation of circadian rhythm,6/565,83/10364,0.29857339172773106,0.4926882167405607,0.3244220098919024,SIK1/BHLHE40/ADCY1/PTGDS/RORC/TOP2A,6
GO:0048839,inner ear development,6/565,83/10364,0.29857339172773106,0.4926882167405607,0.3244220098919024,PRRX1/ALDH1A3/NTN1/SOX9/FRZB/PDGFRB,6
GO:0048562,embryonic organ morphogenesis,9/565,133/10364,0.3004945765522476,0.49565866092058886,0.32637796791649604,PRRX1/APLNR/FBN1/ALDH1A3/NTN1/SOX9/FRZB/SOX18/EDN1,9
GO:0046634,regulation of alpha-beta T cell activation,5/565,67/10364,0.3014258051666028,0.49699446087477717,0.327257556449825,ZBTB16/NFKBIZ/BCL6/HLA-DRB1/CD3E,5
GO:0002753,cytoplasmic pattern recognition receptor signaling pathway,4/565,51/10364,0.30207702678169746,0.4976673431164062,0.3277006314043957,BIRC3/OAS3/HSPA1A/HSPA1B,4
GO:0042306,regulation of protein import into nucleus,4/565,51/10364,0.30207702678169746,0.4976673431164062,0.3277006314043957,PTGS2/APOD/CD36/ANGPT1,4
GO:0035148,tube formation,7/565,100/10364,0.3034183122165348,0.49947509859850964,0.3288909900266843,ADM/SOX9/ATOH8/TGM2/SFRP2/VEGFA/SFRP1,7
GO:0098727,maintenance of cell number,7/565,100/10364,0.3034183122165348,0.49947509859850964,0.3288909900266843,PRRX1/IGF1/SOX9/LIF/PTN/SFRP1/KLF4,7
GO:0099003,vesicle-mediated transport in synapse,8/565,117/10364,0.3063708758583062,0.5041327836671646,0.33195795103787534,SNCG/ADRA2A/SYT7/P2RX1/ITGB3/ADCY1/NSG1/RAB27B,8
GO:0006813,potassium ion transport,6/565,84/10364,0.3082236004337521,0.5069776698175094,0.33383123245896223,ATP1A2/KCNMA1/ADRA2A/SLC1A3/AQP1/KCNN4,6
GO:0030218,erythrocyte differentiation,7/565,101/10364,0.312233018617916,0.5131942632293285,0.33792469290882937,ISG15/KLF2/ZFP36/BCL6/HSPA1A/HSPA1B/VEGFA,7
GO:0043279,response to alkaloid,5/565,68/10364,0.3122537639727057,0.5131942632293285,0.33792469290882937,NQO1/ICAM1/FOSB/TGM2/SLC1A3,5
GO:0006110,regulation of glycolytic process,3/565,36/10364,0.3127866224201147,0.5132458646043886,0.3379586710338208,DDIT4/IGF1/MLXIPL,3
GO:0010803,regulation of tumor necrosis factor-mediated signaling pathway,3/565,36/10364,0.3127866224201147,0.5132458646043886,0.3379586710338208,CCDC3/HSPA1A/HSPA1B,3
GO:0045682,regulation of epidermis development,3/565,36/10364,0.3127866224201147,0.5132458646043886,0.3379586710338208,ZFP36/MAFF/AQP3,3
GO:0097120,receptor localization to synapse,3/565,36/10364,0.3127866224201147,0.5132458646043886,0.3379586710338208,TYROBP/RELN/NSG1,3
GO:0021510,spinal cord development,4/565,52/10364,0.3145807545461016,0.5153635890803282,0.33935313594598526,PHGDH/MDGA1/RELN/PTN,4
GO:0035567,non-canonical Wnt signaling pathway,4/565,52/10364,0.3145807545461016,0.5153635890803282,0.33935313594598526,FRZB/SFRP2/SFRP1/GPC3,4
GO:0045445,myoblast differentiation,4/565,52/10364,0.3145807545461016,0.5153635890803282,0.33935313594598526,ID3/IGF1/SOX9/IGFBP3,4
GO:0070227,lymphocyte apoptotic process,4/565,52/10364,0.3145807545461016,0.5153635890803282,0.33935313594598526,CCL5/BCL6/IL7R/TSC22D3,4
GO:0043547,positive regulation of GTPase activity,12/565,186/10364,0.3154106404294037,0.5165164647671915,0.34011227374303277,RGS16/RGS1/THY1/CX3CL1/CCL2/CCL5/CCL14/ICAM1/TGM2/SFRP1/CCL21/RAP1GAP,12
GO:0003203,endocardial cushion morphogenesis,2/565,21/10364,0.31879720849526483,0.5183303302540168,0.3413066556399704,APLNR/SOX9,2
GO:0009994,oocyte differentiation,2/565,21/10364,0.31879720849526483,0.5183303302540168,0.3413066556399704,IGF1/INHBB,2
GO:0014808,release of sequestered calcium ion into cytosol by sarcoplasmic reticulum,2/565,21/10364,0.31879720849526483,0.5183303302540168,0.3413066556399704,ATP1A2/PLN,2
GO:0014888,striated muscle adaptation,2/565,21/10364,0.31879720849526483,0.5183303302540168,0.3413066556399704,IGFBP5/KLF15,2
GO:0031076,embryonic camera-type eye development,2/565,21/10364,0.31879720849526483,0.5183303302540168,0.3413066556399704,NES/ALDH1A3,2
GO:0032148,activation of protein kinase B activity,2/565,21/10364,0.31879720849526483,0.5183303302540168,0.3413066556399704,ADRA2A/IGF1,2
GO:0034643,"establishment of mitochondrion localization, microtubule-mediated",2/565,21/10364,0.31879720849526483,0.5183303302540168,0.3413066556399704,UCHL1/MAP1B,2
GO:0042092,type 2 immune response,2/565,21/10364,0.31879720849526483,0.5183303302540168,0.3413066556399704,BCL3/BCL6,2
GO:0047497,mitochondrion transport along microtubule,2/565,21/10364,0.31879720849526483,0.5183303302540168,0.3413066556399704,UCHL1/MAP1B,2
GO:0048546,digestive tract morphogenesis,2/565,21/10364,0.31879720849526483,0.5183303302540168,0.3413066556399704,SFRP2/SFRP1,2
GO:0048599,oocyte development,2/565,21/10364,0.31879720849526483,0.5183303302540168,0.3413066556399704,IGF1/INHBB,2
GO:0051875,pigment granule localization,2/565,21/10364,0.31879720849526483,0.5183303302540168,0.3413066556399704,MLPH/RAB27B,2
GO:0070498,interleukin-1-mediated signaling pathway,2/565,21/10364,0.31879720849526483,0.5183303302540168,0.3413066556399704,IL1RN/EGR1,2
GO:0071425,hematopoietic stem cell proliferation,2/565,21/10364,0.31879720849526483,0.5183303302540168,0.3413066556399704,ACE/SFRP2,2
GO:0090169,regulation of spindle assembly,2/565,21/10364,0.31879720849526483,0.5183303302540168,0.3413066556399704,HSPA1A/HSPA1B,2
GO:1900078,positive regulation of cellular response to insulin stimulus,2/565,21/10364,0.31879720849526483,0.5183303302540168,0.3413066556399704,AGT/IGF2,2
GO:1903514,release of sequestered calcium ion into cytosol by endoplasmic reticulum,2/565,21/10364,0.31879720849526483,0.5183303302540168,0.3413066556399704,ATP1A2/PLN,2
GO:2001258,negative regulation of cation channel activity,2/565,21/10364,0.31879720849526483,0.5183303302540168,0.3413066556399704,RRAD/GEM,2
GO:0032956,regulation of actin cytoskeleton organization,17/565,273/10364,0.32007561616483193,0.5202022916152529,0.3425392921159753,LMOD1/CXCL12/MDK/CX3CL1/ICAM1/ID1/FAM107A/SLIT2/SYNPO2/CSF1R/PDGFRB/EDN1/CCN2/ELN/SFRP1/CCL21/TENM1,17
GO:1902904,negative regulation of supramolecular fiber organization,8/565,119/10364,0.32273172491697444,0.5241305035321252,0.34512591457222963,LMOD1/CRYAB/LDLR/APOE/EMILIN1/SLIT2/MAP1B/CLU,8
GO:0044843,cell cycle G1/S phase transition,11/565,170/10364,0.3227981932096084,0.5241305035321252,0.34512591457222963,MUC1/BCAT1/CCL2/ADAMTS1/SUSD2/FAM107A/CDKN1A/GPNMB/TCIM/KLF4/PLPP2,11
GO:0001824,blastocyst development,5/565,69/10364,0.3231327286065178,0.5241305035321252,0.34512591457222963,IGF1/JUNB/HOPX/KLF4/ELF3,5
GO:0055123,digestive system development,5/565,69/10364,0.3231327286065178,0.5241305035321252,0.34512591457222963,IGF2/CXCL8/SFRP2/CDKN1A/SFRP1,5
GO:1902882,regulation of response to oxidative stress,5/565,69/10364,0.3231327286065178,0.5241305035321252,0.34512591457222963,ALOX5/H19/HSPB1/CD36/NR4A3,5
GO:0001961,positive regulation of cytokine-mediated signaling pathway,3/565,37/10364,0.32798828925404944,0.5305349886235,0.3493430966664396,EDN1/HSPA1A/HSPA1B,3
GO:0006458,'de novo' protein folding,3/565,37/10364,0.32798828925404944,0.5305349886235,0.3493430966664396,HSPA6/HSPA1A/HSPA1B,3
GO:0032873,negative regulation of stress-activated MAPK cascade,3/565,37/10364,0.32798828925404944,0.5305349886235,0.3493430966664396,SFRP2/DUSP1/SFRP1,3
GO:0043954,cellular component maintenance,3/565,37/10364,0.32798828925404944,0.5305349886235,0.3493430966664396,FCGR2B/APOE/CSF1R,3
GO:0070231,T cell apoptotic process,3/565,37/10364,0.32798828925404944,0.5305349886235,0.3493430966664396,CCL5/IL7R/TSC22D3,3
GO:0070303,negative regulation of stress-activated protein kinase signaling cascade,3/565,37/10364,0.32798828925404944,0.5305349886235,0.3493430966664396,SFRP2/DUSP1/SFRP1,3
GO:0097035,regulation of membrane lipid distribution,3/565,37/10364,0.32798828925404944,0.5305349886235,0.3493430966664396,MFSD2A/ABCA1/KCNN4,3
GO:0035967,cellular response to topologically incorrect protein,7/565,103/10364,0.3299987009187894,0.5331549650992596,0.351068281083795,HSPA6/ATF3/CREB3L1/HSPB8/HSPA1A/HSPA1B/DERL3,7
GO:0046631,alpha-beta T cell activation,7/565,103/10364,0.3299987009187894,0.5331549650992596,0.351068281083795,ZBTB16/BCL3/NFKBIZ/BCL6/HLA-DRB1/RORC/CD3E,7
GO:0099173,postsynapse organization,7/565,103/10364,0.3299987009187894,0.5331549650992596,0.351068281083795,FCGR2B/SRGN/APOE/LILRB2/RELN/PTN/LRRC4,7
GO:0044262,cellular carbohydrate metabolic process,13/565,206/10364,0.3333173538702314,0.5380919742684256,0.3543191695424467,PFKFB3/DDIT4/IGF2/DGAT2/NNMT/IGF1/C1QTNF1/HK2/SIK1/HK3/GPER1/PDK4/RORC,13
GO:0060070,canonical Wnt signaling pathway,13/565,206/10364,0.3333173538702314,0.5380919742684256,0.3543191695424467,MDK/IGFBP6/COL1A1/SOX9/APOE/NR4A2/FRZB/IGFBP2/SFRP2/EGR1/SFRP1/KLF4/GPC3,13
GO:0003279,cardiac septum development,5/565,70/10364,0.3340529867288345,0.5390669797665938,0.3549611845787794,CCN1/APLNR/SLIT2/SLIT3/SEMA3C,5
GO:0006613,cotranslational protein targeting to membrane,2/565,22/10364,0.33916008913507256,0.5440914596077535,0.3582696701348461,RN7SL1/RN7SL2,2
GO:0009948,anterior/posterior axis specification,2/565,22/10364,0.33916008913507256,0.5440914596077535,0.3582696701348461,BASP1/GPC3,2
GO:0017145,stem cell division,2/565,22/10364,0.33916008913507256,0.5440914596077535,0.3582696701348461,ZBTB16/SFRP2,2
GO:0021799,cerebral cortex radially oriented cell migration,2/565,22/10364,0.33916008913507256,0.5440914596077535,0.3582696701348461,MDGA1/RELN,2
GO:0022011,myelination in peripheral nervous system,2/565,22/10364,0.33916008913507256,0.5440914596077535,0.3582696701348461,ITGB4/NTRK2,2
GO:0032292,peripheral nervous system axon ensheathment,2/565,22/10364,0.33916008913507256,0.5440914596077535,0.3582696701348461,ITGB4/NTRK2,2
GO:0038095,Fc-epsilon receptor signaling pathway,2/565,22/10364,0.33916008913507256,0.5440914596077535,0.3582696701348461,FCER1G/NR4A3,2
GO:0043268,positive regulation of potassium ion transport,2/565,22/10364,0.33916008913507256,0.5440914596077535,0.3582696701348461,ADRA2A/KCNN4,2
GO:0045736,negative regulation of cyclin-dependent protein serine/threonine kinase activity,2/565,22/10364,0.33916008913507256,0.5440914596077535,0.3582696701348461,CDKN1C/CDKN1A,2
GO:0048512,circadian behavior,2/565,22/10364,0.33916008913507256,0.5440914596077535,0.3582696701348461,EGR1/PTGDS,2
GO:0048713,regulation of oligodendrocyte differentiation,2/565,22/10364,0.33916008913507256,0.5440914596077535,0.3582696701348461,MDK/PTN,2
GO:0086004,regulation of cardiac muscle cell contraction,2/565,22/10364,0.33916008913507256,0.5440914596077535,0.3582696701348461,ATP1A2/PLN,2
GO:0090102,cochlea development,2/565,22/10364,0.33916008913507256,0.5440914596077535,0.3582696701348461,SOX9/FRZB,2
GO:1901861,regulation of muscle tissue development,2/565,22/10364,0.33916008913507256,0.5440914596077535,0.3582696701348461,IGF2/IGFBP5,2
GO:2000516,"positive regulation of CD4-positive, alpha-beta T cell activation",2/565,22/10364,0.33916008913507256,0.5440914596077535,0.3582696701348461,NFKBIZ/HLA-DRB1,2
GO:1904589,regulation of protein import,4/565,54/10364,0.3397047184832338,0.5447517107208615,0.35870442782920475,PTGS2/APOD/CD36/ANGPT1,4
GO:0002218,activation of innate immune response,3/565,38/10364,0.34318406796293865,0.5494703067032737,0.36181149704756227,MNDA/CLEC7A/TYROBP,3
GO:0006111,regulation of gluconeogenesis,3/565,38/10364,0.34318406796293865,0.5494703067032737,0.36181149704756227,DGAT2/NNMT/SIK1,3
GO:0045576,mast cell activation,3/565,38/10364,0.34318406796293865,0.5494703067032737,0.36181149704756227,HMOX1/NR4A3/PTGDS,3
GO:0046579,positive regulation of Ras protein signal transduction,3/565,38/10364,0.34318406796293865,0.5494703067032737,0.36181149704756227,IGF1/COL3A1/PDGFRB,3
GO:1903578,regulation of ATP metabolic process,5/565,71/10364,0.3450050056739455,0.5521698566181129,0.36358907844573246,MTCO2P12/DDIT4/H19/IGF1/MLXIPL,5
GO:0060828,regulation of canonical Wnt signaling pathway,11/565,174/10364,0.35045565032897436,0.5606742604325209,0.3691890008401733,MDK/IGFBP6/COL1A1/SOX9/APOE/FRZB/IGFBP2/SFRP2/EGR1/SFRP1/GPC3,11
GO:0006029,proteoglycan metabolic process,4/565,55/10364,0.35229651532641976,0.5633991928696728,0.3709832959502307,DCN/IGF1/SULF1/BGN,4
GO:0046031,ADP metabolic process,5/565,72/10364,0.35597944856860375,0.5690667170792127,0.3747152090195829,DDIT4/IGF1/HK2/HK3/MLXIPL,5
GO:0048016,inositol phosphate-mediated signaling,3/565,39/10364,0.35835106864599453,0.5717459952669462,0.3764794420277812,CLEC7A/IGF1/EDN1,3
GO:0048255,mRNA stabilization,3/565,39/10364,0.35835106864599453,0.5717459952669462,0.3764794420277812,TENT5C/ZFP36/SLC11A1,3
GO:0002335,mature B cell differentiation,2/565,23/10364,0.3593313253106626,0.5717459952669462,0.3764794420277812,FCGR2B/BCL3,2
GO:0030204,chondroitin sulfate metabolic process,2/565,23/10364,0.3593313253106626,0.5717459952669462,0.3764794420277812,DCN/BGN,2
GO:0035066,positive regulation of histone acetylation,2/565,23/10364,0.3593313253106626,0.5717459952669462,0.3764794420277812,MUC1/LIF,2
GO:0045746,negative regulation of Notch signaling pathway,2/565,23/10364,0.3593313253106626,0.5717459952669462,0.3764794420277812,BCL6/TCIM,2
GO:0046621,negative regulation of organ growth,2/565,23/10364,0.3593313253106626,0.5717459952669462,0.3764794420277812,RGS2/PI16,2
GO:0050885,neuromuscular process controlling balance,2/565,23/10364,0.3593313253106626,0.5717459952669462,0.3764794420277812,ALDH1A3/SLC1A3,2
GO:0060218,hematopoietic stem cell differentiation,2/565,23/10364,0.3593313253106626,0.5717459952669462,0.3764794420277812,ACE/SFRP1,2
GO:0070296,sarcoplasmic reticulum calcium ion transport,2/565,23/10364,0.3593313253106626,0.5717459952669462,0.3764794420277812,ATP1A2/PLN,2
GO:1903115,regulation of actin filament-based movement,2/565,23/10364,0.3593313253106626,0.5717459952669462,0.3764794420277812,ATP1A2/PLN,2
GO:1904030,negative regulation of cyclin-dependent protein kinase activity,2/565,23/10364,0.3593313253106626,0.5717459952669462,0.3764794420277812,CDKN1C/CDKN1A,2
GO:0006094,gluconeogenesis,4/565,56/10364,0.3648900033904453,0.5803650636676314,0.38215486798467696,ATF3/DGAT2/NNMT/SIK1,4
GO:0033209,tumor necrosis factor-mediated signaling pathway,5/565,73/10364,0.366967188952424,0.5830267794836067,0.3839075366409165,CCDC3/BIRC3/PLVAP/HSPA1A/HSPA1B,5
GO:1905897,regulation of response to endoplasmic reticulum stress,5/565,73/10364,0.366967188952424,0.5830267794836067,0.3839075366409165,FCGR2B/ALOX5/CREB3L1/HSPA1A/CLU,5
GO:0015748,organophosphate ester transport,6/565,90/10364,0.36699072074481054,0.5830267794836067,0.3839075366409165,MFSD2A/LDLR/APOE/APOC1/ABCA1/KCNN4,6
GO:0045930,negative regulation of mitotic cell cycle,10/565,159/10364,0.3672607004521654,0.5832293668158127,0.3840409349793784,MUC1/CDKN1C/CCL2/FAM107A/BCL6/DUSP1/CDKN1A/GPNMB/GAS1/KLF4,10
GO:0009581,detection of external stimulus,3/565,40/10364,0.3734677277103978,0.5917093178198022,0.3896247558523419,CXCL12/NGFR/SERPINE2,3
GO:0051646,mitochondrion localization,3/565,40/10364,0.3734677277103978,0.5917093178198022,0.3896247558523419,PLIN5/UCHL1/MAP1B,3
GO:0060071,"Wnt signaling pathway, planar cell polarity pathway",3/565,40/10364,0.3734677277103978,0.5917093178198022,0.3896247558523419,SFRP2/SFRP1/GPC3,3
GO:0090342,regulation of cell aging,3/565,40/10364,0.3734677277103978,0.5917093178198022,0.3896247558523419,BCL6/HLA-G/NAMPT,3
GO:1990090,cellular response to nerve growth factor stimulus,3/565,40/10364,0.3734677277103978,0.5917093178198022,0.3896247558523419,ID1/NTRK2/LCN2,3
GO:2000514,"regulation of CD4-positive, alpha-beta T cell activation",3/565,40/10364,0.3734677277103978,0.5917093178198022,0.3896247558523419,NFKBIZ/BCL6/HLA-DRB1,3
GO:0016239,positive regulation of macroautophagy,4/565,57/10364,0.37747215020618585,0.596747428045302,0.3929422166518444,DCN/HSPB8/HMOX1/ELAPOR1,4
GO:0048524,positive regulation of viral process,4/565,57/10364,0.37747215020618585,0.596747428045302,0.3929422166518444,IFIT1/CCL5/HLA-DRB1/TOP2A,4
GO:0031058,positive regulation of histone modification,5/565,74/10364,0.3779593239434207,0.596747428045302,0.3929422166518444,MUC1/APLNR/LIF/BCL6/VEGFA,5
GO:0005979,regulation of glycogen biosynthetic process,2/565,24/10364,0.3792713257874636,0.596747428045302,0.3929422166518444,IGF2/IGF1,2
GO:0006584,catecholamine metabolic process,2/565,24/10364,0.3792713257874636,0.596747428045302,0.3929422166518444,NR4A2/MOXD1,2
GO:0009712,catechol-containing compound metabolic process,2/565,24/10364,0.3792713257874636,0.596747428045302,0.3929422166518444,NR4A2/MOXD1,2
GO:0010862,positive regulation of pathway-restricted SMAD protein phosphorylation,2/565,24/10364,0.3792713257874636,0.596747428045302,0.3929422166518444,GDF15/INHBB,2
GO:0010962,regulation of glucan biosynthetic process,2/565,24/10364,0.3792713257874636,0.596747428045302,0.3929422166518444,IGF2/IGF1,2
GO:0019320,hexose catabolic process,2/565,24/10364,0.3792713257874636,0.596747428045302,0.3929422166518444,HK2/HK3,2
GO:0033137,negative regulation of peptidyl-serine phosphorylation,2/565,24/10364,0.3792713257874636,0.596747428045302,0.3929422166518444,DDIT4/MLXIPL,2
GO:0039529,RIG-I signaling pathway,2/565,24/10364,0.3792713257874636,0.596747428045302,0.3929422166518444,BIRC3/OAS3,2
GO:0043153,entrainment of circadian clock by photoperiod,2/565,24/10364,0.3792713257874636,0.596747428045302,0.3929422166518444,SIK1/BHLHE40,2
GO:0043403,skeletal muscle tissue regeneration,2/565,24/10364,0.3792713257874636,0.596747428045302,0.3929422166518444,IGF1/HOPX,2
GO:0046466,membrane lipid catabolic process,2/565,24/10364,0.3792713257874636,0.596747428045302,0.3929422166518444,CYP1B1/ENPP2,2
GO:0050999,regulation of nitric-oxide synthase activity,2/565,24/10364,0.3792713257874636,0.596747428045302,0.3929422166518444,APOE/NPR3,2
GO:0051491,positive regulation of filopodium assembly,2/565,24/10364,0.3792713257874636,0.596747428045302,0.3929422166518444,CCL21/TENM1,2
GO:0051654,establishment of mitochondrion localization,2/565,24/10364,0.3792713257874636,0.596747428045302,0.3929422166518444,UCHL1/MAP1B,2
GO:0090200,positive regulation of release of cytochrome c from mitochondria,2/565,24/10364,0.3792713257874636,0.596747428045302,0.3929422166518444,TNFSF10/GPER1,2
GO:0009582,detection of abiotic stimulus,3/565,41/10364,0.38851379571613753,0.6105855967991812,0.40205428056532105,CXCL12/NGFR/SERPINE2,3
GO:0009798,axis specification,3/565,41/10364,0.38851379571613753,0.6105855967991812,0.40205428056532105,BASP1/SFRP1/GPC3,3
GO:0090175,regulation of establishment of planar polarity,3/565,41/10364,0.38851379571613753,0.6105855967991812,0.40205428056532105,SFRP2/SFRP1/GPC3,3
GO:0071805,potassium ion transmembrane transport,5/565,75/10364,0.3889471859956448,0.6110321486823369,0.40234832303382734,ATP1A2/KCNMA1/SLC1A3/AQP1/KCNN4,5
GO:0051017,actin filament bundle assembly,8/565,127/10364,0.3893976239322264,0.6115051294125565,0.40265976819107735,CX3CL1/ID1/FAM107A/SYNPO2/CCN2/ELN/SFRP1/ESPN,8
GO:0098655,cation transmembrane transport,26/565,446/10364,0.38979590831274774,0.611895877543094,0.4029170653813961,MTCO2P12/ATP1A2/RGS2/AGT/KCNMA1/ADRA2A/APLNR/THY1/CACNA1H/CX3CL1/RRAD/SLC7A5/P2RX1/CCL2/SCN7A/SLC11A1/SLC1A3/PLN/GPER1/AQP1/RAMP3/RELN/GEM/CCL21/KCNN4/LCN2,26
GO:0006887,exocytosis,14/565,233/10364,0.3928316636248562,0.6164250022537989,0.40589937283623767,FCGR2B/ADRA2A/SYT7/TNFAIP2/CACNA1H/P2RX1/CCL5/HMOX1/CCR1/ANXA3/ADCY1/NR4A3/PTGDS/RAB27B,14
GO:0044242,cellular lipid catabolic process,9/565,145/10364,0.39359325259231703,0.6173834391237341,0.4065304778741375,MFSD2A/AKR1C3/PLIN5/LDLR/APOC1/CYP1B1/CYP26B1/LPL/ENPP2,9
GO:0002221,pattern recognition receptor signaling pathway,8/565,128/10364,0.3978011032447121,0.6226772189940272,0.4100162902948355,BIRC3/OAS1/OAS3/LTF/CD14/HSPA1A/HSPA1B/CD36,8
GO:0002262,myeloid cell homeostasis,8/565,128/10364,0.3978011032447121,0.6226772189940272,0.4100162902948355,ISG15/KLF2/ZFP36/HMOX1/BCL6/HSPA1A/HSPA1B/VEGFA,8
GO:0009187,cyclic nucleotide metabolic process,2/565,25/10364,0.398945370156652,0.6226772189940272,0.4100162902948355,GUCY1A2/ADCY1,2
GO:0009648,photoperiodism,2/565,25/10364,0.398945370156652,0.6226772189940272,0.4100162902948355,SIK1/BHLHE40,2
GO:0014044,Schwann cell development,2/565,25/10364,0.398945370156652,0.6226772189940272,0.4100162902948355,ITGB4/NTRK2,2
GO:0021536,diencephalon development,2/565,25/10364,0.398945370156652,0.6226772189940272,0.4100162902948355,NR4A2/PTN,2
GO:0045910,negative regulation of DNA recombination,2/565,25/10364,0.398945370156652,0.6226772189940272,0.4100162902948355,BCL6/H1-2,2
GO:0048147,negative regulation of fibroblast proliferation,2/565,25/10364,0.398945370156652,0.6226772189940272,0.4100162902948355,IFI30/SFRP1,2
GO:0060416,response to growth hormone,2/565,25/10364,0.398945370156652,0.6226772189940272,0.4100162902948355,GDF15/IGFBP5,2
GO:0070884,regulation of calcineurin-NFAT signaling cascade,2/565,25/10364,0.398945370156652,0.6226772189940272,0.4100162902948355,CLEC7A/IGF1,2
GO:0099172,presynapse organization,2/565,25/10364,0.398945370156652,0.6226772189940272,0.4100162902948355,C5AR1/MDGA1,2
GO:0099601,regulation of neurotransmitter receptor activity,2/565,25/10364,0.398945370156652,0.6226772189940272,0.4100162902948355,CCL2/RELN,2
GO:0106056,regulation of calcineurin-mediated signaling,2/565,25/10364,0.398945370156652,0.6226772189940272,0.4100162902948355,CLEC7A/IGF1,2
GO:0006165,nucleoside diphosphate phosphorylation,5/565,76/10364,0.39992235329855785,0.6234890001539588,0.41055082647116153,DDIT4/IGF1/HK2/HK3/MLXIPL,5
GO:0010769,regulation of cell morphogenesis involved in differentiation,5/565,76/10364,0.39992235329855785,0.6234890001539588,0.41055082647116153,GBP1/MDK/POSTN/FBLN1/RELN,5
GO:0062207,regulation of pattern recognition receptor signaling pathway,5/565,76/10364,0.39992235329855785,0.6234890001539588,0.41055082647116153,BIRC3/LTF/HSPA1A/HSPA1B/CD36,5
GO:0007276,gamete generation,20/565,341/10364,0.4002519210319926,0.6237652701579663,0.41073274287778055,PTGS2/RGS2/MDK/BIRC3/ZBTB16/IGF1/TMEM119/ACE/SOX9/CYP26B1/INHBB/ADAMTS1/SPATC1L/GGT5/BCL6/HPGD/ADAMTS2/PTN/ADAM28/TOP2A,20
GO:0002793,positive regulation of peptide secretion,4/565,59/10364,0.4025528078714429,0.6268737905765261,0.4127796204115094,S100A8/CD38/HLA-DRB1/GPER1,4
GO:0019319,hexose biosynthetic process,4/565,59/10364,0.4025528078714429,0.6268737905765261,0.4127796204115094,ATF3/DGAT2/NNMT/SIK1,4
GO:0046486,glycerolipid metabolic process,17/565,288/10364,0.40296453003698063,0.6272763444758169,0.4130446913847138,PLA2G2A/FABP3/MFSD2A/DGAT2/SOCS3/PLIN5/C3/LDLR/APOE/APOC1/SIK1/CSF1R/PDGFRB/TNXB/LPL/ENPP2/PLCH2,17
GO:0061572,actin filament bundle organization,8/565,129/10364,0.4062069979818026,0.63208340925028506,0.4162100149358444,CX3CL1/ID1/FAM107A/SYNPO2/CCN2/ELN/SFRP1/ESPN,8
GO:0017157,regulation of exocytosis,8/565,130/10364,0.41461149248816254,0.6435040866169792,0.4237302254457316,FCGR2B/ADRA2A/SYT7/CACNA1H/P2RX1/HMOX1/ADCY1/RAB27B,8
GO:0002708,positive regulation of lymphocyte mediated immunity,4/565,60/10364,0.4150277990884811,0.6435040866169792,0.4237302254457316,C3/HLA-G/HLA-DRB1/AZGP1,4
GO:0006885,regulation of pH,4/565,60/10364,0.4150277990884811,0.6435040866169792,0.4237302254457316,SLC11A1/EDN1/PDK4/CA2,4
GO:1903828,negative regulation of cellular protein localization,6/565,95/10364,0.41636029440310496,0.6435040866169792,0.4237302254457316,GBP1/DCLK1/APOD/CD36/ANGPT1/DERL3,6
GO:0002011,morphogenesis of an epithelial sheet,3/565,43/10364,0.41831961696051556,0.6435040866169792,0.4237302254457316,CCN1/HBEGF/COL5A1,3
GO:0010761,fibroblast migration,3/565,43/10364,0.41831961696051556,0.6435040866169792,0.4237302254457316,THBS1/AKAP12/CCN3,3
GO:0010823,negative regulation of mitochondrion organization,3/565,43/10364,0.41831961696051556,0.6435040866169792,0.4237302254457316,IGF1/HSPA1A/CLU,3
GO:0060760,positive regulation of response to cytokine stimulus,3/565,43/10364,0.41831961696051556,0.6435040866169792,0.4237302254457316,EDN1/HSPA1A/HSPA1B,3
GO:0003197,endocardial cushion development,2/565,26/10364,0.41832319700898146,0.6435040866169792,0.4237302254457316,APLNR/SOX9,2
GO:0009069,serine family amino acid metabolic process,2/565,26/10364,0.41832319700898146,0.6435040866169792,0.4237302254457316,PHGDH/THNSL2,2
GO:0010765,positive regulation of sodium ion transport,2/565,26/10364,0.41832319700898146,0.6435040866169792,0.4237302254457316,CNTN1/PRSS8,2
GO:0032743,positive regulation of interleukin-2 production,2/565,26/10364,0.41832319700898146,0.6435040866169792,0.4237302254457316,CLEC7A/CD3E,2
GO:0033003,regulation of mast cell activation,2/565,26/10364,0.41832319700898146,0.6435040866169792,0.4237302254457316,HMOX1/NR4A3,2
GO:0035019,somatic stem cell population maintenance,2/565,26/10364,0.41832319700898146,0.6435040866169792,0.4237302254457316,SOX9/SFRP1,2
GO:0042220,response to cocaine,2/565,26/10364,0.41832319700898146,0.6435040866169792,0.4237302254457316,TGM2/SLC1A3,2
GO:0043029,T cell homeostasis,2/565,26/10364,0.41832319700898146,0.6435040866169792,0.4237302254457316,TNFSF14/TSC22D3,2
GO:0046365,monosaccharide catabolic process,2/565,26/10364,0.41832319700898146,0.6435040866169792,0.4237302254457316,HK2/HK3,2
GO:0050654,chondroitin sulfate proteoglycan metabolic process,2/565,26/10364,0.41832319700898146,0.6435040866169792,0.4237302254457316,DCN/BGN,2
GO:0046939,nucleotide phosphorylation,5/565,78/10364,0.4218021983958984,0.6435040866169792,0.4237302254457316,DDIT4/IGF1/HK2/HK3/MLXIPL,5
GO:0016331,morphogenesis of embryonic epithelium,6/565,96/10364,0.4262017598465102,0.6435040866169792,0.4237302254457316,ADM/ALDH1A3/SOX9/SFRP2/SFRP1/SULF1,6
GO:0016079,synaptic vesicle exocytosis,4/565,61/10364,0.42744442210944433,0.6435040866169792,0.4237302254457316,ADRA2A/SYT7/P2RX1/ADCY1,4
GO:0072332,intrinsic apoptotic signaling pathway by p53 class mediator,4/565,61/10364,0.42744442210944433,0.6435040866169792,0.4237302254457316,MUC1/DDIT4/BCL3/CDKN1A,4
GO:1903510,mucopolysaccharide metabolic process,4/565,61/10364,0.42744442210944433,0.6435040866169792,0.4237302254457316,ITIH5/DCN/ANGPT1/BGN,4
GO:0010948,negative regulation of cell cycle process,12/565,203/10364,0.42889842727681315,0.6435040866169792,0.4237302254457316,MUC1/CCL2/SUSD2/LIF/FAM107A/BCL6/DUSP1/HLA-G/CDKN1A/GPER1/GPNMB/KLF4,12
GO:0051604,protein maturation,12/565,203/10364,0.42889842727681315,0.6435040866169792,0.4237302254457316,F3/SRGN/CPXM2/THBS1/ACE/SERPINE2/CLEC3B/MME/ADAMTS2/SERPINE1/PLAT/GAS1,12
GO:0000712,resolution of meiotic recombination intermediates,1/565,10/10364,0.4292646948097143,0.6435040866169792,0.4237302254457316,TOP2A,1
GO:0001963,"synaptic transmission, dopaminergic",1/565,10/10364,0.4292646948097143,0.6435040866169792,0.4237302254457316,PTGS2,1
GO:0003184,pulmonary valve morphogenesis,1/565,10/10364,0.4292646948097143,0.6435040866169792,0.4237302254457316,SLIT2,1
GO:0003215,cardiac right ventricle morphogenesis,1/565,10/10364,0.4292646948097143,0.6435040866169792,0.4237302254457316,SEMA3C,1
GO:0003376,sphingosine-1-phosphate receptor signaling pathway,1/565,10/10364,0.4292646948097143,0.6435040866169792,0.4237302254457316,S1PR3,1
GO:0006000,fructose metabolic process,1/565,10/10364,0.4292646948097143,0.6435040866169792,0.4237302254457316,PFKFB3,1
GO:0006067,ethanol metabolic process,1/565,10/10364,0.4292646948097143,0.6435040866169792,0.4237302254457316,ADH1B,1
GO:0006086,acetyl-CoA biosynthetic process from pyruvate,1/565,10/10364,0.4292646948097143,0.6435040866169792,0.4237302254457316,PDK4,1
GO:0006596,polyamine biosynthetic process,1/565,10/10364,0.4292646948097143,0.6435040866169792,0.4237302254457316,NNMT,1
GO:0006750,glutathione biosynthetic process,1/565,10/10364,0.4292646948097143,0.6435040866169792,0.4237302254457316,GGT5,1
GO:0007274,neuromuscular synaptic transmission,1/565,10/10364,0.4292646948097143,0.6435040866169792,0.4237302254457316,EGR3,1
GO:0008211,glucocorticoid metabolic process,1/565,10/10364,0.4292646948097143,0.6435040866169792,0.4237302254457316,CACNA1H,1
GO:0010453,regulation of cell fate commitment,1/565,10/10364,0.4292646948097143,0.6435040866169792,0.4237302254457316,SFRP2,1
GO:0010839,negative regulation of keratinocyte proliferation,1/565,10/10364,0.4292646948097143,0.6435040866169792,0.4237302254457316,EPPK1,1
GO:0010893,positive regulation of steroid biosynthetic process,1/565,10/10364,0.4292646948097143,0.6435040866169792,0.4237302254457316,ADM,1
GO:0014047,glutamate secretion,1/565,10/10364,0.4292646948097143,0.6435040866169792,0.4237302254457316,NTRK2,1
GO:0014841,skeletal muscle satellite cell proliferation,1/565,10/10364,0.4292646948097143,0.6435040866169792,0.4237302254457316,ANGPT1,1
GO:0014857,regulation of skeletal muscle cell proliferation,1/565,10/10364,0.4292646948097143,0.6435040866169792,0.4237302254457316,ANGPT1,1
GO:0015801,aromatic amino acid transport,1/565,10/10364,0.4292646948097143,0.6435040866169792,0.4237302254457316,SLC7A5,1
GO:0020027,hemoglobin metabolic process,1/565,10/10364,0.4292646948097143,0.6435040866169792,0.4237302254457316,KLF4,1
GO:0021670,lateral ventricle development,1/565,10/10364,0.4292646948097143,0.6435040866169792,0.4237302254457316,AQP1,1
GO:0021819,layer formation in cerebral cortex,1/565,10/10364,0.4292646948097143,0.6435040866169792,0.4237302254457316,RELN,1
GO:0022010,central nervous system myelination,1/565,10/10364,0.4292646948097143,0.6435040866169792,0.4237302254457316,CLU,1
GO:0030202,heparin metabolic process,1/565,10/10364,0.4292646948097143,0.6435040866169792,0.4237302254457316,ANGPT1,1
GO:0031272,regulation of pseudopodium assembly,1/565,10/10364,0.4292646948097143,0.6435040866169792,0.4237302254457316,CCL21,1
GO:0031274,positive regulation of pseudopodium assembly,1/565,10/10364,0.4292646948097143,0.6435040866169792,0.4237302254457316,CCL21,1
GO:0032291,axon ensheathment in central nervous system,1/565,10/10364,0.4292646948097143,0.6435040866169792,0.4237302254457316,CLU,1
GO:0032331,negative regulation of chondrocyte differentiation,1/565,10/10364,0.4292646948097143,0.6435040866169792,0.4237302254457316,SOX9,1
GO:0033561,regulation of water loss via skin,1/565,10/10364,0.4292646948097143,0.6435040866169792,0.4237302254457316,CYP26B1,1
GO:0034112,positive regulation of homotypic cell-cell adhesion,1/565,10/10364,0.4292646948097143,0.6435040866169792,0.4237302254457316,CCL5,1
GO:0034145,positive regulation of toll-like receptor 4 signaling pathway,1/565,10/10364,0.4292646948097143,0.6435040866169792,0.4237302254457316,LTF,1
GO:0035672,oligopeptide transmembrane transport,1/565,10/10364,0.4292646948097143,0.6435040866169792,0.4237302254457316,CA2,1
GO:0036342,post-anal tail morphogenesis,1/565,10/10364,0.4292646948097143,0.6435040866169792,0.4237302254457316,SFRP2,1
GO:0039530,MDA-5 signaling pathway,1/565,10/10364,0.4292646948097143,0.6435040866169792,0.4237302254457316,OAS3,1
GO:0042053,regulation of dopamine metabolic process,1/565,10/10364,0.4292646948097143,0.6435040866169792,0.4237302254457316,NR4A2,1
GO:0042069,regulation of catecholamine metabolic process,1/565,10/10364,0.4292646948097143,0.6435040866169792,0.4237302254457316,NR4A2,1
GO:0042492,gamma-delta T cell differentiation,1/565,10/10364,0.4292646948097143,0.6435040866169792,0.4237302254457316,EGR3,1
GO:0042789,mRNA transcription by RNA polymerase II,1/565,10/10364,0.4292646948097143,0.6435040866169792,0.4237302254457316,C5AR1,1
GO:0043586,tongue development,1/565,10/10364,0.4292646948097143,0.6435040866169792,0.4237302254457316,CYP26B1,1
GO:0045059,positive thymic T cell selection,1/565,10/10364,0.4292646948097143,0.6435040866169792,0.4237302254457316,CD3E,1
GO:0045475,locomotor rhythm,1/565,10/10364,0.4292646948097143,0.6435040866169792,0.4237302254457316,EGR1,1
GO:0045837,negative regulation of membrane potential,1/565,10/10364,0.4292646948097143,0.6435040866169792,0.4237302254457316,PTN,1
GO:0046643,regulation of gamma-delta T cell activation,1/565,10/10364,0.4292646948097143,0.6435040866169792,0.4237302254457316,EGR3,1
GO:0047484,regulation of response to osmotic stress,1/565,10/10364,0.4292646948097143,0.6435040866169792,0.4237302254457316,PTGS2,1
GO:0048096,chromatin-mediated maintenance of transcription,1/565,10/10364,0.4292646948097143,0.6435040866169792,0.4237302254457316,PADI2,1
GO:0050862,positive regulation of T cell receptor signaling pathway,1/565,10/10364,0.4292646948097143,0.6435040866169792,0.4237302254457316,KCNN4,1
GO:0051561,positive regulation of mitochondrial calcium ion concentration,1/565,10/10364,0.4292646948097143,0.6435040866169792,0.4237302254457316,TGM2,1
GO:0051957,positive regulation of amino acid transport,1/565,10/10364,0.4292646948097143,0.6435040866169792,0.4237302254457316,AGT,1
GO:0055003,cardiac myofibril assembly,1/565,10/10364,0.4292646948097143,0.6435040866169792,0.4237302254457316,PDGFRB,1
GO:0060571,morphogenesis of an epithelial fold,1/565,10/10364,0.4292646948097143,0.6435040866169792,0.4237302254457316,SULF1,1
GO:0060576,intestinal epithelial cell development,1/565,10/10364,0.4292646948097143,0.6435040866169792,0.4237302254457316,CDKN1A,1
GO:0060749,mammary gland alveolus development,1/565,10/10364,0.4292646948097143,0.6435040866169792,0.4237302254457316,VEGFA,1
GO:0061377,mammary gland lobule development,1/565,10/10364,0.4292646948097143,0.6435040866169792,0.4237302254457316,VEGFA,1
GO:0070862,negative regulation of protein exit from endoplasmic reticulum,1/565,10/10364,0.4292646948097143,0.6435040866169792,0.4237302254457316,DERL3,1
GO:0070886,positive regulation of calcineurin-NFAT signaling cascade,1/565,10/10364,0.4292646948097143,0.6435040866169792,0.4237302254457316,IGF1,1
GO:0071679,commissural neuron axon guidance,1/565,10/10364,0.4292646948097143,0.6435040866169792,0.4237302254457316,VEGFA,1
GO:0090231,regulation of spindle checkpoint,1/565,10/10364,0.4292646948097143,0.6435040866169792,0.4237302254457316,DUSP1,1
GO:0090266,regulation of mitotic cell cycle spindle assembly checkpoint,1/565,10/10364,0.4292646948097143,0.6435040866169792,0.4237302254457316,DUSP1,1
GO:0090336,positive regulation of brown fat cell differentiation,1/565,10/10364,0.4292646948097143,0.6435040866169792,0.4237302254457316,PTGS2,1
GO:0098884,postsynaptic neurotransmitter receptor internalization,1/565,10/10364,0.4292646948097143,0.6435040866169792,0.4237302254457316,ITGB3,1
GO:0099590,neurotransmitter receptor internalization,1/565,10/10364,0.4292646948097143,0.6435040866169792,0.4237302254457316,ITGB3,1
GO:0106058,positive regulation of calcineurin-mediated signaling,1/565,10/10364,0.4292646948097143,0.6435040866169792,0.4237302254457316,IGF1,1
GO:0140239,postsynaptic endocytosis,1/565,10/10364,0.4292646948097143,0.6435040866169792,0.4237302254457316,ITGB3,1
GO:1901678,iron coordination entity transport,1/565,10/10364,0.4292646948097143,0.6435040866169792,0.4237302254457316,LCN2,1
GO:1901741,positive regulation of myoblast fusion,1/565,10/10364,0.4292646948097143,0.6435040866169792,0.4237302254457316,GDF15,1
GO:1902074,response to salt,1/565,10/10364,0.4292646948097143,0.6435040866169792,0.4237302254457316,EDN1,1
GO:1902287,semaphorin-plexin signaling pathway involved in axon guidance,1/565,10/10364,0.4292646948097143,0.6435040866169792,0.4237302254457316,PLXNA4,1
GO:1902931,negative regulation of alcohol biosynthetic process,1/565,10/10364,0.4292646948097143,0.6435040866169792,0.4237302254457316,APOE,1
GO:1903429,regulation of cell maturation,1/565,10/10364,0.4292646948097143,0.6435040866169792,0.4237302254457316,CLEC7A,1
GO:1903504,regulation of mitotic spindle checkpoint,1/565,10/10364,0.4292646948097143,0.6435040866169792,0.4237302254457316,DUSP1,1
GO:1990822,basic amino acid transmembrane transport,1/565,10/10364,0.4292646948097143,0.6435040866169792,0.4237302254457316,AGT,1
GO:2000104,negative regulation of DNA-dependent DNA replication,1/565,10/10364,0.4292646948097143,0.6435040866169792,0.4237302254457316,BCL6,1
GO:2000644,regulation of receptor catabolic process,1/565,10/10364,0.4292646948097143,0.6435040866169792,0.4237302254457316,APOE,1
GO:2000774,positive regulation of cellular senescence,1/565,10/10364,0.4292646948097143,0.6435040866169792,0.4237302254457316,HLA-G,1
GO:2001214,positive regulation of vasculogenesis,1/565,10/10364,0.4292646948097143,0.6435040866169792,0.4237302254457316,ADM,1
GO:2001257,regulation of cation channel activity,5/565,79/10364,0.43269133687261796,0.6482220347246487,0.4268368680559034,RRAD/CCL2/PLN/RELN/GEM,5
GO:0002637,regulation of immunoglobulin production,3/565,44/10364,0.43304525280212847,0.6482220347246487,0.4268368680559034,FCGR2B/BCL6/CD22,3
GO:0038093,Fc receptor signaling pathway,3/565,44/10364,0.43304525280212847,0.6482220347246487,0.4268368680559034,FCER1G/FCGR2B/NR4A3,3
GO:1902373,negative regulation of mRNA catabolic process,3/565,44/10364,0.43304525280212847,0.6482220347246487,0.4268368680559034,TENT5C/ZFP36/SLC11A1,3
GO:0019827,stem cell population maintenance,6/565,97/10364,0.436018747700637,0.6518485912415803,0.4292248585014494,PRRX1/SOX9/LIF/PTN/SFRP1/KLF4,6
GO:0003254,regulation of membrane depolarization,2/565,27/10364,0.4373786224085543,0.6518485912415803,0.4292248585014494,IFI6/DCN,2
GO:0006739,"NADP metabolic process",2/565,27/10364,0.4373786224085543,0.6518485912415803,0.4292248585014494,FMO2/NQO1,2
GO:0009649,entrainment of circadian clock,2/565,27/10364,0.4373786224085543,0.6518485912415803,0.4292248585014494,SIK1/BHLHE40,2
GO:0010939,regulation of necrotic cell death,2/565,27/10364,0.4373786224085543,0.6518485912415803,0.4292248585014494,MTCO2P12/BIRC3,2
GO:0031571,mitotic G1 DNA damage checkpoint signaling,2/565,27/10364,0.4373786224085543,0.6518485912415803,0.4292248585014494,MUC1/CDKN1A,2
GO:0032715,negative regulation of interleukin-6 production,2/565,27/10364,0.4373786224085543,0.6518485912415803,0.4292248585014494,CX3CL1/KLF2,2
GO:0038094,Fc-gamma receptor signaling pathway,2/565,27/10364,0.4373786224085543,0.6518485912415803,0.4292248585014494,FCER1G/FCGR2B,2
GO:0039694,viral RNA genome replication,2/565,27/10364,0.4373786224085543,0.6518485912415803,0.4292248585014494,CXCL8/TOP2A,2
GO:0044819,mitotic G1/S transition checkpoint signaling,2/565,27/10364,0.4373786224085543,0.6518485912415803,0.4292248585014494,MUC1/CDKN1A,2
GO:0061099,negative regulation of protein tyrosine kinase activity,2/565,27/10364,0.4373786224085543,0.6518485912415803,0.4292248585014494,THY1/GPRC5A,2
GO:1902235,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,2/565,27/10364,0.4373786224085543,0.6518485912415803,0.4292248585014494,CREB3L1/HSPA1A,2
GO:0046364,monosaccharide biosynthetic process,4/565,62/10364,0.4397922271171649,0.6552071971680034,0.4314364106515971,ATF3/DGAT2/NNMT/SIK1,4
GO:0032479,regulation of type I interferon production,5/565,80/10364,0.4435367141057426,0.6603052027450582,0.4347933109377251,ISG15/OAS1/OAS3/OAS2/CD14,5
GO:0032606,type I interferon production,5/565,80/10364,0.4435367141057426,0.6603052027450582,0.4347933109377251,ISG15/OAS1/OAS3/OAS2/CD14,5
GO:0006575,cellular modified amino acid metabolic process,7/565,116/10364,0.4472354820751656,0.6653277847440872,0.43810054681552146,MFSD2A/GSTM1/GSTM3/GSTM5/CKB/GGT5/ALDH1L1,7
GO:1900180,regulation of protein localization to nucleus,7/565,116/10364,0.4472354820751656,0.6653277847440872,0.43810054681552146,PTGS2/DCLK1/NGFR/LIF/APOD/CD36/ANGPT1,7
GO:0031113,regulation of microtubule polymerization,3/565,45/10364,0.44763200344782017,0.6654340675800203,0.43817053121961075,MAP1B/HSPA1A/HSPA1B,3
GO:0045666,positive regulation of neuron differentiation,3/565,45/10364,0.44763200344782017,0.6654340675800203,0.43817053121961075,CXCL12/BCL6/MAP1B,3
GO:0008593,regulation of Notch signaling pathway,4/565,63/10364,0.45206129129751627,0.6676986833002754,0.4396617200863923,POSTN/BCL6/TCIM/CCN3,4
GO:0007346,regulation of mitotic cell cycle,18/565,315/10364,0.45319509279812886,0.6676986833002754,0.4396617200863923,MUC1/IGF2/CDKN1C/IGF1/CCL2/ADAMTS1/SIK1/FAM107A/BCL6/PDGFRB/DUSP1/EDN1/CDKN1A/SMOC2/GPNMB/GAS1/KLF4/MKI67,18
GO:0009135,purine nucleoside diphosphate metabolic process,5/565,81/10364,0.4543312491233381,0.6676986833002754,0.4396617200863923,DDIT4/IGF1/HK2/HK3/MLXIPL,5
GO:0009179,purine ribonucleoside diphosphate metabolic process,5/565,81/10364,0.4543312491233381,0.6676986833002754,0.4396617200863923,DDIT4/IGF1/HK2/HK3/MLXIPL,5
GO:0018209,peptidyl-serine modification,14/565,243/10364,0.45511997801693826,0.6676986833002754,0.4396617200863923,PTGS2/DDIT4/DCN/DCLK1/LIF/SFRP2/VEGFA/SGK1/RAMP3/MLXIPL/ANGPT1/NTRK2/TENM1/BGN,14
GO:0001881,receptor recycling,2/565,28/10364,0.4560891865958151,0.6676986833002754,0.4396617200863923,RAMP3/NSG1,2
GO:0003229,ventricular cardiac muscle tissue development,2/565,28/10364,0.4560891865958151,0.6676986833002754,0.4396617200863923,ADAMTS9/HOPX,2
GO:0046329,negative regulation of JNK cascade,2/565,28/10364,0.4560891865958151,0.6676986833002754,0.4396617200863923,SFRP2/SFRP1,2
GO:0048821,erythrocyte development,2/565,28/10364,0.4560891865958151,0.6676986833002754,0.4396617200863923,KLF2/BCL6,2
GO:0060236,regulation of mitotic spindle organization,2/565,28/10364,0.4560891865958151,0.6676986833002754,0.4396617200863923,HSPA1A/HSPA1B,2
GO:0070839,metal ion export,2/565,28/10364,0.4560891865958151,0.6676986833002754,0.4396617200863923,ATP1A2/SLC11A1,2
GO:0070873,regulation of glycogen metabolic process,2/565,28/10364,0.4560891865958151,0.6676986833002754,0.4396617200863923,IGF2/IGF1,2
GO:1900077,negative regulation of cellular response to insulin stimulus,2/565,28/10364,0.4560891865958151,0.6676986833002754,0.4396617200863923,SOCS3/LPL,2
GO:2000272,negative regulation of signaling receptor activity,2/565,28/10364,0.4560891865958151,0.6676986833002754,0.4396617200863923,GPRC5A/RAMP3,2
GO:2000758,positive regulation of peptidyl-lysine acetylation,2/565,28/10364,0.4560891865958151,0.6676986833002754,0.4396617200863923,MUC1/LIF,2
GO:0002717,positive regulation of natural killer cell mediated immunity,1/565,11/10364,0.4604087403411523,0.6676986833002754,0.4396617200863923,HLA-G,1
GO:0002834,regulation of response to tumor cell,1/565,11/10364,0.4604087403411523,0.6676986833002754,0.4396617200863923,HLA-DRB1,1
GO:0002837,regulation of immune response to tumor cell,1/565,11/10364,0.4604087403411523,0.6676986833002754,0.4396617200863923,HLA-DRB1,1
GO:0003413,chondrocyte differentiation involved in endochondral bone morphogenesis,1/565,11/10364,0.4604087403411523,0.6676986833002754,0.4396617200863923,SOX9,1
GO:0003417,growth plate cartilage development,1/565,11/10364,0.4604087403411523,0.6676986833002754,0.4396617200863923,SOX9,1
GO:0007340,acrosome reaction,1/565,11/10364,0.4604087403411523,0.6676986833002754,0.4396617200863923,CACNA1H,1
GO:0007350,blastoderm segmentation,1/565,11/10364,0.4604087403411523,0.6676986833002754,0.4396617200863923,BASP1,1
GO:0009125,nucleoside monophosphate catabolic process,1/565,11/10364,0.4604087403411523,0.6676986833002754,0.4396617200863923,TYMP,1
GO:0014856,skeletal muscle cell proliferation,1/565,11/10364,0.4604087403411523,0.6676986833002754,0.4396617200863923,ANGPT1,1
GO:0030948,negative regulation of vascular endothelial growth factor receptor signaling pathway,1/565,11/10364,0.4604087403411523,0.6676986833002754,0.4396617200863923,EMILIN1,1
GO:0031645,negative regulation of nervous system process,1/565,11/10364,0.4604087403411523,0.6676986833002754,0.4396617200863923,CCN3,1
GO:0032740,positive regulation of interleukin-17 production,1/565,11/10364,0.4604087403411523,0.6676986833002754,0.4396617200863923,SLC7A5,1
GO:0033145,positive regulation of intracellular steroid hormone receptor signaling pathway,1/565,11/10364,0.4604087403411523,0.6676986833002754,0.4396617200863923,LMO3,1
GO:0033623,regulation of integrin activation,1/565,11/10364,0.4604087403411523,0.6676986833002754,0.4396617200863923,SELP,1
GO:0035461,vitamin transmembrane transport,1/565,11/10364,0.4604087403411523,0.6676986833002754,0.4396617200863923,FOLR2,1
GO:0040020,regulation of meiotic nuclear division,1/565,11/10364,0.4604087403411523,0.6676986833002754,0.4396617200863923,LIF,1
GO:0043011,myeloid dendritic cell differentiation,1/565,11/10364,0.4604087403411523,0.6676986833002754,0.4396617200863923,ITGB8,1
GO:0043249,erythrocyte maturation,1/565,11/10364,0.4604087403411523,0.6676986833002754,0.4396617200863923,KLF2,1
GO:0045217,cell-cell junction maintenance,1/565,11/10364,0.4604087403411523,0.6676986833002754,0.4396617200863923,CSF1R,1
GO:0045342,MHC class II biosynthetic process,1/565,11/10364,0.4604087403411523,0.6676986833002754,0.4396617200863923,SLC11A1,1
GO:0045624,positive regulation of T-helper cell differentiation,1/565,11/10364,0.4604087403411523,0.6676986833002754,0.4396617200863923,NFKBIZ,1
GO:0045721,negative regulation of gluconeogenesis,1/565,11/10364,0.4604087403411523,0.6676986833002754,0.4396617200863923,SIK1,1
GO:0045820,negative regulation of glycolytic process,1/565,11/10364,0.4604087403411523,0.6676986833002754,0.4396617200863923,DDIT4,1
GO:0045844,positive regulation of striated muscle tissue development,1/565,11/10364,0.4604087403411523,0.6676986833002754,0.4396617200863923,IGF2,1
GO:0046184,aldehyde biosynthetic process,1/565,11/10364,0.4604087403411523,0.6676986833002754,0.4396617200863923,CACNA1H,1
GO:0046459,short-chain fatty acid metabolic process,1/565,11/10364,0.4604087403411523,0.6676986833002754,0.4396617200863923,THNSL2,1
GO:0048012,hepatocyte growth factor receptor signaling pathway,1/565,11/10364,0.4604087403411523,0.6676986833002754,0.4396617200863923,MUC20,1
GO:0048636,positive regulation of muscle organ development,1/565,11/10364,0.4604087403411523,0.6676986833002754,0.4396617200863923,IGF2,1
GO:0050665,hydrogen peroxide biosynthetic process,1/565,11/10364,0.4604087403411523,0.6676986833002754,0.4396617200863923,MTCO2P12,1
GO:0060049,regulation of protein glycosylation,1/565,11/10364,0.4604087403411523,0.6676986833002754,0.4396617200863923,RAMP1,1
GO:0060438,trachea development,1/565,11/10364,0.4604087403411523,0.6676986833002754,0.4396617200863923,SOX9,1
GO:0060563,neuroepithelial cell differentiation,1/565,11/10364,0.4604087403411523,0.6676986833002754,0.4396617200863923,SERPINE1,1
GO:0061323,cell proliferation involved in heart morphogenesis,1/565,11/10364,0.4604087403411523,0.6676986833002754,0.4396617200863923,SOX9,1
GO:0061744,motor behavior,1/565,11/10364,0.4604087403411523,0.6676986833002754,0.4396617200863923,MFSD2A,1
GO:0071361,cellular response to ethanol,1/565,11/10364,0.4604087403411523,0.6676986833002754,0.4396617200863923,CYBB,1
GO:0071472,cellular response to salt stress,1/565,11/10364,0.4604087403411523,0.6676986833002754,0.4396617200863923,AQP1,1
GO:0072202,cell differentiation involved in metanephros development,1/565,11/10364,0.4604087403411523,0.6676986833002754,0.4396617200863923,LIF,1
GO:0090520,sphingolipid mediated signaling pathway,1/565,11/10364,0.4604087403411523,0.6676986833002754,0.4396617200863923,S1PR3,1
GO:0090557,establishment of endothelial intestinal barrier,1/565,11/10364,0.4604087403411523,0.6676986833002754,0.4396617200863923,ICAM1,1
GO:0099638,endosome to plasma membrane protein transport,1/565,11/10364,0.4604087403411523,0.6676986833002754,0.4396617200863923,NSG1,1
GO:0150011,regulation of neuron projection arborization,1/565,11/10364,0.4604087403411523,0.6676986833002754,0.4396617200863923,MFSD2A,1
GO:0150065,regulation of deacetylase activity,1/565,11/10364,0.4604087403411523,0.6676986833002754,0.4396617200863923,VEGFA,1
GO:1900006,positive regulation of dendrite development,1/565,11/10364,0.4604087403411523,0.6676986833002754,0.4396617200863923,PTN,1
GO:1902285,semaphorin-plexin signaling pathway involved in neuron projection guidance,1/565,11/10364,0.4604087403411523,0.6676986833002754,0.4396617200863923,PLXNA4,1
GO:1902932,positive regulation of alcohol biosynthetic process,1/565,11/10364,0.4604087403411523,0.6676986833002754,0.4396617200863923,GPER1,1
GO:1903859,regulation of dendrite extension,1/565,11/10364,0.4604087403411523,0.6676986833002754,0.4396617200863923,CPNE5,1
GO:1903975,regulation of glial cell migration,1/565,11/10364,0.4604087403411523,0.6676986833002754,0.4396617200863923,CX3CL1,1
GO:1905063,regulation of vascular associated smooth muscle cell differentiation,1/565,11/10364,0.4604087403411523,0.6676986833002754,0.4396617200863923,GPER1,1
GO:2000136,regulation of cell proliferation involved in heart morphogenesis,1/565,11/10364,0.4604087403411523,0.6676986833002754,0.4396617200863923,SOX9,1
GO:2000303,regulation of ceramide biosynthetic process,1/565,11/10364,0.4604087403411523,0.6676986833002754,0.4396617200863923,CCN1,1
GO:2000392,regulation of lamellipodium morphogenesis,1/565,11/10364,0.4604087403411523,0.6676986833002754,0.4396617200863923,ENPP2,1
GO:2000786,positive regulation of autophagosome assembly,1/565,11/10364,0.4604087403411523,0.6676986833002754,0.4396617200863923,ELAPOR1,1
GO:2001171,positive regulation of ATP biosynthetic process,1/565,11/10364,0.4604087403411523,0.6676986833002754,0.4396617200863923,MTCO2P12,1
GO:2001212,regulation of vasculogenesis,1/565,11/10364,0.4604087403411523,0.6676986833002754,0.4396617200863923,ADM,1
GO:0043470,regulation of carbohydrate catabolic process,3/565,46/10364,0.46206582426660836,0.6698645483525123,0.44108788428014917,DDIT4/IGF1/MLXIPL,3
GO:0010564,regulation of cell cycle process,25/565,444/10364,0.4633423054999557,0.6714773092802897,0.4421498442050812,MUC1/IGF2/IGF1/CCL2/SOX9/ADAMTS1/SUSD2/LIF/FAM107A/BCL6/PDGFRB/DUSP1/EDN1/HLA-G/HSPA1A/HSPA1B/CDKN1A/CCN2/GPER1/GPNMB/TCIM/SFRP1/KLF4/MKI67/PLPP2,25
GO:1901615,organic hydroxy compound metabolic process,18/565,317/10364,0.4641437945719621,0.6720677644529556,0.4425386431399016,AKR1C2/AKR1C3/DGAT2/IGF1/ALDH1A3/CACNA1H/CES1/LDLR/CYP4F12/APOE/CYP1B1/CYP26B1/NR4A2/ADH1B/GPER1/ABCA1/PLPP2/MOXD1,18
GO:0010717,regulation of epithelial to mesenchymal transition,4/565,64/10364,0.46424221736027316,0.6720677644529556,0.4425386431399016,MDK/COL1A1/SFRP2/SFRP1,4
GO:0048565,digestive tract development,4/565,64/10364,0.46424221736027316,0.6720677644529556,0.4425386431399016,CXCL8/SFRP2/CDKN1A/SFRP1,4
GO:0051493,regulation of cytoskeleton organization,23/565,408/10364,0.4650355420120885,0.6729782640500144,0.4431381827660727,S100A9/S100A8/NES/LMOD1/CXCL12/MDK/CX3CL1/ICAM1/ID1/FAM107A/SLIT2/SYNPO2/MAP1B/CSF1R/PDGFRB/EDN1/HSPA1A/HSPA1B/CCN2/ELN/SFRP1/CCL21/TENM1,23
GO:0030111,regulation of Wnt signaling pathway,13/565,227/10364,0.4684423467869301,0.6776688931963575,0.44622683657107237,MDK/IGFBP6/COL1A1/SOX9/APOE/FRZB/IGFBP2/KLF15/SFRP2/EGR1/SFRP1/SULF1/GPC3,13
GO:0001825,blastocyst formation,2/565,29/10364,0.47443582698416864,0.6848872622260883,0.4509799394649454,JUNB/HOPX,2
GO:0015804,neutral amino acid transport,2/565,29/10364,0.47443582698416864,0.6848872622260883,0.4509799394649454,RGS2/SLC7A5,2
GO:0071320,cellular response to cAMP,2/565,29/10364,0.47443582698416864,0.6848872622260883,0.4509799394649454,IGFBP5/AQP1,2
GO:1902275,regulation of chromatin organization,2/565,29/10364,0.47443582698416864,0.6848872622260883,0.4509799394649454,MKI67/PADI2,2
GO:1902930,regulation of alcohol biosynthetic process,2/565,29/10364,0.47443582698416864,0.6848872622260883,0.4509799394649454,APOE/GPER1,2
GO:2000279,negative regulation of DNA biosynthetic process,2/565,29/10364,0.47443582698416864,0.6848872622260883,0.4509799394649454,DUSP1/CDKN1A,2
GO:0009185,ribonucleoside diphosphate metabolic process,5/565,84/10364,0.4863432437841849,0.6920190095821754,0.45567600430410393,DDIT4/IGF1/HK2/HK3/MLXIPL,5
GO:0032231,regulation of actin filament bundle assembly,5/565,84/10364,0.4863432437841849,0.6920190095821754,0.45567600430410393,CX3CL1/ID1/SYNPO2/CCN2/SFRP1,5
GO:0050905,neuromuscular process,4/565,66/10364,0.48830467246289777,0.6920190095821754,0.45567600430410393,NR4A1/ALDH1A3/UCHL1/SLC1A3,4
GO:1902414,protein localization to cell junction,4/565,66/10364,0.48830467246289777,0.6920190095821754,0.45567600430410393,HSPB1/RELN/NSG1/RAB27B,4
GO:0001946,lymphangiogenesis,1/565,12/10364,0.4898561528503039,0.6920190095821754,0.45567600430410393,SOX18,1
GO:0001956,positive regulation of neurotransmitter secretion,1/565,12/10364,0.4898561528503039,0.6920190095821754,0.45567600430410393,GPER1,1
GO:0002371,dendritic cell cytokine production,1/565,12/10364,0.4898561528503039,0.6920190095821754,0.45567600430410393,CLEC7A,1
GO:0002730,regulation of dendritic cell cytokine production,1/565,12/10364,0.4898561528503039,0.6920190095821754,0.45567600430410393,CLEC7A,1
GO:0003156,regulation of animal organ formation,1/565,12/10364,0.4898561528503039,0.6920190095821754,0.45567600430410393,SULF1,1
GO:0006071,glycerol metabolic process,1/565,12/10364,0.4898561528503039,0.6920190095821754,0.45567600430410393,DGAT2,1
GO:0006213,pyrimidine nucleoside metabolic process,1/565,12/10364,0.4898561528503039,0.6920190095821754,0.45567600430410393,TYMP,1
GO:0006349,regulation of gene expression by genetic imprinting,1/565,12/10364,0.4898561528503039,0.6920190095821754,0.45567600430410393,IGF2,1
GO:0006857,oligopeptide transport,1/565,12/10364,0.4898561528503039,0.6920190095821754,0.45567600430410393,CA2,1
GO:0007143,female meiotic nuclear division,1/565,12/10364,0.4898561528503039,0.6920190095821754,0.45567600430410393,TOP2A,1
GO:0008298,intracellular mRNA localization,1/565,12/10364,0.4898561528503039,0.6920190095821754,0.45567600430410393,ZFP36,1
GO:0008356,asymmetric cell division,1/565,12/10364,0.4898561528503039,0.6920190095821754,0.45567600430410393,ZBTB16,1
GO:0010561,negative regulation of glycoprotein biosynthetic process,1/565,12/10364,0.4898561528503039,0.6920190095821754,0.45567600430410393,HBEGF,1
GO:0015721,bile acid and bile salt transport,1/565,12/10364,0.4898561528503039,0.6920190095821754,0.45567600430410393,ABCC3,1
GO:0019184,nonribosomal peptide biosynthetic process,1/565,12/10364,0.4898561528503039,0.6920190095821754,0.45567600430410393,GGT5,1
GO:0021756,striatum development,1/565,12/10364,0.4898561528503039,0.6920190095821754,0.45567600430410393,ALDH1A3,1
GO:0030810,positive regulation of nucleotide biosynthetic process,1/565,12/10364,0.4898561528503039,0.6920190095821754,0.45567600430410393,MTCO2P12,1
GO:0031268,pseudopodium organization,1/565,12/10364,0.4898561528503039,0.6920190095821754,0.45567600430410393,CCL21,1
GO:0031269,pseudopodium assembly,1/565,12/10364,0.4898561528503039,0.6920190095821754,0.45567600430410393,CCL21,1
GO:0033005,positive regulation of mast cell activation,1/565,12/10364,0.4898561528503039,0.6920190095821754,0.45567600430410393,NR4A3,1
GO:0035590,purinergic nucleotide receptor signaling pathway,1/565,12/10364,0.4898561528503039,0.6920190095821754,0.45567600430410393,P2RX1,1
GO:0036295,cellular response to increased oxygen levels,1/565,12/10364,0.4898561528503039,0.6920190095821754,0.45567600430410393,LCN2,1
GO:0042532,negative regulation of tyrosine phosphorylation of STAT protein,1/565,12/10364,0.4898561528503039,0.6920190095821754,0.45567600430410393,SOCS3,1
GO:0042634,regulation of hair cycle,1/565,12/10364,0.4898561528503039,0.6920190095821754,0.45567600430410393,NGFR,1
GO:0044794,positive regulation by host of viral process,1/565,12/10364,0.4898561528503039,0.6920190095821754,0.45567600430410393,APOE,1
GO:0045623,negative regulation of T-helper cell differentiation,1/565,12/10364,0.4898561528503039,0.6920190095821754,0.45567600430410393,BCL6,1
GO:0045651,positive regulation of macrophage differentiation,1/565,12/10364,0.4898561528503039,0.6920190095821754,0.45567600430410393,LIF,1
GO:0045686,negative regulation of glial cell differentiation,1/565,12/10364,0.4898561528503039,0.6920190095821754,0.45567600430410393,LDLR,1
GO:0045717,negative regulation of fatty acid biosynthetic process,1/565,12/10364,0.4898561528503039,0.6920190095821754,0.45567600430410393,APOC1,1
GO:0048596,embryonic camera-type eye morphogenesis,1/565,12/10364,0.4898561528503039,0.6920190095821754,0.45567600430410393,ALDH1A3,1
GO:0048641,regulation of skeletal muscle tissue development,1/565,12/10364,0.4898561528503039,0.6920190095821754,0.45567600430410393,IGF2,1
GO:0051095,regulation of helicase activity,1/565,12/10364,0.4898561528503039,0.6920190095821754,0.45567600430410393,IFIT1,1
GO:0051307,meiotic chromosome separation,1/565,12/10364,0.4898561528503039,0.6920190095821754,0.45567600430410393,TOP2A,1
GO:0060546,negative regulation of necroptotic process,1/565,12/10364,0.4898561528503039,0.6920190095821754,0.45567600430410393,BIRC3,1
GO:0060575,intestinal epithelial cell differentiation,1/565,12/10364,0.4898561528503039,0.6920190095821754,0.45567600430410393,CDKN1A,1
GO:0070831,basement membrane assembly,1/565,12/10364,0.4898561528503039,0.6920190095821754,0.45567600430410393,LAMB3,1
GO:0071071,regulation of phospholipid biosynthetic process,1/565,12/10364,0.4898561528503039,0.6920190095821754,0.45567600430410393,FABP3,1
GO:0071236,cellular response to antibiotic,1/565,12/10364,0.4898561528503039,0.6920190095821754,0.45567600430410393,CRIP1,1
GO:0071318,cellular response to ATP,1/565,12/10364,0.4898561528503039,0.6920190095821754,0.45567600430410393,PTGS2,1
GO:0071380,cellular response to prostaglandin E stimulus,1/565,12/10364,0.4898561528503039,0.6920190095821754,0.45567600430410393,SFRP1,1
GO:0071732,cellular response to nitric oxide,1/565,12/10364,0.4898561528503039,0.6920190095821754,0.45567600430410393,AQP1,1
GO:0090153,regulation of sphingolipid biosynthetic process,1/565,12/10364,0.4898561528503039,0.6920190095821754,0.45567600430410393,CCN1,1
GO:0090343,positive regulation of cell aging,1/565,12/10364,0.4898561528503039,0.6920190095821754,0.45567600430410393,HLA-G,1
GO:0098969,neurotransmitter receptor transport to postsynaptic membrane,1/565,12/10364,0.4898561528503039,0.6920190095821754,0.45567600430410393,NSG1,1
GO:1900153,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay",1/565,12/10364,0.4898561528503039,0.6920190095821754,0.45567600430410393,ZFP36,1
GO:1900373,positive regulation of purine nucleotide biosynthetic process,1/565,12/10364,0.4898561528503039,0.6920190095821754,0.45567600430410393,MTCO2P12,1
GO:1901503,ether biosynthetic process,1/565,12/10364,0.4898561528503039,0.6920190095821754,0.45567600430410393,ALOX5,1
GO:1901739,regulation of myoblast fusion,1/565,12/10364,0.4898561528503039,0.6920190095821754,0.45567600430410393,GDF15,1
GO:1901863,positive regulation of muscle tissue development,1/565,12/10364,0.4898561528503039,0.6920190095821754,0.45567600430410393,IGF2,1
GO:1903025,regulation of RNA polymerase II regulatory region sequence-specific DNA binding,1/565,12/10364,0.4898561528503039,0.6920190095821754,0.45567600430410393,LIF,1
GO:1903206,negative regulation of hydrogen peroxide-induced cell death,1/565,12/10364,0.4898561528503039,0.6920190095821754,0.45567600430410393,NR4A3,1
GO:1903540,establishment of protein localization to postsynaptic membrane,1/565,12/10364,0.4898561528503039,0.6920190095821754,0.45567600430410393,NSG1,1
GO:1903779,regulation of cardiac conduction,1/565,12/10364,0.4898561528503039,0.6920190095821754,0.45567600430410393,AGT,1
GO:1903792,negative regulation of anion transport,1/565,12/10364,0.4898561528503039,0.6920190095821754,0.45567600430410393,RGS2,1
GO:1904152,"regulation of retrograde protein transport, ER to cytosol",1/565,12/10364,0.4898561528503039,0.6920190095821754,0.45567600430410393,DERL3,1
GO:1904925,positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization,1/565,12/10364,0.4898561528503039,0.6920190095821754,0.45567600430410393,HK2,1
GO:1905038,regulation of membrane lipid metabolic process,1/565,12/10364,0.4898561528503039,0.6920190095821754,0.45567600430410393,CCN1,1
GO:2000463,positive regulation of excitatory postsynaptic potential,1/565,12/10364,0.4898561528503039,0.6920190095821754,0.45567600430410393,RELN,1
GO:0007338,single fertilization,3/565,48/10364,0.49042416670717925,0.6923261715740641,0.4558782622582928,FOLR2/CACNA1H/PLAT,3
GO:0043489,RNA stabilization,3/565,48/10364,0.49042416670717925,0.6923261715740641,0.4558782622582928,TENT5C/ZFP36/SLC11A1,3
GO:0043087,regulation of GTPase activity,15/565,267/10364,0.4905809046742452,0.6923261715740641,0.4558782622582928,RGS16/RGS1/THY1/CX3CL1/CCL2/CCL5/CCL14/ICAM1/TGM2/BCL6/PLXNA4/SFRP1/CCL21/NTRK2/RAP1GAP,15
GO:1901991,negative regulation of mitotic cell cycle phase transition,7/565,121/10364,0.4917165593336381,0.6936897291219554,0.4567761284244794,MUC1/CCL2/FAM107A/DUSP1/CDKN1A/GPNMB/KLF4,7
GO:0032885,regulation of polysaccharide biosynthetic process,2/565,30/10364,0.4924025756412105,0.6941791131801363,0.45709837473435555,IGF2/IGF1,2
GO:0039528,cytoplasmic pattern recognition receptor signaling pathway in response to virus,2/565,30/10364,0.4924025756412105,0.6941791131801363,0.45709837473435555,BIRC3/OAS3,2
GO:0001837,epithelial to mesenchymal transition,6/565,103/10364,0.49410840447567783,0.696104545052796,0.45836622011164235,S100A4/MDK/COL1A1/SOX9/SFRP2/SFRP1,6
GO:0006694,steroid biosynthetic process,6/565,103/10364,0.49410840447567783,0.696104545052796,0.45836622011164235,AKR1C3/ADM/CACNA1H/CES1/APOE/EGR1,6
GO:0031056,regulation of histone modification,7/565,122/10364,0.5004916827475452,0.7048548156754214,0.4641280392216477,MUC1/IGF2/APLNR/NNMT/LIF/BCL6/VEGFA,7
GO:0010332,response to gamma radiation,3/565,49/10364,0.5043261494096496,0.709035458682385,0.4668808807974669,CRYAB/EGR1/CDKN1A,3
GO:0036465,synaptic vesicle recycling,3/565,49/10364,0.5043261494096496,0.709035458682385,0.4668808807974669,SNCG/SYT7/RAB27B,3
GO:0046626,regulation of insulin receptor signaling pathway,3/565,49/10364,0.5043261494096496,0.709035458682385,0.4668808807974669,AGT/IGF2/SOCS3,3
GO:0097194,execution phase of apoptosis,3/565,49/10364,0.5043261494096496,0.709035458682385,0.4668808807974669,PTGIS/GPER1/TOP2A,3
GO:0098930,axonal transport,3/565,49/10364,0.5043261494096496,0.709035458682385,0.4668808807974669,UCHL1/HSPB1/RAB27B,3
GO:0002224,toll-like receptor signaling pathway,5/565,86/10364,0.5073133490132054,0.7116828837149487,0.4686241393551497,BIRC3/OAS1/LTF/CD14/CD36,5
GO:0009880,embryonic pattern specification,2/565,31/10364,0.509976279564112,0.7116828837149487,0.4686241393551497,ZBTB16/BASP1,2
GO:0010677,negative regulation of cellular carbohydrate metabolic process,2/565,31/10364,0.509976279564112,0.7116828837149487,0.4686241393551497,DDIT4/SIK1,2
GO:0010799,regulation of peptidyl-threonine phosphorylation,2/565,31/10364,0.509976279564112,0.7116828837149487,0.4686241393551497,CHI3L1/DDIT4,2
GO:0021695,cerebellar cortex development,2/565,31/10364,0.509976279564112,0.7116828837149487,0.4686241393551497,MDK/SERPINE2,2
GO:0032768,regulation of monooxygenase activity,2/565,31/10364,0.509976279564112,0.7116828837149487,0.4686241393551497,APOE/NPR3,2
GO:0045454,cell redox homeostasis,2/565,31/10364,0.509976279564112,0.7116828837149487,0.4686241393551497,NQO1/SLC11A1,2
GO:0045665,negative regulation of neuron differentiation,2/565,31/10364,0.509976279564112,0.7116828837149487,0.4686241393551497,SOX9/RAP1GAP,2
GO:0090224,regulation of spindle organization,2/565,31/10364,0.509976279564112,0.7116828837149487,0.4686241393551497,HSPA1A/HSPA1B,2
GO:1901570,fatty acid derivative biosynthetic process,2/565,31/10364,0.509976279564112,0.7116828837149487,0.4686241393551497,ALOX5/GGT5,2
GO:1903307,positive regulation of regulated secretory pathway,2/565,31/10364,0.509976279564112,0.7116828837149487,0.4686241393551497,SYT7/CACNA1H,2
GO:0006672,ceramide metabolic process,4/565,68/10364,0.5119147619579675,0.7116828837149487,0.4686241393551497,CCN1/P2RX1/ITGB8/PLPP2,4
GO:0030148,sphingolipid biosynthetic process,4/565,68/10364,0.5119147619579675,0.7116828837149487,0.4686241393551497,CCN1/P2RX1/ABCA8/PLPP2,4
GO:0046785,microtubule polymerization,4/565,68/10364,0.5119147619579675,0.7116828837149487,0.4686241393551497,TPPP3/MAP1B/HSPA1A/HSPA1B,4
GO:0099504,synaptic vesicle cycle,6/565,105/10364,0.5130447920493746,0.7116828837149487,0.4686241393551497,SNCG/ADRA2A/SYT7/P2RX1/ADCY1/RAB27B,6
GO:0001832,blastocyst growth,1/565,13/10364,0.5176992047861214,0.7116828837149487,0.4686241393551497,IGF1,1
GO:0001845,phagolysosome assembly,1/565,13/10364,0.5176992047861214,0.7116828837149487,0.4686241393551497,SYT7,1
GO:0002716,negative regulation of natural killer cell mediated immunity,1/565,13/10364,0.5176992047861214,0.7116828837149487,0.4686241393551497,HLA-G,1
GO:0002825,regulation of T-helper 1 type immune response,1/565,13/10364,0.5176992047861214,0.7116828837149487,0.4686241393551497,SLC11A1,1
GO:0003283,atrial septum development,1/565,13/10364,0.5176992047861214,0.7116828837149487,0.4686241393551497,CCN1,1
GO:0003299,muscle hypertrophy in response to stress,1/565,13/10364,0.5176992047861214,0.7116828837149487,0.4686241393551497,KLF15,1
GO:0006123,"mitochondrial electron transport, cytochrome c to oxygen",1/565,13/10364,0.5176992047861214,0.7116828837149487,0.4686241393551497,MTCO2P12,1
GO:0006206,pyrimidine nucleobase metabolic process,1/565,13/10364,0.5176992047861214,0.7116828837149487,0.4686241393551497,TYMP,1
GO:0006266,DNA ligation,1/565,13/10364,0.5176992047861214,0.7116828837149487,0.4686241393551497,TOP2A,1
GO:0006595,polyamine metabolic process,1/565,13/10364,0.5176992047861214,0.7116828837149487,0.4686241393551497,NNMT,1
GO:0006684,sphingomyelin metabolic process,1/565,13/10364,0.5176992047861214,0.7116828837149487,0.4686241393551497,ABCA8,1
GO:0007175,negative regulation of epidermal growth factor-activated receptor activity,1/565,13/10364,0.5176992047861214,0.7116828837149487,0.4686241393551497,GPRC5A,1
GO:0007250,activation of NF-kappaB-inducing kinase activity,1/565,13/10364,0.5176992047861214,0.7116828837149487,0.4686241393551497,CHI3L1,1
GO:0009650,UV protection,1/565,13/10364,0.5176992047861214,0.7116828837149487,0.4686241393551497,MFAP4,1
GO:0010225,response to UV-C,1/565,13/10364,0.5176992047861214,0.7116828837149487,0.4686241393551497,BCL3,1
GO:0010804,negative regulation of tumor necrosis factor-mediated signaling pathway,1/565,13/10364,0.5176992047861214,0.7116828837149487,0.4686241393551497,CCDC3,1
GO:0010894,negative regulation of steroid biosynthetic process,1/565,13/10364,0.5176992047861214,0.7116828837149487,0.4686241393551497,APOE,1
GO:0014887,cardiac muscle adaptation,1/565,13/10364,0.5176992047861214,0.7116828837149487,0.4686241393551497,KLF15,1
GO:0014898,cardiac muscle hypertrophy in response to stress,1/565,13/10364,0.5176992047861214,0.7116828837149487,0.4686241393551497,KLF15,1
GO:0019896,axonal transport of mitochondrion,1/565,13/10364,0.5176992047861214,0.7116828837149487,0.4686241393551497,UCHL1,1
GO:0021544,subpallium development,1/565,13/10364,0.5176992047861214,0.7116828837149487,0.4686241393551497,ALDH1A3,1
GO:0030325,adrenal gland development,1/565,13/10364,0.5176992047861214,0.7116828837149487,0.4686241393551497,MDK,1
GO:0030852,regulation of granulocyte differentiation,1/565,13/10364,0.5176992047861214,0.7116828837149487,0.4686241393551497,C1QC,1
GO:0034138,toll-like receptor 3 signaling pathway,1/565,13/10364,0.5176992047861214,0.7116828837149487,0.4686241393551497,OAS1,1
GO:0034698,response to gonadotropin,1/565,13/10364,0.5176992047861214,0.7116828837149487,0.4686241393551497,ICAM1,1
GO:0035791,platelet-derived growth factor receptor-beta signaling pathway,1/565,13/10364,0.5176992047861214,0.7116828837149487,0.4686241393551497,PDGFRB,1
GO:0042133,neurotransmitter metabolic process,1/565,13/10364,0.5176992047861214,0.7116828837149487,0.4686241393551497,MOXD1,1
GO:0043649,dicarboxylic acid catabolic process,1/565,13/10364,0.5176992047861214,0.7116828837149487,0.4686241393551497,ALDH1L1,1
GO:0044090,positive regulation of vacuole organization,1/565,13/10364,0.5176992047861214,0.7116828837149487,0.4686241393551497,ELAPOR1,1
GO:0045663,positive regulation of myoblast differentiation,1/565,13/10364,0.5176992047861214,0.7116828837149487,0.4686241393551497,IGFBP3,1
GO:0045953,negative regulation of natural killer cell mediated cytotoxicity,1/565,13/10364,0.5176992047861214,0.7116828837149487,0.4686241393551497,HLA-G,1
GO:0046641,positive regulation of alpha-beta T cell proliferation,1/565,13/10364,0.5176992047861214,0.7116828837149487,0.4686241393551497,CD3E,1
GO:0050996,positive regulation of lipid catabolic process,1/565,13/10364,0.5176992047861214,0.7116828837149487,0.4686241393551497,PLIN5,1
GO:0051590,positive regulation of neurotransmitter transport,1/565,13/10364,0.5176992047861214,0.7116828837149487,0.4686241393551497,GPER1,1
GO:0060213,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening,1/565,13/10364,0.5176992047861214,0.7116828837149487,0.4686241393551497,ZFP36,1
GO:0060766,negative regulation of androgen receptor signaling pathway,1/565,13/10364,0.5176992047861214,0.7116828837149487,0.4686241393551497,SFRP1,1
GO:0061158,3'-UTR-mediated mRNA destabilization,1/565,13/10364,0.5176992047861214,0.7116828837149487,0.4686241393551497,ZFP36,1
GO:0062099,negative regulation of programmed necrotic cell death,1/565,13/10364,0.5176992047861214,0.7116828837149487,0.4686241393551497,BIRC3,1
GO:0062149,detection of stimulus involved in sensory perception of pain,1/565,13/10364,0.5176992047861214,0.7116828837149487,0.4686241393551497,CXCL12,1
GO:0071391,cellular response to estrogen stimulus,1/565,13/10364,0.5176992047861214,0.7116828837149487,0.4686241393551497,SFRP1,1
GO:0097186,amelogenesis,1/565,13/10364,0.5176992047861214,0.7116828837149487,0.4686241393551497,CSF3R,1
GO:0110156,methylguanosine-cap decapping,1/565,13/10364,0.5176992047861214,0.7116828837149487,0.4686241393551497,ZFP36,1
GO:1900117,regulation of execution phase of apoptosis,1/565,13/10364,0.5176992047861214,0.7116828837149487,0.4686241393551497,PTGIS,1
GO:1901881,positive regulation of protein depolymerization,1/565,13/10364,0.5176992047861214,0.7116828837149487,0.4686241393551497,NES,1
GO:1902166,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,1/565,13/10364,0.5176992047861214,0.7116828837149487,0.4686241393551497,MUC1,1
GO:1903019,negative regulation of glycoprotein metabolic process,1/565,13/10364,0.5176992047861214,0.7116828837149487,0.4686241393551497,HBEGF,1
GO:1904923,regulation of autophagy of mitochondrion in response to mitochondrial depolarization,1/565,13/10364,0.5176992047861214,0.7116828837149487,0.4686241393551497,HK2,1
GO:2000010,positive regulation of protein localization to cell surface,1/565,13/10364,0.5176992047861214,0.7116828837149487,0.4686241393551497,TYROBP,1
GO:0007254,JNK cascade,7/565,124/10364,0.5178917310016848,0.7116828837149487,0.4686241393551497,FCGR2B/GADD45B/SFRP2/CCN2/SFRP1/CCL21/GADD45G,7
GO:0001736,establishment of planar polarity,3/565,50/10364,0.5180300423718972,0.7116828837149487,0.4686241393551497,SFRP2/SFRP1/GPC3,3
GO:0007164,establishment of tissue polarity,3/565,50/10364,0.5180300423718972,0.7116828837149487,0.4686241393551497,SFRP2/SFRP1/GPC3,3
GO:0034121,regulation of toll-like receptor signaling pathway,3/565,50/10364,0.5180300423718972,0.7116828837149487,0.4686241393551497,BIRC3/LTF/CD36,3
GO:0034394,protein localization to cell surface,3/565,50/10364,0.5180300423718972,0.7116828837149487,0.4686241393551497,FGF7/TYROBP/ANGPT1,3
GO:0006665,sphingolipid metabolic process,6/565,106/10364,0.5224129522842305,0.7174634775751894,0.47243050576454887,CCN1/P2RX1/ABCA8/ITGB8/ENPP2/PLPP2,6
GO:0090398,cellular senescence,4/565,69/10364,0.523532117856518,0.7187593864871176,0.47328382711375006,BCL6/HLA-G/CDKN1A/NAMPT,4
GO:0045216,cell-cell junction organization,7/565,125/10364,0.5265099335886063,0.7226053195145002,0.47581627112247327,AGT/APLNR/ACE/CLDN5/CSF1R/VEGFA/SVEP1,7
GO:0010762,regulation of fibroblast migration,2/565,32/10364,0.5271463421697744,0.722751883738465,0.47591277974293805,THBS1/AKAP12,2
GO:0051452,intracellular pH reduction,2/565,32/10364,0.5271463421697744,0.722751883738465,0.47591277974293805,SLC11A1/CA2,2
GO:0060999,positive regulation of dendritic spine development,2/565,32/10364,0.5271463421697744,0.722751883738465,0.47591277974293805,APOE/RELN,2
GO:0006476,protein deacetylation,5/565,88/10364,0.527934378752027,0.7233478402311909,0.4763052011498419,APLNR/NNMT/BCL6/HOPX/VEGFA,5
GO:2000278,regulation of DNA biosynthetic process,5/565,88/10364,0.527934378752027,0.7233478402311909,0.4763052011498419,PDGFRB/DUSP1/CDKN1A/SMOC2/KLF4,5
GO:0110053,regulation of actin filament organization,12/565,218/10364,0.5290395396751271,0.724619563542981,0.47714259692838673,LMOD1/CXCL12/CX3CL1/ICAM1/ID1/SLIT2/SYNPO2/CCN2/ELN/SFRP1/CCL21/TENM1,12
GO:0000041,transition metal ion transport,4/565,70/10364,0.535015701561226,0.7307214566435759,0.4811605302918773,SLC11A1/LTF/STEAP4/LCN2,4
GO:0034976,response to endoplasmic reticulum stress,12/565,219/10364,0.5355536382728445,0.7307214566435759,0.4811605302918773,JUN/FCGR2B/NIBAN1/ATF3/ALOX5/CREB3L1/THBS1/CXCL8/THBS4/HSPA1A/CLU/DERL3,12
GO:0032271,regulation of protein polymerization,10/565,182/10364,0.5365201251782985,0.7307214566435759,0.4811605302918773,LMOD1/TPPP3/ICAM1/SLIT2/MAP1B/HSPA1A/HSPA1B/ELN/CCL21/TENM1,10
GO:0031032,actomyosin structure organization,8/565,145/10364,0.5381305631095974,0.7307214566435759,0.4811605302918773,LMOD1/KRT19/CNN1/PDGFRB/EDN1/CCN2/ELN/SFRP1,8
GO:0071322,cellular response to carbohydrate stimulus,6/565,108/10364,0.5409294742141524,0.7307214566435759,0.4811605302918773,ADRA2A/CLEC7A/ICAM1/HLA-DRB1/GPER1/MLXIPL,6
GO:0006040,amino sugar metabolic process,2/565,33/10364,0.5439044845243468,0.7307214566435759,0.4811605302918773,CHI3L2/CHI3L1,2
GO:0033173,calcineurin-NFAT signaling cascade,2/565,33/10364,0.5439044845243468,0.7307214566435759,0.4811605302918773,CLEC7A/IGF1,2
GO:0045047,protein targeting to ER,2/565,33/10364,0.5439044845243468,0.7307214566435759,0.4811605302918773,RN7SL1/RN7SL2,2
GO:0045851,pH reduction,2/565,33/10364,0.5439044845243468,0.7307214566435759,0.4811605302918773,SLC11A1/CA2,2
GO:0048644,muscle organ morphogenesis,2/565,33/10364,0.5439044845243468,0.7307214566435759,0.4811605302918773,LIF/MYLK,2
GO:0051784,negative regulation of nuclear division,2/565,33/10364,0.5439044845243468,0.7307214566435759,0.4811605302918773,LIF/DUSP1,2
GO:0120009,intermembrane lipid transfer,2/565,33/10364,0.5439044845243468,0.7307214566435759,0.4811605302918773,APOE/ABCA1,2
GO:2000249,regulation of actin cytoskeleton reorganization,2/565,33/10364,0.5439044845243468,0.7307214566435759,0.4811605302918773,MDK/CSF1R,2
GO:0002902,regulation of B cell apoptotic process,1/565,14/10364,0.5440251587321983,0.7307214566435759,0.4811605302918773,BCL6,1
GO:0003148,outflow tract septum morphogenesis,1/565,14/10364,0.5440251587321983,0.7307214566435759,0.4811605302918773,SEMA3C,1
GO:0003161,cardiac conduction system development,1/565,14/10364,0.5440251587321983,0.7307214566435759,0.4811605302918773,HOPX,1
GO:0003177,pulmonary valve development,1/565,14/10364,0.5440251587321983,0.7307214566435759,0.4811605302918773,SLIT2,1
GO:0006670,sphingosine metabolic process,1/565,14/10364,0.5440251587321983,0.7307214566435759,0.4811605302918773,PLPP2,1
GO:0006825,copper ion transport,1/565,14/10364,0.5440251587321983,0.7307214566435759,0.4811605302918773,STEAP4,1
GO:0006878,cellular copper ion homeostasis,1/565,14/10364,0.5440251587321983,0.7307214566435759,0.4811605302918773,MT2A,1
GO:0007628,adult walking behavior,1/565,14/10364,0.5440251587321983,0.7307214566435759,0.4811605302918773,UCHL1,1
GO:0009162,deoxyribonucleoside monophosphate metabolic process,1/565,14/10364,0.5440251587321983,0.7307214566435759,0.4811605302918773,TYMP,1
GO:0009223,pyrimidine deoxyribonucleotide catabolic process,1/565,14/10364,0.5440251587321983,0.7307214566435759,0.4811605302918773,TYMP,1
GO:0009299,mRNA transcription,1/565,14/10364,0.5440251587321983,0.7307214566435759,0.4811605302918773,C5AR1,1
GO:0010954,positive regulation of protein processing,1/565,14/10364,0.5440251587321983,0.7307214566435759,0.4811605302918773,CLEC3B,1
GO:0021772,olfactory bulb development,1/565,14/10364,0.5440251587321983,0.7307214566435759,0.4811605302918773,SLIT2,1
GO:0035036,sperm-egg recognition,1/565,14/10364,0.5440251587321983,0.7307214566435759,0.4811605302918773,FOLR2,1
GO:0035136,forelimb morphogenesis,1/565,14/10364,0.5440251587321983,0.7307214566435759,0.4811605302918773,ZBTB16,1
GO:0035902,response to immobilization stress,1/565,14/10364,0.5440251587321983,0.7307214566435759,0.4811605302918773,FOS,1
GO:0042921,glucocorticoid receptor signaling pathway,1/565,14/10364,0.5440251587321983,0.7307214566435759,0.4811605302918773,LMO3,1
GO:0043217,myelin maintenance,1/565,14/10364,0.5440251587321983,0.7307214566435759,0.4811605302918773,CLU,1
GO:0044764,multi-organism cellular process,1/565,14/10364,0.5440251587321983,0.7307214566435759,0.4811605302918773,SIGLEC1,1
GO:0045061,thymic T cell selection,1/565,14/10364,0.5440251587321983,0.7307214566435759,0.4811605302918773,CD3E,1
GO:0045540,regulation of cholesterol biosynthetic process,1/565,14/10364,0.5440251587321983,0.7307214566435759,0.4811605302918773,APOE,1
GO:0045939,negative regulation of steroid metabolic process,1/565,14/10364,0.5440251587321983,0.7307214566435759,0.4811605302918773,APOE,1
GO:0046058,cAMP metabolic process,1/565,14/10364,0.5440251587321983,0.7307214566435759,0.4811605302918773,ADCY1,1
GO:0046629,gamma-delta T cell activation,1/565,14/10364,0.5440251587321983,0.7307214566435759,0.4811605302918773,EGR3,1
GO:0048268,clathrin coat assembly,1/565,14/10364,0.5440251587321983,0.7307214566435759,0.4811605302918773,NSG1,1
GO:0048566,embryonic digestive tract development,1/565,14/10364,0.5440251587321983,0.7307214566435759,0.4811605302918773,CXCL8,1
GO:0060074,synapse maturation,1/565,14/10364,0.5440251587321983,0.7307214566435759,0.4811605302918773,RELN,1
GO:0060547,negative regulation of necrotic cell death,1/565,14/10364,0.5440251587321983,0.7307214566435759,0.4811605302918773,BIRC3,1
GO:0060628,regulation of ER to Golgi vesicle-mediated transport,1/565,14/10364,0.5440251587321983,0.7307214566435759,0.4811605302918773,GAS1,1
GO:0071360,cellular response to exogenous dsRNA,1/565,14/10364,0.5440251587321983,0.7307214566435759,0.4811605302918773,IFIT1,1
GO:0071474,cellular hyperosmotic response,1/565,14/10364,0.5440251587321983,0.7307214566435759,0.4811605302918773,AQP1,1
GO:0071731,response to nitric oxide,1/565,14/10364,0.5440251587321983,0.7307214566435759,0.4811605302918773,AQP1,1
GO:0086012,membrane depolarization during cardiac muscle cell action potential,1/565,14/10364,0.5440251587321983,0.7307214566435759,0.4811605302918773,ATP1A2,1
GO:0090239,regulation of histone H4 acetylation,1/565,14/10364,0.5440251587321983,0.7307214566435759,0.4811605302918773,MUC1,1
GO:0097150,neuronal stem cell population maintenance,1/565,14/10364,0.5440251587321983,0.7307214566435759,0.4811605302918773,PRRX1,1
GO:0097284,hepatocyte apoptotic process,1/565,14/10364,0.5440251587321983,0.7307214566435759,0.4811605302918773,H19,1
GO:0098877,neurotransmitter receptor transport to plasma membrane,1/565,14/10364,0.5440251587321983,0.7307214566435759,0.4811605302918773,NSG1,1
GO:0106118,regulation of sterol biosynthetic process,1/565,14/10364,0.5440251587321983,0.7307214566435759,0.4811605302918773,APOE,1
GO:1900016,negative regulation of cytokine production involved in inflammatory response,1/565,14/10364,0.5440251587321983,0.7307214566435759,0.4811605302918773,APOD,1
GO:1902004,positive regulation of amyloid-beta formation,1/565,14/10364,0.5440251587321983,0.7307214566435759,0.4811605302918773,CLU,1
GO:1902170,cellular response to reactive nitrogen species,1/565,14/10364,0.5440251587321983,0.7307214566435759,0.4811605302918773,AQP1,1
GO:1904424,regulation of GTP binding,1/565,14/10364,0.5440251587321983,0.7307214566435759,0.4811605302918773,RAP1GAP,1
GO:1905146,lysosomal protein catabolic process,1/565,14/10364,0.5440251587321983,0.7307214566435759,0.4811605302918773,LDLR,1
GO:2000269,regulation of fibroblast apoptotic process,1/565,14/10364,0.5440251587321983,0.7307214566435759,0.4811605302918773,SFRP1,1
GO:2000810,regulation of bicellular tight junction assembly,1/565,14/10364,0.5440251587321983,0.7307214566435759,0.4811605302918773,CLDN5,1
GO:2001044,regulation of integrin-mediated signaling pathway,1/565,14/10364,0.5440251587321983,0.7307214566435759,0.4811605302918773,TIMP1,1
GO:0032024,positive regulation of insulin secretion,3/565,52/10364,0.5448095355177247,0.7310554698163111,0.48138046903030685,CD38/HLA-DRB1/GPER1,3
GO:0033077,T cell differentiation in thymus,3/565,52/10364,0.5448095355177247,0.7310554698163111,0.48138046903030685,IL7R/EGR3/CD3E,3
GO:0046847,filopodium assembly,3/565,52/10364,0.5448095355177247,0.7310554698163111,0.48138046903030685,ITGB4/CCL21/TENM1,3
GO:0050773,regulation of dendrite development,4/565,71/10364,0.5463596237037504,0.7328952488345851,0.48259191429444187,MFSD2A/ID1/RELN/PTN,4
GO:1905114,cell surface receptor signaling pathway involved in cell-cell signaling,19/565,351/10364,0.5473993071237486,0.7340493820388558,0.4833518801330599,MDK/IGFBP6/P2RX1/COL1A1/SOX9/C3/APOE/NR4A2/FRZB/IGFBP2/KLF15/SFRP2/EGR1/RELN/SFRP1/SULF1/KLF4/GPC3/CD24,19
GO:0006941,striated muscle contraction,5/565,90/10364,0.5481667975178312,0.7345973384739773,0.4837126947861713,ATP1A2/RGS2/NR4A1/PLN/CCN2,5
GO:0008203,cholesterol metabolic process,5/565,90/10364,0.5481667975178312,0.7345973384739773,0.4837126947861713,DGAT2/CES1/LDLR/APOE/ABCA1,5
GO:0098662,inorganic cation transmembrane transport,21/565,389/10364,0.5517136753482961,0.7391085690039019,0.48668321940168996,MTCO2P12/ATP1A2/KCNMA1/ADRA2A/APLNR/THY1/CACNA1H/CX3CL1/RRAD/P2RX1/SCN7A/SLC11A1/SLC1A3/PLN/GPER1/AQP1/RAMP3/GEM/CCL21/KCNN4/LCN2,21
GO:0009895,negative regulation of catabolic process,13/565,241/10364,0.5569251561968735,0.7458461202060845,0.49111971661938714,MFSD2A/TENT5C/DDIT4/ADRA2A/PLIN5/ZFP36/APOC1/SLC11A1/SERPINE2/TIMP3/HMOX1/NAMPT/TIMP1,13
GO:0016575,histone deacetylation,4/565,72/10364,0.5575584575352295,0.7459903502968126,0.4912146882755604,APLNR/BCL6/HOPX/VEGFA,4
GO:0032092,positive regulation of protein binding,4/565,72/10364,0.5575584575352295,0.7459903502968126,0.4912146882755604,ACE/APOE/RAMP1/CLDN5,4
GO:0061337,cardiac conduction,3/565,53/10364,0.5578704196205562,0.7459903502968126,0.4912146882755604,ATP1A2/AGT/PLN,3
GO:2000756,regulation of peptidyl-lysine acetylation,3/565,53/10364,0.5578704196205562,0.7459903502968126,0.4912146882755604,MUC1/LIF/KLF15,3
GO:0030183,B cell differentiation,5/565,91/10364,0.5581261463016944,0.7459903502968126,0.4912146882755604,VCAM1/FCGR2B/BCL3/BCL6/SFRP1,5
GO:0031109,microtubule polymerization or depolymerization,5/565,91/10364,0.5581261463016944,0.7459903502968126,0.4912146882755604,CRYAB/TPPP3/MAP1B/HSPA1A/HSPA1B,5
GO:0003208,cardiac ventricle morphogenesis,2/565,34/10364,0.5602445249341039,0.7475181191984116,0.4922206832250359,SFRP2/SEMA3C,2
GO:0007020,microtubule nucleation,2/565,34/10364,0.5602445249341039,0.7475181191984116,0.4922206832250359,HSPA1A/HSPA1B,2
GO:0032881,regulation of polysaccharide metabolic process,2/565,34/10364,0.5602445249341039,0.7475181191984116,0.4922206832250359,IGF2/IGF1,2
GO:0042398,cellular modified amino acid biosynthetic process,2/565,34/10364,0.5602445249341039,0.7475181191984116,0.4922206832250359,CKB/GGT5,2
GO:1903202,negative regulation of oxidative stress-induced cell death,2/565,34/10364,0.5602445249341039,0.7475181191984116,0.4922206832250359,HSPB1/NR4A3,2
GO:0006606,protein import into nucleus,7/565,129/10364,0.5603647063556241,0.7475181191984116,0.4922206832250359,PTGS2/AGT/BCL3/APOD/CDKN1A/CD36/ANGPT1,7
GO:0051259,protein complex oligomerization,8/565,148/10364,0.5617311000639023,0.7481992645312717,0.4926691992041207,ISG15/GBP5/PRF1/ALDH1A3/HLA-G/HLA-DRB1/STEAP4/COL1A2,8
GO:0001773,myeloid dendritic cell activation,1/565,15/10364,0.5689165389559963,0.7481992645312717,0.4926691992041207,ITGB8,1
GO:0003209,cardiac atrium morphogenesis,1/565,15/10364,0.5689165389559963,0.7481992645312717,0.4926691992041207,CCN1,1
GO:0006027,glycosaminoglycan catabolic process,1/565,15/10364,0.5689165389559963,0.7481992645312717,0.4926691992041207,LYVE1,1
GO:0007252,I-kappaB phosphorylation,1/565,15/10364,0.5689165389559963,0.7481992645312717,0.4926691992041207,CX3CL1,1
GO:0008210,estrogen metabolic process,1/565,15/10364,0.5689165389559963,0.7481992645312717,0.4926691992041207,CYP1B1,1
GO:0009048,dosage compensation by inactivation of X chromosome,1/565,15/10364,0.5689165389559963,0.7481992645312717,0.4926691992041207,XIST,1
GO:0009070,serine family amino acid biosynthetic process,1/565,15/10364,0.5689165389559963,0.7481992645312717,0.4926691992041207,PHGDH,1
GO:0009129,pyrimidine nucleoside monophosphate metabolic process,1/565,15/10364,0.5689165389559963,0.7481992645312717,0.4926691992041207,TYMP,1
GO:0009651,response to salt stress,1/565,15/10364,0.5689165389559963,0.7481992645312717,0.4926691992041207,AQP1,1
GO:0010310,regulation of hydrogen peroxide metabolic process,1/565,15/10364,0.5689165389559963,0.7481992645312717,0.4926691992041207,MTCO2P12,1
GO:0019400,alditol metabolic process,1/565,15/10364,0.5689165389559963,0.7481992645312717,0.4926691992041207,DGAT2,1
GO:0031128,developmental induction,1/565,15/10364,0.5689165389559963,0.7481992645312717,0.4926691992041207,SOX9,1
GO:0031958,corticosteroid receptor signaling pathway,1/565,15/10364,0.5689165389559963,0.7481992645312717,0.4926691992041207,LMO3,1
GO:0034244,negative regulation of transcription elongation from RNA polymerase II promoter,1/565,15/10364,0.5689165389559963,0.7481992645312717,0.4926691992041207,RN7SK,1
GO:0035278,miRNA mediated inhibition of translation,1/565,15/10364,0.5689165389559963,0.7481992645312717,0.4926691992041207,ZFP36,1
GO:0040018,positive regulation of multicellular organism growth,1/565,15/10364,0.5689165389559963,0.7481992645312717,0.4926691992041207,IGF2,1
GO:0040033,"negative regulation of translation, ncRNA-mediated",1/565,15/10364,0.5689165389559963,0.7481992645312717,0.4926691992041207,ZFP36,1
GO:0043923,positive regulation by host of viral transcription,1/565,15/10364,0.5689165389559963,0.7481992645312717,0.4926691992041207,JUN,1
GO:0044827,modulation by host of viral genome replication,1/565,15/10364,0.5689165389559963,0.7481992645312717,0.4926691992041207,IFI27,1
GO:0045761,regulation of adenylate cyclase activity,1/565,15/10364,0.5689165389559963,0.7481992645312717,0.4926691992041207,NPR3,1
GO:0045974,"regulation of translation, ncRNA-mediated",1/565,15/10364,0.5689165389559963,0.7481992645312717,0.4926691992041207,ZFP36,1
GO:0048169,regulation of long-term neuronal synaptic plasticity,1/565,15/10364,0.5689165389559963,0.7481992645312717,0.4926691992041207,AGT,1
GO:0048668,collateral sprouting,1/565,15/10364,0.5689165389559963,0.7481992645312717,0.4926691992041207,SPP1,1
GO:0051291,protein heterooligomerization,1/565,15/10364,0.5689165389559963,0.7481992645312717,0.4926691992041207,COL1A2,1
GO:0060211,regulation of nuclear-transcribed mRNA poly(A) tail shortening,1/565,15/10364,0.5689165389559963,0.7481992645312717,0.4926691992041207,ZFP36,1
GO:0061003,positive regulation of dendritic spine morphogenesis,1/565,15/10364,0.5689165389559963,0.7481992645312717,0.4926691992041207,RELN,1
GO:0070734,histone H3-K27 methylation,1/565,15/10364,0.5689165389559963,0.7481992645312717,0.4926691992041207,H1-2,1
GO:0080182,histone H3-K4 trimethylation,1/565,15/10364,0.5689165389559963,0.7481992645312717,0.4926691992041207,H1-2,1
GO:0090335,regulation of brown fat cell differentiation,1/565,15/10364,0.5689165389559963,0.7481992645312717,0.4926691992041207,PTGS2,1
GO:0090659,walking behavior,1/565,15/10364,0.5689165389559963,0.7481992645312717,0.4926691992041207,UCHL1,1
GO:0098760,response to interleukin-7,1/565,15/10364,0.5689165389559963,0.7481992645312717,0.4926691992041207,IL7R,1
GO:0098761,cellular response to interleukin-7,1/565,15/10364,0.5689165389559963,0.7481992645312717,0.4926691992041207,IL7R,1
GO:0099174,regulation of presynapse organization,1/565,15/10364,0.5689165389559963,0.7481992645312717,0.4926691992041207,MDGA1,1
GO:1900151,"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay",1/565,15/10364,0.5689165389559963,0.7481992645312717,0.4926691992041207,ZFP36,1
GO:1902165,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,1/565,15/10364,0.5689165389559963,0.7481992645312717,0.4926691992041207,MUC1,1
GO:1902894,negative regulation of pri-miRNA transcription by RNA polymerase II,1/565,15/10364,0.5689165389559963,0.7481992645312717,0.4926691992041207,SOX9,1
GO:1903204,negative regulation of oxidative stress-induced neuron death,1/565,15/10364,0.5689165389559963,0.7481992645312717,0.4926691992041207,NR4A3,1
GO:1903319,positive regulation of protein maturation,1/565,15/10364,0.5689165389559963,0.7481992645312717,0.4926691992041207,CLEC3B,1
GO:1904861,excitatory synapse assembly,1/565,15/10364,0.5689165389559963,0.7481992645312717,0.4926691992041207,LRRC4,1
GO:1905606,regulation of presynapse assembly,1/565,15/10364,0.5689165389559963,0.7481992645312717,0.4926691992041207,MDGA1,1
GO:2000047,regulation of cell-cell adhesion mediated by cadherin,1/565,15/10364,0.5689165389559963,0.7481992645312717,0.4926691992041207,VEGFA,1
GO:2000178,negative regulation of neural precursor cell proliferation,1/565,15/10364,0.5689165389559963,0.7481992645312717,0.4926691992041207,PTN,1
GO:2000479,regulation of cAMP-dependent protein kinase activity,1/565,15/10364,0.5689165389559963,0.7481992645312717,0.4926691992041207,SPATC1L,1
GO:0016358,dendrite development,9/565,168/10364,0.5704737036440919,0.7498270000227975,0.4937410194786682,MFSD2A/DCLK1/NTN1/APOE/ID1/MAP1B/RELN/PTN/CD3E,9
GO:0006576,cellular biogenic amine metabolic process,3/565,54/10364,0.5707036961580452,0.7498270000227975,0.4937410194786682,NNMT/NR4A2/MOXD1,3
GO:0048706,embryonic skeletal system development,3/565,54/10364,0.5707036961580452,0.7498270000227975,0.4937410194786682,PRRX1/COL1A1/SULF1,3
GO:0005978,glycogen biosynthetic process,2/565,35/10364,0.5761621756108365,0.755060162276173,0.4971869168203223,IGF2/IGF1,2
GO:0009250,glucan biosynthetic process,2/565,35/10364,0.5761621756108365,0.755060162276173,0.4971869168203223,IGF2/IGF1,2
GO:0042733,embryonic digit morphogenesis,2/565,35/10364,0.5761621756108365,0.755060162276173,0.4971869168203223,ZBTB16/SFRP2,2
GO:0043300,regulation of leukocyte degranulation,2/565,35/10364,0.5761621756108365,0.755060162276173,0.4971869168203223,FCGR2B/HMOX1,2
GO:0045806,negative regulation of endocytosis,2/565,35/10364,0.5761621756108365,0.755060162276173,0.4971869168203223,ITGB3/APOC1,2
GO:0046164,alcohol catabolic process,2/565,35/10364,0.5761621756108365,0.755060162276173,0.4971869168203223,AKR1C3/APOE,2
GO:0097178,ruffle assembly,2/565,35/10364,0.5761621756108365,0.755060162276173,0.4971869168203223,CSPG4/ICAM1,2
GO:0097720,calcineurin-mediated signaling,2/565,35/10364,0.5761621756108365,0.755060162276173,0.4971869168203223,CLEC7A/IGF1,2
GO:0050714,positive regulation of protein secretion,5/565,93/10364,0.5777112511828133,0.75684795594958,0.4983641311256202,IGF1/CD38/HLA-DRB1/GPER1/KCNN4,5
GO:0060048,cardiac muscle contraction,4/565,74/10364,0.5795013926018645,0.7589503203173491,0.4997484818174815,ATP1A2/RGS2/PLN/CCN2,4
GO:0051262,protein tetramerization,3/565,55/10364,0.5833041104367929,0.7636862897755772,0.5028669910048732,GBP5/ALDH1A3/HLA-DRB1,3
GO:0000082,G1/S transition of mitotic cell cycle,8/565,151/10364,0.5847990938657256,0.7653988140301409,0.503994642411537,MUC1/BCAT1/CCL2/ADAMTS1/FAM107A/CDKN1A/GPNMB/KLF4,8
GO:0009132,nucleoside diphosphate metabolic process,5/565,94/10364,0.5873298578889952,0.7678049963764929,0.5055790491142874,DDIT4/IGF1/HK2/HK3/MLXIPL,5
GO:0035264,multicellular organism growth,5/565,94/10364,0.5873298578889952,0.7678049963764929,0.5055790491142874,MFSD2A/IGF2/IGF1/KLF2/GDF15,5
GO:0072599,establishment of protein localization to endoplasmic reticulum,2/565,36/10364,0.59165485521029,0.7678049963764929,0.5055790491142874,RN7SL1/RN7SL2,2
GO:1901985,positive regulation of protein acetylation,2/565,36/10364,0.59165485521029,0.7678049963764929,0.5055790491142874,MUC1/LIF,2
GO:0003272,endocardial cushion formation,1/565,16/10364,0.5924513882641282,0.7678049963764929,0.5055790491142874,APLNR,1
GO:0006244,pyrimidine nucleotide catabolic process,1/565,16/10364,0.5924513882641282,0.7678049963764929,0.5055790491142874,TYMP,1
GO:0007039,protein catabolic process in the vacuole,1/565,16/10364,0.5924513882641282,0.7678049963764929,0.5055790491142874,LDLR,1
GO:0007205,protein kinase C-activating G protein-coupled receptor signaling pathway,1/565,16/10364,0.5924513882641282,0.7678049963764929,0.5055790491142874,EDN1,1
GO:0010801,negative regulation of peptidyl-threonine phosphorylation,1/565,16/10364,0.5924513882641282,0.7678049963764929,0.5055790491142874,DDIT4,1
GO:0018195,peptidyl-arginine modification,1/565,16/10364,0.5924513882641282,0.7678049963764929,0.5055790491142874,PADI2,1
GO:0030050,vesicle transport along actin filament,1/565,16/10364,0.5924513882641282,0.7678049963764929,0.5055790491142874,MYO7B,1
GO:0031498,chromatin disassembly,1/565,16/10364,0.5924513882641282,0.7678049963764929,0.5055790491142874,PADI2,1
GO:0032689,negative regulation of interferon-gamma production,1/565,16/10364,0.5924513882641282,0.7678049963764929,0.5055790491142874,HLA-DRB1,1
GO:0032785,"negative regulation of DNA-templated transcription, elongation",1/565,16/10364,0.5924513882641282,0.7678049963764929,0.5055790491142874,RN7SK,1
GO:0043371,"negative regulation of CD4-positive, alpha-beta T cell differentiation",1/565,16/10364,0.5924513882641282,0.7678049963764929,0.5055790491142874,BCL6,1
GO:0045056,transcytosis,1/565,16/10364,0.5924513882641282,0.7678049963764929,0.5055790491142874,MFSD2A,1
GO:0045815,"positive regulation of gene expression, epigenetic",1/565,16/10364,0.5924513882641282,0.7678049963764929,0.5055790491142874,PADI2,1
GO:0046519,sphingoid metabolic process,1/565,16/10364,0.5924513882641282,0.7678049963764929,0.5055790491142874,PLPP2,1
GO:0046653,tetrahydrofolate metabolic process,1/565,16/10364,0.5924513882641282,0.7678049963764929,0.5055790491142874,ALDH1L1,1
GO:0046794,transport of virus,1/565,16/10364,0.5924513882641282,0.7678049963764929,0.5055790491142874,SIGLEC1,1
GO:0050849,negative regulation of calcium-mediated signaling,1/565,16/10364,0.5924513882641282,0.7678049963764929,0.5055790491142874,CD22,1
GO:0060965,negative regulation of gene silencing by miRNA,1/565,16/10364,0.5924513882641282,0.7678049963764929,0.5055790491142874,NEAT1,1
GO:0061484,hematopoietic stem cell homeostasis,1/565,16/10364,0.5924513882641282,0.7678049963764929,0.5055790491142874,CCN3,1
GO:0070262,peptidyl-serine dephosphorylation,1/565,16/10364,0.5924513882641282,0.7678049963764929,0.5055790491142874,DUSP1,1
GO:0070935,3'-UTR-mediated mRNA stabilization,1/565,16/10364,0.5924513882641282,0.7678049963764929,0.5055790491142874,ZFP36,1
GO:0099637,neurotransmitter receptor transport,1/565,16/10364,0.5924513882641282,0.7678049963764929,0.5055790491142874,NSG1,1
GO:0110154,RNA decapping,1/565,16/10364,0.5924513882641282,0.7678049963764929,0.5055790491142874,ZFP36,1
GO:1902176,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,1/565,16/10364,0.5924513882641282,0.7678049963764929,0.5055790491142874,HSPB1,1
GO:1902683,regulation of receptor localization to synapse,1/565,16/10364,0.5924513882641282,0.7678049963764929,0.5055790491142874,TYROBP,1
GO:1905207,regulation of cardiocyte differentiation,1/565,16/10364,0.5924513882641282,0.7678049963764929,0.5055790491142874,GPER1,1
GO:2000108,positive regulation of leukocyte apoptotic process,1/565,16/10364,0.5924513882641282,0.7678049963764929,0.5055790491142874,CCL5,1
GO:0018105,peptidyl-serine phosphorylation,12/565,228/10364,0.5926922109913597,0.7678740227210844,0.505624501115547,PTGS2/DDIT4/DCLK1/LIF/SFRP2/VEGFA/SGK1/RAMP3/MLXIPL/ANGPT1/NTRK2/TENM1,12
GO:0051170,import into nucleus,7/565,133/10364,0.5930980172385507,0.7680715674725564,0.5057545790494993,PTGS2/AGT/BCL3/APOD/CDKN1A/CD36/ANGPT1,7
GO:0034504,protein localization to nucleus,13/565,247/10364,0.5932199062892584,0.7680715674725564,0.5057545790494993,PTGS2/AGT/ZBTB16/DCLK1/NGFR/COL1A1/SOX9/BCL3/LIF/APOD/CDKN1A/CD36/ANGPT1,13
GO:0010638,positive regulation of organelle organization,21/565,398/10364,0.5950061489948212,0.7701407442253551,0.507117076584767,NES/LMOD1/IGF2/DCN/IGF1/CX3CL1/ICAM1/ID1/TNFSF10/SYNPO2/MAP1B/PDGFRB/EDN1/HSPA1A/HSPA1B/CCN2/GPER1/SFRP1/CCL21/TENM1/ELAPOR1,21
GO:1902369,negative regulation of RNA catabolic process,3/565,56/10364,0.5956671730997942,0.7707526569755239,0.5075200047603211,TENT5C/ZFP36/SLC11A1,3
GO:0046822,regulation of nucleocytoplasmic transport,5/565,95/10364,0.5968281669715445,0.7720109053969995,0.508348527684086,PTGS2/IFI27/APOD/CD36/ANGPT1,5
GO:0032409,regulation of transporter activity,8/565,153/10364,0.5998540764655829,0.775679908101736,0.5107644678087435,ATP1A2/ADRA2A/RRAD/CCL2/PLN/SGK1/RELN/GEM,8
GO:0035195,gene silencing by miRNA,4/565,76/10364,0.6008098679481929,0.776670539747364,0.5114167722451339,H19/NEAT1/MEG3/ZFP36,4
GO:0008154,actin polymerization or depolymerization,9/565,173/10364,0.60615817578017706,0.7815978247337251,0.5146612575895586,LMOD1/CXCL12/ICAM1/SPATC1L/FAM107A/SLIT2/ELN/CCL21/TENM1,9
GO:0002228,natural killer cell mediated immunity,2/565,37/10364,0.6067215161220758,0.7815978247337251,0.5146612575895586,HLA-G/SLAMF7,2
GO:0008089,anterograde axonal transport,2/565,37/10364,0.6067215161220758,0.7815978247337251,0.5146612575895586,HSPB1/RAB27B,2
GO:0008631,intrinsic apoptotic signaling pathway in response to oxidative stress,2/565,37/10364,0.6067215161220758,0.7815978247337251,0.5146612575895586,CYP1B1/HSPB1,2
GO:0010718,positive regulation of epithelial to mesenchymal transition,2/565,37/10364,0.6067215161220758,0.7815978247337251,0.5146612575895586,MDK/COL1A1,2
GO:0042267,natural killer cell mediated cytotoxicity,2/565,37/10364,0.6067215161220758,0.7815978247337251,0.5146612575895586,HLA-G/SLAMF7,2
GO:0043388,positive regulation of DNA binding,2/565,37/10364,0.6067215161220758,0.7815978247337251,0.5146612575895586,IGF1/KLF4,2
GO:0045912,negative regulation of carbohydrate metabolic process,2/565,37/10364,0.6067215161220758,0.7815978247337251,0.5146612575895586,DDIT4/SIK1,2
GO:0051289,protein homotetramerization,2/565,37/10364,0.6067215161220758,0.7815978247337251,0.5146612575895586,GBP5/ALDH1A3,2
GO:2000736,regulation of stem cell differentiation,2/565,37/10364,0.6067215161220758,0.7815978247337251,0.5146612575895586,SOX9/PTN,2
GO:2001259,positive regulation of cation channel activity,2/565,37/10364,0.6067215161220758,0.7815978247337251,0.5146612575895586,CCL2/RELN,2
GO:0002312,B cell activation involved in immune response,3/565,57/10364,0.607789118816106,0.7822347225504991,0.5150806377630496,FCGR2B/BCL3/BCL6,3
GO:0008652,cellular amino acid biosynthetic process,3/565,57/10364,0.607789118816106,0.7822347225504991,0.5150806377630496,PHGDH/BCAT1/SLC1A3,3
GO:2000573,positive regulation of DNA biosynthetic process,3/565,57/10364,0.607789118816106,0.7822347225504991,0.5150806377630496,PDGFRB/SMOC2/KLF4,3
GO:0098656,anion transmembrane transport,7/565,135/10364,0.6089957758870119,0.7830106328126665,0.5155915539128477,ATP1A2/RGS2/AGT/FOLR2/SLC7A5/SLC16A3/SLC1A3,7
GO:0045185,maintenance of protein location,4/565,77/10364,0.611217167075768,0.7830106328126665,0.5155915539128477,SRGN/FBN1/LTBP1/HK2,4
GO:0000578,embryonic axis specification,1/565,17/10364,0.6147035109574768,0.7830106328126665,0.5155915539128477,BASP1,1
GO:0001573,ganglioside metabolic process,1/565,17/10364,0.6147035109574768,0.7830106328126665,0.5155915539128477,ITGB8,1
GO:0003009,skeletal muscle contraction,1/565,17/10364,0.6147035109574768,0.7830106328126665,0.5155915539128477,NR4A1,1
GO:0006085,acetyl-CoA biosynthetic process,1/565,17/10364,0.6147035109574768,0.7830106328126665,0.5155915539128477,PDK4,1
GO:0006541,glutamine metabolic process,1/565,17/10364,0.6147035109574768,0.7830106328126665,0.5155915539128477,PHGDH,1
GO:0007549,dosage compensation,1/565,17/10364,0.6147035109574768,0.7830106328126665,0.5155915539128477,XIST,1
GO:0009081,branched-chain amino acid metabolic process,1/565,17/10364,0.6147035109574768,0.7830106328126665,0.5155915539128477,BCAT1,1
GO:0032516,positive regulation of phosphoprotein phosphatase activity,1/565,17/10364,0.6147035109574768,0.7830106328126665,0.5155915539128477,PDGFRB,1
GO:0032816,positive regulation of natural killer cell activation,1/565,17/10364,0.6147035109574768,0.7830106328126665,0.5155915539128477,TYROBP,1
GO:0032958,inositol phosphate biosynthetic process,1/565,17/10364,0.6147035109574768,0.7830106328126665,0.5155915539128477,GPER1,1
GO:0034143,regulation of toll-like receptor 4 signaling pathway,1/565,17/10364,0.6147035109574768,0.7830106328126665,0.5155915539128477,LTF,1
GO:0034629,cellular protein-containing complex localization,1/565,17/10364,0.6147035109574768,0.7830106328126665,0.5155915539128477,TNFAIP2,1
GO:0039535,regulation of RIG-I signaling pathway,1/565,17/10364,0.6147035109574768,0.7830106328126665,0.5155915539128477,BIRC3,1
GO:0042402,cellular biogenic amine catabolic process,1/565,17/10364,0.6147035109574768,0.7830106328126665,0.5155915539128477,MOXD1,1
GO:0044346,fibroblast apoptotic process,1/565,17/10364,0.6147035109574768,0.7830106328126665,0.5155915539128477,SFRP1,1
GO:0046639,negative regulation of alpha-beta T cell differentiation,1/565,17/10364,0.6147035109574768,0.7830106328126665,0.5155915539128477,BCL6,1
GO:0050857,positive regulation of antigen receptor-mediated signaling pathway,1/565,17/10364,0.6147035109574768,0.7830106328126665,0.5155915539128477,KCNN4,1
GO:0055070,copper ion homeostasis,1/565,17/10364,0.6147035109574768,0.7830106328126665,0.5155915539128477,MT2A,1
GO:0060149,negative regulation of posttranscriptional gene silencing,1/565,17/10364,0.6147035109574768,0.7830106328126665,0.5155915539128477,NEAT1,1
GO:0060314,regulation of ryanodine-sensitive calcium-release channel activity,1/565,17/10364,0.6147035109574768,0.7830106328126665,0.5155915539128477,PLN,1
GO:0060396,growth hormone receptor signaling pathway,1/565,17/10364,0.6147035109574768,0.7830106328126665,0.5155915539128477,GDF15,1
GO:0060544,regulation of necroptotic process,1/565,17/10364,0.6147035109574768,0.7830106328126665,0.5155915539128477,BIRC3,1
GO:0060967,negative regulation of gene silencing by RNA,1/565,17/10364,0.6147035109574768,0.7830106328126665,0.5155915539128477,NEAT1,1
GO:0071378,cellular response to growth hormone stimulus,1/565,17/10364,0.6147035109574768,0.7830106328126665,0.5155915539128477,GDF15,1
GO:0071514,genetic imprinting,1/565,17/10364,0.6147035109574768,0.7830106328126665,0.5155915539128477,IGF2,1
GO:0072673,lamellipodium morphogenesis,1/565,17/10364,0.6147035109574768,0.7830106328126665,0.5155915539128477,ENPP2,1
GO:0086064,cell communication by electrical coupling involved in cardiac conduction,1/565,17/10364,0.6147035109574768,0.7830106328126665,0.5155915539128477,ATP1A2,1
GO:1901381,positive regulation of potassium ion transmembrane transport,1/565,17/10364,0.6147035109574768,0.7830106328126665,0.5155915539128477,KCNN4,1
GO:1902254,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator,1/565,17/10364,0.6147035109574768,0.7830106328126665,0.5155915539128477,MUC1,1
GO:1990573,potassium ion import across plasma membrane,1/565,17/10364,0.6147035109574768,0.7830106328126665,0.5155915539128477,ATP1A2,1
GO:2000757,negative regulation of peptidyl-lysine acetylation,1/565,17/10364,0.6147035109574768,0.7830106328126665,0.5155915539128477,KLF15,1
GO:1902652,secondary alcohol metabolic process,5/565,97/10364,0.6154524017092304,0.7837207255357976,0.5160591309739999,DGAT2/CES1/LDLR/APOE/ABCA1,5
GO:0032412,regulation of ion transmembrane transporter activity,7/565,136/10364,0.6168201601562071,0.785218201392883,0.5170451787640895,ATP1A2/ADRA2A/RRAD/CCL2/PLN/RELN/GEM,7
GO:0051223,regulation of protein transport,20/565,384/10364,0.617843718135537,0.7862767118579075,0.5177421795870981,PTGS2/ALOX5/ADRA2A/SYT7/IGF1/IFI27/CCL5/APOE/INHBB/APOD/CD38/HLA-DRB1/GPER1/CD36/SFRP1/ANGPT1/CCN3/TENM1/KCNN4/DERL3,20
GO:0008088,axo-dendritic transport,3/565,58/10364,0.6196668657618016,0.7873731062783413,0.5184641259812389,UCHL1/HSPB1/RAB27B,3
GO:0030330,"DNA damage response, signal transduction by p53 class mediator",3/565,58/10364,0.6196668657618016,0.7873731062783413,0.5184641259812389,MUC1/BCL3/CDKN1A,3
GO:0044106,cellular amine metabolic process,3/565,58/10364,0.6196668657618016,0.7873731062783413,0.5184641259812389,NNMT/NR4A2/MOXD1,3
GO:0090277,positive regulation of peptide hormone secretion,3/565,58/10364,0.6196668657618016,0.7873731062783413,0.5184641259812389,CD38/HLA-DRB1/GPER1,3
GO:0097061,dendritic spine organization,3/565,58/10364,0.6196668657618016,0.7873731062783413,0.5184641259812389,FCGR2B/APOE/RELN,3
GO:0009953,dorsal/ventral pattern formation,2/565,38/10364,0.6213624854642494,0.7884227154151535,0.5191552655177559,EDN1/SFRP1,2
GO:0031016,pancreas development,2/565,38/10364,0.6213624854642494,0.7884227154151535,0.5191552655177559,IGF2/SOX9,2
GO:0035307,positive regulation of protein dephosphorylation,2/565,38/10364,0.6213624854642494,0.7884227154151535,0.5191552655177559,LILRB2/PDGFRB,2
GO:0060964,regulation of gene silencing by miRNA,2/565,38/10364,0.6213624854642494,0.7884227154151535,0.5191552655177559,NEAT1/ZFP36,2
GO:0030838,positive regulation of actin filament polymerization,4/565,78/10364,0.6214558140314363,0.7884227154151535,0.5191552655177559,LMOD1/ICAM1/CCL21/TENM1,4
GO:0035601,protein deacylation,5/565,98/10364,0.6245731910398107,0.7916416854851346,0.5212748711920988,APLNR/NNMT/BCL6/HOPX/VEGFA,5
GO:0046165,alcohol biosynthetic process,5/565,98/10364,0.6245731910398107,0.7916416854851346,0.5212748711920988,CACNA1H/CES1/APOE/GPER1/MOXD1,5
GO:0071333,cellular response to glucose stimulus,5/565,98/10364,0.6245731910398107,0.7916416854851346,0.5212748711920988,ADRA2A/ICAM1/HLA-DRB1/GPER1/MLXIPL,5
GO:0017038,protein import,9/565,176/10364,0.6268473386260482,0.7942782433720338,0.5230109740250891,PTGS2/AGT/BCL3/APOE/APOD/CDKN1A/CD36/CLU/ANGPT1,9
GO:0005975,carbohydrate metabolic process,22/565,424/10364,0.627824855810706,0.7952707177255663,0.5236644918353368,CHI3L2/CHI3L1/ATF3/PFKFB3/DDIT4/PGGHG/IGF2/DGAT2/NNMT/SLC2A3/IGF1/OAS1/C1QTNF1/HK2/SIK1/APOD/HK3/GPER1/MLXIPL/PDK4/ABO/RORC,22
GO:0035270,endocrine system development,3/565,59/10364,0.6312979760059283,0.7971609876251979,0.5249091839940688,MDK/SOX9/RAP1GAP,3
GO:0045921,positive regulation of exocytosis,3/565,59/10364,0.6312979760059283,0.7971609876251979,0.5249091839940688,SYT7/CACNA1H/RAB27B,3
GO:1901657,glycosyl compound metabolic process,3/565,59/10364,0.6312979760059283,0.7971609876251979,0.5249091839940688,AKR1C2/AKR1C3/TYMP,3
GO:0090263,positive regulation of canonical Wnt signaling pathway,4/565,79/10364,0.63152325281324,0.7971609876251979,0.5249091839940688,COL1A1/SFRP2/SFRP1/GPC3,4
GO:0016055,Wnt signaling pathway,16/565,311/10364,0.6321330596736172,0.7971609876251979,0.5249091839940688,MDK/IGFBP6/COL1A1/SOX9/APOE/NR4A2/FRZB/IGFBP2/KLF15/SFRP2/EGR1/SFRP1/SULF1/KLF4/GPC3/CD24,16
GO:0071326,cellular response to monosaccharide stimulus,5/565,99/10364,0.6335633976729185,0.7971609876251979,0.5249091839940688,ADRA2A/ICAM1/HLA-DRB1/GPER1/MLXIPL,5
GO:0071331,cellular response to hexose stimulus,5/565,99/10364,0.6335633976729185,0.7971609876251979,0.5249091839940688,ADRA2A/ICAM1/HLA-DRB1/GPER1/MLXIPL,5
GO:0001947,heart looping,2/565,39/10364,0.635579318805777,0.7971609876251979,0.5249091839940688,APLNR/SOX18,2
GO:0045995,regulation of embryonic development,2/565,39/10364,0.635579318805777,0.7971609876251979,0.5249091839940688,SFRP2/LAMA2,2
GO:0051489,regulation of filopodium assembly,2/565,39/10364,0.635579318805777,0.7971609876251979,0.5249091839940688,CCL21/TENM1,2
GO:0060079,excitatory postsynaptic potential,2/565,39/10364,0.635579318805777,0.7971609876251979,0.5249091839940688,P2RX1/RELN,2
GO:0000002,mitochondrial genome maintenance,1/565,18/10364,0.6357427026370961,0.7971609876251979,0.5249091839940688,TYMP,1
GO:0002828,regulation of type 2 immune response,1/565,18/10364,0.6357427026370961,0.7971609876251979,0.5249091839940688,BCL6,1
GO:0006699,bile acid biosynthetic process,1/565,18/10364,0.6357427026370961,0.7971609876251979,0.5249091839940688,CES1,1
GO:0007097,nuclear migration,1/565,18/10364,0.6357427026370961,0.7971609876251979,0.5249091839940688,NTN1,1
GO:0009310,amine catabolic process,1/565,18/10364,0.6357427026370961,0.7971609876251979,0.5249091839940688,MOXD1,1
GO:0010288,response to lead ion,1/565,18/10364,0.6357427026370961,0.7971609876251979,0.5249091839940688,PTGS2,1
GO:0010661,positive regulation of muscle cell apoptotic process,1/565,18/10364,0.6357427026370961,0.7971609876251979,0.5249091839940688,AGT,1
GO:0010800,positive regulation of peptidyl-threonine phosphorylation,1/565,18/10364,0.6357427026370961,0.7971609876251979,0.5249091839940688,CHI3L1,1
GO:0015740,C4-dicarboxylate transport,1/565,18/10364,0.6357427026370961,0.7971609876251979,0.5249091839940688,SLC1A3,1
GO:0021801,cerebral cortex radial glia-guided migration,1/565,18/10364,0.6357427026370961,0.7971609876251979,0.5249091839940688,RELN,1
GO:0022030,telencephalon glial cell migration,1/565,18/10364,0.6357427026370961,0.7971609876251979,0.5249091839940688,RELN,1
GO:0032288,myelin assembly,1/565,18/10364,0.6357427026370961,0.7971609876251979,0.5249091839940688,ITGB4,1
GO:0035336,long-chain fatty-acyl-CoA metabolic process,1/565,18/10364,0.6357427026370961,0.7971609876251979,0.5249091839940688,DGAT2,1
GO:0048873,homeostasis of number of cells within a tissue,1/565,18/10364,0.6357427026370961,0.7971609876251979,0.5249091839940688,SOX9,1
GO:0071359,cellular response to dsRNA,1/565,18/10364,0.6357427026370961,0.7971609876251979,0.5249091839940688,IFIT1,1
GO:0097320,plasma membrane tubulation,1/565,18/10364,0.6357427026370961,0.7971609876251979,0.5249091839940688,CAVIN2,1
GO:0097484,dendrite extension,1/565,18/10364,0.6357427026370961,0.7971609876251979,0.5249091839940688,CPNE5,1
GO:0098780,response to mitochondrial depolarisation,1/565,18/10364,0.6357427026370961,0.7971609876251979,0.5249091839940688,HK2,1
GO:0099515,actin filament-based transport,1/565,18/10364,0.6357427026370961,0.7971609876251979,0.5249091839940688,MYO7B,1
GO:1901028,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,1/565,18/10364,0.6357427026370961,0.7971609876251979,0.5249091839940688,HSPA1A,1
GO:1902993,positive regulation of amyloid precursor protein catabolic process,1/565,18/10364,0.6357427026370961,0.7971609876251979,0.5249091839940688,CLU,1
GO:1903205,regulation of hydrogen peroxide-induced cell death,1/565,18/10364,0.6357427026370961,0.7971609876251979,0.5249091839940688,NR4A3,1
GO:0198738,cell-cell signaling by wnt,16/565,312/10364,0.6372593629921152,0.7988180747365952,0.5260003315250611,MDK/IGFBP6/COL1A1/SOX9/APOE/NR4A2/FRZB/IGFBP2/KLF15/SFRP2/EGR1/SFRP1/SULF1/KLF4/GPC3/CD24,16
GO:0035194,post-transcriptional gene silencing by RNA,4/565,80/10364,0.6414172811662664,0.8037840064569007,0.5292702647098766,H19/NEAT1/MEG3/ZFP36,4
GO:0098732,macromolecule deacylation,5/565,100/10364,0.64242103407875,0.8047955059725833,0.5299363100804222,APLNR/NNMT/BCL6/HOPX/VEGFA,5
GO:0007015,actin filament organization,17/565,333/10364,0.646754364708203,0.8099762524060518,0.5333476930069417,LMOD1/CXCL12/CX3CL1/ICAM1/MYO7B/ID1/SPATC1L/FAM107A/SLIT2/SYNPO2/CCN2/ELN/SFRP1/CCL21/TPM2/TENM1/ESPN,17
GO:0016051,carbohydrate biosynthetic process,7/565,140/10364,0.6472469542601316,0.8103452693397488,0.5335906807855133,ATF3/IGF2/DGAT2/NNMT/IGF1/SIK1/GPER1,7
GO:0060147,regulation of posttranscriptional gene silencing,2/565,40/10364,0.6493746657055338,0.8125121886914595,0.5350175392072681,NEAT1/ZFP36,2
GO:0061371,determination of heart left/right asymmetry,2/565,40/10364,0.6493746657055338,0.8125121886914595,0.5350175392072681,APLNR/SOX18,2
GO:0007043,cell-cell junction assembly,4/565,81/10364,0.6511360360775873,0.8128920524643269,0.535267669339249,AGT/APLNR/ACE/CLDN5,4
GO:0032418,lysosome localization,3/565,61/10364,0.6538135235232276,0.8128920524643269,0.535267669339249,HMOX1/NR4A3/PTGDS,3
GO:0001783,B cell apoptotic process,1/565,19/10364,0.6556349675713745,0.8128920524643269,0.535267669339249,BCL6,1
GO:0002082,regulation of oxidative phosphorylation,1/565,19/10364,0.6556349675713745,0.8128920524643269,0.535267669339249,MLXIPL,1
GO:0003230,cardiac atrium development,1/565,19/10364,0.6556349675713745,0.8128920524643269,0.535267669339249,CCN1,1
GO:0006516,glycoprotein catabolic process,1/565,19/10364,0.6556349675713745,0.8128920524643269,0.535267669339249,ADAMTS9,1
GO:0006658,phosphatidylserine metabolic process,1/565,19/10364,0.6556349675713745,0.8128920524643269,0.535267669339249,MFSD2A,1
GO:0006972,hyperosmotic response,1/565,19/10364,0.6556349675713745,0.8128920524643269,0.535267669339249,AQP1,1
GO:0007026,negative regulation of microtubule depolymerization,1/565,19/10364,0.6556349675713745,0.8128920524643269,0.535267669339249,MAP1B,1
GO:0007140,male meiotic nuclear division,1/565,19/10364,0.6556349675713745,0.8128920524643269,0.535267669339249,CYP26B1,1
GO:0009219,pyrimidine deoxyribonucleotide metabolic process,1/565,19/10364,0.6556349675713745,0.8128920524643269,0.535267669339249,TYMP,1
GO:0010644,cell communication by electrical coupling,1/565,19/10364,0.6556349675713745,0.8128920524643269,0.535267669339249,ATP1A2,1
GO:0014904,myotube cell development,1/565,19/10364,0.6556349675713745,0.8128920524643269,0.535267669339249,IGF1,1
GO:0021517,ventral spinal cord development,1/565,19/10364,0.6556349675713745,0.8128920524643269,0.535267669339249,RELN,1
GO:0021591,ventricular system development,1/565,19/10364,0.6556349675713745,0.8128920524643269,0.535267669339249,AQP1,1
GO:0021696,cerebellar cortex morphogenesis,1/565,19/10364,0.6556349675713745,0.8128920524643269,0.535267669339249,SERPINE2,1
GO:0030212,hyaluronan metabolic process,1/565,19/10364,0.6556349675713745,0.8128920524643269,0.535267669339249,ITIH5,1
GO:0032620,interleukin-17 production,1/565,19/10364,0.6556349675713745,0.8128920524643269,0.535267669339249,SLC7A5,1
GO:0032660,regulation of interleukin-17 production,1/565,19/10364,0.6556349675713745,0.8128920524643269,0.535267669339249,SLC7A5,1
GO:0035162,embryonic hemopoiesis,1/565,19/10364,0.6556349675713745,0.8128920524643269,0.535267669339249,VEGFA,1
GO:0046339,diacylglycerol metabolic process,1/565,19/10364,0.6556349675713745,0.8128920524643269,0.535267669339249,DGAT2,1
GO:0048663,neuron fate commitment,1/565,19/10364,0.6556349675713745,0.8128920524643269,0.535267669339249,PRRX1,1
GO:0060251,regulation of glial cell proliferation,1/565,19/10364,0.6556349675713745,0.8128920524643269,0.535267669339249,PTN,1
GO:0060969,negative regulation of gene silencing,1/565,19/10364,0.6556349675713745,0.8128920524643269,0.535267669339249,NEAT1,1
GO:0061162,establishment of monopolar cell polarity,1/565,19/10364,0.6556349675713745,0.8128920524643269,0.535267669339249,MAP1B,1
GO:0061339,establishment or maintenance of monopolar cell polarity,1/565,19/10364,0.6556349675713745,0.8128920524643269,0.535267669339249,MAP1B,1
GO:0061384,heart trabecula morphogenesis,1/565,19/10364,0.6556349675713745,0.8128920524643269,0.535267669339249,ADAMTS1,1
GO:0072337,modified amino acid transport,1/565,19/10364,0.6556349675713745,0.8128920524643269,0.535267669339249,FOLR2,1
GO:0090141,positive regulation of mitochondrial fission,1/565,19/10364,0.6556349675713745,0.8128920524643269,0.535267669339249,DCN,1
GO:1901984,negative regulation of protein acetylation,1/565,19/10364,0.6556349675713745,0.8128920524643269,0.535267669339249,KLF15,1
GO:0046777,protein autophosphorylation,9/565,181/10364,0.660009073255041,0.818067558554689,0.5386756016400275,THY1/ACE/SIK1/FGFR3/CSF1R/PDGFRB/VEGFA/GPNMB/NTRK2,9
GO:0016441,posttranscriptional gene silencing,4/565,82/10364,0.6606779792836714,0.8186488036281329,0.5390583359709069,H19/NEAT1/MEG3/ZFP36,4
GO:0022898,regulation of transmembrane transporter activity,7/565,142/10364,0.6619170824919384,0.8194827202101229,0.539607447730472,ATP1A2/ADRA2A/RRAD/CCL2/PLN/RELN/GEM,7
GO:1901617,organic hydroxy compound biosynthetic process,7/565,142/10364,0.6619170824919384,0.8194827202101229,0.539607447730472,AKR1C3/CACNA1H/CES1/APOE/NR4A2/GPER1/MOXD1,7
GO:0048488,synaptic vesicle endocytosis,2/565,41/10364,0.6627521462178106,0.8194827202101229,0.539607447730472,SNCG/RAB27B,2
GO:0060966,regulation of gene silencing by RNA,2/565,41/10364,0.6627521462178106,0.8194827202101229,0.539607447730472,NEAT1/ZFP36,2
GO:0099072,regulation of postsynaptic membrane neurotransmitter receptor levels,2/565,41/10364,0.6627521462178106,0.8194827202101229,0.539607447730472,ITGB3/NSG1,2
GO:0099565,"chemical synaptic transmission, postsynaptic",2/565,41/10364,0.6627521462178106,0.8194827202101229,0.539607447730472,P2RX1/RELN,2
GO:0140238,presynaptic endocytosis,2/565,41/10364,0.6627521462178106,0.8194827202101229,0.539607447730472,SNCG/RAB27B,2
GO:0010822,positive regulation of mitochondrion organization,3/565,62/10364,0.6646959623235359,0.8213900602935574,0.5408633801485616,DCN/TNFSF10/GPER1,3
GO:1901983,regulation of protein acetylation,3/565,62/10364,0.6646959623235359,0.8213900602935574,0.5408633801485616,MUC1/LIF/KLF15,3
GO:0098660,inorganic ion transmembrane transport,21/565,414/10364,0.6674305525447692,0.8245204230894041,0.5429246403033873,MTCO2P12/ATP1A2/KCNMA1/ADRA2A/APLNR/THY1/CACNA1H/CX3CL1/RRAD/P2RX1/SCN7A/SLC11A1/SLC1A3/PLN/GPER1/AQP1/RAMP3/GEM/CCL21/KCNN4/LCN2,21
GO:0030177,positive regulation of Wnt signaling pathway,5/565,103/10364,0.6681819114628041,0.8251996215772912,0.5433718743371411,COL1A1/SFRP2/SFRP1/SULF1/GPC3,5
GO:0006457,protein folding,8/565,163/10364,0.6707426624854966,0.827514889804963,0.5448964165249558,HSPA6/CRYAB/HSPB6/HSPA1A/HSPA1B/FKBP5/HSPB1/CLU,8
GO:0003016,respiratory system process,1/565,20/10364,0.6744427242965725,0.827514889804963,0.5448964165249558,ATP1A2,1
GO:0003382,epithelial cell morphogenesis,1/565,20/10364,0.6744427242965725,0.827514889804963,0.5448964165249558,COL15A1,1
GO:0007215,glutamate receptor signaling pathway,1/565,20/10364,0.6744427242965725,0.827514889804963,0.5448964165249558,CX3CL1,1
GO:0009268,response to pH,1/565,20/10364,0.6744427242965725,0.827514889804963,0.5448964165249558,CA2,1
GO:0016202,regulation of striated muscle tissue development,1/565,20/10364,0.6744427242965725,0.827514889804963,0.5448964165249558,IGF2,1
GO:0018230,peptidyl-L-cysteine S-palmitoylation,1/565,20/10364,0.6744427242965725,0.827514889804963,0.5448964165249558,ZDHHC11B,1
GO:0018231,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine,1/565,20/10364,0.6744427242965725,0.827514889804963,0.5448964165249558,ZDHHC11B,1
GO:0021515,cell differentiation in spinal cord,1/565,20/10364,0.6744427242965725,0.827514889804963,0.5448964165249558,MDGA1,1
GO:0034389,lipid droplet organization,1/565,20/10364,0.6744427242965725,0.827514889804963,0.5448964165249558,PLIN5,1
GO:0035024,negative regulation of Rho protein signal transduction,1/565,20/10364,0.6744427242965725,0.827514889804963,0.5448964165249558,BCL6,1
GO:0039531,regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway,1/565,20/10364,0.6744427242965725,0.827514889804963,0.5448964165249558,BIRC3,1
GO:0044273,sulfur compound catabolic process,1/565,20/10364,0.6744427242965725,0.827514889804963,0.5448964165249558,GGT5,1
GO:0044331,cell-cell adhesion mediated by cadherin,1/565,20/10364,0.6744427242965725,0.827514889804963,0.5448964165249558,VEGFA,1
GO:0045577,regulation of B cell differentiation,1/565,20/10364,0.6744427242965725,0.827514889804963,0.5448964165249558,SFRP1,1
GO:0051647,nucleus localization,1/565,20/10364,0.6744427242965725,0.827514889804963,0.5448964165249558,NTN1,1
GO:0062098,regulation of programmed necrotic cell death,1/565,20/10364,0.6744427242965725,0.827514889804963,0.5448964165249558,BIRC3,1
GO:0098815,modulation of excitatory postsynaptic potential,1/565,20/10364,0.6744427242965725,0.827514889804963,0.5448964165249558,RELN,1
GO:1901223,negative regulation of NIK/NF-kappaB signaling,1/565,20/10364,0.6744427242965725,0.827514889804963,0.5448964165249558,CCN3,1
GO:1901522,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus,1/565,20/10364,0.6744427242965725,0.827514889804963,0.5448964165249558,VEGFA,1
GO:2000515,"negative regulation of CD4-positive, alpha-beta T cell activation",1/565,20/10364,0.6744427242965725,0.827514889804963,0.5448964165249558,BCL6,1
GO:0031330,negative regulation of cellular catabolic process,10/565,203/10364,0.6751006749284318,0.827514889804963,0.5448964165249558,MFSD2A/TENT5C/PLIN5/ZFP36/APOC1/SLC11A1/TIMP3/HMOX1/NAMPT/TIMP1,10
GO:0006695,cholesterol biosynthetic process,2/565,42/10364,0.6757162375715661,0.827514889804963,0.5448964165249558,CES1/APOE,2
GO:0006821,chloride transport,2/565,42/10364,0.6757162375715661,0.827514889804963,0.5448964165249558,CLIC6/SLC1A3,2
GO:0042149,cellular response to glucose starvation,2/565,42/10364,0.6757162375715661,0.827514889804963,0.5448964165249558,LOC102724428/SIK1,2
GO:0051496,positive regulation of stress fiber assembly,2/565,42/10364,0.6757162375715661,0.827514889804963,0.5448964165249558,CCN2/SFRP1,2
GO:0086003,cardiac muscle cell contraction,2/565,42/10364,0.6757162375715661,0.827514889804963,0.5448964165249558,ATP1A2/PLN,2
GO:1902653,secondary alcohol biosynthetic process,2/565,42/10364,0.6757162375715661,0.827514889804963,0.5448964165249558,CES1/APOE,2
GO:0001838,embryonic epithelial tube formation,4/565,84/10364,0.679226814792006,0.8315653647603087,0.5475635459211556,ADM/SOX9/SFRP2/SFRP1,4
GO:0010821,regulation of mitochondrion organization,6/565,125/10364,0.6832890320011102,0.8362885790769942,0.5506736561890783,DCN/IGF1/TNFSF10/HSPA1A/GPER1/CLU,6
GO:0106027,neuron projection organization,3/565,64/10364,0.6857089489165364,0.8387488607302959,0.5522936858381425,FCGR2B/APOE/RELN,3
GO:1901879,regulation of protein depolymerization,3/565,64/10364,0.6857089489165364,0.8387488607302959,0.5522936858381425,NES/LMOD1/MAP1B,3
GO:0019080,viral gene expression,4/565,85/10364,0.6882321250030115,0.8405179515407348,0.5534585848085317,JUN/IFITM3/CCL5/ZFP36,4
GO:0016925,protein sumoylation,2/565,43/10364,0.6882721702843,0.8405179515407348,0.5534585848085317,EGR2/EGR1,2
GO:0046513,ceramide biosynthetic process,2/565,43/10364,0.6882721702843,0.8405179515407348,0.5534585848085317,CCN1/P2RX1,2
GO:0060078,regulation of postsynaptic membrane potential,2/565,43/10364,0.6882721702843,0.8405179515407348,0.5534585848085317,P2RX1/RELN,2
GO:0070265,necrotic cell death,2/565,43/10364,0.6882721702843,0.8405179515407348,0.5534585848085317,MTCO2P12/BIRC3,2
GO:0006643,membrane lipid metabolic process,7/565,146/10364,0.6901234564272083,0.8405179515407348,0.5534585848085317,CCN1/P2RX1/ABCA8/CYP1B1/ITGB8/ENPP2/PLPP2,7
GO:0002715,regulation of natural killer cell mediated immunity,1/565,21/10364,0.6922250000866379,0.8405179515407348,0.5534585848085317,HLA-G,1
GO:0006359,regulation of transcription by RNA polymerase III,1/565,21/10364,0.6922250000866379,0.8405179515407348,0.5534585848085317,TENM1,1
GO:0008156,negative regulation of DNA replication,1/565,21/10364,0.6922250000866379,0.8405179515407348,0.5534585848085317,BCL6,1
GO:0014072,response to isoquinoline alkaloid,1/565,21/10364,0.6922250000866379,0.8405179515407348,0.5534585848085317,FOSB,1
GO:0030149,sphingolipid catabolic process,1/565,21/10364,0.6922250000866379,0.8405179515407348,0.5534585848085317,ENPP2,1
GO:0033233,regulation of protein sumoylation,1/565,21/10364,0.6922250000866379,0.8405179515407348,0.5534585848085317,EGR1,1
GO:0034331,cell junction maintenance,1/565,21/10364,0.6922250000866379,0.8405179515407348,0.5534585848085317,CSF1R,1
GO:0036474,cell death in response to hydrogen peroxide,1/565,21/10364,0.6922250000866379,0.8405179515407348,0.5534585848085317,NR4A3,1
GO:0042269,regulation of natural killer cell mediated cytotoxicity,1/565,21/10364,0.6922250000866379,0.8405179515407348,0.5534585848085317,HLA-G,1
GO:0043278,response to morphine,1/565,21/10364,0.6922250000866379,0.8405179515407348,0.5534585848085317,FOSB,1
GO:0043368,positive T cell selection,1/565,21/10364,0.6922250000866379,0.8405179515407348,0.5534585848085317,CD3E,1
GO:0048634,regulation of muscle organ development,1/565,21/10364,0.6922250000866379,0.8405179515407348,0.5534585848085317,IGF2,1
GO:0050687,negative regulation of defense response to virus,1/565,21/10364,0.6922250000866379,0.8405179515407348,0.5534585848085317,FGL2,1
GO:0051339,regulation of lyase activity,1/565,21/10364,0.6922250000866379,0.8405179515407348,0.5534585848085317,NPR3,1
GO:0051703,biological process involved in intraspecies interaction between organisms,1/565,21/10364,0.6922250000866379,0.8405179515407348,0.5534585848085317,LTF,1
GO:0090382,phagosome maturation,1/565,21/10364,0.6922250000866379,0.8405179515407348,0.5534585848085317,SYT7,1
GO:1903077,negative regulation of protein localization to plasma membrane,1/565,21/10364,0.6922250000866379,0.8405179515407348,0.5534585848085317,GBP1,1
GO:1903203,regulation of oxidative stress-induced neuron death,1/565,21/10364,0.6922250000866379,0.8405179515407348,0.5534585848085317,NR4A3,1
GO:0031333,negative regulation of protein-containing complex assembly,5/565,106/10364,0.6926984778940986,0.8405179515407348,0.5534585848085317,LMOD1/CRYAB/SOX9/SLIT2/CLU,5
GO:0043401,steroid hormone mediated signaling pathway,5/565,106/10364,0.6926984778940986,0.8405179515407348,0.5534585848085317,LMO3/GPER1/SFRP1/NR4A3/PADI2,5
GO:0051260,protein homooligomerization,5/565,106/10364,0.6926984778940986,0.8405179515407348,0.5534585848085317,GBP5/PRF1/ALDH1A3/HLA-G/STEAP4,5
GO:0009566,fertilization,3/565,65/10364,0.6958403756244672,0.8440801474982427,0.5558041955475277,FOLR2/CACNA1H/PLAT,3
GO:0002244,hematopoietic progenitor cell differentiation,4/565,86/10364,0.6970574311488555,0.8450557071730572,0.5564465754943563,ACE/CSF1R/SFRP1/TOP2A,4
GO:0051053,negative regulation of DNA metabolic process,4/565,86/10364,0.6970574311488555,0.8450557071730572,0.5564465754943563,BCL6/DUSP1/H1-2/CDKN1A,4
GO:0003143,embryonic heart tube morphogenesis,2/565,44/10364,0.7004258330215465,0.8480827695940341,0.5584398151159133,APLNR/SOX18,2
GO:0033059,cellular pigmentation,2/565,44/10364,0.7004258330215465,0.8480827695940341,0.5584398151159133,MLPH/RAB27B,2
GO:0035065,regulation of histone acetylation,2/565,44/10364,0.7004258330215465,0.8480827695940341,0.5584398151159133,MUC1/LIF,2
GO:0043266,regulation of potassium ion transport,2/565,44/10364,0.7004258330215465,0.8480827695940341,0.5584398151159133,ADRA2A/KCNN4,2
GO:0001889,liver development,5/565,107/10364,0.700590114012463,0.8480827695940341,0.5584398151159133,MDK/SOX9/FRZB/HMOX1/PTN,5
GO:0008064,regulation of actin polymerization or depolymerization,7/565,148/10364,0.7036457875487552,0.8515299598653869,0.5607096976873103,LMOD1/CXCL12/ICAM1/SLIT2/ELN/CCL21/TENM1,7
GO:0015698,inorganic anion transport,4/565,87/10364,0.7057026049373532,0.8532870872033504,0.5618667190311318,ABCC3/SLC11A1/CLIC6/SLC1A3,4
GO:0030968,endoplasmic reticulum unfolded protein response,3/565,66/10364,0.7057230281559709,0.8532870872033504,0.5618667190311318,ATF3/CREB3L1/DERL3,3
GO:0031110,regulation of microtubule polymerization or depolymerization,3/565,66/10364,0.7057230281559709,0.8532870872033504,0.5618667190311318,MAP1B/HSPA1A/HSPA1B,3
GO:0006622,protein targeting to lysosome,1/565,22/10364,0.7090376148938551,0.853764704522189,0.5621812172579452,CLU,1
GO:0006760,folic acid-containing compound metabolic process,1/565,22/10364,0.7090376148938551,0.853764704522189,0.5621812172579452,ALDH1L1,1
GO:0007035,vacuolar acidification,1/565,22/10364,0.7090376148938551,0.853764704522189,0.5621812172579452,SLC11A1,1
GO:0009264,deoxyribonucleotide catabolic process,1/565,22/10364,0.7090376148938551,0.853764704522189,0.5621812172579452,TYMP,1
GO:0018279,protein N-linked glycosylation via asparagine,1/565,22/10364,0.7090376148938551,0.853764704522189,0.5621812172579452,DERL3,1
GO:0018904,ether metabolic process,1/565,22/10364,0.7090376148938551,0.853764704522189,0.5621812172579452,ALOX5,1
GO:0031114,regulation of microtubule depolymerization,1/565,22/10364,0.7090376148938551,0.853764704522189,0.5621812172579452,MAP1B,1
GO:0034123,positive regulation of toll-like receptor signaling pathway,1/565,22/10364,0.7090376148938551,0.853764704522189,0.5621812172579452,LTF,1
GO:0034311,diol metabolic process,1/565,22/10364,0.7090376148938551,0.853764704522189,0.5621812172579452,PLPP2,1
GO:0048536,spleen development,1/565,22/10364,0.7090376148938551,0.853764704522189,0.5621812172579452,BCL3,1
GO:0070861,regulation of protein exit from endoplasmic reticulum,1/565,22/10364,0.7090376148938551,0.853764704522189,0.5621812172579452,DERL3,1
GO:0072529,pyrimidine-containing compound catabolic process,1/565,22/10364,0.7090376148938551,0.853764704522189,0.5621812172579452,TYMP,1
GO:1900027,regulation of ruffle assembly,1/565,22/10364,0.7090376148938551,0.853764704522189,0.5621812172579452,ICAM1,1
GO:1904376,negative regulation of protein localization to cell periphery,1/565,22/10364,0.7090376148938551,0.853764704522189,0.5621812172579452,GBP1,1
GO:0030041,actin filament polymerization,7/565,149/10364,0.7102594702848258,0.8547331779382943,0.5628189310929914,LMOD1/ICAM1/FAM107A/SLIT2/ELN/CCL21/TENM1,7
GO:0030832,regulation of actin filament length,7/565,149/10364,0.7102594702848258,0.8547331779382943,0.5628189310929914,LMOD1/CXCL12/ICAM1/SLIT2/ELN/CCL21/TENM1,7
GO:0051258,protein polymerization,11/565,229/10364,0.7107602996280342,0.8550845332580582,0.5630502891712872,LMOD1/TPPP3/ICAM1/FAM107A/SLIT2/MAP1B/HSPA1A/HSPA1B/ELN/CCL21/TENM1,11
GO:0002260,lymphocyte homeostasis,2/565,45/10364,0.7121836855598593,0.8552889435852344,0.5631848879031665,TNFSF14/TSC22D3,2
GO:0034198,cellular response to amino acid starvation,2/565,45/10364,0.7121836855598593,0.8552889435852344,0.5631848879031665,ATF3/CDKN1A,2
GO:0061178,regulation of insulin secretion involved in cellular response to glucose stimulus,2/565,45/10364,0.7121836855598593,0.8552889435852344,0.5631848879031665,ADRA2A/HLA-DRB1,2
GO:0061180,mammary gland epithelium development,2/565,45/10364,0.7121836855598593,0.8552889435852344,0.5631848879031665,NTN1/CSF1R,2
GO:0120193,tight junction organization,2/565,45/10364,0.7121836855598593,0.8552889435852344,0.5631848879031665,CLDN5/SVEP1,2
GO:1902743,regulation of lamellipodium organization,2/565,45/10364,0.7121836855598593,0.8552889435852344,0.5631848879031665,SLIT2/ENPP2,2
GO:0072329,monocarboxylic acid catabolic process,4/565,88/10364,0.7141677585652255,0.8574201769988368,0.5645882480893788,MFSD2A/PLIN5/CYP4F12/CYP26B1,4
GO:0001738,morphogenesis of a polarized epithelium,3/565,67/10364,0.715358326474035,0.8580946348036036,0.565032360510125,SFRP2/SFRP1/GPC3,3
GO:0032411,positive regulation of transporter activity,3/565,67/10364,0.715358326474035,0.8580946348036036,0.565032360510125,CCL2/SGK1/RELN,3
GO:0036473,cell death in response to oxidative stress,3/565,67/10364,0.715358326474035,0.8580946348036036,0.565032360510125,CYP1B1/HSPB1/NR4A3,3
GO:0061008,hepaticobiliary system development,5/565,109/10364,0.7159497719267174,0.8585525384499064,0.5653338778109713,MDK/SOX9/FRZB/HMOX1/PTN,5
GO:0070201,regulation of establishment of protein localization,20/565,407/10364,0.7186308788941634,0.8615153201149942,0.5672847902744711,PTGS2/ALOX5/ADRA2A/SYT7/IGF1/IFI27/CCL5/APOE/INHBB/APOD/CD38/HLA-DRB1/GPER1/CD36/SFRP1/ANGPT1/CCN3/TENM1/KCNN4/DERL3,20
GO:0008286,insulin receptor signaling pathway,4/565,89/10364,0.7224532314426797,0.8620032404062703,0.5676060727330003,AGT/IGF2/SOCS3/PDK4,4
GO:0040029,"regulation of gene expression, epigenetic",4/565,89/10364,0.7224532314426797,0.8620032404062703,0.5676060727330003,IGF2/KLF2/XIST/PADI2,4
GO:0072175,epithelial tube formation,4/565,89/10364,0.7224532314426797,0.8620032404062703,0.5676060727330003,ADM/SOX9/SFRP2/SFRP1,4
GO:0006767,water-soluble vitamin metabolic process,2/565,46/10364,0.7235526792550071,0.8620032404062703,0.5676060727330003,NNMT/SLC2A3,2
GO:0030101,natural killer cell activation,2/565,46/10364,0.7235526792550071,0.8620032404062703,0.5676060727330003,TYROBP/SLAMF7,2
GO:0030837,negative regulation of actin filament polymerization,2/565,46/10364,0.7235526792550071,0.8620032404062703,0.5676060727330003,LMOD1/SLIT2,2
GO:0060998,regulation of dendritic spine development,2/565,46/10364,0.7235526792550071,0.8620032404062703,0.5676060727330003,APOE/RELN,2
GO:1903078,positive regulation of protein localization to plasma membrane,2/565,46/10364,0.7235526792550071,0.8620032404062703,0.5676060727330003,GPER1/RAMP3,2
GO:0000038,very long-chain fatty acid metabolic process,1/565,23/10364,0.7249333553294549,0.8620032404062703,0.5676060727330003,CYP4F12,1
GO:0002714,positive regulation of B cell mediated immunity,1/565,23/10364,0.7249333553294549,0.8620032404062703,0.5676060727330003,C3,1
GO:0002891,positive regulation of immunoglobulin mediated immune response,1/565,23/10364,0.7249333553294549,0.8620032404062703,0.5676060727330003,C3,1
GO:0007094,mitotic spindle assembly checkpoint signaling,1/565,23/10364,0.7249333553294549,0.8620032404062703,0.5676060727330003,DUSP1,1
GO:0018196,peptidyl-asparagine modification,1/565,23/10364,0.7249333553294549,0.8620032404062703,0.5676060727330003,DERL3,1
GO:0021587,cerebellum morphogenesis,1/565,23/10364,0.7249333553294549,0.8620032404062703,0.5676060727330003,SERPINE2,1
GO:0033006,regulation of mast cell activation involved in immune response,1/565,23/10364,0.7249333553294549,0.8620032404062703,0.5676060727330003,HMOX1,1
GO:0043304,regulation of mast cell degranulation,1/565,23/10364,0.7249333553294549,0.8620032404062703,0.5676060727330003,HMOX1,1
GO:0045948,positive regulation of translational initiation,1/565,23/10364,0.7249333553294549,0.8620032404062703,0.5676060727330003,CCL5,1
GO:0046386,deoxyribose phosphate catabolic process,1/565,23/10364,0.7249333553294549,0.8620032404062703,0.5676060727330003,TYMP,1
GO:0046640,regulation of alpha-beta T cell proliferation,1/565,23/10364,0.7249333553294549,0.8620032404062703,0.5676060727330003,CD3E,1
GO:0051150,regulation of smooth muscle cell differentiation,1/565,23/10364,0.7249333553294549,0.8620032404062703,0.5676060727330003,GPER1,1
GO:0051560,mitochondrial calcium ion homeostasis,1/565,23/10364,0.7249333553294549,0.8620032404062703,0.5676060727330003,TGM2,1
GO:0051788,response to misfolded protein,1/565,23/10364,0.7249333553294549,0.8620032404062703,0.5676060727330003,CLU,1
GO:0071173,spindle assembly checkpoint signaling,1/565,23/10364,0.7249333553294549,0.8620032404062703,0.5676060727330003,DUSP1,1
GO:0071174,mitotic spindle checkpoint signaling,1/565,23/10364,0.7249333553294549,0.8620032404062703,0.5676060727330003,DUSP1,1
GO:0099054,presynapse assembly,1/565,23/10364,0.7249333553294549,0.8620032404062703,0.5676060727330003,MDGA1,1
GO:1902175,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,1/565,23/10364,0.7249333553294549,0.8620032404062703,0.5676060727330003,HSPB1,1
GO:1902476,chloride transmembrane transport,1/565,23/10364,0.7249333553294549,0.8620032404062703,0.5676060727330003,SLC1A3,1
GO:2000036,regulation of stem cell population maintenance,1/565,23/10364,0.7249333553294549,0.8620032404062703,0.5676060727330003,PTN,1
GO:1901988,negative regulation of cell cycle phase transition,8/565,173/10364,0.7334903423835069,0.8714017719997815,0.573794754349482,MUC1/CCL2/SUSD2/FAM107A/DUSP1/CDKN1A/GPNMB/KLF4,8
GO:0031397,negative regulation of protein ubiquitination,3/565,69/10364,0.7338942072514808,0.8714017719997815,0.573794754349482,ISG15/HSPA1A/HSPA1B,3
GO:0006754,ATP biosynthetic process,2/565,47/10364,0.7345401844580474,0.8714017719997815,0.573794754349482,MTCO2P12/H19,2
GO:0016126,sterol biosynthetic process,2/565,47/10364,0.7345401844580474,0.8714017719997815,0.573794754349482,CES1/APOE,2
GO:0018958,phenol-containing compound metabolic process,2/565,47/10364,0.7345401844580474,0.8714017719997815,0.573794754349482,NR4A2/MOXD1,2
GO:0033692,cellular polysaccharide biosynthetic process,2/565,47/10364,0.7345401844580474,0.8714017719997815,0.573794754349482,IGF2/IGF1,2
GO:0035050,embryonic heart tube development,2/565,47/10364,0.7345401844580474,0.8714017719997815,0.573794754349482,APLNR/SOX18,2
GO:2001244,positive regulation of intrinsic apoptotic signaling pathway,2/565,47/10364,0.7345401844580474,0.8714017719997815,0.573794754349482,S100A9/S100A8,2
GO:0030833,regulation of actin filament polymerization,6/565,133/10364,0.7393287655096819,0.8727758565189461,0.5746995522446252,LMOD1/ICAM1/SLIT2/ELN/CCL21/TENM1,6
GO:0014003,oligodendrocyte development,1/565,24/10364,0.7399621392225847,0.8727758565189461,0.5746995522446252,CLU,1
GO:0031279,regulation of cyclase activity,1/565,24/10364,0.7399621392225847,0.8727758565189461,0.5746995522446252,NPR3,1
GO:0031577,spindle checkpoint signaling,1/565,24/10364,0.7399621392225847,0.8727758565189461,0.5746995522446252,DUSP1,1
GO:0032469,endoplasmic reticulum calcium ion homeostasis,1/565,24/10364,0.7399621392225847,0.8727758565189461,0.5746995522446252,TGM2,1
GO:0032814,regulation of natural killer cell activation,1/565,24/10364,0.7399621392225847,0.8727758565189461,0.5746995522446252,TYROBP,1
GO:0033046,negative regulation of sister chromatid segregation,1/565,24/10364,0.7399621392225847,0.8727758565189461,0.5746995522446252,DUSP1,1
GO:0033048,negative regulation of mitotic sister chromatid segregation,1/565,24/10364,0.7399621392225847,0.8727758565189461,0.5746995522446252,DUSP1,1
GO:0033260,nuclear DNA replication,1/565,24/10364,0.7399621392225847,0.8727758565189461,0.5746995522446252,BCL6,1
GO:0035774,positive regulation of insulin secretion involved in cellular response to glucose stimulus,1/565,24/10364,0.7399621392225847,0.8727758565189461,0.5746995522446252,HLA-DRB1,1
GO:0045841,negative regulation of mitotic metaphase/anaphase transition,1/565,24/10364,0.7399621392225847,0.8727758565189461,0.5746995522446252,DUSP1,1
GO:0051443,positive regulation of ubiquitin-protein transferase activity,1/565,24/10364,0.7399621392225847,0.8727758565189461,0.5746995522446252,ARRDC3,1
GO:0060390,regulation of SMAD protein signal transduction,1/565,24/10364,0.7399621392225847,0.8727758565189461,0.5746995522446252,CCN3,1
GO:0062237,protein localization to postsynapse,1/565,24/10364,0.7399621392225847,0.8727758565189461,0.5746995522446252,NSG1,1
GO:1902253,regulation of intrinsic apoptotic signaling pathway by p53 class mediator,1/565,24/10364,0.7399621392225847,0.8727758565189461,0.5746995522446252,MUC1,1
GO:1903539,protein localization to postsynaptic membrane,1/565,24/10364,0.7399621392225847,0.8727758565189461,0.5746995522446252,NSG1,1
GO:1903902,positive regulation of viral life cycle,1/565,24/10364,0.7399621392225847,0.8727758565189461,0.5746995522446252,HLA-DRB1,1
GO:1904031,positive regulation of cyclin-dependent protein kinase activity,1/565,24/10364,0.7399621392225847,0.8727758565189461,0.5746995522446252,CDKN1A,1
GO:2000144,"positive regulation of DNA-templated transcription, initiation",1/565,24/10364,0.7399621392225847,0.8727758565189461,0.5746995522446252,JUN,1
GO:2000816,negative regulation of mitotic sister chromatid separation,1/565,24/10364,0.7399621392225847,0.8727758565189461,0.5746995522446252,DUSP1,1
GO:0007283,spermatogenesis,12/565,255/10364,0.7416887732218782,0.87456043708824,0.5758746508068245,RGS2/BIRC3/ZBTB16/TMEM119/ACE/SOX9/CYP26B1/SPATC1L/GGT5/BCL6/ADAMTS2/ADAM28,12
GO:0000018,regulation of DNA recombination,3/565,70/10364,0.7427992149689551,0.8756176176455233,0.5765707759211645,BCL6/IL7R/H1-2,3
GO:0016052,carbohydrate catabolic process,5/565,113/10364,0.7449728314892992,0.87713058261383,0.577567022876615,DDIT4/IGF1/HK2/HK3/MLXIPL,5
GO:0001578,microtubule bundle formation,2/565,48/10364,0.7451539243602591,0.87713058261383,0.577567022876615,TPPP3/MAP1B,2
GO:0035306,positive regulation of dephosphorylation,2/565,48/10364,0.7451539243602591,0.87713058261383,0.577567022876615,LILRB2/PDGFRB,2
GO:0090307,mitotic spindle assembly,2/565,48/10364,0.7451539243602591,0.87713058261383,0.577567022876615,HSPA1A/HSPA1B,2
GO:1990928,response to amino acid starvation,2/565,48/10364,0.7451539243602591,0.87713058261383,0.577567022876615,ATF3/CDKN1A,2
GO:1903312,negative regulation of mRNA metabolic process,3/565,71/10364,0.7514656675247726,0.8826691752907644,0.5812140379810371,TENT5C/ZFP36/SLC11A1,3
GO:0021915,neural tube development,5/565,114/10364,0.7518765227751001,0.8826691752907644,0.5812140379810371,PHGDH/ADM/SFRP2/SEMA3C/SFRP1,5
GO:0030518,intracellular steroid hormone receptor signaling pathway,4/565,93/10364,0.7538123375984896,0.8826691752907644,0.5812140379810371,LMO3/GPER1/SFRP1/PADI2,4
GO:0031047,gene silencing by RNA,4/565,93/10364,0.7538123375984896,0.8826691752907644,0.5812140379810371,H19/NEAT1/MEG3/ZFP36,4
GO:0007095,mitotic G2 DNA damage checkpoint signaling,1/565,25/10364,0.754171171266999,0.8826691752907644,0.5812140379810371,CDKN1A,1
GO:0008542,visual learning,1/565,25/10364,0.754171171266999,0.8826691752907644,0.5812140379810371,ATP1A2,1
GO:0021575,hindbrain morphogenesis,1/565,25/10364,0.754171171266999,0.8826691752907644,0.5812140379810371,SERPINE2,1
GO:0030201,heparan sulfate proteoglycan metabolic process,1/565,25/10364,0.754171171266999,0.8826691752907644,0.5812140379810371,SULF1,1
GO:0031018,endocrine pancreas development,1/565,25/10364,0.754171171266999,0.8826691752907644,0.5812140379810371,SOX9,1
GO:0032924,activin receptor signaling pathway,1/565,25/10364,0.754171171266999,0.8826691752907644,0.5812140379810371,INHBB,1
GO:0036475,neuron death in response to oxidative stress,1/565,25/10364,0.754171171266999,0.8826691752907644,0.5812140379810371,NR4A3,1
GO:0044786,cell cycle DNA replication,1/565,25/10364,0.754171171266999,0.8826691752907644,0.5812140379810371,BCL6,1
GO:0051569,regulation of histone H3-K4 methylation,1/565,25/10364,0.754171171266999,0.8826691752907644,0.5812140379810371,NNMT,1
GO:0051985,negative regulation of chromosome segregation,1/565,25/10364,0.754171171266999,0.8826691752907644,0.5812140379810371,DUSP1,1
GO:0097421,liver regeneration,1/565,25/10364,0.754171171266999,0.8826691752907644,0.5812140379810371,HMOX1,1
GO:1901797,negative regulation of signal transduction by p53 class mediator,1/565,25/10364,0.754171171266999,0.8826691752907644,0.5812140379810371,MUC1,1
GO:1901976,regulation of cell cycle checkpoint,1/565,25/10364,0.754171171266999,0.8826691752907644,0.5812140379810371,DUSP1,1
GO:1902100,negative regulation of metaphase/anaphase transition of cell cycle,1/565,25/10364,0.754171171266999,0.8826691752907644,0.5812140379810371,DUSP1,1
GO:1905819,negative regulation of chromosome separation,1/565,25/10364,0.754171171266999,0.8826691752907644,0.5812140379810371,DUSP1,1
GO:2000637,positive regulation of gene silencing by miRNA,1/565,25/10364,0.754171171266999,0.8826691752907644,0.5812140379810371,ZFP36,1
GO:0002065,columnar/cuboidal epithelial cell differentiation,2/565,49/10364,0.755401914783689,0.8833520248855821,0.5816636761710271,CDKN1A/SERPINE1,2
GO:0048814,regulation of dendrite morphogenesis,2/565,49/10364,0.755401914783689,0.8833520248855821,0.5816636761710271,ID1/RELN,2
GO:0051568,histone H3-K4 methylation,2/565,49/10364,0.755401914783689,0.8833520248855821,0.5816636761710271,NNMT/H1-2,2
GO:0034250,positive regulation of cellular amide metabolic process,6/565,136/10364,0.7584192277233458,0.8866271611363157,0.583820265772788,CCN1/NIBAN1/THBS1/CCL5/BCL3/CLU,6
GO:0051099,positive regulation of binding,6/565,137/10364,0.7645502259305121,0.8905632910778576,0.5864121020364573,IGF1/ACE/APOE/RAMP1/CLDN5/KLF4,6
GO:0046902,regulation of mitochondrial membrane permeability,2/565,50/10364,0.7652924094675138,0.8905632910778576,0.5864121020364573,HK2/HSPA1A,2
GO:0050688,regulation of defense response to virus,2/565,50/10364,0.7652924094675138,0.8905632910778576,0.5864121020364573,IFIT1/FGL2,2
GO:0051058,negative regulation of small GTPase mediated signal transduction,2/565,50/10364,0.7652924094675138,0.8905632910778576,0.5864121020364573,BCL6/SLIT2,2
GO:1903201,regulation of oxidative stress-induced cell death,2/565,50/10364,0.7652924094675138,0.8905632910778576,0.5864121020364573,HSPB1/NR4A3,2
GO:0002433,immune response-regulating cell surface receptor signaling pathway involved in phagocytosis,1/565,26/10364,0.7676050902373193,0.8905632910778576,0.5864121020364573,FCGR2B,1
GO:0008206,bile acid metabolic process,1/565,26/10364,0.7676050902373193,0.8905632910778576,0.5864121020364573,CES1,1
GO:0009112,nucleobase metabolic process,1/565,26/10364,0.7676050902373193,0.8905632910778576,0.5864121020364573,TYMP,1
GO:0010922,positive regulation of phosphatase activity,1/565,26/10364,0.7676050902373193,0.8905632910778576,0.5864121020364573,PDGFRB,1
GO:0018345,protein palmitoylation,1/565,26/10364,0.7676050902373193,0.8905632910778576,0.5864121020364573,ZDHHC11B,1
GO:0032801,receptor catabolic process,1/565,26/10364,0.7676050902373193,0.8905632910778576,0.5864121020364573,APOE,1
GO:0034067,protein localization to Golgi apparatus,1/565,26/10364,0.7676050902373193,0.8905632910778576,0.5864121020364573,GBP5,1
GO:0038096,Fc-gamma receptor signaling pathway involved in phagocytosis,1/565,26/10364,0.7676050902373193,0.8905632910778576,0.5864121020364573,FCGR2B,1
GO:0042059,negative regulation of epidermal growth factor receptor signaling pathway,1/565,26/10364,0.7676050902373193,0.8905632910778576,0.5864121020364573,GPRC5A,1
GO:0045191,regulation of isotype switching,1/565,26/10364,0.7676050902373193,0.8905632910778576,0.5864121020364573,BCL6,1
GO:0045740,positive regulation of DNA replication,1/565,26/10364,0.7676050902373193,0.8905632910778576,0.5864121020364573,JUN,1
GO:0046627,negative regulation of insulin receptor signaling pathway,1/565,26/10364,0.7676050902373193,0.8905632910778576,0.5864121020364573,SOCS3,1
GO:0046633,alpha-beta T cell proliferation,1/565,26/10364,0.7676050902373193,0.8905632910778576,0.5864121020364573,CD3E,1
GO:0048701,embryonic cranial skeleton morphogenesis,1/565,26/10364,0.7676050902373193,0.8905632910778576,0.5864121020364573,PRRX1,1
GO:0050879,multicellular organismal movement,1/565,26/10364,0.7676050902373193,0.8905632910778576,0.5864121020364573,NR4A1,1
GO:0050881,musculoskeletal movement,1/565,26/10364,0.7676050902373193,0.8905632910778576,0.5864121020364573,NR4A1,1
GO:0060148,positive regulation of posttranscriptional gene silencing,1/565,26/10364,0.7676050902373193,0.8905632910778576,0.5864121020364573,ZFP36,1
GO:0060765,regulation of androgen receptor signaling pathway,1/565,26/10364,0.7676050902373193,0.8905632910778576,0.5864121020364573,SFRP1,1
GO:0071353,cellular response to interleukin-4,1/565,26/10364,0.7676050902373193,0.8905632910778576,0.5864121020364573,MRC1,1
GO:0086009,membrane repolarization,1/565,26/10364,0.7676050902373193,0.8905632910778576,0.5864121020364573,ATP1A2,1
GO:1905476,negative regulation of protein localization to membrane,1/565,26/10364,0.7676050902373193,0.8905632910778576,0.5864121020364573,GBP1,1
GO:0001843,neural tube closure,3/565,73/10364,0.7680945238876198,0.8905632910778576,0.5864121020364573,ADM/SFRP2/SFRP1,3
GO:0007156,homophilic cell adhesion via plasma membrane adhesion molecules,3/565,73/10364,0.7680945238876198,0.8905632910778576,0.5864121020364573,HMCN1/PCDH9/CLSTN2,3
GO:0060606,tube closure,3/565,73/10364,0.7680945238876198,0.8905632910778576,0.5864121020364573,ADM/SFRP2/SFRP1,3
GO:0046034,ATP metabolic process,10/565,221/10364,0.7719645363597772,0.8947969455993567,0.5891998502763872,MTCO2P12/ATP1A2/DDIT4/H19/IGF1/HK2/HK3/HSPA1A/HSPA1B/MLXIPL,10
GO:0006334,nucleosome assembly,2/565,51/10364,0.7748338504316454,0.8976145398039491,0.5910551606813345,SOX9/H1-2,2
GO:0051453,regulation of intracellular pH,2/565,51/10364,0.7748338504316454,0.8976145398039491,0.5910551606813345,SLC11A1/CA2,2
GO:0048232,male gamete generation,12/565,263/10364,0.7780637074564529,0.9008948694575927,0.593215169999973,RGS2/BIRC3/ZBTB16/TMEM119/ACE/SOX9/CYP26B1/SPATC1L/GGT5/BCL6/ADAMTS2/ADAM28,12
GO:0000289,nuclear-transcribed mRNA poly(A) tail shortening,1/565,27/10364,0.7803061082307337,0.9008948694575927,0.593215169999973,ZFP36,1
GO:0006084,acetyl-CoA metabolic process,1/565,27/10364,0.7803061082307337,0.9008948694575927,0.593215169999973,PDK4,1
GO:0007632,visual behavior,1/565,27/10364,0.7803061082307337,0.9008948694575927,0.593215169999973,ATP1A2,1
GO:0030851,granulocyte differentiation,1/565,27/10364,0.7803061082307337,0.9008948694575927,0.593215169999973,C1QC,1
GO:0030970,"retrograde protein transport, ER to cytosol",1/565,27/10364,0.7803061082307337,0.9008948694575927,0.593215169999973,DERL3,1
GO:0033047,regulation of mitotic sister chromatid segregation,1/565,27/10364,0.7803061082307337,0.9008948694575927,0.593215169999973,DUSP1,1
GO:0043243,positive regulation of protein-containing complex disassembly,1/565,27/10364,0.7803061082307337,0.9008948694575927,0.593215169999973,NES,1
GO:0043330,response to exogenous dsRNA,1/565,27/10364,0.7803061082307337,0.9008948694575927,0.593215169999973,IFIT1,1
GO:0070266,necroptotic process,1/565,27/10364,0.7803061082307337,0.9008948694575927,0.593215169999973,BIRC3,1
GO:0070670,response to interleukin-4,1/565,27/10364,0.7803061082307337,0.9008948694575927,0.593215169999973,MRC1,1
GO:1903513,endoplasmic reticulum to cytosol transport,1/565,27/10364,0.7803061082307337,0.9008948694575927,0.593215169999973,DERL3,1
GO:0050821,protein stabilization,7/565,161/10364,0.7818638522343536,0.902438852846756,0.5942318417557252,CRYAB/IGF1/IFI30/TYROBP/HSPA1A/HSPA1B/CLU,7
GO:0006323,DNA packaging,4/565,97/10364,0.7823742271228944,0.9027734176553353,0.5944521437316005,SOX9/H1-2/GPER1/TOP2A,4
GO:0014020,primary neural tube formation,3/565,75/10364,0.7838060146982391,0.9029081759430269,0.5945408784588723,ADM/SFRP2/SFRP1,3
GO:0045017,glycerolipid biosynthetic process,9/565,203/10364,0.783989485429136,0.9029081759430269,0.5945408784588723,FABP3/MFSD2A/DGAT2/SOCS3/PLIN5/C3/LDLR/SIK1/LPL,9
GO:0006611,protein export from nucleus,2/565,52/10364,0.7840348230282024,0.9029081759430269,0.5945408784588723,EGR2/IFI27,2
GO:0035773,insulin secretion involved in cellular response to glucose stimulus,2/565,52/10364,0.7840348230282024,0.9029081759430269,0.5945408784588723,ADRA2A/HLA-DRB1,2
GO:0070059,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,2/565,52/10364,0.7840348230282024,0.9029081759430269,0.5945408784588723,CREB3L1/HSPA1A,2
GO:1901880,negative regulation of protein depolymerization,2/565,52/10364,0.7840348230282024,0.9029081759430269,0.5945408784588723,LMOD1/MAP1B,2
GO:1904377,positive regulation of protein localization to cell periphery,2/565,52/10364,0.7840348230282024,0.9029081759430269,0.5945408784588723,GPER1/RAMP3,2
GO:1901136,carbohydrate derivative catabolic process,5/565,119/10364,0.7843128686883891,0.9029743769432691,0.594584470046464,CHI3L2/CHI3L1/LYVE1/TYMP/ADAMTS9,5
GO:0071897,DNA biosynthetic process,6/565,141/10364,0.7879241109509141,0.9068769497422103,0.5971542098294812,PDGFRB/DUSP1/CDKN1A/CCN2/SMOC2/KLF4,6
GO:0006275,regulation of DNA replication,3/565,76/10364,0.791326404290707,0.9083545502222864,0.5981271702155337,ID3/JUN/BCL6,3
GO:1900182,positive regulation of protein localization to nucleus,3/565,76/10364,0.791326404290707,0.9083545502222864,0.5981271702155337,PTGS2/NGFR/LIF,3
GO:0007019,microtubule depolymerization,1/565,28/10364,0.7923141423653601,0.9083545502222864,0.5981271702155337,MAP1B,1
GO:0007131,reciprocal meiotic recombination,1/565,28/10364,0.7923141423653601,0.9083545502222864,0.5981271702155337,TOP2A,1
GO:0035337,fatty-acyl-CoA metabolic process,1/565,28/10364,0.7923141423653601,0.9083545502222864,0.5981271702155337,DGAT2,1
GO:0042558,pteridine-containing compound metabolic process,1/565,28/10364,0.7923141423653601,0.9083545502222864,0.5981271702155337,ALDH1L1,1
GO:0046636,negative regulation of alpha-beta T cell activation,1/565,28/10364,0.7923141423653601,0.9083545502222864,0.5981271702155337,BCL6,1
GO:0046825,regulation of protein export from nucleus,1/565,28/10364,0.7923141423653601,0.9083545502222864,0.5981271702155337,IFI27,1
GO:0051973,positive regulation of telomerase activity,1/565,28/10364,0.7923141423653601,0.9083545502222864,0.5981271702155337,KLF4,1
GO:0090140,regulation of mitochondrial fission,1/565,28/10364,0.7923141423653601,0.9083545502222864,0.5981271702155337,DCN,1
GO:0097345,mitochondrial outer membrane permeabilization,1/565,28/10364,0.7923141423653601,0.9083545502222864,0.5981271702155337,HSPA1A,1
GO:0140527,reciprocal homologous recombination,1/565,28/10364,0.7923141423653601,0.9083545502222864,0.5981271702155337,TOP2A,1
GO:1900087,positive regulation of G1/S transition of mitotic cell cycle,1/565,28/10364,0.7923141423653601,0.9083545502222864,0.5981271702155337,ADAMTS1,1
GO:1903715,regulation of aerobic respiration,1/565,28/10364,0.7923141423653601,0.9083545502222864,0.5981271702155337,MLXIPL,1
GO:0000271,polysaccharide biosynthetic process,2/565,53/10364,0.7929040153186984,0.9085219811684162,0.5982374190142993,IGF2/IGF1,2
GO:0006024,glycosaminoglycan biosynthetic process,2/565,53/10364,0.7929040153186984,0.9085219811684162,0.5982374190142993,PDGFRB/ANGPT1,2
GO:0031398,positive regulation of protein ubiquitination,4/565,99/10364,0.7956376181824794,0.911399107117815,0.6001319294805553,BIRC3/FAM107A/ARRDC3/ANGPT1,4
GO:0022411,cellular component disassembly,16/565,349/10364,0.7986227163741408,0.9140574684726338,0.6018823893138651,C1QA/C1QC/C1QB/NES/ADAMTS4/LMOD1/DDIT4/MMP2/CX3CL1/C3/HK2/ADAMTS5/MAP1B/GPER1/PADI2/TOP2A,16
GO:0110020,regulation of actomyosin structure organization,3/565,77/10364,0.7986281301237448,0.9140574684726338,0.6018823893138651,EDN1/CCN2/SFRP1,3
GO:0140013,meiotic nuclear division,3/565,77/10364,0.7986281301237448,0.9140574684726338,0.6018823893138651,CYP26B1/LIF/TOP2A,3
GO:0007212,dopamine receptor signaling pathway,1/565,29/10364,0.80366693934326,0.9175160205441457,0.6041597533267058,NSG1,1
GO:0016266,O-glycan processing,1/565,29/10364,0.80366693934326,0.9175160205441457,0.6041597533267058,GALNT15,1
GO:0034243,regulation of transcription elongation from RNA polymerase II promoter,1/565,29/10364,0.80366693934326,0.9175160205441457,0.6041597533267058,RN7SK,1
GO:0045058,T cell selection,1/565,29/10364,0.80366693934326,0.9175160205441457,0.6041597533267058,CD3E,1
GO:0045839,negative regulation of mitotic nuclear division,1/565,29/10364,0.80366693934326,0.9175160205441457,0.6041597533267058,DUSP1,1
GO:0046473,phosphatidic acid metabolic process,1/565,29/10364,0.80366693934326,0.9175160205441457,0.6041597533267058,PLA2G2A,1
GO:0051693,actin filament capping,1/565,29/10364,0.80366693934326,0.9175160205441457,0.6041597533267058,LMOD1,1
GO:1901185,negative regulation of ERBB signaling pathway,1/565,29/10364,0.80366693934326,0.9175160205441457,0.6041597533267058,GPRC5A,1
GO:2000008,regulation of protein localization to cell surface,1/565,29/10364,0.80366693934326,0.9175160205441457,0.6041597533267058,TYROBP,1
GO:0006644,phospholipid metabolic process,13/565,290/10364,0.8050864113792041,0.9188803368236581,0.6050581190973667,PLA2G2A/FABP3/MFSD2A/ABCA8/SOCS3/LDLR/APOC1/CSF1R/PDGFRB/LPL/ENPP2/PLCH2/PLPP2,13
GO:1903321,negative regulation of protein modification by small protein conjugation or removal,3/565,78/10364,0.8057150227674372,0.919341500337204,0.6053617829335818,ISG15/HSPA1A/HSPA1B,3
GO:0090068,positive regulation of cell cycle process,6/565,145/10364,0.8094909144134776,0.9220691384713953,0.6071578596727544,IGF2/IGF1/ADAMTS1/PDGFRB/EDN1/CCN2,6
GO:0006023,aminoglycan biosynthetic process,2/565,55/10364,0.80968210864794,0.9220691384713953,0.6071578596727544,PDGFRB/ANGPT1,2
GO:0009206,purine ribonucleoside triphosphate biosynthetic process,2/565,55/10364,0.80968210864794,0.9220691384713953,0.6071578596727544,MTCO2P12/H19,2
GO:0032507,maintenance of protein location in cell,2/565,55/10364,0.80968210864794,0.9220691384713953,0.6071578596727544,SRGN/HK2,2
GO:0051983,regulation of chromosome segregation,2/565,55/10364,0.80968210864794,0.9220691384713953,0.6071578596727544,DUSP1/MKI67,2
GO:0070252,actin-mediated cell contraction,2/565,55/10364,0.80968210864794,0.9220691384713953,0.6071578596727544,ATP1A2/PLN,2
GO:0071806,protein transmembrane transport,2/565,55/10364,0.80968210864794,0.9220691384713953,0.6071578596727544,AZGP1/ABCA1,2
GO:0002066,columnar/cuboidal epithelial cell development,1/565,30/10364,0.8144001932640204,0.925382845190924,0.6093398468963456,CDKN1A,1
GO:0031111,negative regulation of microtubule polymerization or depolymerization,1/565,30/10364,0.8144001932640204,0.925382845190924,0.6093398468963456,MAP1B,1
GO:0033144,negative regulation of intracellular steroid hormone receptor signaling pathway,1/565,30/10364,0.8144001932640204,0.925382845190924,0.6093398468963456,SFRP1,1
GO:0035825,homologous recombination,1/565,30/10364,0.8144001932640204,0.925382845190924,0.6093398468963456,TOP2A,1
GO:0045747,positive regulation of Notch signaling pathway,1/565,30/10364,0.8144001932640204,0.925382845190924,0.6093398468963456,CCN3,1
GO:0050775,positive regulation of dendrite morphogenesis,1/565,30/10364,0.8144001932640204,0.925382845190924,0.6093398468963456,RELN,1
GO:0060415,muscle tissue morphogenesis,1/565,30/10364,0.8144001932640204,0.925382845190924,0.6093398468963456,MYLK,1
GO:0098900,regulation of action potential,1/565,30/10364,0.8144001932640204,0.925382845190924,0.6093398468963456,CD36,1
GO:0005977,glycogen metabolic process,2/565,56/10364,0.8176085877423157,0.9272270244368533,0.6105541895926726,IGF2/IGF1,2
GO:0006073,cellular glucan metabolic process,2/565,56/10364,0.8176085877423157,0.9272270244368533,0.6105541895926726,IGF2/IGF1,2
GO:0009145,purine nucleoside triphosphate biosynthetic process,2/565,56/10364,0.8176085877423157,0.9272270244368533,0.6105541895926726,MTCO2P12/H19,2
GO:0030641,regulation of cellular pH,2/565,56/10364,0.8176085877423157,0.9272270244368533,0.6105541895926726,SLC11A1/CA2,2
GO:0034637,cellular carbohydrate biosynthetic process,2/565,56/10364,0.8176085877423157,0.9272270244368533,0.6105541895926726,IGF2/IGF1,2
GO:0044042,glucan metabolic process,2/565,56/10364,0.8176085877423157,0.9272270244368533,0.6105541895926726,IGF2/IGF1,2
GO:0060968,regulation of gene silencing,2/565,56/10364,0.8176085877423157,0.9272270244368533,0.6105541895926726,NEAT1/ZFP36,2
GO:0009100,glycoprotein metabolic process,12/565,273/10364,0.8182808983847545,0.927301888827212,0.6106034857908852,DCN/IGF1/RAMP1/GALNT15/ADAMTS9/HBEGF/SULF1/IL33/CCL21/ABO/BGN/DERL3,12
GO:0007281,germ cell development,5/565,125/10364,0.8187909670576313,0.927301888827212,0.6106034857908852,MDK/ZBTB16/IGF1/INHBB/PTN,5
GO:0019751,polyol metabolic process,3/565,80/10364,0.8192601201485162,0.927301888827212,0.6106034857908852,DGAT2/GPER1/PLPP2,3
GO:0032436,positive regulation of proteasomal ubiquitin-dependent protein catabolic process,3/565,80/10364,0.8192601201485162,0.927301888827212,0.6106034857908852,HSPA1A/HSPA1B/CLU,3
GO:0035725,sodium ion transmembrane transport,3/565,80/10364,0.8192601201485162,0.927301888827212,0.6106034857908852,ATP1A2/CACNA1H/SCN7A,3
GO:0042158,lipoprotein biosynthetic process,3/565,80/10364,0.8192601201485162,0.927301888827212,0.6106034857908852,APOE/ZDHHC11B/ABCA1,3
GO:1905477,positive regulation of protein localization to membrane,3/565,80/10364,0.8192601201485162,0.927301888827212,0.6106034857908852,GPER1/RAMP3/PTN,3
GO:0046467,membrane lipid biosynthetic process,4/565,103/10364,0.8202090537666016,0.9281193659813342,0.6111417726270015,CCN1/P2RX1/ABCA8/PLPP2,4
GO:0034249,negative regulation of cellular amide metabolic process,7/565,169/10364,0.8217464141963642,0.9296020502127423,0.6121180805273014,RGS2/IGF1/ZFP36/APOE/IGFBP5/CLU/NTRK2,7
GO:0046578,regulation of Ras protein signal transduction,6/565,148/10364,0.8245140931510756,0.9303417783587882,0.6126051717216097,IGF1/APOE/COL3A1/BCL6/PDGFRB/ABCA1,6
GO:0009394,2'-deoxyribonucleotide metabolic process,1/565,31/10364,0.8245476570540172,0.9303417783587882,0.6126051717216097,TYMP,1
GO:0033120,positive regulation of RNA splicing,1/565,31/10364,0.8245476570540172,0.9303417783587882,0.6126051717216097,HSPA1A,1
GO:0043507,positive regulation of JUN kinase activity,1/565,31/10364,0.8245476570540172,0.9303417783587882,0.6126051717216097,EDN1,1
GO:0048645,animal organ formation,1/565,31/10364,0.8245476570540172,0.9303417783587882,0.6126051717216097,SULF1,1
GO:1900026,positive regulation of substrate adhesion-dependent cell spreading,1/565,31/10364,0.8245476570540172,0.9303417783587882,0.6126051717216097,MDK,1
GO:1902110,positive regulation of mitochondrial membrane permeability involved in apoptotic process,1/565,31/10364,0.8245476570540172,0.9303417783587882,0.6126051717216097,HSPA1A,1
GO:1905898,positive regulation of response to endoplasmic reticulum stress,1/565,31/10364,0.8245476570540172,0.9303417783587882,0.6126051717216097,FCGR2B,1
GO:2000142,"regulation of DNA-templated transcription, initiation",1/565,31/10364,0.8245476570540172,0.9303417783587882,0.6126051717216097,JUN,1
GO:0045732,positive regulation of protein catabolic process,8/565,191/10364,0.8246727683595608,0.9303417783587882,0.6126051717216097,ADRA2A/SOX9/LDLR/APOE/HSPA1A/HSPA1B/CLU/GPC3,8
GO:0007265,Ras protein signal transduction,12/565,275/10364,0.8256348190956602,0.9305048193829537,0.6127125298742047,JUN/ADRA2A/IGF1/NTN1/NGFR/APOE/COL3A1/BCL6/PDGFRB/CDKN1A/COL1A2/ABCA1,12
GO:0001841,neural tube formation,3/565,81/10364,0.8257264310743211,0.9305048193829537,0.6127125298742047,ADM/SFRP2/SFRP1,3
GO:0030048,actin filament-based movement,3/565,81/10364,0.8257264310743211,0.9305048193829537,0.6127125298742047,ATP1A2/MYO7B/PLN,3
GO:0051261,protein depolymerization,3/565,81/10364,0.8257264310743211,0.9305048193829537,0.6127125298742047,NES/LMOD1/MAP1B,3
GO:0048813,dendrite morphogenesis,4/565,104/10364,0.8259576680550601,0.9305092716063336,0.6127154615441905,DCLK1/ID1/RELN/PTN,4
GO:0009755,hormone-mediated signaling pathway,5/565,127/10364,0.8292515267026979,0.9339630674885405,0.614989693733616,LMO3/GPER1/SFRP1/NR4A3/PADI2,5
GO:1903076,regulation of protein localization to plasma membrane,3/565,82/10364,0.8319940938005483,0.9366813541839418,0.6167796128005232,GBP1/GPER1/RAMP3,3
GO:0006368,transcription elongation from RNA polymerase II promoter,2/565,58/10364,0.8325802266427367,0.9366813541839418,0.6167796128005232,RN7SK/PADI2,2
GO:0032272,negative regulation of protein polymerization,2/565,58/10364,0.8325802266427367,0.9366813541839418,0.6167796128005232,LMOD1/SLIT2,2
GO:0072665,protein localization to vacuole,2/565,58/10364,0.8325802266427367,0.9366813541839418,0.6167796128005232,GBP1/CLU,2
GO:0000413,protein peptidyl-prolyl isomerization,1/565,32/10364,0.8341412478567349,0.9370657718153358,0.6170327415265151,FKBP5,1
GO:0043331,response to dsRNA,1/565,32/10364,0.8341412478567349,0.9370657718153358,0.6170327415265151,IFIT1,1
GO:0071763,nuclear membrane organization,1/565,32/10364,0.8341412478567349,0.9370657718153358,0.6170327415265151,GPER1,1
GO:0090329,regulation of DNA-dependent DNA replication,1/565,32/10364,0.8341412478567349,0.9370657718153358,0.6170327415265151,BCL6,1
GO:1902745,positive regulation of lamellipodium organization,1/565,32/10364,0.8341412478567349,0.9370657718153358,0.6170327415265151,ENPP2,1
GO:0016241,regulation of macroautophagy,5/565,128/10364,0.8342952462791644,0.9370657718153358,0.6170327415265151,DCN/HSPB8/HMOX1/UCHL1/ELAPOR1,5
GO:0072331,signal transduction by p53 class mediator,5/565,129/10364,0.8392168291174096,0.9420382205031418,0.6203069659600817,MUC1/DDIT4/BCL3/CDKN1A/SGK1,5
GO:0051304,chromosome separation,2/565,59/10364,0.8396427617528002,0.9420382205031418,0.6203069659600817,DUSP1/TOP2A,2
GO:0051881,regulation of mitochondrial membrane potential,2/565,59/10364,0.8396427617528002,0.9420382205031418,0.6203069659600817,IFI6/DCN,2
GO:0090559,regulation of membrane permeability,2/565,59/10364,0.8396427617528002,0.9420382205031418,0.6203069659600817,HK2/HSPA1A,2
GO:0009165,nucleotide biosynthetic process,8/565,195/10364,0.841241496271952,0.9431984794082813,0.6210709654088418,MTCO2P12/H19/GUCY1A2/NNMT/PTGIS/ADCY1/PDK4/NAMPT,8
GO:1901293,nucleoside phosphate biosynthetic process,8/565,195/10364,0.841241496271952,0.9431984794082813,0.6210709654088418,MTCO2P12/H19/GUCY1A2/NNMT/PTGIS/ADCY1/PDK4/NAMPT,8
GO:0043467,regulation of generation of precursor metabolites and energy,4/565,107/10364,0.8422960813740812,0.9431984794082813,0.6210709654088418,DDIT4/IGF2/IGF1/MLXIPL,4
GO:0009066,aspartate family amino acid metabolic process,1/565,33/10364,0.8432111467108719,0.9431984794082813,0.6210709654088418,PHGDH,1
GO:0010591,regulation of lamellipodium assembly,1/565,33/10364,0.8432111467108719,0.9431984794082813,0.6210709654088418,SLIT2,1
GO:0016242,negative regulation of macroautophagy,1/565,33/10364,0.8432111467108719,0.9431984794082813,0.6210709654088418,HMOX1,1
GO:0019068,virion assembly,1/565,33/10364,0.8432111467108719,0.9431984794082813,0.6210709654088418,APOE,1
GO:0019692,deoxyribose phosphate metabolic process,1/565,33/10364,0.8432111467108719,0.9431984794082813,0.6210709654088418,TYMP,1
GO:0030835,negative regulation of actin filament depolymerization,1/565,33/10364,0.8432111467108719,0.9431984794082813,0.6210709654088418,LMOD1,1
GO:0042490,mechanoreceptor differentiation,1/565,33/10364,0.8432111467108719,0.9431984794082813,0.6210709654088418,NTRK2,1
GO:1902686,mitochondrial outer membrane permeabilization involved in programmed cell death,1/565,33/10364,0.8432111467108719,0.9431984794082813,0.6210709654088418,HSPA1A,1
GO:0032414,positive regulation of ion transmembrane transporter activity,2/565,60/10364,0.8464345598512996,0.9460836230959032,0.6229707553412202,CCL2/RELN,2
GO:0043242,negative regulation of protein-containing complex disassembly,2/565,60/10364,0.8464345598512996,0.9460836230959032,0.6229707553412202,LMOD1/MAP1B,2
GO:0006650,glycerophospholipid metabolic process,10/565,239/10364,0.8464837106498029,0.9460836230959032,0.6229707553412202,PLA2G2A/FABP3/MFSD2A/SOCS3/LDLR/APOC1/CSF1R/PDGFRB/ENPP2/PLCH2,10
GO:0031396,regulation of protein ubiquitination,7/565,175/10364,0.8477456568857362,0.9472354583215622,0.6237292080224002,ISG15/BIRC3/FAM107A/ARRDC3/HSPA1A/HSPA1B/ANGPT1,7
GO:1903364,positive regulation of cellular protein catabolic process,5/565,131/10364,0.8487005408241011,0.9480436600638117,0.6242613872479422,LDLR/APOE/HSPA1A/HSPA1B/CLU,5
GO:0006790,sulfur compound metabolic process,10/565,240/10364,0.8499938129526415,0.9489225462384685,0.624840110281212,GSTM1/GSTM3/GSTM5/PHGDH/DGAT2/DCN/GGT5/PDK4/ANGPT1/BGN,10
GO:0009262,deoxyribonucleotide metabolic process,1/565,34/10364,0.8517858928253195,0.9489225462384685,0.624840110281212,TYMP,1
GO:0044818,mitotic G2/M transition checkpoint,1/565,34/10364,0.8517858928253195,0.9489225462384685,0.624840110281212,CDKN1A,1
GO:0045599,negative regulation of fat cell differentiation,1/565,34/10364,0.8517858928253195,0.9489225462384685,0.624840110281212,GPER1,1
GO:0046839,phospholipid dephosphorylation,1/565,34/10364,0.8517858928253195,0.9489225462384685,0.624840110281212,PLPP2,1
GO:0048013,ephrin receptor signaling pathway,1/565,34/10364,0.8517858928253195,0.9489225462384685,0.624840110281212,MMP2,1
GO:0061001,regulation of dendritic spine morphogenesis,1/565,34/10364,0.8517858928253195,0.9489225462384685,0.624840110281212,RELN,1
GO:0086065,cell communication involved in cardiac conduction,1/565,34/10364,0.8517858928253195,0.9489225462384685,0.624840110281212,ATP1A2,1
GO:0097300,programmed necrotic cell death,1/565,34/10364,0.8517858928253195,0.9489225462384685,0.624840110281212,BIRC3,1
GO:0001776,leukocyte homeostasis,2/565,61/10364,0.8529640865064885,0.9489225462384685,0.624840110281212,TNFSF14/TSC22D3,2
GO:0006112,energy reserve metabolic process,2/565,61/10364,0.8529640865064885,0.9489225462384685,0.624840110281212,IGF2/IGF1,2
GO:0009201,ribonucleoside triphosphate biosynthetic process,2/565,61/10364,0.8529640865064885,0.9489225462384685,0.624840110281212,MTCO2P12/H19,2
GO:0010770,positive regulation of cell morphogenesis involved in differentiation,2/565,61/10364,0.8529640865064885,0.9489225462384685,0.624840110281212,MDK/RELN,2
GO:0070972,protein localization to endoplasmic reticulum,2/565,61/10364,0.8529640865064885,0.9489225462384685,0.624840110281212,RN7SL1/RN7SL2,2
GO:1901264,carbohydrate derivative transport,2/565,61/10364,0.8529640865064885,0.9489225462384685,0.624840110281212,MFSD2A/ABCC3,2
GO:0031532,actin cytoskeleton reorganization,3/565,86/10364,0.8551625845263897,0.9511099215025915,0.6262804383740357,MDK/FGF7/CSF1R,3
GO:1901990,regulation of mitotic cell cycle phase transition,8/565,199/10364,0.8565506451020101,0.9519739814525281,0.6268493987349714,MUC1/CCL2/ADAMTS1/FAM107A/DUSP1/CDKN1A/GPNMB/KLF4,8
GO:0046434,organophosphate catabolic process,4/565,110/10364,0.8573271215298329,0.9519739814525281,0.6268493987349714,LDLR/APOC1/TYMP/ENPP2,4
GO:0016458,gene silencing,5/565,133/10364,0.8577169181836529,0.9519739814525281,0.6268493987349714,H19/NEAT1/MEG3/ZFP36/XIST,5
GO:1905475,regulation of protein localization to membrane,5/565,133/10364,0.8577169181836529,0.9519739814525281,0.6268493987349714,GBP1/GPER1/RAMP3/PTN/GPC3,5
GO:0000079,regulation of cyclin-dependent protein serine/threonine kinase activity,2/565,62/10364,0.8592396906459203,0.9519739814525281,0.6268493987349714,CDKN1C/CDKN1A,2
GO:0033143,regulation of intracellular steroid hormone receptor signaling pathway,2/565,62/10364,0.8592396906459203,0.9519739814525281,0.6268493987349714,LMO3/SFRP1,2
GO:1901987,regulation of cell cycle phase transition,11/565,264/10364,0.859370566770744,0.9519739814525281,0.6268493987349714,MUC1/CCL2/ADAMTS1/SUSD2/FAM107A/DUSP1/CDKN1A/GPNMB/TCIM/KLF4/PLPP2,11
GO:0002204,somatic recombination of immunoglobulin genes involved in immune response,1/565,35/10364,0.8598924727433924,0.9519739814525281,0.6268493987349714,BCL6,1
GO:0002208,somatic diversification of immunoglobulins involved in immune response,1/565,35/10364,0.8598924727433924,0.9519739814525281,0.6268493987349714,BCL6,1
GO:0006623,protein targeting to vacuole,1/565,35/10364,0.8598924727433924,0.9519739814525281,0.6268493987349714,CLU,1
GO:0042168,heme metabolic process,1/565,35/10364,0.8598924727433924,0.9519739814525281,0.6268493987349714,HMOX1,1
GO:0042307,positive regulation of protein import into nucleus,1/565,35/10364,0.8598924727433924,0.9519739814525281,0.6268493987349714,PTGS2,1
GO:0045190,isotype switching,1/565,35/10364,0.8598924727433924,0.9519739814525281,0.6268493987349714,BCL6,1
GO:0071985,multivesicular body sorting pathway,1/565,35/10364,0.8598924727433924,0.9519739814525281,0.6268493987349714,RAB27B,1
GO:0072348,sulfur compound transport,1/565,35/10364,0.8598924727433924,0.9519739814525281,0.6268493987349714,ABCG2,1
GO:1902108,regulation of mitochondrial membrane permeability involved in apoptotic process,1/565,35/10364,0.8598924727433924,0.9519739814525281,0.6268493987349714,HSPA1A,1
GO:2000649,regulation of sodium ion transmembrane transporter activity,1/565,35/10364,0.8598924727433924,0.9519739814525281,0.6268493987349714,ATP1A2,1
GO:0030038,contractile actin filament bundle assembly,3/565,87/10364,0.8605004409402839,0.9521321095160871,0.626953521834443,CCN2/ELN/SFRP1,3
GO:0043149,stress fiber assembly,3/565,87/10364,0.8605004409402839,0.9521321095160871,0.626953521834443,CCN2/ELN/SFRP1,3
GO:0006635,fatty acid beta-oxidation,2/565,63/10364,0.8652695921138246,0.9571504215385026,0.6302579460468735,MFSD2A/PLIN5,2
GO:1903046,meiotic cell cycle process,3/565,88/10364,0.8656651238476389,0.9573292860702954,0.6303757235559166,CYP26B1/LIF/TOP2A,3
GO:0010508,positive regulation of autophagy,4/565,112/10364,0.866656638714247,0.9573520001970061,0.6303906802006871,DCN/HSPB8/HMOX1/ELAPOR1,4
GO:0044272,sulfur compound biosynthetic process,4/565,112/10364,0.866656638714247,0.9573520001970061,0.6303906802006871,GSTM1/GGT5/PDK4/ANGPT1,4
GO:0140014,mitotic nuclear division,8/565,202/10364,0.8672371194266537,0.9573520001970061,0.6303906802006871,IGF2/IGF1/PDGFRB/DUSP1/EDN1/HSPA1A/HSPA1B/MKI67,8
GO:0000266,mitochondrial fission,1/565,36/10364,0.8675564046729097,0.9573520001970061,0.6303906802006871,DCN,1
GO:0034332,adherens junction organization,1/565,36/10364,0.8675564046729097,0.9573520001970061,0.6303906802006871,VEGFA,1
GO:0035794,positive regulation of mitochondrial membrane permeability,1/565,36/10364,0.8675564046729097,0.9573520001970061,0.6303906802006871,HSPA1A,1
GO:0070830,bicellular tight junction assembly,1/565,36/10364,0.8675564046729097,0.9573520001970061,0.6303906802006871,CLDN5,1
GO:1902808,positive regulation of cell cycle G1/S phase transition,1/565,36/10364,0.8675564046729097,0.9573520001970061,0.6303906802006871,ADAMTS1,1
GO:0032869,cellular response to insulin stimulus,6/565,158/10364,0.8678806822543338,0.95745176856622,0.6304563750027228,AGT/IGF2/SOCS3/INHBB/PDK4/LPL,6
GO:0007264,small GTPase mediated signal transduction,18/565,413/10364,0.8683319813943042,0.9576915764623604,0.6306142820867778,JUN/ADRA2A/IGF1/RRAD/NTN1/NGFR/APOE/COL3A1/TGM2/HMOX1/BCL6/SLIT2/PDGFRB/CDKN1A/COL1A2/RELN/ABCA1/RAP1GAP,18
GO:0044282,small molecule catabolic process,10/565,246/10364,0.8697484322881595,0.958737232576124,0.6313028186633723,MFSD2A/AKR1C3/PLIN5/CYP4F12/APOE/CYP26B1/HK2/THNSL2/ALDH1L1/HK3,10
GO:0051056,regulation of small GTPase mediated signal transduction,10/565,246/10364,0.8697484322881595,0.958737232576124,0.6313028186633723,IGF1/APOE/COL3A1/TGM2/BCL6/SLIT2/PDGFRB/RELN/ABCA1/RAP1GAP,10
GO:0009152,purine ribonucleotide biosynthetic process,5/565,136/10364,0.8703975306928109,0.9591944793153075,0.6316039034084547,MTCO2P12/H19/GUCY1A2/ADCY1/PDK4,5
GO:0044773,mitotic DNA damage checkpoint signaling,2/565,64/10364,0.8710618709266404,0.9594100886665767,0.631745876398093,MUC1/CDKN1A,2
GO:1904029,regulation of cyclin-dependent protein kinase activity,2/565,64/10364,0.8710618709266404,0.9594100886665767,0.631745876398093,CDKN1C/CDKN1A,2
GO:0000280,nuclear division,11/565,268/10364,0.8716469324505504,0.9597962725800304,0.632000168173568,IGF2/IGF1/CYP26B1/LIF/PDGFRB/DUSP1/EDN1/HSPA1A/HSPA1B/MKI67/TOP2A,11
GO:0006687,glycosphingolipid metabolic process,1/565,37/10364,0.8748018182437661,0.9619765360972278,0.6334358133713008,ITGB8,1
GO:0030071,regulation of mitotic metaphase/anaphase transition,1/565,37/10364,0.8748018182437661,0.9619765360972278,0.6334358133713008,DUSP1,1
GO:0045132,meiotic chromosome segregation,1/565,37/10364,0.8748018182437661,0.9619765360972278,0.6334358133713008,TOP2A,1
GO:1904591,positive regulation of protein import,1/565,37/10364,0.8748018182437661,0.9619765360972278,0.6334358133713008,PTGS2,1
GO:1904888,cranial skeletal system development,1/565,37/10364,0.8748018182437661,0.9619765360972278,0.6334358133713008,PRRX1,1
GO:0006333,chromatin assembly or disassembly,3/565,90/10364,0.8754919672027206,0.962218554020923,0.6335951756993762,SOX9/H1-2/PADI2,3
GO:0051225,spindle assembly,3/565,90/10364,0.8754919672027206,0.962218554020923,0.6335951756993762,GOLGA8B/HSPA1A/HSPA1B,3
GO:0007040,lysosome organization,2/565,65/10364,0.8766244580790903,0.9626879107767693,0.6339042345664531,SYT7/ABCA1,2
GO:0080171,lytic vacuole organization,2/565,65/10364,0.8766244580790903,0.9626879107767693,0.6339042345664531,SYT7/ABCA1,2
GO:2001251,negative regulation of chromosome organization,2/565,65/10364,0.8766244580790903,0.9626879107767693,0.6339042345664531,DUSP1/TOP2A,2
GO:0016054,organic acid catabolic process,6/565,161/10364,0.8790140586621293,0.9648439891944527,0.6353239545231772,MFSD2A/PLIN5/CYP4F12/CYP26B1/THNSL2/ALDH1L1,6
GO:1903320,regulation of protein modification by small protein conjugation or removal,8/565,206/10364,0.8804703996744072,0.9648439891944527,0.6353239545231772,ISG15/BIRC3/FAM107A/ARRDC3/EGR1/HSPA1A/HSPA1B/ANGPT1,8
GO:0006778,porphyrin-containing compound metabolic process,1/565,38/10364,0.8816515299405099,0.9648439891944527,0.6353239545231772,HMOX1,1
GO:0014855,striated muscle cell proliferation,1/565,38/10364,0.8816515299405099,0.9648439891944527,0.6353239545231772,ANGPT1,1
GO:0030521,androgen receptor signaling pathway,1/565,38/10364,0.8816515299405099,0.9648439891944527,0.6353239545231772,SFRP1,1
GO:0032007,negative regulation of TOR signaling,1/565,38/10364,0.8816515299405099,0.9648439891944527,0.6353239545231772,DDIT4,1
GO:0035384,thioester biosynthetic process,1/565,38/10364,0.8816515299405099,0.9648439891944527,0.6353239545231772,PDK4,1
GO:0043647,inositol phosphate metabolic process,1/565,38/10364,0.8816515299405099,0.9648439891944527,0.6353239545231772,GPER1,1
GO:0048704,embryonic skeletal system morphogenesis,1/565,38/10364,0.8816515299405099,0.9648439891944527,0.6353239545231772,PRRX1,1
GO:0061462,protein localization to lysosome,1/565,38/10364,0.8816515299405099,0.9648439891944527,0.6353239545231772,CLU,1
GO:0071616,acyl-CoA biosynthetic process,1/565,38/10364,0.8816515299405099,0.9648439891944527,0.6353239545231772,PDK4,1
GO:1902099,regulation of metaphase/anaphase transition of cell cycle,1/565,38/10364,0.8816515299405099,0.9648439891944527,0.6353239545231772,DUSP1,1
GO:1905710,positive regulation of membrane permeability,1/565,38/10364,0.8816515299405099,0.9648439891944527,0.6353239545231772,HSPA1A,1
GO:0044774,mitotic DNA integrity checkpoint signaling,2/565,66/10364,0.8819651277641879,0.9649292445394402,0.635380092887025,MUC1/CDKN1A,2
GO:0045727,positive regulation of translation,4/565,116/10364,0.8837537755947097,0.966369646710668,0.6363285591818634,NIBAN1/THBS1/CCL5/BCL3,4
GO:0070507,regulation of microtubule cytoskeleton organization,4/565,116/10364,0.8837537755947097,0.966369646710668,0.6363285591818634,FAM107A/MAP1B/HSPA1A/HSPA1B,4
GO:2000060,positive regulation of ubiquitin-dependent protein catabolic process,3/565,92/10364,0.8846768804444094,0.9671207339224064,0.6368231300170424,HSPA1A/HSPA1B/CLU,3
GO:0007368,determination of left/right symmetry,2/565,67/10364,0.887091490880808,0.9688229167423296,0.6379439718656587,APLNR/SOX18,2
GO:0035335,peptidyl-tyrosine dephosphorylation,2/565,67/10364,0.887091490880808,0.9688229167423296,0.6379439718656587,DUSP5/DUSP1,2
GO:1903322,positive regulation of protein modification by small protein conjugation or removal,4/565,117/10364,0.8877184609913079,0.9688229167423296,0.6379439718656587,BIRC3/FAM107A/ARRDC3/ANGPT1,4
GO:0007091,metaphase/anaphase transition of mitotic cell cycle,1/565,39/10364,0.8881271144440555,0.9688229167423296,0.6379439718656587,DUSP1,1
GO:0010965,regulation of mitotic sister chromatid separation,1/565,39/10364,0.8881271144440555,0.9688229167423296,0.6379439718656587,DUSP1,1
GO:0051972,regulation of telomerase activity,1/565,39/10364,0.8881271144440555,0.9688229167423296,0.6379439718656587,KLF4,1
GO:0072595,maintenance of protein localization in organelle,1/565,39/10364,0.8881271144440555,0.9688229167423296,0.6379439718656587,HK2,1
GO:2000785,regulation of autophagosome assembly,1/565,39/10364,0.8881271144440555,0.9688229167423296,0.6379439718656587,ELAPOR1,1
GO:0031497,chromatin assembly,2/565,68/10364,0.892010989711993,0.9725414092891875,0.640392499727357,SOX9/H1-2,2
GO:0044264,cellular polysaccharide metabolic process,2/565,68/10364,0.892010989711993,0.9725414092891875,0.640392499727357,IGF2/IGF1,2
GO:0120032,regulation of plasma membrane bounded cell projection assembly,5/565,142/10364,0.8929089867954147,0.973167275862267,0.6408046161219927,ICAM1/SLIT2/CCL21/TENM1/RAP1GAP,5
GO:0042177,negative regulation of protein catabolic process,3/565,94/10364,0.8932531243875639,0.973167275862267,0.6408046161219927,SERPINE2/TIMP3/TIMP1,3
GO:0006220,pyrimidine nucleotide metabolic process,1/565,40/10364,0.8942489721040177,0.973167275862267,0.6408046161219927,TYMP,1
GO:0009116,nucleoside metabolic process,1/565,40/10364,0.8942489721040177,0.973167275862267,0.6408046161219927,TYMP,1
GO:0044784,metaphase/anaphase transition of cell cycle,1/565,40/10364,0.8942489721040177,0.973167275862267,0.6408046161219927,DUSP1,1
GO:0098661,inorganic anion transmembrane transport,1/565,40/10364,0.8942489721040177,0.973167275862267,0.6408046161219927,SLC1A3,1
GO:0120192,tight junction assembly,1/565,40/10364,0.8942489721040177,0.973167275862267,0.6408046161219927,CLDN5,1
GO:0032386,regulation of intracellular transport,11/565,277/10364,0.8961393098687394,0.9743142990097557,0.6415599001784343,PTGS2/CRYAB/IFI27/APOD/MAP1B/PLN/CD36/ANGPT1/GAS1/TENM1/DERL3,11
GO:0006637,acyl-CoA metabolic process,2/565,69/10364,0.896730893666038,0.9743142990097557,0.6415599001784343,DGAT2/PDK4,2
GO:0009142,nucleoside triphosphate biosynthetic process,2/565,69/10364,0.896730893666038,0.9743142990097557,0.6415599001784343,MTCO2P12/H19,2
GO:0009205,purine ribonucleoside triphosphate metabolic process,2/565,69/10364,0.896730893666038,0.9743142990097557,0.6415599001784343,MTCO2P12/H19,2
GO:0010507,negative regulation of autophagy,2/565,69/10364,0.896730893666038,0.9743142990097557,0.6415599001784343,HMOX1/NAMPT,2
GO:0035383,thioester metabolic process,2/565,69/10364,0.896730893666038,0.9743142990097557,0.6415599001784343,DGAT2/PDK4,2
GO:0007093,mitotic cell cycle checkpoint signaling,3/565,95/10364,0.8973232087962563,0.9746991819612293,0.6418133353052499,MUC1/DUSP1/CDKN1A,3
GO:0009150,purine ribonucleotide metabolic process,11/565,278/10364,0.8986068943625278,0.97480132061463,0.6418805908760105,MTCO2P12/DDIT4/H19/DGAT2/GUCY1A2/IGF1/HK2/HK3/ADCY1/MLXIPL/PDK4,11
GO:0051321,meiotic cell cycle,4/565,120/10364,0.898912627540112,0.97480132061463,0.6418805908760105,CYP26B1/LIF/DUSP1/TOP2A,4
GO:0060491,regulation of cell projection assembly,5/565,144/10364,0.8996251055337992,0.97480132061463,0.6418805908760105,ICAM1/SLIT2/CCL21/TENM1/RAP1GAP,5
GO:0018023,peptidyl-lysine trimethylation,1/565,41/10364,0.9000363927511728,0.97480132061463,0.6418805908760105,H1-2,1
GO:0030834,regulation of actin filament depolymerization,1/565,41/10364,0.9000363927511728,0.97480132061463,0.6418805908760105,LMOD1,1
GO:0032008,positive regulation of TOR signaling,1/565,41/10364,0.9000363927511728,0.97480132061463,0.6418805908760105,RELN,1
GO:0043457,regulation of cellular respiration,1/565,41/10364,0.9000363927511728,0.97480132061463,0.6418805908760105,MLXIPL,1
GO:0051306,mitotic sister chromatid separation,1/565,41/10364,0.9000363927511728,0.97480132061463,0.6418805908760105,DUSP1,1
GO:0072583,clathrin-dependent endocytosis,1/565,41/10364,0.9000363927511728,0.97480132061463,0.6418805908760105,SIGLEC1,1
GO:0072666,establishment of protein localization to vacuole,1/565,41/10364,0.9000363927511728,0.97480132061463,0.6418805908760105,CLU,1
GO:1901379,regulation of potassium ion transmembrane transport,1/565,41/10364,0.9000363927511728,0.97480132061463,0.6418805908760105,KCNN4,1
GO:0043244,regulation of protein-containing complex disassembly,3/565,96/10364,0.9012532847935861,0.9756085308685392,0.6424121172330056,NES/LMOD1/MAP1B,3
GO:0022406,membrane docking,2/565,70/10364,0.9012582959806583,0.9756085308685392,0.6424121172330056,VCAM1/ICAM1,2
GO:0009117,nucleotide metabolic process,15/565,365/10364,0.9017355433646324,0.9758671198876037,0.6425823911840571,MTCO2P12/DDIT4/H19/DGAT2/GUCY1A2/NNMT/IGF1/HK2/PTGIS/TYMP/HK3/ADCY1/MLXIPL/PDK4/NAMPT,15
GO:0006164,purine nucleotide biosynthetic process,5/565,145/10364,0.9028441837880963,0.9768086914451549,0.6432023908649479,MTCO2P12/H19/GUCY1A2/ADCY1/PDK4,5
GO:0010972,negative regulation of G2/M transition of mitotic cell cycle,1/565,42/10364,0.9055076160482364,0.9769504230974738,0.6432957173662691,CDKN1A,1
GO:0016447,somatic recombination of immunoglobulin gene segments,1/565,42/10364,0.9055076160482364,0.9769504230974738,0.6432957173662691,BCL6,1
GO:0030166,proteoglycan biosynthetic process,1/565,42/10364,0.9055076160482364,0.9769504230974738,0.6432957173662691,IGF1,1
GO:0030520,intracellular estrogen receptor signaling pathway,1/565,42/10364,0.9055076160482364,0.9769504230974738,0.6432957173662691,PADI2,1
GO:0032527,protein exit from endoplasmic reticulum,1/565,42/10364,0.9055076160482364,0.9769504230974738,0.6432957173662691,DERL3,1
GO:0046173,polyol biosynthetic process,1/565,42/10364,0.9055076160482364,0.9769504230974738,0.6432957173662691,GPER1,1
GO:0060997,dendritic spine morphogenesis,1/565,42/10364,0.9055076160482364,0.9769504230974738,0.6432957173662691,RELN,1
GO:1902305,regulation of sodium ion transmembrane transport,1/565,42/10364,0.9055076160482364,0.9769504230974738,0.6432957173662691,ATP1A2,1
GO:0006446,regulation of translational initiation,2/565,71/10364,0.90560011129822,0.9769504230974738,0.6432957173662691,CCL5/HSPB1,2
GO:0043473,pigmentation,2/565,71/10364,0.90560011129822,0.9769504230974738,0.6432957173662691,MLPH/RAB27B,2
GO:0072384,organelle transport along microtubule,2/565,71/10364,0.90560011129822,0.9769504230974738,0.6432957173662691,UCHL1/MAP1B,2
GO:0006612,protein targeting to membrane,3/565,98/10364,0.9087091330338237,0.9795910309487509,0.6450344869924539,RN7SL1/RN7SL2/ZDHHC11B,3
GO:1904375,regulation of protein localization to cell periphery,3/565,98/10364,0.9087091330338237,0.9795910309487509,0.6450344869924539,GBP1/GPER1/RAMP3,3
GO:0009855,determination of bilateral symmetry,2/565,72/10364,0.9097630740271638,0.9795910309487509,0.6450344869924539,APLNR/SOX18,2
GO:0006753,nucleoside phosphate metabolic process,15/565,369/10364,0.9098795967542845,0.9795910309487509,0.6450344869924539,MTCO2P12/DDIT4/H19/DGAT2/GUCY1A2/NNMT/IGF1/HK2/PTGIS/TYMP/HK3/ADCY1/MLXIPL/PDK4/NAMPT,15
GO:0006305,DNA alkylation,1/565,43/10364,0.9106798885664253,0.9795910309487509,0.6450344869924539,FOS,1
GO:0006306,DNA methylation,1/565,43/10364,0.9106798885664253,0.9795910309487509,0.6450344869924539,FOS,1
GO:0006998,nuclear envelope organization,1/565,43/10364,0.9106798885664253,0.9795910309487509,0.6450344869924539,GPER1,1
GO:0033045,regulation of sister chromatid segregation,1/565,43/10364,0.9106798885664253,0.9795910309487509,0.6450344869924539,DUSP1,1
GO:0045010,actin nucleation,1/565,43/10364,0.9106798885664253,0.9795910309487509,0.6450344869924539,LMOD1,1
GO:0046580,negative regulation of Ras protein signal transduction,1/565,43/10364,0.9106798885664253,0.9795910309487509,0.6450344869924539,BCL6,1
GO:0051438,regulation of ubiquitin-protein transferase activity,1/565,43/10364,0.9106798885664253,0.9795910309487509,0.6450344869924539,ARRDC3,1
GO:0009260,ribonucleotide biosynthetic process,5/565,148/10364,0.9119685307535936,0.9807195074613113,0.6457775585859714,MTCO2P12/H19/GUCY1A2/ADCY1/PDK4,5
GO:0033157,regulation of intracellular protein transport,7/565,195/10364,0.9131065434328842,0.9810723104917869,0.6460098699430403,PTGS2/IFI27/APOD/CD36/ANGPT1/TENM1/DERL3,7
GO:0009799,specification of symmetry,2/565,73/10364,0.9137537374113763,0.9810723104917869,0.6460098699430403,APLNR/SOX18,2
GO:0035304,regulation of protein dephosphorylation,2/565,73/10364,0.9137537374113763,0.9810723104917869,0.6460098699430403,LILRB2/PDGFRB,2
GO:0051492,regulation of stress fiber assembly,2/565,73/10364,0.9137537374113763,0.9810723104917869,0.6460098699430403,CCN2/SFRP1,2
GO:0060996,dendritic spine development,2/565,73/10364,0.9137537374113763,0.9810723104917869,0.6460098699430403,APOE/RELN,2
GO:0031050,dsRNA processing,1/565,44/10364,0.9155695177651434,0.9810723104917869,0.6460098699430403,H19,1
GO:0035196,production of miRNAs involved in gene silencing by miRNA,1/565,44/10364,0.9155695177651434,0.9810723104917869,0.6460098699430403,H19,1
GO:0043297,apical junction assembly,1/565,44/10364,0.9155695177651434,0.9810723104917869,0.6460098699430403,CLDN5,1
GO:0043666,regulation of phosphoprotein phosphatase activity,1/565,44/10364,0.9155695177651434,0.9810723104917869,0.6460098699430403,PDGFRB,1
GO:0070918,production of small RNA involved in gene silencing by RNA,1/565,44/10364,0.9155695177651434,0.9810723104917869,0.6460098699430403,H19,1
GO:0086001,cardiac muscle cell action potential,1/565,44/10364,0.9155695177651434,0.9810723104917869,0.6460098699430403,ATP1A2,1
GO:1902750,negative regulation of cell cycle G2/M phase transition,1/565,44/10364,0.9155695177651434,0.9810723104917869,0.6460098699430403,CDKN1A,1
GO:1905818,regulation of chromosome separation,1/565,44/10364,0.9155695177651434,0.9810723104917869,0.6460098699430403,DUSP1,1
GO:1901800,positive regulation of proteasomal protein catabolic process,3/565,100/10364,0.9156515140178598,0.9810723104917869,0.6460098699430403,HSPA1A/HSPA1B/CLU,3
GO:0006383,transcription by RNA polymerase III,1/565,45/10364,0.9201919230425363,0.9850493003407991,0.6486286113626581,TENM1,1
GO:0044088,regulation of vacuole organization,1/565,45/10364,0.9201919230425363,0.9850493003407991,0.6486286113626581,ELAPOR1,1
GO:0051310,metaphase plate congression,1/565,45/10364,0.9201919230425363,0.9850493003407991,0.6486286113626581,GEM,1
GO:0048285,organelle fission,12/565,310/10364,0.9208554180102575,0.9850493003407991,0.6486286113626581,IGF2/DCN/IGF1/CYP26B1/LIF/PDGFRB/DUSP1/EDN1/HSPA1A/HSPA1B/MKI67/TOP2A,12
GO:0010639,negative regulation of organelle organization,10/565,266/10364,0.920950387315735,0.9850493003407991,0.6486286113626581,LMOD1/IGF1/LILRB2/LIF/SLIT2/MAP1B/DUSP1/HSPA1A/CLU/TOP2A,10
GO:0005976,polysaccharide metabolic process,2/565,75/10364,0.9212434720994821,0.9850493003407991,0.6486286113626581,IGF2/IGF1,2
GO:0009144,purine nucleoside triphosphate metabolic process,2/565,75/10364,0.9212434720994821,0.9850493003407991,0.6486286113626581,MTCO2P12/H19,2
GO:0010970,transport along microtubule,4/565,127/10364,0.9212881707388665,0.9850493003407991,0.6486286113626581,UCHL1/MAP1B/HSPB1/RAB27B,4
GO:0045787,positive regulation of cell cycle,7/565,199/10364,0.9227958910636309,0.9864037540507845,0.6495204828951378,IGF2/IGF1/ADAMTS1/PDGFRB/EDN1/CCN2/SMOC2,7
GO:0030042,actin filament depolymerization,1/565,46/10364,0.9245616840155925,0.9879817126212722,0.6505595263988581,LMOD1,1
GO:0009199,ribonucleoside triphosphate metabolic process,2/565,76/10364,0.924754744202422,0.9879817126212722,0.6505595263988581,MTCO2P12/H19,2
GO:0043624,cellular protein complex disassembly,3/565,103/10364,0.9251672943606822,0.9881645977335334,0.6506799513525773,NES/LMOD1/MAP1B,3
GO:0072522,purine-containing compound biosynthetic process,5/565,153/10364,0.9255127217464185,0.9882757127881684,0.6507531176434062,MTCO2P12/H19/GUCY1A2/ADCY1/PDK4,5
GO:0097581,lamellipodium organization,2/565,77/10364,0.9281181205778534,0.9896063112494682,0.6516292811328229,SLIT2/ENPP2,2
GO:1901796,regulation of signal transduction by p53 class mediator,2/565,77/10364,0.9281181205778534,0.9896063112494682,0.6516292811328229,MUC1/SGK1,2
GO:2001020,regulation of response to DNA damage stimulus,6/565,178/10364,0.9282026900662115,0.9896063112494682,0.6516292811328229,MUC1/CXCL12/ACKR3/SFRP2/IER3/CLU,6
GO:0006163,purine nucleotide metabolic process,11/565,292/10364,0.9283448119215074,0.9896063112494682,0.6516292811328229,MTCO2P12/DDIT4/H19/DGAT2/GUCY1A2/IGF1/HK2/HK3/ADCY1/MLXIPL/PDK4,11
GO:0009259,ribonucleotide metabolic process,11/565,292/10364,0.9283448119215074,0.9896063112494682,0.6516292811328229,MTCO2P12/DDIT4/H19/DGAT2/GUCY1A2/IGF1/HK2/HK3/ADCY1/MLXIPL/PDK4,11
GO:0018208,peptidyl-proline modification,1/565,47/10364,0.9286925861798869,0.9896063112494682,0.6516292811328229,FKBP5,1
GO:0032784,"regulation of DNA-templated transcription, elongation",1/565,47/10364,0.9286925861798869,0.9896063112494682,0.6516292811328229,RN7SK,1
GO:0033013,tetrapyrrole metabolic process,1/565,47/10364,0.9286925861798869,0.9896063112494682,0.6516292811328229,HMOX1,1
GO:0046390,ribose phosphate biosynthetic process,5/565,155/10364,0.9303913597233868,0.9911585289376907,0.6526513749542144,MTCO2P12/H19/GUCY1A2/ADCY1/PDK4,5
GO:0006497,protein lipidation,2/565,78/10364,0.9313392547307591,0.9919102260321873,0.6531463473808735,ZDHHC11B/ABCA1,2
GO:0031331,positive regulation of cellular catabolic process,14/565,360/10364,0.9320896858858805,0.9919602070117745,0.6531792585187963,ADRA2A/DCN/IGF1/HSPB8/PLIN5/LDLR/ZFP36/APOE/HMOX1/HSPA1A/HSPA1B/MLXIPL/CLU/ELAPOR1,14
GO:0002088,lens development in camera-type eye,1/565,48/10364,0.9325976640909428,0.9919602070117745,0.6531792585187963,CRYAB,1
GO:0009064,glutamine family amino acid metabolic process,1/565,48/10364,0.9325976640909428,0.9919602070117745,0.6531792585187963,PHGDH,1
GO:0016445,somatic diversification of immunoglobulins,1/565,48/10364,0.9325976640909428,0.9919602070117745,0.6531792585187963,BCL6,1
GO:1901606,alpha-amino acid catabolic process,1/565,48/10364,0.9325976640909428,0.9919602070117745,0.6531792585187963,THNSL2,1
GO:0009101,glycoprotein biosynthetic process,8/565,227/10364,0.9332512857234898,0.9923976009745369,0.6534672707417245,IGF1/RAMP1/GALNT15/HBEGF/IL33/CCL21/ABO/DERL3,8
GO:0006354,"DNA-templated transcription, elongation",2/565,79/10364,0.9344236246280078,0.9933862163664149,0.6541182475289612,RN7SK/PADI2,2
GO:0030705,cytoskeleton-dependent intracellular transport,5/565,157/10364,0.9349834238552089,0.9934653872990462,0.654170379470048,MYO7B/UCHL1/MAP1B/HSPB1/RAB27B,5
GO:0046395,carboxylic acid catabolic process,5/565,157/10364,0.9349834238552089,0.9934653872990462,0.654170379470048,MFSD2A/PLIN5/CYP4F12/CYP26B1/ALDH1L1,5
GO:0000288,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay",1/565,49/10364,0.9362892422015106,0.994078879038637,0.6545743473678938,ZFP36,1
GO:0002562,somatic diversification of immune receptors via germline recombination within a single locus,1/565,49/10364,0.9362892422015106,0.994078879038637,0.6545743473678938,BCL6,1
GO:0016444,somatic cell DNA recombination,1/565,49/10364,0.9362892422015106,0.994078879038637,0.6545743473678938,BCL6,1
GO:0046488,phosphatidylinositol metabolic process,4/565,133/10364,0.9368206659561785,0.9943852233405743,0.6547760668951252,SOCS3/CSF1R/PDGFRB/PLCH2,4
GO:0009896,positive regulation of catabolic process,16/565,408/10364,0.9390017422561716,0.9964419732495507,0.6561303816861902,ADRA2A/DCN/IGF1/HSPB8/SOX9/PLIN5/LDLR/ZFP36/APOE/HMOX1/HSPA1A/HSPA1B/MLXIPL/CLU/GPC3/ELAPOR1,16
GO:0007127,meiosis I,1/565,50/10364,0.9397789734817963,0.9966834730467378,0.6562894028418212,TOP2A,1
GO:0009062,fatty acid catabolic process,2/565,81/10364,0.9402031199087693,0.9966834730467378,0.6562894028418212,MFSD2A/PLIN5,2
GO:0034728,nucleosome organization,2/565,81/10364,0.9402031199087693,0.9966834730467378,0.6562894028418212,SOX9/H1-2,2
GO:0120034,positive regulation of plasma membrane bounded cell projection assembly,2/565,81/10364,0.9402031199087693,0.9966834730467378,0.6562894028418212,CCL21/TENM1,2
GO:0030010,establishment of cell polarity,3/565,109/10364,0.9413120159660227,0.9976006713344284,0.6568933533765642,CYP26B1/MAP1B/CCL21,3
GO:0006906,vesicle fusion,2/565,82/10364,0.9429083455614748,0.9979221566580048,0.657105042861479,SYT7/DYSF,2
GO:0045931,positive regulation of mitotic cell cycle,2/565,82/10364,0.9429083455614748,0.9979221566580048,0.657105042861479,ADAMTS1/SMOC2,2
GO:0033866,nucleoside bisphosphate biosynthetic process,1/565,51/10364,0.9430778759427993,0.9979221566580048,0.657105042861479,PDK4,1
GO:0034030,ribonucleoside bisphosphate biosynthetic process,1/565,51/10364,0.9430778759427993,0.9979221566580048,0.657105042861479,PDK4,1
GO:0034033,purine nucleoside bisphosphate biosynthetic process,1/565,51/10364,0.9430778759427993,0.9979221566580048,0.657105042861479,PDK4,1
GO:1901607,alpha-amino acid biosynthetic process,1/565,51/10364,0.9430778759427993,0.9979221566580048,0.657105042861479,PHGDH,1
GO:0022900,electron transport chain,4/565,136/10364,0.9434952345434017,0.998105811426534,0.6572259746132604,MTCO2P12/PHGDH/STEAP4/CYBB,4
GO:0019693,ribose phosphate metabolic process,11/565,302/10364,0.9447226765006767,0.9991461218273754,0.6579109911809088,MTCO2P12/DDIT4/H19/DGAT2/GUCY1A2/IGF1/HK2/HK3/ADCY1/MLXIPL/PDK4,11
GO:0061982,meiosis I cell cycle process,1/565,52/10364,0.9461963671764189,0.9999999999390938,0.6584732470737715,TOP2A,1
GO:0140029,exocytic process,1/565,52/10364,0.9461963671764189,0.9999999999390938,0.6584732470737715,P2RX1,1
GO:0051303,establishment of chromosome localization,1/565,53/10364,0.9491442970198365,0.9999999999390938,0.6584732470737715,GEM,1
GO:0099111,microtubule-based transport,4/565,139/10364,0.9495207641209209,0.9999999999390938,0.6584732470737715,UCHL1/MAP1B/HSPB1/RAB27B,4
GO:1903052,positive regulation of proteolysis involved in cellular protein catabolic process,3/565,113/10364,0.9502153643187674,0.9999999999390938,0.6584732470737715,HSPA1A/HSPA1B/CLU,3
GO:0072521,purine-containing compound metabolic process,11/565,306/10364,0.9503010949572304,0.9999999999390938,0.6584732470737715,MTCO2P12/DDIT4/H19/DGAT2/GUCY1A2/IGF1/HK2/HK3/ADCY1/MLXIPL/PDK4,11
GO:0031060,regulation of histone methylation,1/565,54/10364,0.9519309784458663,0.9999999999390938,0.6584732470737715,NNMT,1
GO:0046824,positive regulation of nucleocytoplasmic transport,1/565,54/10364,0.9519309784458663,0.9999999999390938,0.6584732470737715,PTGS2,1
GO:0061025,membrane fusion,3/565,114/10364,0.9522358254538443,0.9999999999390938,0.6584732470737715,SYT7/FOLR2/DYSF,3
GO:0090174,organelle membrane fusion,2/565,86/10364,0.952609277638298,0.9999999999390938,0.6584732470737715,SYT7/DYSF,2
GO:0006913,nucleocytoplasmic transport,9/565,262/10364,0.952701419151214,0.9999999999390938,0.6584732470737715,PTGS2/AGT/EGR2/IFI27/BCL3/APOD/CDKN1A/CD36/ANGPT1,9
GO:0051169,nuclear transport,9/565,262/10364,0.952701419151214,0.9999999999390938,0.6584732470737715,PTGS2/AGT/EGR2/IFI27/BCL3/APOD/CDKN1A/CD36/ANGPT1,9
GO:0009166,nucleotide catabolic process,1/565,55/10364,0.9545652167754575,0.9999999999390938,0.6584732470737715,TYMP,1
GO:0046854,phosphatidylinositol phosphate biosynthetic process,1/565,55/10364,0.9545652167754575,0.9999999999390938,0.6584732470737715,SOCS3,1
GO:0050000,chromosome localization,1/565,55/10364,0.9545652167754575,0.9999999999390938,0.6584732470737715,GEM,1
GO:0007052,mitotic spindle organization,2/565,87/10364,0.9547765443841336,0.9999999999390938,0.6584732470737715,HSPA1A/HSPA1B,2
GO:0090630,activation of GTPase activity,2/565,87/10364,0.9547765443841336,0.9999999999390938,0.6584732470737715,CCL21/RAP1GAP,2
GO:0018107,peptidyl-threonine phosphorylation,2/565,88/10364,0.9568489030012614,0.9999999999390938,0.6584732470737715,CHI3L1/DDIT4,2
GO:0002200,somatic diversification of immune receptors,1/565,56/10364,0.9570553373033328,0.9999999999390938,0.6584732470737715,BCL6,1
GO:0043966,histone H3 acetylation,1/565,56/10364,0.9570553373033328,0.9999999999390938,0.6584732470737715,LIF,1
GO:0061951,establishment of protein localization to plasma membrane,1/565,56/10364,0.9570553373033328,0.9999999999390938,0.6584732470737715,NSG1,1
GO:0032006,regulation of TOR signaling,2/565,89/10364,0.9588302366901137,0.9999999999390938,0.6584732470737715,DDIT4/RELN,2
GO:0072527,pyrimidine-containing compound metabolic process,1/565,57/10364,0.9594092114228144,0.9999999999390938,0.6584732470737715,TYMP,1
GO:0099518,vesicle cytoskeletal trafficking,1/565,57/10364,0.9594092114228144,0.9999999999390938,0.6584732470737715,MYO7B,1
GO:1901992,positive regulation of mitotic cell cycle phase transition,1/565,57/10364,0.9594092114228144,0.9999999999390938,0.6584732470737715,ADAMTS1,1
GO:1902117,positive regulation of organelle assembly,1/565,57/10364,0.9594092114228144,0.9999999999390938,0.6584732470737715,ELAPOR1,1
GO:0032434,regulation of proteasomal ubiquitin-dependent protein catabolic process,3/565,118/10364,0.9595766167359157,0.9999999999390938,0.6584732470737715,HSPA1A/HSPA1B/CLU,3
GO:0051494,negative regulation of cytoskeleton organization,3/565,119/10364,0.9612390669231872,0.9999999999390938,0.6584732470737715,LMOD1/SLIT2/MAP1B,3
GO:0051052,regulation of DNA metabolic process,9/565,269/10364,0.9614630006329788,0.9999999999390938,0.6584732470737715,BCL6/ANXA3/IL7R/PDGFRB/DUSP1/H1-2/CDKN1A/SMOC2/KLF4,9
GO:0009123,nucleoside monophosphate metabolic process,1/565,58/10364,0.9616342813312369,0.9999999999390938,0.6584732470737715,TYMP,1
GO:0044728,DNA methylation or demethylation,1/565,58/10364,0.9616342813312369,0.9999999999390938,0.6584732470737715,FOS,1
GO:0016311,dephosphorylation,11/565,316/10364,0.9621428175761642,0.9999999999390938,0.6584732470737715,ALPL/ATP1A2/PFKFB3/DUSP5/ACP5/LILRB2/THNSL2/PDGFRB/DUSP1/DUSP4/PLPP2,11
GO:1903827,regulation of cellular protein localization,16/565,429/10364,0.9627253224046359,0.9999999999390938,0.6584732470737715,GBP1/PTGS2/DCLK1/IFI27/NGFR/TYROBP/LIF/APOD/GPER1/RAMP3/CD36/PTN/ANGPT1/TENM1/GPC3/DERL3,16
GO:0051656,establishment of organelle localization,10/565,294/10364,0.9632811384445581,0.9999999999390938,0.6584732470737715,NTN1/MYO7B/MLPH/HMOX1/UCHL1/MAP1B/GEM/NR4A3/PTGDS/RAB27B,10
GO:0006487,protein N-linked glycosylation,1/565,59/10364,0.963737583392934,0.9999999999390938,0.6584732470737715,DERL3,1
GO:0030032,lamellipodium assembly,1/565,59/10364,0.963737583392934,0.9999999999390938,0.6584732470737715,SLIT2,1
GO:0042176,regulation of protein catabolic process,11/565,318/10364,0.9641856349743,0.9999999999390938,0.6584732470737715,ADRA2A/SOX9/LDLR/APOE/SERPINE2/TIMP3/HSPA1A/HSPA1B/CLU/TIMP1/GPC3,11
GO:0000045,autophagosome assembly,2/565,92/10364,0.9642648368750365,0.9999999999390938,0.6584732470737715,SYNPO2/ELAPOR1,2
GO:0033865,nucleoside bisphosphate metabolic process,2/565,92/10364,0.9642648368750365,0.9999999999390938,0.6584732470737715,DGAT2/PDK4,2
GO:0033875,ribonucleoside bisphosphate metabolic process,2/565,92/10364,0.9642648368750365,0.9999999999390938,0.6584732470737715,DGAT2/PDK4,2
GO:0034032,purine nucleoside bisphosphate metabolic process,2/565,92/10364,0.9642648368750365,0.9999999999390938,0.6584732470737715,DGAT2/PDK4,2
GO:0031503,protein-containing complex localization,5/565,174/10364,0.9642917172923695,0.9999999999390938,0.6584732470737715,TNFAIP2/ITGB3/TYROBP/RELN/NSG1,5
GO:0042440,pigment metabolic process,1/565,60/10364,0.9657257702326227,0.9999999999390938,0.6584732470737715,HMOX1,1
GO:0034248,regulation of cellular amide metabolic process,14/565,388/10364,0.9658876953571283,0.9999999999390938,0.6584732470737715,CCN1/NIBAN1/RGS2/IGF1/THBS1/CCL5/ZFP36/BCL3/APOE/IGFBP5/HSPB1/PDK4/CLU/NTRK2,14
GO:0009141,nucleoside triphosphate metabolic process,2/565,93/10364,0.9659181512706942,0.9999999999390938,0.6584732470737715,MTCO2P12/H19,2
GO:0044770,cell cycle phase transition,13/565,366/10364,0.9663876233832557,0.9999999999390938,0.6584732470737715,MUC1/NES/BCAT1/CCL2/ADAMTS1/SUSD2/FAM107A/DUSP1/CDKN1A/GPNMB/TCIM/KLF4/PLPP2,13
GO:1903829,positive regulation of cellular protein localization,7/565,226/10364,0.9668284422525126,0.9999999999390938,0.6584732470737715,PTGS2/NGFR/TYROBP/LIF/GPER1/RAMP3/PTN,7
GO:0044772,mitotic cell cycle phase transition,10/565,298/10364,0.9672842540479791,0.9999999999390938,0.6584732470737715,MUC1/NES/BCAT1/CCL2/ADAMTS1/FAM107A/DUSP1/CDKN1A/GPNMB/KLF4,10
GO:0000077,DNA damage checkpoint signaling,2/565,94/10364,0.9674978257681537,0.9999999999390938,0.6584732470737715,MUC1/CDKN1A,2
GO:0034968,histone lysine methylation,2/565,94/10364,0.9674978257681537,0.9999999999390938,0.6584732470737715,NNMT/H1-2,2
GO:0043967,histone H4 acetylation,1/565,61/10364,0.9676051316280584,0.9999999999390938,0.6584732470737715,MUC1,1
GO:0070936,protein K48-linked ubiquitination,1/565,61/10364,0.9676051316280584,0.9999999999390938,0.6584732470737715,IFI27,1
GO:1901292,nucleoside phosphate catabolic process,1/565,61/10364,0.9676051316280584,0.9999999999390938,0.6584732470737715,TYMP,1
GO:0018210,peptidyl-threonine modification,2/565,95/10364,0.9690069573159363,0.9999999999390938,0.6584732470737715,CHI3L1/DDIT4,2
GO:0010389,regulation of G2/M transition of mitotic cell cycle,1/565,62/10364,0.9693816142671099,0.9999999999390938,0.6584732470737715,CDKN1A,1
GO:0010921,regulation of phosphatase activity,1/565,62/10364,0.9693816142671099,0.9999999999390938,0.6584732470737715,PDGFRB,1
GO:1905037,autophagosome organization,2/565,96/10364,0.9704485248164119,0.9999999999390938,0.6584732470737715,SYNPO2/ELAPOR1,2
GO:0061912,selective autophagy,1/565,63/10364,0.9710608404308725,0.9999999999390938,0.6584732470737715,HSPB8,1
GO:0031647,regulation of protein stability,8/565,255/10364,0.9714762280604294,0.9999999999390938,0.6584732470737715,CRYAB/IGF1/IFI30/TYROBP/FAM107A/HSPA1A/HSPA1B/CLU,8
GO:0031570,DNA integrity checkpoint signaling,2/565,97/10364,0.971825392764706,0.9999999999390938,0.6584732470737715,MUC1/CDKN1A,2
GO:0000075,cell cycle checkpoint signaling,3/565,127/10364,0.9724043782749685,0.9999999999390938,0.6584732470737715,MUC1/DUSP1/CDKN1A,3
GO:0000086,G2/M transition of mitotic cell cycle,2/565,98/10364,0.9731403148424328,0.9999999999390938,0.6584732470737715,NES/CDKN1A,2
GO:0006493,protein O-linked glycosylation,1/565,65/10364,0.9741484954670672,0.9999999999390938,0.6584732470737715,GALNT15,1
GO:0032456,endocytic recycling,1/565,65/10364,0.9741484954670672,0.9999999999390938,0.6584732470737715,NSG1,1
GO:0090502,"RNA phosphodiester bond hydrolysis, endonucleolytic",1/565,65/10364,0.9741484954670672,0.9999999999390938,0.6584732470737715,RNASE1,1
GO:0055086,nucleobase-containing small molecule metabolic process,15/565,422/10364,0.974621433688372,0.9999999999390938,0.6584732470737715,MTCO2P12/DDIT4/H19/DGAT2/GUCY1A2/NNMT/IGF1/HK2/PTGIS/TYMP/HK3/ADCY1/MLXIPL/PDK4/NAMPT,15
GO:0051222,positive regulation of protein transport,7/565,235/10364,0.9753783991897227,0.9999999999390938,0.6584732470737715,PTGS2/IGF1/CD38/HLA-DRB1/GPER1/TENM1/KCNN4,7
GO:0043488,regulation of mRNA stability,3/565,130/10364,0.9757456112193905,0.9999999999390938,0.6584732470737715,TENT5C/ZFP36/SLC11A1,3
GO:0007041,lysosomal transport,2/565,101/10364,0.976739354464013,0.9999999999390938,0.6584732470737715,HSPA1A/CLU,2
GO:0051650,establishment of vesicle localization,3/565,131/10364,0.9767713268064346,0.9999999999390938,0.6584732470737715,MYO7B/MLPH/RAB27B,3
GO:0032508,DNA duplex unwinding,1/565,67/10364,0.9769072346125683,0.9999999999390938,0.6584732470737715,TOP2A,1
GO:1902749,regulation of cell cycle G2/M phase transition,1/565,67/10364,0.9769072346125683,0.9999999999390938,0.6584732470737715,CDKN1A,1
GO:0072594,establishment of protein localization to organelle,12/565,357/10364,0.977046084600146,0.9999999999390938,0.6584732470737715,PTGS2/AGT/RN7SL1/RN7SL2/CD68/BCL3/HK2/APOD/CDKN1A/CD36/CLU/ANGPT1,12
GO:0061136,regulation of proteasomal protein catabolic process,4/565,160/10364,0.9777132197050886,0.9999999999390938,0.6584732470737715,APOE/HSPA1A/HSPA1B/CLU,4
GO:0007006,mitochondrial membrane organization,2/565,102/10364,0.9778319363887558,0.9999999999390938,0.6584732470737715,HK2/HSPA1A,2
GO:0035303,regulation of dephosphorylation,2/565,102/10364,0.9778319363887558,0.9999999999390938,0.6584732470737715,LILRB2/PDGFRB,2
GO:0065004,protein-DNA complex assembly,2/565,102/10364,0.9778319363887558,0.9999999999390938,0.6584732470737715,SOX9/H1-2,2
GO:0051054,positive regulation of DNA metabolic process,4/565,161/10364,0.9785883915291175,0.9999999999390938,0.6584732470737715,ANXA3/PDGFRB/SMOC2/KLF4,4
GO:0018022,peptidyl-lysine methylation,2/565,103/10364,0.9788748005873316,0.9999999999390938,0.6584732470737715,NNMT/H1-2,2
GO:0007033,vacuole organization,4/565,163/10364,0.9802425858150878,0.9999999999390938,0.6584732470737715,SYT7/SYNPO2/ABCA1/ELAPOR1,4
GO:0007163,establishment or maintenance of cell polarity,4/565,163/10364,0.9802425858150878,0.9999999999390938,0.6584732470737715,CYP26B1/MAP1B/AQP1/CCL21,4
GO:0019646,aerobic electron transport chain,1/565,70/10364,0.9805041237802721,0.9999999999390938,0.6584732470737715,MTCO2P12,1
GO:0043648,dicarboxylic acid metabolic process,1/565,70/10364,0.9805041237802721,0.9999999999390938,0.6584732470737715,ALDH1L1,1
GO:0044839,cell cycle G2/M phase transition,2/565,105/10364,0.9808199328354815,0.9999999999390938,0.6584732470737715,NES/CDKN1A,2
GO:1902600,proton transmembrane transport,2/565,105/10364,0.9808199328354815,0.9999999999390938,0.6584732470737715,MTCO2P12/ATP1A2,2
GO:1902850,microtubule cytoskeleton organization involved in mitosis,2/565,105/10364,0.9808199328354815,0.9999999999390938,0.6584732470737715,HSPA1A/HSPA1B,2
GO:0061013,regulation of mRNA catabolic process,3/565,136/10364,0.9813105291744808,0.9999999999390938,0.6584732470737715,TENT5C/ZFP36/SLC11A1,3
GO:0051648,vesicle localization,3/565,137/10364,0.9821106213371364,0.9999999999390938,0.6584732470737715,MYO7B/MLPH/RAB27B,3
GO:0032392,DNA geometric change,1/565,72/10364,0.9825856051447439,0.9999999999390938,0.6584732470737715,TOP2A,1
GO:1901989,positive regulation of cell cycle phase transition,1/565,72/10364,0.9825856051447439,0.9999999999390938,0.6584732470737715,ADAMTS1,1
GO:0007051,spindle organization,3/565,138/10364,0.9828779482264043,0.9999999999390938,0.6584732470737715,GOLGA8B/HSPA1A/HSPA1B,3
GO:0032886,regulation of microtubule-based process,4/565,167/10364,0.9831960910600599,0.9999999999390938,0.6584732470737715,FAM107A/MAP1B/HSPA1A/HSPA1B,4
GO:0072657,protein localization to membrane,15/565,438/10364,0.9833793211480849,0.9999999999390938,0.6584732470737715,GBP1/THY1/RN7SL1/RN7SL2/APOE/RAMP1/ZDHHC11B/GPER1/RAMP3/RELN/PTN/GPC3/NSG1/CD24/LRRC4,15
GO:0048515,spermatid differentiation,1/565,73/10364,0.9835416033077073,0.9999999999390938,0.6584732470737715,TMEM119,1
GO:0061157,mRNA destabilization,1/565,73/10364,0.9835416033077073,0.9999999999390938,0.6584732470737715,ZFP36,1
GO:0042770,signal transduction in response to DNA damage,3/565,139/10364,0.9836137684640253,0.9999999999390938,0.6584732470737715,MUC1/BCL3/CDKN1A,3
GO:0006520,cellular amino acid metabolic process,5/565,195/10364,0.9836686925029767,0.9999999999390938,0.6584732470737715,PHGDH/BCAT1/THNSL2/GGT5/SLC1A3,5
GO:0006486,protein glycosylation,4/565,168/10364,0.9838663618434519,0.9999999999390938,0.6584732470737715,RAMP1/GALNT15/ABO/DERL3,4
GO:0043413,macromolecule glycosylation,4/565,168/10364,0.9838663618434519,0.9999999999390938,0.6584732470737715,RAMP1/GALNT15/ABO/DERL3,4
GO:0006413,translational initiation,2/565,109/10364,0.9842029918351046,0.9999999999390938,0.6584732470737715,CCL5/HSPB1,2
GO:0031929,TOR signaling,2/565,109/10364,0.9842029918351046,0.9999999999390938,0.6584732470737715,DDIT4/RELN,2
GO:0006664,glycolipid metabolic process,1/565,74/10364,0.9844452078292452,0.9999999999390938,0.6584732470737715,ITGB8,1
GO:1903509,liposaccharide metabolic process,1/565,74/10364,0.9844452078292452,0.9999999999390938,0.6584732470737715,ITGB8,1
GO:0043487,regulation of RNA stability,3/565,141/10364,0.9849957066701618,0.9999999999390938,0.6584732470737715,TENT5C/ZFP36/SLC11A1,3
GO:2000058,regulation of ubiquitin-dependent protein catabolic process,3/565,141/10364,0.9849957066701618,0.9999999999390938,0.6584732470737715,HSPA1A/HSPA1B/CLU,3
GO:1901361,organic cyclic compound catabolic process,12/565,373/10364,0.9855338285124928,0.9999999999390938,0.6584732470737715,TENT5C/OAS2/ZFP36/APOE/SLC11A1/HMOX1/TYMP/ALDH1L1/SPP1/HSPA1A/HSPA1B/MOXD1,12
GO:0010506,regulation of autophagy,8/565,276/10364,0.9856261404560036,0.9999999999390938,0.6584732470737715,DEPP1/DCN/HSPB8/HMOX1/UCHL1/HSPB1/NAMPT/ELAPOR1,8
GO:0070585,protein localization to mitochondrion,2/565,111/10364,0.985669627615799,0.9999999999390938,0.6584732470737715,ISG15/HK2,2
GO:0071103,DNA conformation change,4/565,171/10364,0.9857285255634052,0.9999999999390938,0.6584732470737715,SOX9/H1-2/GPER1/TOP2A,4
GO:1904951,positive regulation of establishment of protein localization,7/565,251/10364,0.985766253841657,0.9999999999390938,0.6584732470737715,PTGS2/IGF1/CD38/HLA-DRB1/GPER1/TENM1/KCNN4,7
GO:0000422,autophagy of mitochondrion,1/565,76/10364,0.9861065458875959,0.9999999999390938,0.6584732470737715,HK2,1
GO:0006304,DNA modification,1/565,76/10364,0.9861065458875959,0.9999999999390938,0.6584732470737715,FOS,1
GO:0042773,ATP synthesis coupled electron transport,1/565,76/10364,0.9861065458875959,0.9999999999390938,0.6584732470737715,MTCO2P12,1
GO:0042775,mitochondrial ATP synthesis coupled electron transport,1/565,76/10364,0.9861065458875959,0.9999999999390938,0.6584732470737715,MTCO2P12,1
GO:0050779,RNA destabilization,1/565,76/10364,0.9861065458875959,0.9999999999390938,0.6584732470737715,ZFP36,1
GO:0061014,positive regulation of mRNA catabolic process,1/565,76/10364,0.9861065458875959,0.9999999999390938,0.6584732470737715,ZFP36,1
GO:0061726,mitochondrion disassembly,1/565,76/10364,0.9861065458875959,0.9999999999390938,0.6584732470737715,HK2,1
GO:0016571,histone methylation,2/565,113/10364,0.9870035474371921,0.9999999999390938,0.6584732470737715,NNMT/H1-2,2
GO:0048284,organelle fusion,2/565,113/10364,0.9870035474371921,0.9999999999390938,0.6584732470737715,SYT7/DYSF,2
GO:0006402,mRNA catabolic process,5/565,201/10364,0.9870375603325934,0.9999999999390938,0.6584732470737715,TENT5C/ZFP36/SLC11A1/HSPA1A/HSPA1B,5
GO:0018394,peptidyl-lysine acetylation,3/565,145/10364,0.9874321922505365,0.9999999999390938,0.6584732470737715,MUC1/LIF/KLF15,3
GO:0030433,ubiquitin-dependent ERAD pathway,1/565,78/10364,0.9875907241688808,0.9999999999390938,0.6584732470737715,DERL3,1
GO:0006119,oxidative phosphorylation,2/565,115/10364,0.9882163428365387,0.9999999999390938,0.6584732470737715,MTCO2P12/MLXIPL,2
GO:0070085,glycosylation,4/565,176/10364,0.9883867798410724,0.9999999999390938,0.6584732470737715,RAMP1/GALNT15/ABO/DERL3,4
GO:0006091,generation of precursor metabolites and energy,12/565,382/10364,0.9889328534512132,0.9999999999390938,0.6584732470737715,MTCO2P12/PHGDH/DDIT4/IGF2/IGF1/HK2/ADH1B/HK3/MLXIPL/STEAP4/NR4A3/CYBB,12
GO:0017148,negative regulation of translation,3/565,149/10364,0.9894863765475166,0.9999999999390938,0.6584732470737715,RGS2/ZFP36/IGFBP5,3
GO:0090407,organophosphate biosynthetic process,14/565,432/10364,0.9897254251576569,0.9999999999390938,0.6584732470737715,MTCO2P12/FABP3/MFSD2A/H19/GUCY1A2/NNMT/CKB/ABCA8/SOCS3/PTGIS/GPER1/ADCY1/PDK4/NAMPT,14
GO:1901605,alpha-amino acid metabolic process,2/565,120/10364,0.9907860107597952,0.9999999999390938,0.6584732470737715,PHGDH/THNSL2,2
GO:1902115,regulation of organelle assembly,3/565,152/10364,0.9908108651369888,0.9999999999390938,0.6584732470737715,HSPA1A/HSPA1B/ELAPOR1,3
GO:0032984,protein-containing complex disassembly,4/565,183/10364,0.9913276293354951,0.9999999999390938,0.6584732470737715,NES/LMOD1/DDIT4/MAP1B,4
GO:0090150,establishment of protein localization to membrane,5/565,212/10364,0.9915793934912865,0.9999999999390938,0.6584732470737715,RN7SL1/RN7SL2/ZDHHC11B/NSG1/CD24,5
GO:0006401,RNA catabolic process,6/565,241/10364,0.9921114769461252,0.9999999999390938,0.6584732470737715,TENT5C/OAS2/ZFP36/SLC11A1/HSPA1A/HSPA1B,6
GO:1901137,carbohydrate derivative biosynthetic process,15/565,465/10364,0.9921698438062283,0.9999999999390938,0.6584732470737715,MTCO2P12/H19/GUCY1A2/IGF1/RAMP1/GALNT15/HBEGF/PDGFRB/ADCY1/PDK4/ANGPT1/IL33/CCL21/ABO/DERL3,15
GO:0010256,endomembrane system organization,12/565,394/10364,0.9923232744438862,0.9999999999390938,0.6584732470737715,S100A9/SRGN/SYT7/FOLR2/GOLGA8B/DYSF/CAVIN2/SERPINE2/GPER1/CLU/ABCA1/COL5A1,12
GO:1903050,regulation of proteolysis involved in cellular protein catabolic process,4/565,186/10364,0.9923567328124666,0.9999999999390938,0.6584732470737715,APOE/HSPA1A/HSPA1B/CLU,4
GO:0043484,regulation of RNA splicing,2/565,124/10364,0.9924400162881379,0.9999999999390938,0.6584732470737715,AHNAK2/HSPA1A,2
GO:1903362,regulation of cellular protein catabolic process,5/565,215/10364,0.9925264812675663,0.9999999999390938,0.6584732470737715,LDLR/APOE/HSPA1A/HSPA1B/CLU,5
GO:0010608,posttranscriptional regulation of gene expression,14/565,448/10364,0.9935691885666706,0.9999999999390938,0.6584732470737715,TENT5C/NIBAN1/RGS2/H19/NEAT1/MEG3/THBS1/CCL5/ACE/ZFP36/BCL3/IGFBP5/SLC11A1/HSPB1,14
GO:0140694,non-membrane-bounded organelle assembly,7/565,275/10364,0.9939843511097501,0.9999999999390938,0.6584732470737715,LMOD1/GOLGA8B/KRT19/PDGFRB/EDN1/HSPA1A/HSPA1B,7
GO:0090501,RNA phosphodiester bond hydrolysis,2/565,129/10364,0.9941038320785196,0.9999999999390938,0.6584732470737715,RNASE1/AZGP1,2
GO:0072659,protein localization to plasma membrane,5/565,222/10364,0.9943575168145125,0.9999999999390938,0.6584732470737715,GBP1/RAMP1/GPER1/RAMP3/NSG1,5
GO:0016573,histone acetylation,2/565,130/10364,0.9943906792794435,0.9999999999390938,0.6584732470737715,MUC1/LIF,2
GO:0022904,respiratory electron transport chain,1/565,93/10364,0.9946855923405614,0.9999999999390938,0.6584732470737715,MTCO2P12,1
GO:0120031,plasma membrane bounded cell projection assembly,11/565,382/10364,0.9948472518308178,0.9999999999390938,0.6584732470737715,EMP1/CSPG4/NTN1/ITGB4/ICAM1/MYLK/SLIT2/CCL21/TENM1/ESPN/RAP1GAP,11
GO:0006473,protein acetylation,3/565,166/10364,0.99513910034291,0.9999999999390938,0.6584732470737715,MUC1/LIF/KLF15,3
GO:0018393,internal peptidyl-lysine acetylation,2/565,134/10364,0.9954074918799565,0.9999999999390938,0.6584732470737715,MUC1/LIF,2
GO:0071824,protein-DNA complex subunit organization,2/565,134/10364,0.9954074918799565,0.9999999999390938,0.6584732470737715,SOX9/H1-2,2
GO:0036503,ERAD pathway,1/565,96/10364,0.9955153334920941,0.9999999999390938,0.6584732470737715,DERL3,1
GO:0018205,peptidyl-lysine modification,8/565,310/10364,0.9955986772056626,0.9999999999390938,0.6584732470737715,MUC1/EGR2/NNMT/TGM2/LIF/KLF15/EGR1/H1-2,8
GO:0006475,internal protein amino acid acetylation,2/565,135/10364,0.99563202005464,0.9999999999390938,0.6584732470737715,MUC1/LIF,2
GO:0019439,aromatic compound catabolic process,10/565,362/10364,0.9956548116907021,0.9999999999390938,0.6584732470737715,TENT5C/OAS2/ZFP36/SLC11A1/HMOX1/TYMP/ALDH1L1/HSPA1A/HSPA1B/MOXD1,10
GO:0006914,autophagy,14/565,461/10364,0.9956561528786763,0.9999999999390938,0.6584732470737715,S100A9/S100A8/DEPP1/DCN/HSPB8/ITGB4/HK2/HMOX1/UCHL1/SYNPO2/HSPB1/NAMPT/CLU/ELAPOR1,14
GO:0061919,process utilizing autophagic mechanism,14/565,461/10364,0.9956561528786763,0.9999999999390938,0.6584732470737715,S100A9/S100A8/DEPP1/DCN/HSPB8/ITGB4/HK2/HMOX1/UCHL1/SYNPO2/HSPB1/NAMPT/CLU/ELAPOR1,14
GO:0043543,protein acylation,4/565,200/10364,0.9957976060483772,0.9999999999390938,0.6584732470737715,MUC1/LIF/KLF15/ZDHHC11B,4
GO:0000819,sister chromatid segregation,2/565,136/10364,0.9958457736498663,0.9999999999390938,0.6584732470737715,DUSP1/TOP2A,2
GO:0030031,cell projection assembly,11/565,390/10364,0.996036636706273,0.9999999999390938,0.6584732470737715,EMP1/CSPG4/NTN1/ITGB4/ICAM1/MYLK/SLIT2/CCL21/TENM1/ESPN/RAP1GAP,11
GO:0090316,positive regulation of intracellular protein transport,2/565,137/10364,0.9960492573878327,0.9999999999390938,0.6584732470737715,PTGS2/TENM1,2
GO:0007018,microtubule-based movement,4/565,202/10364,0.9961460717578132,0.9999999999390938,0.6584732470737715,UCHL1/MAP1B/HSPB1/RAB27B,4
GO:1903313,positive regulation of mRNA metabolic process,1/565,99/10364,0.9962157198687147,0.9999999999390938,0.6584732470737715,ZFP36,1
GO:0051168,nuclear export,2/565,138/10364,0.9962429531107948,0.9999999999390938,0.6584732470737715,EGR2/IFI27,2
GO:0006352,"DNA-templated transcription, initiation",1/565,100/10364,0.9964240119558239,0.9999999999390938,0.6584732470737715,JUN,1
GO:0016579,protein deubiquitination,1/565,100/10364,0.9964240119558239,0.9999999999390938,0.6584732470737715,UCHL1,1
GO:0098813,nuclear chromosome segregation,3/565,173/10364,0.9964815617717004,0.9999999999390938,0.6584732470737715,DUSP1/GEM/TOP2A,3
GO:0051640,organelle localization,11/565,394/10364,0.9965292503411176,0.9999999999390938,0.6584732470737715,NTN1/PLIN5/MYO7B/MLPH/HMOX1/UCHL1/MAP1B/GEM/NR4A3/PTGDS/RAB27B,11
GO:0007034,vacuolar transport,2/565,140/10364,0.9966027993742856,0.9999999999390938,0.6584732470737715,HSPA1A/CLU,2
GO:0006310,DNA recombination,4/565,205/10364,0.996617018295813,0.9999999999390938,0.6584732470737715,BCL6/IL7R/H1-2/TOP2A,4
GO:0090305,nucleic acid phosphodiester bond hydrolysis,4/565,207/10364,0.9968995592944405,0.9999999999390938,0.6584732470737715,RNASE1/ZFP36/AZGP1/ENPP2,4
GO:0046474,glycerophospholipid biosynthetic process,3/565,176/10364,0.9969394567686777,0.9999999999390938,0.6584732470737715,FABP3/MFSD2A/SOCS3,3
GO:0006479,protein methylation,2/565,143/10364,0.9970799956984223,0.9999999999390938,0.6584732470737715,NNMT/H1-2,2
GO:0008213,protein alkylation,2/565,143/10364,0.9970799956984223,0.9999999999390938,0.6584732470737715,NNMT/H1-2,2
GO:0016236,macroautophagy,6/565,267/10364,0.9971230024063757,0.9999999999390938,0.6584732470737715,DCN/HSPB8/HMOX1/UCHL1/SYNPO2/ELAPOR1,6
GO:1903008,organelle disassembly,1/565,104/10364,0.9971488338292095,0.9999999999390938,0.6584732470737715,HK2,1
GO:0000956,nuclear-transcribed mRNA catabolic process,1/565,105/10364,0.9973058424926107,0.9999999999390938,0.6584732470737715,ZFP36,1
GO:0046700,heterocycle catabolic process,9/565,350/10364,0.9973112315166719,0.9999999999390938,0.6584732470737715,TENT5C/OAS2/ZFP36/SLC11A1/HMOX1/TYMP/ALDH1L1/HSPA1A/HSPA1B,9
GO:0016050,vesicle organization,5/565,242/10364,0.9975196533067632,0.9999999999390938,0.6584732470737715,SRGN/SYT7/DYSF/SERPINE2/ABCA1,5
GO:0044270,cellular nitrogen compound catabolic process,9/565,353/10364,0.997585224542707,0.9999999999390938,0.6584732470737715,TENT5C/OAS2/ZFP36/SLC11A1/HMOX1/TYMP/ALDH1L1/HSPA1A/HSPA1B,9
GO:0072655,establishment of protein localization to mitochondrion,1/565,107/10364,0.997594438382383,0.9999999999390938,0.6584732470737715,HK2,1
GO:0008654,phospholipid biosynthetic process,4/565,214/10364,0.9977196572080207,0.9999999999390938,0.6584732470737715,FABP3/MFSD2A/ABCA8/SOCS3,4
GO:0006997,nucleus organization,1/565,108/10364,0.99772694713874,0.9999999999390938,0.6584732470737715,GPER1,1
GO:0016570,histone modification,10/565,382/10364,0.997818144144835,0.9999999999390938,0.6584732470737715,MUC1/IGF2/APLNR/NNMT/LIF/BCL6/HOPX/H1-2/VEGFA/PADI2,10
GO:0006470,protein dephosphorylation,4/565,217/10364,0.9980027928886404,0.9999999999390938,0.6584732470737715,DUSP5/LILRB2/PDGFRB/DUSP1,4
GO:0006261,DNA-dependent DNA replication,1/565,111/10364,0.9980823300089702,0.9999999999390938,0.6584732470737715,BCL6,1
GO:0033044,regulation of chromosome organization,2/565,152/10364,0.9981501087304571,0.9999999999390938,0.6584732470737715,DUSP1/TOP2A,2
GO:0006661,phosphatidylinositol biosynthetic process,1/565,113/10364,0.9982878660178436,0.9999999999390938,0.6584732470737715,SOCS3,1
GO:0006888,endoplasmic reticulum to Golgi vesicle-mediated transport,1/565,113/10364,0.9982878660178436,0.9999999999390938,0.6584732470737715,GAS1,1
GO:0000070,mitotic sister chromatid segregation,1/565,114/10364,0.9983822329771568,0.9999999999390938,0.6584732470737715,DUSP1,1
GO:0007059,chromosome segregation,4/565,222/10364,0.9984006141295052,0.9999999999390938,0.6584732470737715,DUSP1/GEM/MKI67/TOP2A,4
GO:0016482,cytosolic transport,2/565,155/10364,0.9984123925044571,0.9999999999390938,0.6584732470737715,SYT7/CES1,2
GO:0006417,regulation of translation,8/565,340/10364,0.9985489021033842,0.9999999999390938,0.6584732470737715,NIBAN1/RGS2/THBS1/CCL5/ZFP36/BCL3/IGFBP5/HSPB1,8
GO:0051028,mRNA transport,1/565,116/10364,0.9985556746771285,0.9999999999390938,0.6584732470737715,ZFP36,1
GO:0045333,cellular respiration,3/565,192/10364,0.9985573459335488,0.9999999999390938,0.6584732470737715,MTCO2P12/MLXIPL/NR4A3,3
GO:1990778,protein localization to cell periphery,5/565,255/10364,0.9985660852388403,0.9999999999390938,0.6584732470737715,GBP1/RAMP1/GPER1/RAMP3/NSG1,5
GO:0006338,chromatin remodeling,2/565,157/10364,0.9985665299451572,0.9999999999390938,0.6584732470737715,SOX9/H1-2,2
GO:0009060,aerobic respiration,2/565,157/10364,0.9985665299451572,0.9999999999390938,0.6584732470737715,MTCO2P12/MLXIPL,2
GO:0015980,energy derivation by oxidation of organic compounds,5/565,256/10364,0.9986258442913216,0.9999999999390938,0.6584732470737715,MTCO2P12/IGF2/IGF1/MLXIPL/NR4A3,5
GO:0070646,protein modification by small protein removal,1/565,118/10364,0.9987105509608853,0.9999999999390938,0.6584732470737715,UCHL1,1
GO:0006260,DNA replication,3/565,195/10364,0.9987489700576283,0.9999999999390938,0.6584732470737715,ID3/JUN/BCL6,3
GO:0051301,cell division,11/565,428/10364,0.9989187815335385,0.9999999999390938,0.6584732470737715,HMCN1/IGF2/MDK/ZBTB16/FGF7/SUSD2/SFRP2/THBS4/VEGFA/PTN/TOP2A,11
GO:0098876,vesicle-mediated transport to the plasma membrane,1/565,123/10364,0.9990290233621805,0.9999999999390938,0.6584732470737715,NSG1,1
GO:0016197,endosomal transport,3/565,205/10364,0.9992244953327061,0.9999999999390938,0.6584732470737715,DCLK1/ABCA1/NSG1,3
GO:0032388,positive regulation of intracellular transport,2/565,169/10364,0.9992257233388857,0.9999999999390938,0.6584732470737715,PTGS2/TENM1,2
GO:0007030,Golgi organization,1/565,127/10364,0.9992262371153945,0.9999999999390938,0.6584732470737715,GOLGA8B,1
GO:0034655,nucleobase-containing compound catabolic process,7/565,329/10364,0.999249748691796,0.9999999999390938,0.6584732470737715,TENT5C/OAS2/ZFP36/SLC11A1/TYMP/HSPA1A/HSPA1B,7
GO:0002181,cytoplasmic translation,1/565,142/10364,0.9996700096850183,0.9999999999390938,0.6584732470737715,RPL9,1
GO:0050657,nucleic acid transport,1/565,142/10364,0.9996700096850183,0.9999999999390938,0.6584732470737715,ZFP36,1
GO:0050658,RNA transport,1/565,142/10364,0.9996700096850183,0.9999999999390938,0.6584732470737715,ZFP36,1
GO:0000226,microtubule cytoskeleton organization,9/565,407/10364,0.999680324494437,0.9999999999390938,0.6584732470737715,CRYAB/GOLGA8B/TPPP3/FAM107A/MAP1B/TUBB2A/TUBB2B/HSPA1A/HSPA1B,9
GO:0051236,establishment of RNA localization,1/565,145/10364,0.9997217643340897,0.9999999999390938,0.6584732470737715,ZFP36,1
GO:0006605,protein targeting,4/565,262/10364,0.9997419470087756,0.9999999999390938,0.6584732470737715,RN7SL1/RN7SL2/ZDHHC11B/CLU,4
GO:0007005,mitochondrion organization,10/565,442/10364,0.9997587050805081,0.9999999999390938,0.6584732470737715,IFI6/JUN/DCN/IGF1/HK2/TYMP/TNFSF10/HSPA1A/GPER1/CLU,10
GO:0032259,methylation,4/565,270/10364,0.9998224302282117,0.9999999999390938,0.6584732470737715,NNMT/FOS/H1-2/INMT,4
GO:1903311,regulation of mRNA metabolic process,3/565,237/10364,0.9998369375494024,0.9999999999390938,0.6584732470737715,TENT5C/ZFP36/SLC11A1,3
GO:0043414,macromolecule methylation,3/565,243/10364,0.9998788119787596,0.9999999999390938,0.6584732470737715,NNMT/FOS/H1-2,3
GO:0006325,chromatin organization,4/565,285/10364,0.9999125194149786,0.9999999999390938,0.6584732470737715,SOX9/H1-2/MKI67/PADI2,4
GO:0006839,mitochondrial transport,2/565,216/10364,0.9999335932158087,0.9999999999390938,0.6584732470737715,HK2/HSPA1A,2
GO:0043161,proteasome-mediated ubiquitin-dependent protein catabolic process,6/565,359/10364,0.9999408184170956,0.9999999999390938,0.6584732470737715,IFI27/UCHL1/HSPA1A/HSPA1B/CLU/DERL3,6
GO:0006403,RNA localization,1/565,179/10364,0.9999598970099384,0.9999999999390938,0.6584732470737715,ZFP36,1
GO:0015931,nucleobase-containing compound transport,1/565,185/10364,0.9999715276438452,0.9999999999390938,0.6584732470737715,ZFP36,1
GO:0010498,proteasomal protein catabolic process,7/565,421/10364,0.9999847166518478,0.9999999999390938,0.6584732470737715,IFI27/APOE/UCHL1/HSPA1A/HSPA1B/CLU/DERL3,7
GO:0000209,protein polyubiquitination,1/565,201/10364,0.9999885894583738,0.9999999999390938,0.6584732470737715,IFI27,1
GO:0048193,Golgi vesicle transport,1/565,268/10364,0.9999997560166144,0.9999999999390938,0.6584732470737715,GAS1,1
GO:0008380,RNA splicing,2/565,364/10364,0.9999999784990958,0.9999999999390938,0.6584732470737715,AHNAK2/HSPA1A,2
GO:0006281,DNA repair,1/565,411/10364,0.9999999999390938,0.9999999999390938,0.6584732470737715,PRRX1,1
